<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25174596</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1827-6806</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>15</Volume>
<Issue>7-8</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Giornale italiano di cardiologia (2006)</Title>
<ISOAbbreviation>G Ital Cardiol (Rome)</ISOAbbreviation>
</Journal>
<ArticleTitle>[Right ventricular dysfunction in advanced heart failure].</ArticleTitle>
<Pagination>
<MedlinePgn>430-40</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1714/1596.17420</ELocationID>
<Abstract>
<AbstractText>The role of the right ventricle has often been underestimated in heart failure. It has been thought that the right cavity has a less prominent impact on symptoms, therapeutic approach, and prognosis. Right ventricular dysfunction is a complex issue and its diagnosis has acquired a relevant role, in particular with the improvement of new therapeutic options such as ventricular assist devices. The complex geometry of the right ventricle and its interaction with the left ventricle are still a matter of debate, leaving several open questions about the best therapeutic approach to manage right ventricular dysfunction. Echocardiography remains the first-line imaging technique, but an integrated multimodality evaluation with clinical, biochemical and hemodynamic parameters, and cardiovascular magnetic resonance imaging can provide a more comprehensive way to choose the most appropriate treatment for patients with heart failure associated with right ventricular dysfunction. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cipriani</LastName>
<ForeName>Manlio</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>De Chiara</LastName>
<ForeName>Benedetta</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ammirati</LastName>
<ForeName>Enrico</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Roghi</LastName>
<ForeName>Alberto</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>D'Angelo</LastName>
<ForeName>Luciana</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Oliva</LastName>
<ForeName>Fabrizio</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Moreo</LastName>
<ForeName>Antonella</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bonacina</LastName>
<ForeName>Edgardo</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Martinelli</LastName>
<ForeName>Luigi</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>La disfunzione ventricolare destra nell'insufficienza cardiaca avanzata.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>G Ital Cardiol (Rome)</MedlineTA>
<NlmUniqueID>101263411</NlmUniqueID>
<ISSNLinking>1827-6806</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006328">Cardiac Catheterization</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004452">Echocardiography</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019317">Evidence-Based Medicine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006333">Heart Failure</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018497">Ventricular Dysfunction, Right</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24971605</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0715</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>14</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery. Pediatrics</Title>
<ISOAbbreviation>J Neurosurg Pediatr</ISOAbbreviation>
</Journal>
<ArticleTitle>Dynamic cervicomedullary cord compression and alterations in cerebrospinal fluid dynamics in children with achondroplasia: review of an 11-year surgical case series.</ArticleTitle>
<Pagination>
<MedlinePgn>238-44</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.5.PEDS12614</ELocationID>
<Abstract>
<AbstractText Label="OBJECT" NlmCategory="OBJECTIVE">Achondroplasia may be associated with compression at the cervicomedullary junction. Determining which patients are at greatest risk for neurological complications of cervicomedullary compression can be difficult. In the current study the authors reviewed their records to determine the incidence and clinical significance of dynamic cervicomedullary stenosis and obstruction of CSF flow along with surgical outcomes following posterior fossa decompression.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The authors reviewed 34 consecutive cases involving symptomatic children with achondroplasia undergoing cervicomedullary decompression performed by a single surgeon over 11 years. Of these patients, 29 had undergone preoperative dynamic MRI of the cervicomedullary junction with cine (cinema) CSF flow studies; 13 of these patients underwent postoperative dynamic MRI studies. Clinical outcomes included changes in polysomnography, head circumference percentile, and fontanel characteristics. Radiographic outcomes included changes in dynamic spinal cord diameter, improvement in CSF flow at the foramen magnum, and change in the Evans ratio.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients were predominantly female, with a mean age at presentation of 6.6 years and mean follow-up of 3.7 years (range 1-10 years). All patients had moderate to excellent improvement in postoperative polysomnography, slight decrease in average head circumference percentile (from 46.9th percentile to 45.7th percentile), and no subjective worsening of fontanel characteristics. The Evans ratio decreased by 2%, spinal cord diameter increased an average of 3.1 mm, 5.2 mm, and 0.2 mm in the neutral, flexed, and extended positions, respectively, and CSF flow improved qualitatively in all 3 positions. There were no postoperative infections, CSF leaks, or other major complications. None of the patients undergoing initial foramen magnum decompression performed at our medical center required reoperation.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients with achondroplasia and symptomatic cervicomedullary compression have increased risk of dynamic stenosis at the foramen magnum evident upon dynamic cine MRI. Operative decompression may be offered with low risk of complications or need for reoperation.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mukherjee</LastName>
<ForeName>Debraj</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Maxine Dunitz Neurosurgical Institute.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pressman</LastName>
<ForeName>Barry D</ForeName>
<Initials>BD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Krakow</LastName>
<ForeName>Deborah</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rimoin</LastName>
<ForeName>David L</ForeName>
<Initials>DL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Danielpour</LastName>
<ForeName>Moise</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg Pediatr</MedlineTA>
<NlmUniqueID>101463759</NlmUniqueID>
<ISSNLinking>1933-0707</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000130">Achondroplasia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002508">Cephalometry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D002555">Cerebrospinal Fluid</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002574">Cervical Vertebrae</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003251">Constriction, Pathologic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055762">Cranial Fontanelles</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019299">Decompression, Surgical</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005539">Foramen Magnum</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D057446">Hydrodynamics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008526">Medulla Oblongata</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017286">Polysomnography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013117">Spinal Cord Compression</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">CMJ = cervicomedullary junction</Keyword>
<Keyword MajorTopicYN="N">VP = ventriculoperitoneal</Keyword>
<Keyword MajorTopicYN="N">achondroplasia</Keyword>
<Keyword MajorTopicYN="N">cerebrospinal fluid dynamics</Keyword>
<Keyword MajorTopicYN="N">cervicomedullary junction</Keyword>
<Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword>
<Keyword MajorTopicYN="N">spine</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24971607</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0715</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>14</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery. Pediatrics</Title>
<ISOAbbreviation>J Neurosurg Pediatr</ISOAbbreviation>
</Journal>
<ArticleTitle>Asymptomatic lipomas of the medullary conus: surgical treatment versus conservative management.</ArticleTitle>
<Pagination>
<MedlinePgn>245-54</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.5.PEDS13399</ELocationID>
<Abstract>
<AbstractText Label="OBJECT" NlmCategory="OBJECTIVE">The goal of this study was to compare long-term results of surgery with the outcomes of conservative treatment in patients with asymptomatic lipomas of the conus medullaris.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The parents of 56 consecutive children with a diagnosis of asymptomatic lipoma of the conus medullaris underwent detailed neurosurgical consultation. The pros and cons of both prophylactic surgery and conservative treatment were carefully presented. Both options were offered, and the parents were free to choose the preferred management. A total of 32 children underwent surgical treatment, and 24 were conservatively treated. Afterward, all patients entered the same protocol of serial neurological and urological follow-up at the Centro Spina Bifida. The mean follow-up periods were 9.7 years in the surgical treatment group and 10.4 years in the conservative treatment group.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Permanent surgical morbidity was 3.1% (1 patient). During follow-up, tethered cord syndrome occurred in 9.7% of the surgically treated patients (3 of 32 patients) and in 29.1% of the conservatively managed children (7 of 24 patients). This difference did not result in statistical significance, but a clear trend in favor of surgery emerged. Young age at surgery and a cord/sac ratio &lt; 50% appeared to be determining factors in the prevention of subsequent tethered cord syndrome.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The small size of this series does not provide enough statistical evidence that surgical treatment can really improve the natural history of asymptomatic lipomas of the conus medullaris. Nevertheless, surgery appears at least advisable since it reduces by 75% the odds of TCS (p = 0.067), which is quite close to statistical significance.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Talamonti</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>D'Aliberti</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nichelatti</LastName>
<ForeName>Michele</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Debernardi</LastName>
<ForeName>Alberto</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Picano</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Redaelli</LastName>
<ForeName>Tiziana</ForeName>
<Initials>T</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg Pediatr</MedlineTA>
<NlmUniqueID>101463759</NlmUniqueID>
<ISSNLinking>1933-0707</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000367">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000553">Ambulatory Care</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002985">Clinical Protocols</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020233">Gait Disorders, Neurologic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D007558">Italy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053208">Kaplan-Meier Estimate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008067">Lipoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059352">Musculoskeletal Pain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009436">Neural Tube Defects</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059906">Neuroimaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019635">Neurosurgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011322">Primary Prevention</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012017">Referral and Consultation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018401">Sample Size</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012585">Sciatica</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013116">Spinal Cord</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013120">Spinal Cord Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014563">Urodynamics</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">LCM = lipoma of the conus medullaris</Keyword>
<Keyword MajorTopicYN="N">TCS = tethered cord syndrome</Keyword>
<Keyword MajorTopicYN="N">conus medullaris</Keyword>
<Keyword MajorTopicYN="N">lipoma</Keyword>
<Keyword MajorTopicYN="N">natural history</Keyword>
<Keyword MajorTopicYN="N">pediatric neurosurgery</Keyword>
<Keyword MajorTopicYN="N">spinal dysraphism</Keyword>
<Keyword MajorTopicYN="N">spine</Keyword>
<Keyword MajorTopicYN="N">tethered cord syndrome</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24995816</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0715</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>14</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery. Pediatrics</Title>
<ISOAbbreviation>J Neurosurg Pediatr</ISOAbbreviation>
</Journal>
<ArticleTitle>Prenatal and postnatal evaluation for syringomyelia in patients with spinal dysraphism.</ArticleTitle>
<Pagination>
<MedlinePgn>316-21</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.5.PEDS13482</ELocationID>
<Abstract>
<AbstractText Label="OBJECT" NlmCategory="OBJECTIVE">Syringomyelia can be diagnosed in isolation but is more commonly found in the presence of craniocervical junction anomalies or spinal dysraphism. The origin of syringomyelia has been hypothesized to be either congenital or acquired. The purpose of this study was to determine the incidence of syringomyelia within the fetal and postnatal population with neural tube defects (NTDs).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A review was performed of the authors' fetal MRI database of pregnancies with imaging between March 2004 and November 2011 for evaluation of an intrauterine anomaly detected via prenatal ultrasonography. Those cases with an NTD were then selected and a chart review was performed of all prenatal and postnatal imaging as well as available clinical history.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 2362 fetal MRI examinations were performed, and 109 of these were patients with an NTD. Of the 2362 studies reviewed, 2 cases of fetal syringomyelia were identified. Both fetal syrinxes were identified in fetuses with CSF flow disturbances (1 case each of encephalocele and myelomeningocele). Both fetal MRI examinations were performed late in gestation, at 31 and 38 weeks, respectively. The patient with an encephalocele was excluded from the spinal NTD population; therefore a syrinx was identified in 0.08% (2/2362) of the entire population of fetuses who underwent MRI, or 0.9% (1/109) of fetuses with a spinal NTD. Sixty-three of the 109 patients with an NTD had postnatal clinical data available for review. Twenty-nine (46%) of 63 had a syrinx identified during the follow-up period. Of this group, 50 patients had an open NTD and 27 (54%) of 50 developed a syrinx. Among the patients with an open NTD who developed a syrinx, only 7% did not have or develop hydrocephalus, compared with 35% of the patients who did not develop a syrinx (p &lt; 0.05). There were nonsignificantly more frequent shunt revisions among those patients who developed a syrinx, and a syrinx developed in all patients who required surgical Chiari malformation decompression or tethered cord release. The initial identification of a spinal cord syrinx varied greatly between patients, ranging from 38 weeks gestation to greater than 4 years of age.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These data suggest that syringomyelia is not a congenital embryonic condition. A syrinx was not identified in fetuses who underwent imaging for other intrauterine anomalies. In the population of patients with NTDs who are known to be at high risk for developing syringomyelia, the pathology was only identified in 2 third-trimester fetuses or postnatally, typically in the presence of hydrocephalus, shunt placement, Chiari malformation decompression, or tethered cord release. The study supports the authors' hypothesis that a syrinx is an acquired lesion, most likely due to the effects of abnormal CSF flow.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bixenmann</LastName>
<ForeName>Ben J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, University of Cincinnati Medical Center;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kline-Fath</LastName>
<ForeName>Beth M</ForeName>
<Initials>BM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bierbrauer</LastName>
<ForeName>Karin S</ForeName>
<Initials>KS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bansal</LastName>
<ForeName>Danesh</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg Pediatr</MedlineTA>
<NlmUniqueID>101463759</NlmUniqueID>
<ISSNLinking>1933-0707</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016208">Databases, Factual</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015994">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008499">Medical Records</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009436">Neural Tube Defects</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000736">ultrasonography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059906">Neuroimaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D009820">Ohio</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011263">Pregnancy Trimester, Third</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016135">Spinal Dysraphism</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013595">Syringomyelia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000736">ultrasonography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016216">Ultrasonography, Prenatal</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">CCHMC = Cincinnati Children's Hospital Medical Center</Keyword>
<Keyword MajorTopicYN="N">FIESTA = fast imaging employing steady-state acquisition</Keyword>
<Keyword MajorTopicYN="N">NTD = neural tube defect</Keyword>
<Keyword MajorTopicYN="N">congenital</Keyword>
<Keyword MajorTopicYN="N">fetal MRI</Keyword>
<Keyword MajorTopicYN="N">fetal syringomyelia</Keyword>
<Keyword MajorTopicYN="N">spinal cord syrinx</Keyword>
<Keyword MajorTopicYN="N">spinal dysraphism</Keyword>
<Keyword MajorTopicYN="N">syringomyelia</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24995819</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0715</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>14</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery. Pediatrics</Title>
<ISOAbbreviation>J Neurosurg Pediatr</ISOAbbreviation>
</Journal>
<ArticleTitle>Primary medulla oblongata teratomas.</ArticleTitle>
<Pagination>
<MedlinePgn>296-300</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.6.PEDS1423</ELocationID>
<Abstract>
<AbstractText>Medulla oblongata teratomas are rare. The authors report 2 new cases of teratomas that occurred exclusively in the medulla oblongata. The first case was in a 9-year-old boy who presented with a 6-month history of neck pain and repeated paroxysmal vomiting. Based on preoperative radiographic findings, the initial diagnosis was of an intraaxial medulla oblongata hemangioblastoma. Intraoperatively, the cystic component of the tumor was gray, gelatinous, and soft in consistency. The solid component was light pink, rubbery, and nodular in appearance, with an identifiable boundary. The lesion was completely removed. Histopathological investigation revealed a mature teratoma. Postoperatively, the patient was supported with ventilator assistance and received a tracheotomy, but died of intracranial infection. The second case was in a 10-year-old boy with intermittent headache for 1 month. Radiographs revealed an exophytic cystic and solid lesion with dorsal involvement of the medulla oblongata. The lesion was predominantly solid, pinkish gray, tenacious, and moderately vascularized, with clearly delineated surgical dissection planes. The histopathological examination confirmed a diagnosis of immature teratoma. Total resection was achieved, followed by postoperative chemotherapy. He was alive without recurrence of the lesion or symptoms at 59 months after surgery. Resection of medulla oblongata teratoma is challenging, with inherent surgical risks that are contingent on the tumor growth pattern. Teratomas should be considered in the differential diagnosis of brainstem lesions. Chemotherapy has been suggested for immature teratomas. Long-term follow-up and larger studies of teratomas in unusual locations are required to improve practitioners' understanding of this disease's treatment and outcomes. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Da</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hao</LastName>
<ForeName>Shu-Yu</ForeName>
<Initials>SY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Zhen</ForeName>
<Initials>Z</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Li-Wei</ForeName>
<Initials>LW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Jun-Ting</ForeName>
<Initials>JT</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg Pediatr</MedlineTA>
<NlmUniqueID>101463759</NlmUniqueID>
<ISSNLinking>1933-0707</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D020295">Brain Stem Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006261">Headache</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008526">Medulla Oblongata</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019547">Neck Pain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013724">Teratoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014717">Vertigo</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014839">Vomiting</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">GCT = germ cell tumor</Keyword>
<Keyword MajorTopicYN="N">MRSA = methicillin-resistant Staphylococcus aureus</Keyword>
<Keyword MajorTopicYN="N">brainstem</Keyword>
<Keyword MajorTopicYN="N">germ cell tumor</Keyword>
<Keyword MajorTopicYN="N">medulla oblongata</Keyword>
<Keyword MajorTopicYN="N">oncology</Keyword>
<Keyword MajorTopicYN="N">teratoma</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25014323</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0715</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>14</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery. Pediatrics</Title>
<ISOAbbreviation>J Neurosurg Pediatr</ISOAbbreviation>
</Journal>
<ArticleTitle>Magnetoencephalography helps delineate the extent of the epileptogenic zone for surgical planning in children with intractable epilepsy due to porencephalic cyst/encephalomalacia.</ArticleTitle>
<Pagination>
<MedlinePgn>271-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.6.PEDS13415</ELocationID>
<Abstract>
<AbstractText Label="OBJECT" NlmCategory="OBJECTIVE">Porencephalic cyst/encephalomalacia (PC/E) is a brain lesion caused by ischemic insult or hemorrhage. The authors evaluated magnetoencephalography (MEG) spike sources (MEGSS) to localize the epileptogenic zone in children with intractable epilepsy secondary to PC/E.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The authors retrospectively studied 13 children with intractable epilepsy secondary to PC/E (5 girls and 8 boys, age range 1.8-15 years), who underwent prolonged scalp video-electroencephalography (EEG), MRI, and MEG. Interictal MEGSS locations were compared with the ictal and interictal zones as determined from scalp video-EEG.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Magnetic resonance imaging showed PC/E in extratemporal lobes in 3 patients, within the temporal lobe in 2 patients, and in both temporal and extratemporal lobes in 8 patients. Magnetoencephalographic spike sources were asymmetrically clustered at the margin of PC/E in all 13 patients. One cluster of MEGSS was observed in 11 patients, 2 clusters in 1 patient, and 3 clusters in 1 patient. Ictal EEG discharges were lateralized and concordant with MEGSS in 8 patients (62%). Interictal EEG discharges were lateralized and concordant with MEGSS hemisphere in 9 patients (69%). Seven patients underwent lesionectomy in addition to MEGSS clusterectomy with (2 patients) and without (5 patients) intracranial video-EEG. Temporal lobectomy was performed in 1 patient and hemispherectomy in another. Eight of 9 patients achieved seizure freedom following surgery.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Magnetoencephalography delineated the extent of the epileptogenic zone adjacent to PC/E in patients with intractable epilepsy. Complete resection of the MEGSS cluster along with PC/E can provide favorable seizure outcomes.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bennett-Back</LastName>
<ForeName>Odeya</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ochi</LastName>
<ForeName>Ayako</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Widjaja</LastName>
<ForeName>Elysa</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nambu</LastName>
<ForeName>Shohei</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kamiya</LastName>
<ForeName>Akio</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Go</LastName>
<ForeName>Cristina</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chuang</LastName>
<ForeName>Sylvester</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rutka</LastName>
<ForeName>James T</ForeName>
<Initials>JT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Drake</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Snead</LastName>
<ForeName>O Carter</ForeName>
<Initials>OC</Initials>
<Suffix>3rd</Suffix>
</Author>
<Author ValidYN="Y">
<LastName>Otsubo</LastName>
<ForeName>Hiroshi</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg Pediatr</MedlineTA>
<NlmUniqueID>101463759</NlmUniqueID>
<ISSNLinking>1933-0707</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004569">Electroencephalography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004678">Encephalomalacia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004827">Epilepsy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D038421">Hemispherectomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015225">Magnetoencephalography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014741">Video Recording</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ECoG = electrocorticography</Keyword>
<Keyword MajorTopicYN="N">EEG = electroencephalography</Keyword>
<Keyword MajorTopicYN="N">MEG = magnetoencephalography</Keyword>
<Keyword MajorTopicYN="N">MEGSS = MEG spike sources</Keyword>
<Keyword MajorTopicYN="N">PC/E = porencephalic cyst/encephalomalacia</Keyword>
<Keyword MajorTopicYN="N">encephalomalacia</Keyword>
<Keyword MajorTopicYN="N">epilepsy</Keyword>
<Keyword MajorTopicYN="N">epileptogenic zone</Keyword>
<Keyword MajorTopicYN="N">magnetoencephalography</Keyword>
<Keyword MajorTopicYN="N">porencephalic cyst</Keyword>
<Keyword MajorTopicYN="N">surgical planning</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25014324</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0715</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>14</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery. Pediatrics</Title>
<ISOAbbreviation>J Neurosurg Pediatr</ISOAbbreviation>
</Journal>
<ArticleTitle>High-dose methotrexate monotherapy followed by radiation for CD30-positive, anaplastic lymphoma kinase-1-positive anaplastic large-cell lymphoma in the brain of a child.</ArticleTitle>
<Pagination>
<MedlinePgn>311-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.6.PEDS1492</ELocationID>
<Abstract>
<AbstractText>The authors report the case of an 11-year-old immunocompetent boy with primary CNS CD30-positive anaplastic large-cell lymphoma (ALCL) that was also positive for anaplastic lymphoma kinase-1. His initial clinical manifestation was acute meningitis of unknown etiology. Findings on CT scanning were normal. Although he received empirical treatment against infection, his systemic and neurological status deteriorated. Subsequent MRI revealed newly emerged enhanced lesions and concomitant edema in the left parietal lobe. Diagnosis was confirmed following a brain biopsy and immunohistochemical staining. Three courses of systemic high-dose methotrexate (HD-MTX) treatment with 2-week intervals was started, followed by whole-brain radiation. His clinical course improved, and he has remained disease-free for more than 8 years without any additional treatment. Because ALCL originating in the brain is extremely rare and difficult to diagnose, no standard treatment has been established. This report suggests that systemic HD-MTX monotherapy can be an effective and worthwhile tailored therapeutic option for pediatric primary CNS ALCL. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Furuya</LastName>
<ForeName>Kazuhide</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Departments of Neurosurgery and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Takanashi</LastName>
<ForeName>Shigehiko</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ogawa</LastName>
<ForeName>Akiko</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Takahashi</LastName>
<ForeName>Yoshihisa</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nakagomi</LastName>
<ForeName>Tadayoshi</ForeName>
<Initials>T</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg Pediatr</MedlineTA>
<NlmUniqueID>101463759</NlmUniqueID>
<ISSNLinking>1933-0707</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017730">Antigens, CD30</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000964">Antimetabolites, Antineoplastic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.10.1</RegistryNumber>
<NameOfSubstance UI="D020794">Receptor Protein-Tyrosine Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.10.1</RegistryNumber>
<NameOfSubstance UI="C086119">anaplastic lymphoma kinase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>YL5FZ2Y5U1</RegistryNumber>
<NameOfSubstance UI="D008727">Methotrexate</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017730">Antigens, CD30</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000964">Antimetabolites, Antineoplastic</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001706">Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000532">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017024">Chemotherapy, Adjuvant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016371">Cranial Irradiation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019299">Decompression, Surgical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018572">Disease-Free Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004334">Drug Administration Schedule</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007150">Immunohistochemistry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019586">Intracranial Hypertension</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017728">Lymphoma, Large-Cell, Anaplastic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000532">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008727">Methotrexate</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018714">Radiotherapy, Adjuvant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020794">Receptor Protein-Tyrosine Kinases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ALCL = anaplastic large-cell lymphoma</Keyword>
<Keyword MajorTopicYN="N">ALK-1 = anaplastic lymphoma kinase-1</Keyword>
<Keyword MajorTopicYN="N">CD30</Keyword>
<Keyword MajorTopicYN="N">HD-MTX = high-dose methotrexate</Keyword>
<Keyword MajorTopicYN="N">PCNSL = primary CNS lymphoma</Keyword>
<Keyword MajorTopicYN="N">anaplastic large-cell lymphoma</Keyword>
<Keyword MajorTopicYN="N">anaplastic lymphoma kinase-1</Keyword>
<Keyword MajorTopicYN="N">central nervous system</Keyword>
<Keyword MajorTopicYN="N">methotrexate</Keyword>
<Keyword MajorTopicYN="N">oncology</Keyword>
<Keyword MajorTopicYN="N">treatment</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24905389</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1547-5646</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>21</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery. Spine</Title>
<ISOAbbreviation>J Neurosurg Spine</ISOAbbreviation>
</Journal>
<ArticleTitle>Iatrogenic cerebrospinal fluid leak and intracranial hypotension after gynecological surgery.</ArticleTitle>
<Pagination>
<MedlinePgn>450-3</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.5.SPINE13746</ELocationID>
<Abstract>
<AbstractText>Perineural cysts are common lesions of the sacral spine. They have rarely been reported in a presacral location, leading to their misdiagnosis as a gynecological lesion. The authors report the second such case, in a patient undergoing fenestration of what was presumed to be a benign pelvic cyst, and the resultant high-flow CSF leak that occurred. They describe the clinical presentation and manifestations of intracranial hypotension, as well as the pertinent investigations. They also review the literature for the best management options for this condition. Although they are uncommon, large perineural cysts should be included in the differential diagnosis when examining patients with a pelvic lesion. Appropriate imaging investigations should be performed to rule out a perineural cyst. The CSF leak that occurs from iatrogenic cyst fenestration may not respond to traditional first-line treatments for intracranial hypotension and may require early surgical intervention. The authors would recommend neurosurgical involvement prior to definitive treatment. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tu</LastName>
<ForeName>Albert</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurosurgery, University of British Columbia, Vancouver; and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Creedon</LastName>
<ForeName>Kerry</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sahjpaul</LastName>
<ForeName>Ramesh</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg Spine</MedlineTA>
<NlmUniqueID>101223545</NlmUniqueID>
<ISSNLinking>1547-5646</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D065634">Cerebrospinal Fluid Leak</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002559">Cerebrospinal Fluid Rhinorrhea</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013509">Gynecologic Surgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051271">Headache Disorders, Secondary</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007049">Iatrogenic Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019585">Intracranial Hypotension</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012447">Sacrum</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013524">Surgical Flaps</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D052958">Tarlov Cysts</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">complication</Keyword>
<Keyword MajorTopicYN="N">iatrogenic injury</Keyword>
<Keyword MajorTopicYN="N">intracranial hypotension</Keyword>
<Keyword MajorTopicYN="N">review</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24905393</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>28</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1547-5646</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>21</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery. Spine</Title>
<ISOAbbreviation>J Neurosurg Spine</ISOAbbreviation>
</Journal>
<ArticleTitle>Subacute posttraumatic ascending myelopathy in a 15-year-old boy.</ArticleTitle>
<Pagination>
<MedlinePgn>454-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.5.SPINE13754</ELocationID>
<Abstract>
<AbstractText>Secondary injury following initial spinal cord trauma is uncommon and frequently attributed to mismanagement of an unprotected cord in the acute time period after injury. Subacute posttraumatic ascending myelopathy (SPAM) is a rare occurrence in the days to weeks following an initial spinal cord injury that is unrelated to manipulation of an unprotected cord and involves 4 or more vertebral levels above the original injury. The authors present a case of SPAM occurring in a 15-year-old boy who sustained a T3-4 fracture-dislocation resulting in a complete spinal cord injury, and they highlight the imaging findings and optimum treatment for this rare event. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kovanda</LastName>
<ForeName>Timothy J</ForeName>
<Initials>TJ</Initials>
<AffiliationInfo>
<Affiliation>Goodman Campbell Brain and Spine, Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Horn</LastName>
<ForeName>Eric M</ForeName>
<Initials>EM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg Spine</MedlineTA>
<NlmUniqueID>101223545</NlmUniqueID>
<ISSNLinking>1547-5646</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001642">Bicycling</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000293">injuries</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005593">Fracture Fixation, Internal</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016268">Internal Fixators</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007796">Laminectomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013118">Spinal Cord Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016103">Spinal Fractures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013123">Spinal Fusion</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013904">Thoracic Vertebrae</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000293">injuries</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">SPAM = subacute posttraumatic ascending myelopathy</Keyword>
<Keyword MajorTopicYN="N">secondary spinal cord injury</Keyword>
<Keyword MajorTopicYN="N">subacute posttraumatic ascending myelopathy</Keyword>
<Keyword MajorTopicYN="N">trauma</Keyword>
<Keyword MajorTopicYN="N">traumatic spinal cord injury</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24905395</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>28</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1547-5646</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>21</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery. Spine</Title>
<ISOAbbreviation>J Neurosurg Spine</ISOAbbreviation>
</Journal>
<ArticleTitle>Tumor extravasation following a cement augmentation procedure for vertebral compression fracture in metastatic spinal disease.</ArticleTitle>
<Pagination>
<MedlinePgn>372-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.4.SPINE13695</ELocationID>
<Abstract>
<AbstractText>Balloon kyphoplasty (BKP) has been proven to be safe and effective in the management of pathological vertebral compression fracture (VCF) due to metastatic spinal disease. The most common serious complications related to BKP include cement extravasation and new fractures at adjacent levels. Although the potential for "tumor extravasation" has been discussed as a potential iatrogenic complication, it has yet to be confirmed. The authors report on 2 cases of tumor extravasation following BKP, which they base on an observed unusual rapid tumor spread pattern into the adjacent tissues. They postulate that by increasing the vertebral body internal pressure and disrupting the tissues during balloon inflation and cement application, a soft-tissue tumor can be forced beyond the vertebral bony boundaries through pathological cortical defects. This phenomenon can manifest radiologically as subligamentous spread and/or extension into venous sinusoids, resulting in epidural venous plexus involvement, with subsequent tumor migration into the adjacent vertebral segments. Accordingly, the authors advise caution in using BKP when significant epidural tumor is present. The complication they encountered has caused them to modify their preference such that they now first use radiosurgery and subsequently BKP to ensure the target is appropriately treated, and they are currently developing possible modifications of procedural technique to reduce the risk. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cruz</LastName>
<ForeName>Juan Pablo</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Imaging, Toronto Western Hospital, University of Toronto;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sahgal</LastName>
<ForeName>Arjun</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Whyne</LastName>
<ForeName>Cari</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fehlings</LastName>
<ForeName>Michael G</ForeName>
<Initials>MG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Roger</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg Spine</MedlineTA>
<NlmUniqueID>101223545</NlmUniqueID>
<ISSNLinking>1547-5646</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001843">Bone Cements</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001843">Bone Cements</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017809">Fatal Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050815">Fractures, Compression</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058498">Kyphoplasty</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009361">Neoplasm Invasiveness</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016103">Spinal Fractures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013125">Spinal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000556">secondary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013904">Thoracic Vertebrae</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">BKP = balloon kyphoplasty</Keyword>
<Keyword MajorTopicYN="N">SRS = stereotactic radiosurgery</Keyword>
<Keyword MajorTopicYN="N">VCF = vertebral compression fracture</Keyword>
<Keyword MajorTopicYN="N">balloon kyphoplasty</Keyword>
<Keyword MajorTopicYN="N">metastatic disease</Keyword>
<Keyword MajorTopicYN="N">oncology</Keyword>
<Keyword MajorTopicYN="N">pathological vertebral compression fracture</Keyword>
<Keyword MajorTopicYN="N">tumor extravasation</Keyword>
<Keyword MajorTopicYN="N">tumor spread</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24926936</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>28</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1547-5646</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>21</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery. Spine</Title>
<ISOAbbreviation>J Neurosurg Spine</ISOAbbreviation>
</Journal>
<ArticleTitle>Isolated central canal rupture of spinal dermoid. Report of 3 cases.</ArticleTitle>
<Pagination>
<MedlinePgn>361-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.5.SPINE13900</ELocationID>
<Abstract>
<AbstractText>Spinal dermoid tumors are rare, benign, slow-growing tumors. Rupture of spinal dermoids, in contrast to cranial dermoids, is rarely reported. Rupture in the central canal alone is even more rare, with only a few cases reported in the literature. The presence of fat droplets within the central canal is unusual because the central canal is rudimentary in adults. The authors report 3 such cases and review the pertinent literature. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Garg</LastName>
<ForeName>Kanwaljeet</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Rajinder</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg Spine</MedlineTA>
<NlmUniqueID>101223545</NlmUniqueID>
<ISSNLinking>1547-5646</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003884">Dermoid Cyst</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007796">Laminectomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012422">Rupture, Spontaneous</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013120">Spinal Cord Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">MRC = Medical Research Council</Keyword>
<Keyword MajorTopicYN="N">congenital</Keyword>
<Keyword MajorTopicYN="N">dermoid cyst</Keyword>
<Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword>
<Keyword MajorTopicYN="N">rupture</Keyword>
<Keyword MajorTopicYN="N">spinal neoplasm</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24655099</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0693</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>121</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery</Title>
<ISOAbbreviation>J. Neurosurg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Simultaneous subependymomas in monozygotic female twins: further evidence for a common genetic or developmental disorder background.</ArticleTitle>
<Pagination>
<MedlinePgn>570-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.2.JNS122179</ELocationID>
<Abstract>
<AbstractText>In this paper, a rare case of subependymoma of the fourth ventricle in identical female twins is reported. Magnetic resonance imaging and CT showed nearly identical locations of the tumors in the fourth ventricle and similar growth patterns of the tumors in both sisters. Likewise, postoperative histopathological analysis of both tumors revealed the typical histological appearance of subependymomas. Subependymoma is a rare, low-grade glioma of the CNS, slowly growing and usually asymptomatic. If symptomatic, a subependymoma can in some cases lead to sudden death caused by pressure on the brainstem or decompensated secondary hydrocephalus. This case demonstrates the importance of detecting tumors early and thereby preventing symptoms arising from increasing intracranial pressure, and optimizing therapy options. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Noell</LastName>
<ForeName>Susan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Departments of Neurosurgery.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Beschorner</LastName>
<ForeName>Rudi</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bisdas</LastName>
<ForeName>Sotirios</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Beyer</LastName>
<ForeName>Ulrike</ForeName>
<Initials>U</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Weber</LastName>
<ForeName>Ruthild G</ForeName>
<Initials>RG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fallier-Becker</LastName>
<ForeName>Petra</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ritz</LastName>
<ForeName>Rainer</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>03</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg</MedlineTA>
<NlmUniqueID>0253357</NlmUniqueID>
<ISSNLinking>0022-3085</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002551">Cerebral Ventricle Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056915">DNA Copy Number Variations</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004200">Diseases in Twins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020546">Fourth Ventricle</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018315">Glioma, Subependymal</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D014430">Twins, Monozygotic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">GFAP = glial fibrillary acidic protein</Keyword>
<Keyword MajorTopicYN="N">SNP = single nucleotide polymorphism</Keyword>
<Keyword MajorTopicYN="N">familial tumor</Keyword>
<Keyword MajorTopicYN="N">fourth ventricle</Keyword>
<Keyword MajorTopicYN="N">genetics</Keyword>
<Keyword MajorTopicYN="N">monozygotic twins</Keyword>
<Keyword MajorTopicYN="N">oncology</Keyword>
<Keyword MajorTopicYN="N">subependymoma</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24766104</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0693</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>121</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery</Title>
<ISOAbbreviation>J. Neurosurg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Peripheral nerve fibromyxoid sarcoma.</ArticleTitle>
<Pagination>
<MedlinePgn>576-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.3.JNS13838</ELocationID>
<Abstract>
<AbstractText>Low-grade fibromyxoid sarcoma (LGFMS) is a rare soft-tissue neoplasm with metastatic potential and needs to be recognized as such, because it can be mistaken for other types of sarcoma due to its unremarkable appearance. This 49-year-old man presented with an approximately 5-cm mass on the anteromedial aspect of his left thigh that slowly increased over 10 years. Clinical symptoms were limited to local discomfort and intermittent distal numbness. Due to the location, imaging findings, and lack of serious symptoms, the initial differential diagnosis favored a schwannoma. An initial biopsy revealed histopathological findings consistent with a perineurioma, although with atypical features. The patient elected to have the mass excised, and the tumor, which arose from a branch of the saphenous nerve, could be separated well from the surrounding soft tissue. Histopathological investigation of the mass displayed characteristic features of a fibromyxoid sarcoma, which was confirmed by subsequent fluorescence in situ hybridization analysis. Due to concerns about infiltration beyond the margins, radical reexcision was advocated and performed, resulting in definite clear surgical margins. At follow-up, the patient had regained full strength with no residual neurological symptoms or any new deficits. He has since been healthy and disease free for a total of 4 years in follow-up. This case documents, to the authors' knowledge, the first observation of an LGFMS associated with a peripheral nerve. It also supports the use of fluorescence in situ hybridization analysis as an essential diagnostic method in establishing the diagnosis of LGFMS. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Alter</LastName>
<ForeName>Raanan Y</ForeName>
<Initials>RY</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurosurgery and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wamsley</LastName>
<ForeName>Christina C</ForeName>
<Initials>CC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mullen</LastName>
<ForeName>John T</ForeName>
<Initials>JT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Haile</LastName>
<ForeName>Winta Z</ForeName>
<Initials>WZ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Goldsmith</LastName>
<ForeName>Jeffrey D</ForeName>
<Initials>JD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kasper</LastName>
<ForeName>Ekkehard M</ForeName>
<Initials>EM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>04</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg</MedlineTA>
<NlmUniqueID>0253357</NlmUniqueID>
<ISSNLinking>0022-3085</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005350">Fibroma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010524">Peripheral Nervous System Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012509">Sarcoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012983">Soft Tissue Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013848">Thigh</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">EMA = epithelial membrane antigen</Keyword>
<Keyword MajorTopicYN="N">FISH = fluorescence in situ hybridization</Keyword>
<Keyword MajorTopicYN="N">LGFMS = low-grade fibromyxoid sarcoma</Keyword>
<Keyword MajorTopicYN="N">fibromyxoid sarcoma</Keyword>
<Keyword MajorTopicYN="N">fluorescence in situ hybridization</Keyword>
<Keyword MajorTopicYN="N">oncology</Keyword>
<Keyword MajorTopicYN="N">peripheral nerve tumor</Keyword>
<Keyword MajorTopicYN="N">prognosis</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24857241</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0693</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>121</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery</Title>
<ISOAbbreviation>J. Neurosurg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of primary empty sella syndrome on pituitary surgery for Cushing's disease.</ArticleTitle>
<Pagination>
<MedlinePgn>518-26</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.3.JNS132012</ELocationID>
<Abstract>
<AbstractText Label="OBJECT" NlmCategory="OBJECTIVE">Primary empty sella syndrome (ESS) results from herniation of arachnoid mater into the pituitary fossa. It has been suggested to have a negative effect on pituitary surgery; however, outcomes in this cohort have not been defined. This study was performed to determine the effect of ESS on immediate and long-term biochemical outcome after pituitary surgery for Cushing's disease (CD).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Using a matched cohort study design, the authors followed patients treated with pituitary surgery for CD with and without ESS. Complete ESS was defined as pituitary gland height  2 mm, whereas partial ESS was defined as pituitary gland height &gt; 2 mm but less than three-quarters of the total sellar depth. The primary end points were immediate and long-term biochemical outcome. Cerebrospinal fluid leaks were recorded as a secondary end point.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventy-eight patients with CD and primary ESS were identified and matched with 78 patients with CD without ESS. After surgical management, immediate biochemical remission was achieved in 69 patients (88%) with ESS and 75 controls (96%, p = 0.10). Long-term remission was achieved in most patients in both groups (5-year cure: 85% vs 92%, p = 0.10). Among patients with ESS, the presence of complete ESS predicted a worse long-term outcome (p = 0.04). Intraoperative CSF leaks were significantly more frequent with ESS (54% vs 24%, p &lt; 0.001), and despite sellar floor repair, the rate of postoperative CSF leaks was also increased (6% vs 3%, p = 0.27).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Biochemical outcome after pituitary surgery for CD was worse in patients with complete ESS, and the risk of a CSF leak was increased with both partial and complete ESS. However, as outcome remains superior to those following alternative therapies and the biology of these tumors is unchanged in the setting of ESS, pituitary surgery should remain the initial treatment of choice.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mehta</LastName>
<ForeName>Gautam U</ForeName>
<Initials>GU</Initials>
<AffiliationInfo>
<Affiliation>Surgical Neurology Branch, National Institutes of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bakhtian</LastName>
<ForeName>Kamran D</ForeName>
<Initials>KD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Oldfield</LastName>
<ForeName>Edward H</ForeName>
<Initials>EH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg</MedlineTA>
<NlmUniqueID>0253357</NlmUniqueID>
<ISSNLinking>0022-3085</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>WI4X0X7BPJ</RegistryNumber>
<NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016022">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D065634">Cerebrospinal Fluid Leak</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002559">Cerebrospinal Fluid Rhinorrhea</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015897">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004652">Empty Sella Syndrome</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006854">Hydrocortisone</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015994">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047748">Pituitary ACTH Hypersecretion</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010902">Pituitary Gland</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ACTH = adrenocorticotropin</Keyword>
<Keyword MajorTopicYN="N">BMI = body mass index</Keyword>
<Keyword MajorTopicYN="N">CD = Cushing's disease</Keyword>
<Keyword MajorTopicYN="N">CRH = corticotropin-releasing hormone</Keyword>
<Keyword MajorTopicYN="N">Cushing's disease</Keyword>
<Keyword MajorTopicYN="N">DI = diabetes insipidus</Keyword>
<Keyword MajorTopicYN="N">ESS = empty sella syndrome</Keyword>
<Keyword MajorTopicYN="N">GH = growth hormone</Keyword>
<Keyword MajorTopicYN="N">SIADH = syndrome of inappropriate antidiuretic hormone</Keyword>
<Keyword MajorTopicYN="N">UFC = urinary free cortisol</Keyword>
<Keyword MajorTopicYN="N">empty sella syndrome</Keyword>
<Keyword MajorTopicYN="N">pituitary adenoma</Keyword>
<Keyword MajorTopicYN="N">pituitary surgery</Keyword>
<Keyword MajorTopicYN="N">transsphenoidal surgery</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24878286</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0693</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>121</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery</Title>
<ISOAbbreviation>J. Neurosurg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Volumetric response to radiosurgery for brain metastasis varies by cell of origin.</ArticleTitle>
<Pagination>
<MedlinePgn>564-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.4.JNS131502</ELocationID>
<Abstract>
<AbstractText Label="OBJECT" NlmCategory="OBJECTIVE">The aim of this study was to evaluate the imaging response of brain metastases after radiosurgery and to correlate the response with tumor type and patient survival.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The authors conducted a retrospective review of patients who had undergone Gamma Knife radiosurgery for brain metastases from non-small cell lung cancer (NSCLC), breast cancer, or melanoma. The imaging volumetric response by tumor type was plotted at 3-month intervals and classified as a sustained decrease in tumor volume (Type A), a transient decrease followed by a delayed increase in tumor volume (Type B), or a sustained increase in tumor volume (Type C). These imaging responses were then compared with patient survival and tumor type.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Two hundred thirty-three patients with metastases from NSCLC (96 patients), breast cancer (98 patients), and melanoma (39 patients) were eligible for inclusion in this study. The patients with NSCLC were most likely to exhibit a Type A response; those with breast cancer, a Type B response; and those with melanoma, a Type C response. Among patients with NSCLC, the median overall survival was 11.2 months for those with a Type A response (76 patients), 8.6 months for those with a Type B response (6 patients), and 10.5 months for those with a Type C response (14 patients). Among patients with breast cancer, the median overall survival was 16.6 months in those with a Type A response (65 patients), 18.1 months in those with a Type B response (20 patients), and 7.5 months in those with a Type C response (13 patients). For patients with melanoma, the median overall survival was 5.2 months in those with a Type A response (26 patients) and 6.7 months in those with a Type C response (13 patients). None of the patients with melanoma had a Type B response. The imaging response was significantly associated with survival only in patients with breast cancer.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The various types of imaging responses of metastatic brain tumors after stereotactic radiosurgery depend in part on tumor type. However, the type of response only correlates with survival in patients with breast cancer.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Iyer</LastName>
<ForeName>Aditya</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Departments of Neurological Surgery and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harrison</LastName>
<ForeName>Gillian</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kano</LastName>
<ForeName>Hideyuki</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Weiner</LastName>
<ForeName>Gregory M</ForeName>
<Initials>GM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Luther</LastName>
<ForeName>Neal</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Niranjan</LastName>
<ForeName>Ajay</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Flickinger</LastName>
<ForeName>John C</ForeName>
<Initials>JC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lunsford</LastName>
<ForeName>L Dade</ForeName>
<Initials>LD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kondziolka</LastName>
<ForeName>Douglas</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg</MedlineTA>
<NlmUniqueID>0253357</NlmUniqueID>
<ISSNLinking>0022-3085</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000556">secondary</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001943">Breast Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002289">Carcinoma, Non-Small-Cell Lung</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053208">Kaplan-Meier Estimate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008175">Lung Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008545">Melanoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016634">Radiosurgery</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012878">Skin Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015996">Survival Rate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D047368">Tumor Burden</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">GKRS = Gamma Knife radiosurgery</Keyword>
<Keyword MajorTopicYN="N">Gamma Knife</Keyword>
<Keyword MajorTopicYN="N">NSCLC = nonsmall cell lung cancer</Keyword>
<Keyword MajorTopicYN="N">WBRT = whole-brain radiation therapy</Keyword>
<Keyword MajorTopicYN="N">brain metastasis</Keyword>
<Keyword MajorTopicYN="N">breast cancer</Keyword>
<Keyword MajorTopicYN="N">melanoma</Keyword>
<Keyword MajorTopicYN="N">nonsmall cell lung cancer</Keyword>
<Keyword MajorTopicYN="N">oncology</Keyword>
<Keyword MajorTopicYN="N">stereotactic radiosurgery</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24905562</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0693</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>121</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery</Title>
<ISOAbbreviation>J. Neurosurg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Emergent surgical embolectomy for middle cerebral artery occlusion due to carotid plaque rupture followed by elective carotid endarterectomy.</ArticleTitle>
<Pagination>
<MedlinePgn>631-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.4.JNS132441</ELocationID>
<Abstract>
<AbstractText>Embolic intracranial large artery occlusion with severe neurological deficit is associated with an extremely poor prognosis. The safest and most effective treatment strategy has not yet been determined when such emboli are associated with unstable proximal carotid plaque. The authors performed emergent surgical embolectomy for left middle cerebral artery (MCA) occlusion, and the patient experienced marked neurological recovery without focal deficit and regained premorbid activity. Postoperative investigation revealed "vulnerable plaque" of the left internal carotid artery without apparent evidence of cardiac embolism, such as would be seen with atrial fibrillation. Specimens from subsequent elective carotid endarterectomy (CEA) showed ruptured vulnerable plaque that was histologically consistent as a source of the intracranial embolic specimen. Surgical embolectomy for MCA occlusion due to carotid plaque rupture followed by CEA could be a safer and more effective alternative to endovascular treatment from the standpoint of obviating the risk of secondary embolism that could otherwise occur as a result of the manipulation of devices through an extremely unstable portion of plaque. Further, this strategy is associated with a high probability of complete recanalization with direct removal of hard and large, though fragile, emboli. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kiyofuji</LastName>
<ForeName>Satoshi</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Fuji Brain Institute and Hospital, Fujinomiya City, Shizuoka, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Inoue</LastName>
<ForeName>Tomohiro</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hasegawa</LastName>
<ForeName>Hirotaka</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tamura</LastName>
<ForeName>Akira</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Saito</LastName>
<ForeName>Isamu</ForeName>
<Initials>I</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg</MedlineTA>
<NlmUniqueID>0253357</NlmUniqueID>
<ISSNLinking>0022-3085</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016893">Carotid Stenosis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003399">Craniotomy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017128">Embolectomy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016894">Endarterectomy, Carotid</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020244">Infarction, Middle Cerebral Artery</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018810">Magnetic Resonance Angiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012421">Rupture</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">CAS = carotid artery stenting</Keyword>
<Keyword MajorTopicYN="N">CEA = carotid endarterectomy</Keyword>
<Keyword MajorTopicYN="N">DSA = digital subtraction angiography</Keyword>
<Keyword MajorTopicYN="N">DWI = diffusion-weighted imaging</Keyword>
<Keyword MajorTopicYN="N">ECG = electrocardiogram</Keyword>
<Keyword MajorTopicYN="N">ICA = internal carotid artery</Keyword>
<Keyword MajorTopicYN="N">MCA = middle cerebral artery</Keyword>
<Keyword MajorTopicYN="N">MRA = MR angiography</Keyword>
<Keyword MajorTopicYN="N">NIHSS = National Institutes of Health Stroke Scale</Keyword>
<Keyword MajorTopicYN="N">TIMI = Thrombolysis in Myocardial Infarction</Keyword>
<Keyword MajorTopicYN="N">acute ischemic stroke</Keyword>
<Keyword MajorTopicYN="N">carotid endarterectomy</Keyword>
<Keyword MajorTopicYN="N">embolectomy</Keyword>
<Keyword MajorTopicYN="N">internal carotid artery stenosis</Keyword>
<Keyword MajorTopicYN="N">intracranial embolism</Keyword>
<Keyword MajorTopicYN="N">vascular disorders</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24926653</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0693</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>121</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery</Title>
<ISOAbbreviation>J. Neurosurg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Stereotactic radiosurgery for sylvian fissure arteriovenous malformations with emphasis on hemorrhage risks and seizure outcomes.</ArticleTitle>
<Pagination>
<MedlinePgn>637-44</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.5.JNS132244</ELocationID>
<Abstract>
<AbstractText Label="OBJECT" NlmCategory="OBJECTIVE">Sylvian fissure arteriovenous malformations (AVMs) present substantial management challenges because of the critical adjacent blood vessels and functional brain. The authors investigated the outcomes, especially hemorrhage and seizure activity, after stereotactic radiosurgery (SRS) of AVMs within or adjacent to the sylvian fissure.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective single-institution analysis examined the authors' experiences with Gamma Knife surgery for AVMs of the sylvian fissure in cases treated from 1987 through 2009. During this time, 87 patients underwent SRS for AVMs in the region of the sylvian fissure. Before undergoing SRS, 40 (46%) of these patients had experienced hemorrhage and 36 (41%) had had seizures. The median target volume of the AVM was 3.85 cm(3) (range 0.1-17.7 cm(3)), and the median marginal dose of radiation was 20 Gy (range 13-25 Gy).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Over a median follow-up period of 64 months (range 3-275 months), AVM obliteration was confirmed by MRI or angiography for 43 patients. The actuarial rates of confirmation of total obliteration were 35% at 3 years, 60% at 4 and 5 years, and 76% at 10 years. Of the 36 patients who had experienced seizures before SRS, 19 (53%) achieved outcomes of Engel class I after treatment. The rate of seizure improvement was 29% at 3 years, 36% at 5 years, 50% at 10 years, and 60% at 15 years. No seizures developed after SRS in patients who had been seizure free before treatment. The actuarial rate of AVM hemorrhage after SRS was 5% at 1, 5, and 10 years. This rate equated to an annual hemorrhage rate during the latency interval of 1%; no hemorrhages occurred after confirmed obliteration. No permanent neurological deficits developed as an adverse effect of radiation; however, delayed cyst formation occurred in 3 patients.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Stereotactic radiosurgery was an effective treatment for AVMs within the region of the sylvian fissure, particularly for smaller-volume AVMs. After SRS, a low rate of hemorrhage and improved seizure control were also evident.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bowden</LastName>
<ForeName>Greg</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Departments of Neurological Surgery and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kano</LastName>
<ForeName>Hideyuki</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tonetti</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Niranjan</LastName>
<ForeName>Ajay</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Flickinger</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Arai</LastName>
<ForeName>Yoshio</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lunsford</LastName>
<ForeName>L Dade</ForeName>
<Initials>LD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg</MedlineTA>
<NlmUniqueID>0253357</NlmUniqueID>
<ISSNLinking>0022-3085</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002533">Cerebral Angiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002543">Cerebral Hemorrhage</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002550">Cerebral Veins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015994">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002538">Intracranial Arteriovenous Malformations</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053208">Kaplan-Meier Estimate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016634">Radiosurgery</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012640">Seizures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">AVM = arteriovenous malformation</Keyword>
<Keyword MajorTopicYN="N">Gamma Knife</Keyword>
<Keyword MajorTopicYN="N">SRS = stereotactic radiosurgery</Keyword>
<Keyword MajorTopicYN="N">arteriovenous malformation</Keyword>
<Keyword MajorTopicYN="N">epilepsy</Keyword>
<Keyword MajorTopicYN="N">seizure</Keyword>
<Keyword MajorTopicYN="N">stereotactic radiosurgery</Keyword>
<Keyword MajorTopicYN="N">sylvian fissure</Keyword>
<Keyword MajorTopicYN="N">vascular disorders</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24995779</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0693</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>121</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery</Title>
<ISOAbbreviation>J. Neurosurg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Retrosigmoid removal of small acoustic neuroma: curative tumor removal with preservation of function.</ArticleTitle>
<Pagination>
<MedlinePgn>554-63</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.6.JNS132471</ELocationID>
<Abstract>
<AbstractText Label="OBJECT" NlmCategory="OBJECTIVE">Management of small acoustic neuromas (ANs) consists of 3 options: observation with imaging follow-up, radiosurgery, and/or tumor removal. The authors report the long-term outcomes and preservation of function after retrosigmoid tumor removal in 44 patients and clarify the management paradigm for small ANs.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A total of 44 consecutively enrolled patients with small ANs and preserved hearing underwent retrosigmoid tumor removal in an attempt to preserve hearing and facial function by use of intraoperative auditory monitoring of auditory brainstem responses (ABRs) and cochlear nerve compound action potentials (CNAPs). All patients were younger than 70 years of age, had a small AN (purely intracanalicular/cerebellopontine angle tumor  15 mm), and had serviceable hearing preoperatively. According to the guidelines of the Committee on Hearing and Equilibrium of the American Academy of Otolaryngology-Head and Neck Surgery Foundation, preoperative hearing levels of the 44 patients were as follows: Class A, 19 patients; Class B, 17; and Class C, 8. The surgical technique for curative tumor removal with preservation of hearing and facial function included sharp dissection and debulking of the tumor, reconstruction of the internal auditory canal, and wide removal of internal auditory canal dura.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">For all patients, tumors were totally removed without incidence of facial palsy, death, or other complications. Total tumor removal was confirmed by the first postoperative Gd-enhanced MRI performed 12 months after surgery. Postoperative hearing levels were Class A, 5 patients; Class B, 21; Class C, 11; and Class D, 7. Postoperatively, serviceable (Class A, B, or C) and useful (Class A or B) levels of hearing were preserved for 84% and 72% of patients, respectively. Better preoperative hearing resulted in higher rates of postoperative hearing preservation (p = 0.01); preservation rates were 95% among patients with preoperative Class A hearing, 88% among Class B, and 50% among Class C. Reliable monitoring was more frequently provided by CNAPs than by ABRs (66% vs 32%, p &lt; 0.01), and consistently reliable auditory monitoring was significantly associated with better rates of preservation of useful hearing. Long-term follow-up by MRI with Gd administration (81  43 months [range 5-181 months]; median 7 years) showed no tumor recurrence, and although the preserved hearing declined minimally over the long-term postoperative follow-up period (from 39  15 dB to 45  11 dB in 5.1  3.1 years), 80% of useful hearing and 100% of serviceable hearing remained at the same level.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">As a result of a surgical technique that involved sharp dissection and internal auditory canal reconstruction with intraoperative auditory monitoring, retrosigmoid removal of small ANs can lead to successful curative tumor removal without long-term recurrence and with excellent functional outcome. Thus, the authors suggest that tumor removal should be the first-line management strategy for younger patients with small ANs and preserved hearing.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yamakami</LastName>
<ForeName>Iwao</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Neurosurgery, Chiba Central Medical Center, Chiba, Japan;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ito</LastName>
<ForeName>Seiro</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Higuchi</LastName>
<ForeName>Yoshinori</ForeName>
<Initials>Y</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg</MedlineTA>
<NlmUniqueID>0253357</NlmUniqueID>
<ISSNLinking>0022-3085</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000200">Action Potentials</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003056">Cochlear Nerve</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004424">Ear Canal</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016057">Evoked Potentials, Auditory, Brain Stem</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008866">Microsurgery</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009464">Neuroma, Acoustic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010524">Peripheral Nervous System Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ABR = auditory brainstem response</Keyword>
<Keyword MajorTopicYN="N">AN = acoustic neuroma</Keyword>
<Keyword MajorTopicYN="N">CNAP = cochlear nerve compound action potential</Keyword>
<Keyword MajorTopicYN="N">acoustic neuroma</Keyword>
<Keyword MajorTopicYN="N">hearing preservation</Keyword>
<Keyword MajorTopicYN="N">intraoperative auditory monitoring</Keyword>
<Keyword MajorTopicYN="N">microsurgery</Keyword>
<Keyword MajorTopicYN="N">oncology</Keyword>
<Keyword MajorTopicYN="N">tumor removal</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24995789</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0693</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>121</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery</Title>
<ISOAbbreviation>J. Neurosurg.</ISOAbbreviation>
</Journal>
<ArticleTitle>New endoscopic route to the temporal horn of the lateral ventricle: surgical simulation and morphometric assessment.</ArticleTitle>
<Pagination>
<MedlinePgn>751-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.5.JNS132309</ELocationID>
<Abstract>
<AbstractText Label="OBJECT" NlmCategory="OBJECTIVE">The temporal horn of the lateral ventricle is a complex structure affected by specific pathological conditions. Current approaches to the temporal horn involve a certain amount of corticotomy and white matter disruption. Surgeons therefore set aside anterior temporal lobectomy as a last resource and avoid it in the dominant hemisphere. The authors propose a minimally invasive endoscopic intraventricular approach to the temporal horn and describe a standardized analysis and technical assessment of the feasibility of this approach.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">To determine the best trajectory, angulation, and entry point to the temporal horn of the lateral ventricle, the authors evaluated 50 cranial MRI studies (100 temporal lobes) from healthy patients. They studied and systematized the neurosurgical endoscopic anatomy. They also simulated the proposed approach in 9 cadaveric specimens (18 approaches).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Mean scalp entry point coordinates ( SD) were 2.7  0.28 cm lateral to the inion and 5.6  0.41 cm superior to the inion. The mean total distance from the uncal recess to the scalp ( SD) was 10.64  0.6 cm. The mean total intraparenchymal distance crossed by the endoscope was 3.76  0.36 cm. The approach was successfully completed in all studied specimens.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this study, the endoscopic intraventricular approach to the temporal horn is standardized. The morphometric analysis makes this approach anatomically feasible and replicable. This approach provides minimally invasive endoscopic access to the uncal recess, amygdala, hippocampus, fornix, and paraventricular temporal lobe structures. The following essential strategies enabled access to and maneuverability inside the temporal horn: tailored preoperative planning of the trajectory and use of anatomical and radiological references, constant irrigation, and an angled endoscopic lens. Safety assessment and novel instruments and techniques may be proposed to advance this very promising route to pathological changes in the temporal lobe.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Snchez</LastName>
<ForeName>Jose Juan Gonzlez</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Departments of Neurosurgery and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rincon-Torroella</LastName>
<ForeName>Jordina</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Prats-Galino</LastName>
<ForeName>Alberto</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>de Notaris</LastName>
<ForeName>Matteo</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Berenguer</LastName>
<ForeName>Joan</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rodrguez</LastName>
<ForeName>Enrique Ferrer</ForeName>
<Initials>EF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Benet</LastName>
<ForeName>Arnau</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg</MedlineTA>
<NlmUniqueID>0253357</NlmUniqueID>
<ISSNLinking>0022-3085</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002102">Cadaver</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D003198">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005240">Feasibility Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020547">Lateral Ventricles</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019060">Minimally Invasive Surgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D044583">Neuroendoscopy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013702">Temporal Lobe</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">endoscopic anatomy</Keyword>
<Keyword MajorTopicYN="N">intraventricular approach</Keyword>
<Keyword MajorTopicYN="N">minimally invasive neurosurgery</Keyword>
<Keyword MajorTopicYN="N">surgical technique</Keyword>
<Keyword MajorTopicYN="N">ventricular temporal horn</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25014437</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0693</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>121</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery</Title>
<ISOAbbreviation>J. Neurosurg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.</ArticleTitle>
<Pagination>
<MedlinePgn>505-10</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.3.JNS132214</ELocationID>
<Abstract>
<AbstractText Label="OBJECT" NlmCategory="OBJECTIVE">Cavernous sinus (CS) invasion is the most important preoperative predictor of remission in the surgical treatment of growth hormone-producing pituitary adenomas. The purpose of this study was to evaluate the effectiveness of an aggressive technique for removal of tumors invading the CS in patients with acromegaly.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The authors retrospectively reviewed the cases of 150 consecutive patients with acromegaly who underwent primary transsphenoidal surgery in 2010 and 2011. The authors reviewed preoperative Knosp grade, intraoperative findings, histology of the medial wall of the CS, and surgical outcome according to the current consensus criteria for acromegaly.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Cavernous sinus invasion was identified in 55 patients (36.7%): definite CS involvement by the tumor was observed under direct vision in 41 patients (74.5%), while invasion was histologically verified in 39 patients (70.9%). Invasion increased in frequency with the higher Knosp grade but was observed in 14.4% (13 of 90) of Grade 0 and 1 tumors. Overall, the remission rate fulfilling stringent criteria was 84.7% (127 of 150). Although CS invasion was significantly associated with an unfavorable outcome (p &lt; 0.0001), remission was achieved in 69.1% (38 of 55) of patients with invasion. No major complications occurred in this series.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Cavernous sinus invasion is the most significant, independent predictor of unfavorable outcome. Confirmation of invasion requires direct observation within the CS regardless of the microscope or endoscope used. Particularly in cases in which only the medial wall is involved, histological verification is always necessary to detect the occult invasion. Direct removal of the invading tumor, by sharp excision of the medial wall of the CS, is effective and safe and increases the chance of remission.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nishioka</LastName>
<ForeName>Hiroshi</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital; and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fukuhara</LastName>
<ForeName>Noriaki</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Horiguchi</LastName>
<ForeName>Kentaro</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yamada</LastName>
<ForeName>Shozo</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg</MedlineTA>
<NlmUniqueID>0253357</NlmUniqueID>
<ISSNLinking>0022-3085</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Neurosurg. 2014 Sep;121(3):503-4</RefSource>
<PMID Version="1">25317433</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Neurosurg. 2014 Sep;121(3):501-3</RefSource>
<PMID Version="1">25014439</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000172">Acromegaly</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000236">Adenoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002426">Cavernous Sinus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004724">Endoscopy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049912">Growth Hormone-Secreting Pituitary Adenoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010911">Pituitary Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011237">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">CS = cavernous sinus</Keyword>
<Keyword MajorTopicYN="N">GH = growth hormone</Keyword>
<Keyword MajorTopicYN="N">IGF-I = insulin-like growth factorI</Keyword>
<Keyword MajorTopicYN="N">SD = standard deviation</Keyword>
<Keyword MajorTopicYN="N">TSS = transsphenoidal surgery</Keyword>
<Keyword MajorTopicYN="N">acromegaly</Keyword>
<Keyword MajorTopicYN="N">cavernous sinus invasion</Keyword>
<Keyword MajorTopicYN="N">occult invasion</Keyword>
<Keyword MajorTopicYN="N">oncology</Keyword>
<Keyword MajorTopicYN="N">pituitary adenoma</Keyword>
<Keyword MajorTopicYN="N">transsphenoidal surgery</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25036197</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0693</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>121</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery</Title>
<ISOAbbreviation>J. Neurosurg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Idiopathic intracranial hypertension presenting solely as CSF rhinorrhea.</ArticleTitle>
<Pagination>
<MedlinePgn>765-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2012.7.JNS12665</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sen</LastName>
<ForeName>Anitha</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Devi Scans, Thiruvananthapuram, Kerala, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg</MedlineTA>
<NlmUniqueID>0253357</NlmUniqueID>
<ISSNLinking>0022-3085</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Neurosurg. 2011 Jul;115(1):165-70</RefSource>
<PMID Version="1">21476806</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002559">Cerebrospinal Fluid Rhinorrhea</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007427">Intracranial Pressure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050177">Overweight</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011559">Pseudotumor Cerebri</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25036205</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1933-0693</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>121</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurosurgery</Title>
<ISOAbbreviation>J. Neurosurg.</ISOAbbreviation>
</Journal>
<ArticleTitle>A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma.</ArticleTitle>
<Pagination>
<MedlinePgn>536-42</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.4.JNS121952</ELocationID>
<Abstract>
<AbstractText Label="OBJECT" NlmCategory="OBJECTIVE">Robust methodology that allows objective, automated, and observer-independent measurements of brain tumor volume, especially after resection, is lacking. Thus, determination of tumor response and progression in neurooncology is unreliable. The objective of this study was to determine if a semi-automated volumetric method for quantifying enhancing tissue would perform with high reproducibility and low interobserver variability.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Fifty-seven MR images from 13 patients with glioblastoma were assessed using our method, by 2 neuroradiologists, 1 neurosurgeon, 1 neurosurgical resident, 1 nurse practitioner, and 1 medical student. The 2 neuroradiologists also performed traditional 1-dimensional (1D) and 2-dimensional (2D) measurements. Intraclass correlation coefficients (ICCs) assessed interobserver variability between measurements. Radiological response was determined using Response Evaluation Criteria In Solid Tumors (RECIST) guidelines and Macdonald criteria. Kappa statistics described interobserver variability of volumetric radiological response determinations.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">There was strong agreement for 1D (RECIST) and 2D (Macdonald) measurements between neuroradiologists (ICC = 0.42 and 0.61, respectively), but the agreement using the authors' novel automated approach was significantly stronger (ICC = 0.97). The volumetric method had the strongest agreement with regard to radiological response ( = 0.96) when compared with 2D ( = 0.54) or 1D ( = 0.46) methods. Despite diverse levels of experience of the users of the volumetric method, measurements using the volumetric program remained remarkably consistent in all users (0.94).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Interobserver variability using this new semi-automated method is less than the variability with traditional methods of tumor measurement. This new method is objective, quick, and highly reproducible among operators with varying levels of expertise. This approach should be further evaluated as a potential standard for response assessment based on contrast enhancement in brain tumors.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kanaly</LastName>
<ForeName>Charles W</ForeName>
<Initials>CW</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurosurgery, Department of Surgery.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mehta</LastName>
<ForeName>Ankit I</ForeName>
<Initials>AI</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ding</LastName>
<ForeName>Dale</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hoang</LastName>
<ForeName>Jenny K</ForeName>
<Initials>JK</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kranz</LastName>
<ForeName>Peter G</ForeName>
<Initials>PG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Herndon</LastName>
<ForeName>James E</ForeName>
<Initials>JE</Initials>
<Suffix>2nd</Suffix>
</Author>
<Author ValidYN="Y">
<LastName>Coan</LastName>
<ForeName>April</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Crocker</LastName>
<ForeName>Ian</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Waller</LastName>
<ForeName>Anthony F</ForeName>
<Initials>AF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Friedman</LastName>
<ForeName>Allan H</ForeName>
<Initials>AH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reardon</LastName>
<ForeName>David A</ForeName>
<Initials>DA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sampson</LastName>
<ForeName>John H</ForeName>
<Initials>JH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>5R01-CA135272-03</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>5R21-NS067975-02</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D023362">Evaluation Studies</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosurg</MedlineTA>
<NlmUniqueID>0253357</NlmUniqueID>
<ISSNLinking>0022-3085</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018450">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005909">Glioblastoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015588">Observer Variation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D047368">Tumor Burden</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ICC = intraclass correlation coefficient</Keyword>
<Keyword MajorTopicYN="N">RANO = Response Assessment in Neuro-Oncology Working Group</Keyword>
<Keyword MajorTopicYN="N">RECIST = Response Evaluation Criteria In Solid Tumors</Keyword>
<Keyword MajorTopicYN="N">brain neoplasm</Keyword>
<Keyword MajorTopicYN="N">disease progression</Keyword>
<Keyword MajorTopicYN="N">glioma</Keyword>
<Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword>
<Keyword MajorTopicYN="N">oncology</Keyword>
<Keyword MajorTopicYN="N">recurrence</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24912384</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>12</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1759-5053</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>11</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Nature reviews. Gastroenterology &amp; hepatology</Title>
<ISOAbbreviation>Nat Rev Gastroenterol Hepatol</ISOAbbreviation>
</Journal>
<ArticleTitle>Functional brain imaging in gastroenterology: to new beginnings.</ArticleTitle>
<Pagination>
<MedlinePgn>565-76</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/nrgastro.2014.89</ELocationID>
<Abstract>
<AbstractText>With more than 100 studies published over the past two decades, functional brain imaging research in gastroenterology has become an established field; one that has enabled improved insight into the supraspinal responses evoked by gastrointestinal stimulation both in health and disease. However, there remains considerable inter-study variation in the published results, largely owing to methodological differences in stimulation and recording techniques, heterogeneous patient selection, lack of control for psychological factors and so on. These issues with reproducibility, although not unique to studies of the gastrointestinal tract, can lead to unjustified inferences. To obtain consistent and more clinically relevant results, there is a need to optimize and standardize brain imaging studies across different centres. In addition, the use of complementary and more novel brain imaging modalities and analyses, which are now being used in other fields of research, might help unravel the factors at play in functional gastrointestinal disorders. This Review highlights the areas in which functional brain imaging has been useful and what it has revealed, the areas that are in need of improvement, and finally suggestions for future directions. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Al Omran</LastName>
<ForeName>Yasser</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Centre for Digestive Diseases, Blizard Institute, Wingate Institute of Neurogastroenterology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 26 Ashfield Street, London E1 2AJ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aziz</LastName>
<ForeName>Qasim</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>Centre for Digestive Diseases, Blizard Institute, Wingate Institute of Neurogastroenterology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 26 Ashfield Street, London E1 2AJ, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Nat Rev Gastroenterol Hepatol</MedlineTA>
<NlmUniqueID>101500079</NlmUniqueID>
<ISSNLinking>1759-5045</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D059907">Functional Neuroimaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005767">Gastrointestinal Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25173655</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>22</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1557-8275</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>52</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Radiologic clinics of North America</Title>
<ISOAbbreviation>Radiol. Clin. North Am.</ISOAbbreviation>
</Journal>
<ArticleTitle>Imaging of abdominal and pelvic surgical and postprocedural foreign bodies.</ArticleTitle>
<Pagination>
<MedlinePgn>991-1027</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rcl.2014.05.006</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0033-8389(14)00083-9</ELocationID>
<Abstract>
<AbstractText>Every form of medical and surgical treatment, even the most trivial one, carries with it some chance of complications. This risk is usually small, and the benefit of the treatment should clearly outweigh the risk. Treatment-related complications may occur, however, presenting either soon after the intervention or remote from it. In this review, the focus is on imaging findings of surgical materials used in abdominal surgery, and of a wide array of implanted abdominal devices. The pertinent complications of these devices and of retained surgical objects are highlighted and illustrated. </AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gayer</LastName>
<ForeName>Gabriela</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, 2 Derech Sheba, Ramat-Gan 52621, Israel; Department of Radiology, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94304, USA. Electronic address: gayer@post.tau.ac.il.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lubner</LastName>
<ForeName>Meghan G</ForeName>
<Initials>MG</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Wisconsin School of Medicine &amp; Public Health, 600 Highland Avenue, Madison, WI 53792-3252, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bhalla</LastName>
<ForeName>Sanjeev</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 South Kingshighway, St Louis, MO 63110, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pickhardt</LastName>
<ForeName>Perry J</ForeName>
<Initials>PJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Wisconsin School of Medicine &amp; Public Health, 600 Highland Avenue, Madison, WI 53792-3252, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Radiol Clin North Am</MedlineTA>
<NlmUniqueID>0123703</NlmUniqueID>
<ISSNLinking>0033-8389</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000005">Abdomen</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000531">radionuclide imaging</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003952">Diagnostic Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004864">Equipment and Supplies</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005547">Foreign Bodies</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007049">Iatrogenic Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010388">Pelvis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000531">radionuclide imaging</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019736">Prostheses and Implants</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011860">Radiography, Abdominal</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013523">Surgical Equipment</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Computed tomography</Keyword>
<Keyword MajorTopicYN="N">Iatrogenic complication</Keyword>
<Keyword MajorTopicYN="N">Iatrogenic injury</Keyword>
<Keyword MajorTopicYN="N">Implanted devices</Keyword>
<Keyword MajorTopicYN="N">Postprocedural complications</Keyword>
<Keyword MajorTopicYN="N">Surgical foreign bodies</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25173657</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>22</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1557-8275</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>52</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Radiologic clinics of North America</Title>
<ISOAbbreviation>Radiol. Clin. North Am.</ISOAbbreviation>
</Journal>
<ArticleTitle>Radiation-induced effects to nontarget abdominal and pelvic viscera.</ArticleTitle>
<Pagination>
<MedlinePgn>1041-53</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rcl.2014.05.004</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0033-8389(14)00081-5</ELocationID>
<Abstract>
<AbstractText>Radiation injuries often occur during or after radiation therapy in the abdomen or pelvis. Although any organ in the abdomen or pelvis may be exposed to and injured by radiation therapy directed to a nearby organ, this article focuses on more frequently encountered imaging findings of inadvertent radiation damage. It is important for the radiologist to be familiar with the imaging appearances of inadvertent radiation damage to abdominopelvic viscera in order to sustain clinical relevance and not mistake radiation injuries for other entities. </AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Peterson</LastName>
<ForeName>Christine M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Penn State Hershey, Hershey, PA 17033, USA. Electronic address: cpeterson3@hmc.psu.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Menias</LastName>
<ForeName>Christine O</ForeName>
<Initials>CO</Initials>
<AffiliationInfo>
<Affiliation>Mayo Clinic LL Radiology, 13400 East Shea Blvd, Scottsdale, AZ 85259, USA; Mayo Clinic Hospital, 5777 East Mayo Boulevard, Phoenix, AZ 85054, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Katz</LastName>
<ForeName>Douglas S</ForeName>
<Initials>DS</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Winthrop-University Hospital, Mineola, NY 11501, USA; State University of New York at Stony Brook, Stony Brook, NY 11794, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Radiol Clin North Am</MedlineTA>
<NlmUniqueID>0123703</NlmUniqueID>
<ISSNLinking>0033-8389</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000005">Abdomen</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003952">Diagnostic Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010388">Pelvis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011832">Radiation Injuries</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014463">Ultrasonography</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014781">Viscera</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Fistula</Keyword>
<Keyword MajorTopicYN="N">Injury</Keyword>
<Keyword MajorTopicYN="N">Osteopenia</Keyword>
<Keyword MajorTopicYN="N">Radiation</Keyword>
<Keyword MajorTopicYN="N">Stricture</Keyword>
<Keyword MajorTopicYN="N">Veno-occlusion</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25173659</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>22</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1557-8275</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>52</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Radiologic clinics of North America</Title>
<ISOAbbreviation>Radiol. Clin. North Am.</ISOAbbreviation>
</Journal>
<ArticleTitle>Imaging of complications of common bariatric surgical procedures.</ArticleTitle>
<Pagination>
<MedlinePgn>1071-86</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rcl.2014.05.009</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0033-8389(14)00086-4</ELocationID>
<Abstract>
<AbstractText>Several techniques for the surgical management of obesity are available to bariatric surgeons. These interventions are performed more frequently with worsening of the obesity epidemic. Radiologists should be familiar with the surgical techniques, normal postoperative appearances, and potential complications for which imaging may be employed to establish a diagnosis to optimize patient care. </AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lehnert</LastName>
<ForeName>Bruce</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Washington School of Medicine, 1959 Northeast Pacific Street, Seattle, WA 98195, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moshiri</LastName>
<ForeName>Mariam</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Washington School of Medicine, 1959 Northeast Pacific Street, Seattle, WA 98195, USA. Electronic address: Moshiri@uw.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Osman</LastName>
<ForeName>Sherif</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Washington School of Medicine, 1959 Northeast Pacific Street, Seattle, WA 98195, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khandelwal</LastName>
<ForeName>Saurabh</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, University of Washington School of Medicine, 1959 Northeast Pacific Street, Seattle, WA 98195, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Elojeimy</LastName>
<ForeName>Saeed</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Washington School of Medicine, 1959 Northeast Pacific Street, Seattle, WA 98195, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bhargava</LastName>
<ForeName>Puneet</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Washington School of Medicine, 1959 Northeast Pacific Street, Seattle, WA 98195, USA; Department of Radiology, VA Puget Sound Health Care System, 1660 South Columbian Way, Seattle, WA 98108, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Katz</LastName>
<ForeName>Douglas S</ForeName>
<Initials>DS</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Winthrop-University Hospital, 259 First Street, Mineola, NY 11501, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Radiol Clin North Am</MedlineTA>
<NlmUniqueID>0123703</NlmUniqueID>
<ISSNLinking>0033-8389</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050110">Bariatric Surgery</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005767">Gastrointestinal Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D041981">Gastrointestinal Tract</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bariatric surgery complications</Keyword>
<Keyword MajorTopicYN="N">Gastric banding</Keyword>
<Keyword MajorTopicYN="N">Laparoscopy</Keyword>
<Keyword MajorTopicYN="N">Obesity</Keyword>
<Keyword MajorTopicYN="N">Roux en Y</Keyword>
<Keyword MajorTopicYN="N">Sleeve gastrectomy</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25173662</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>22</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1557-8275</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>52</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Radiologic clinics of North America</Title>
<ISOAbbreviation>Radiol. Clin. North Am.</ISOAbbreviation>
</Journal>
<ArticleTitle>Imaging evaluation of maternal complications associated with repeat cesarean deliveries.</ArticleTitle>
<Pagination>
<MedlinePgn>1117-35</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rcl.2014.05.010</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0033-8389(14)00087-6</ELocationID>
<Abstract>
<AbstractText>The rate of cesarean deliveries continues to rise, while the rate of vaginal delivery after cesarean birth continues to decline. Many women now tend to undergo multiple cesarean deliveries, and therefore the associated chronic maternal morbidities are of growing concern. Accurate diagnosis of these conditions is crucial in maternal and fetal well-being. Many of these complications are diagnosed by imaging, and radiologists should be aware of the type and imaging appearances of these conditions. </AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Moshiri</LastName>
<ForeName>Mariam</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Washington School of Medicine, 1959 Northeast Pacific Street, Seattle, WA 98195, USA. Electronic address: Moshiri@uw.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Osman</LastName>
<ForeName>Sherif</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Washington School of Medicine, 1959 Northeast Pacific Street, Seattle, WA 98195, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bhargava</LastName>
<ForeName>Puneet</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Washington School of Medicine, 1959 Northeast Pacific Street, Seattle, WA 98195, USA; Department of Radiology, VA Puget Sound Health Care System, 1660 South Columbian Way, Seattle, WA 98108, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maximin</LastName>
<ForeName>Suresh</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Washington School of Medicine, 1959 Northeast Pacific Street, Seattle, WA 98195, USA; Department of Radiology, VA Puget Sound Health Care System, 1660 South Columbian Way, Seattle, WA 98108, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Robinson</LastName>
<ForeName>Tracy J</ForeName>
<Initials>TJ</Initials>
<AffiliationInfo>
<Affiliation>Seattle Radiologists P.S., Nordstrom Tower, 1229 Madison Street, Suite 900, Seattle, WA 98104, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Katz</LastName>
<ForeName>Douglas S</ForeName>
<Initials>DS</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Winthrop-University Hospital, 259 First Street, Mineola, NY 11501, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Radiol Clin North Am</MedlineTA>
<NlmUniqueID>0123703</NlmUniqueID>
<ISSNLinking>0033-8389</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017604">Cesarean Section, Repeat</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003952">Diagnostic Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011248">Pregnancy Complications</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013529">Surgical Wound Dehiscence</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014463">Ultrasonography</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014591">Uterine Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014597">Uterine Rupture</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cesarean complications</Keyword>
<Keyword MajorTopicYN="N">Cesarean delivery</Keyword>
<Keyword MajorTopicYN="N">Repeat cesarean</Keyword>
<Keyword MajorTopicYN="N">Scar niche</Keyword>
<Keyword MajorTopicYN="N">Scar pregnancy</Keyword>
<Keyword MajorTopicYN="N">Uterine dehiscence</Keyword>
<Keyword MajorTopicYN="N">Uterine rupture</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25012844</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1522-1547</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>307</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>American journal of physiology. Gastrointestinal and liver physiology</Title>
<ISOAbbreviation>Am. J. Physiol. Gastrointest. Liver Physiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparison of manual and semiautomated techniques for analyzing gastric volumes with MRI in humans.</ArticleTitle>
<Pagination>
<MedlinePgn>G582-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1152/ajpgi.00048.2014</ELocationID>
<Abstract>
<AbstractText>Gastric emptying, accommodation, and motility can be quantified with magnetic resonance imaging (MRI). The first step in image analysis entails segmenting the stomach from surrounding structures, usually by a time-consuming manual process. We have developed a semiautomated process to segment and measure gastric volumes with MRI. Gastric images were acquired with a three-dimensional gradient echo MRI sequence at 5, 10, 20, and 30 min after ingestion of a liquid nutrient (Ensure, 296 ml) labeled with gadolinium in 20 healthy volunteers and 29 patients with dyspeptic symptoms. The agreement between gastric volumes measured by manual segmentation and our new semiautomated algorithm was assessed with Lin's concordance correlation coefficient (CCC) and the Bland Altman test. At 5 min after a meal, food volumes measured by manual (352  4 ml) and semiautomated (346  4 ml) techniques were correlated {CCC[95% confidence interval (CI)] 0.70 (0.52, 0.81)}; air volumes measured by manual (88  6 ml) and semiautomated (84  6 ml) techniques were also correlated [CCC (95% CI) 0.89 (0.82, 0.94)]. Findings were similar at subsequent time points. The Bland Altman test was not significant. The time required for semiautomated segmentation ranged from an average of 204 s for the 5-min images to 233 s for the 20-min images. These times were appreciably smaller than the typical times of many tens of minutes, even hours, required for manual segmentation. To conclude, a semiautomated process can measure gastric food and air volume using MRI with comparable accuracy and far better efficiency than a manual process. </AbstractText>
<CopyrightInformation>Copyright  2014 the American Physiological Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bharucha</LastName>
<ForeName>Adil E</ForeName>
<Initials>AE</Initials>
<AffiliationInfo>
<Affiliation>Division of Gastroenterology and Hepatology, Clinical Enteric Neuroscience Translational and Epidemiological Research Program, College of Medicine, Mayo Clinic, Rochester, Minnesota; bharucha.adil@mayo.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Karwoski</LastName>
<ForeName>Ronald A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Biomedical Imaging Resource, College of Medicine, Mayo Clinic, Rochester, Minnesota;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fidler</LastName>
<ForeName>Jeff</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, College of Medicine, Mayo Clinic, Rochester, Minnesota;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Holmes</LastName>
<ForeName>David R</ForeName>
<Initials>DR</Initials>
<Suffix>3rd</Suffix>
<AffiliationInfo>
<Affiliation>Biomedical Imaging Resource, College of Medicine, Mayo Clinic, Rochester, Minnesota;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Robb</LastName>
<ForeName>Richard A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Biomedical Imaging Resource, College of Medicine, Mayo Clinic, Rochester, Minnesota;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Riederer</LastName>
<ForeName>Stephen J</ForeName>
<Initials>SJ</Initials>
<AffiliationInfo>
<Affiliation>MR Research Laboratory, College of Medicine, Mayo Clinic, Rochester, Minnesota; and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zinsmeister</LastName>
<ForeName>Alan R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>Division of Biostatistics, College of Medicine, Mayo Clinic, Rochester, Minnesota.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P01 DK068055</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P01-DK-68055</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Physiol Gastrointest Liver Physiol</MedlineTA>
<NlmUniqueID>100901227</NlmUniqueID>
<ISSNLinking>0193-1857</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>AU0V1LM3JT</RegistryNumber>
<NameOfSubstance UI="D005682">Gadolinium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001330">Automatic Data Processing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016022">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004415">Dyspepsia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005682">Gadolinium</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D005746">Gastric Emptying</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4182289 [Available on 09/01/15]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">emptying</Keyword>
<Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword>
<Keyword MajorTopicYN="N">motility</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24993044</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1522-1539</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>307</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>American journal of physiology. Heart and circulatory physiology</Title>
<ISOAbbreviation>Am. J. Physiol. Heart Circ. Physiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Disease-specific differences of left ventricular rotational mechanics between cardiac amyloidosis and hypertrophic cardiomyopathy.</ArticleTitle>
<Pagination>
<MedlinePgn>H680-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1152/ajpheart.00251.2014</ELocationID>
<Abstract>
<AbstractText>Left ventricular (LV) twist (LVT) and untwisting (LVUT) rate are global and thorough parameters of LV function. The aim of the present study was to investigate the differences in LV rotational mechanics between patients with cardiac amyloidosis (CA) and hypertrophic cardiomyopathy (HCM). Twenty consecutive patients with CA, 20 consecutive patients with HCM, and 20 consecutive subjects without evidence of structural heart disease were included. Cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE) imaging was performed to evaluate biventricular function, LV mass index, and presence/extent of LGE. Feature-tracking analysis was applied to LV basal and apical short-axis images to determine peak LVT, time to peak LVT, peak LVUT rate, and time to peak LVUT rate. Peak LVT and peak LVUT rate were significantly impaired in patients with CA compared with controls (P &lt; 0.05 for both). In patients with HCM, peak LVT was increased (P &lt; 0.05) compared with controls, whereas peak LVUT rate was preserved (P &gt; 0.05). Time to peak LVUT rate was significantly prolonged in patients with CA and in patients with HCM compared with controls (ANOVA P &lt; 0.001). At multivariate analysis, age (P = 0.007), LV ejection fraction (P = 0.035) and extent of LGE (P &lt; 0.001) were independently related to peak LVT, and LV mass index (P = 0.015) and extent of LGE (P = 0.004) were independently related to peak LVUT rate, whereas extent of LGE (P &lt; 0.001) was the only variable independently related to time to peak LVUT rate. In conclusion, CA and HCM have specific behavior of LV rotational mechanics. The extent of LGE significantly influences the LV rotational mechanics. </AbstractText>
<CopyrightInformation>Copyright  2014 the American Physiological Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nucifora</LastName>
<ForeName>Gaetano</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Cardiothoracic Department and gnucifora@cardionet.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Muser</LastName>
<ForeName>Daniele</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Cardiothoracic Department and Postgraduate School of Cardiovascular Sciences, University of Trieste, Trieste, Italy;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Morocutti</LastName>
<ForeName>Giorgio</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Cardiothoracic Department and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Piccoli</LastName>
<ForeName>Gianluca</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Diagnostic Imaging, University Hospital Santa Maria della Misericordia, Udine, Italy;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zanuttini</LastName>
<ForeName>Davide</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Cardiothoracic Department and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gianfagna</LastName>
<ForeName>Pasquale</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Cardiothoracic Department and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Proclemer</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Cardiothoracic Department and I.R.C.A.B. Foundation, Udine, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Physiol Heart Circ Physiol</MedlineTA>
<NlmUniqueID>100901228</NlmUniqueID>
<ISSNLinking>0363-6135</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000686">Amyloidosis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002312">Cardiomyopathy, Hypertrophic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016022">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006352">Heart Ventricles</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012399">Rotation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016277">Ventricular Function, Left</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">cardiac amyloidosis</Keyword>
<Keyword MajorTopicYN="N">cardiac magnetic resonance</Keyword>
<Keyword MajorTopicYN="N">feature-tracking</Keyword>
<Keyword MajorTopicYN="N">hypertrophic cardiomyopathy</Keyword>
<Keyword MajorTopicYN="N">rotational mechanics</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25179988</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>15</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0018-1994</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>60</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Hinyokika kiyo. Acta urologica Japonica</Title>
<ISOAbbreviation>Hinyokika Kiyo</ISOAbbreviation>
</Journal>
<ArticleTitle>[Laparoscopic adrenalectomy due to primary aldosteronism during pregnancy].</ArticleTitle>
<Pagination>
<MedlinePgn>381-5</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Primary aldosteronism (PA) during pregnancy is an extremely rare condition that may cause life threatening complications both for the mother and the fetus. A pregnant 31-year-old woman was referred to our hospital for the management of severe pregnancy hypertension at the beginning of her pregnancy. Her plasma aldosterone concentration (PAC) was markedly elevated (337 pg/ml), plasma rennin activity was suppressed (0.4 ng/ml/hr) and magnetic resonance imaging showed a 1.5 cm left adrenal tumor. PA due to an aldosterone producing-adenoma was diagnosed. Because of progressive uncontrollable hypertension and hypokalemia, a laproscopic adrenalectomy was performed at 24 weeks of gestation. The transabdominal approach was completed without any complication, resulting in normalization of PAC, easier management of blood pressure and improvement of hypokalemia. Because of severe pregnancy hypertension, cesarean operation was performed at 30 weeks of gestation and a girl weighing 1,235 g was delivered. The literature regarding PA during pregnancy was reviewed and the optimal timing of laparoscopic adrenalectomy during pregnancy and perioperative management were discussed.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shiraishi</LastName>
<ForeName>Koji</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>The Department of Urology, Yamaguchi University School of Medicine.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kikuta</LastName>
<ForeName>Kyoko</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>The Department of Obstetrics and Gynecology, Saiseikai Shimonoseki General Hospital.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nitta</LastName>
<ForeName>Yutaka</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>The Department of Nephrology, Saiseikai Shimonoseki General Hospital.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Matsuyama</LastName>
<ForeName>Hideyasu</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>The Department of Urology, Yamaguchi University School of Medicine.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>jpn</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>Hinyokika Kiyo</MedlineTA>
<NlmUniqueID>0421145</NlmUniqueID>
<ISSNLinking>0018-1994</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000315">Adrenalectomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006929">Hyperaldosteronism</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D046110">Hypertension, Pregnancy-Induced</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010535">Laparoscopy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25179989</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>15</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0018-1994</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>60</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Hinyokika kiyo. Acta urologica Japonica</Title>
<ISOAbbreviation>Hinyokika Kiyo</ISOAbbreviation>
</Journal>
<ArticleTitle>[Posterior reversible encephalopathy syndrome (PRES) after kidney transplantation: a case report].</ArticleTitle>
<Pagination>
<MedlinePgn>387-92</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>A 60-year-old woman with chronic renal failure due to a polycystic kidney underwent living kidney transplantation. Initial immunosuppressive therapy consisted of tacrolimus (TAC), mycophenolate mofetil (MMF), prednisolone, and basiliximab. Furthermore, rituximab was administered, and double filtration plasmapheresis and plasma exchange were utilized because of ABO-incompatible transplantation, while intravenous immune serum globulin (IVIG) was given because donor specific antibody was positive. Four days after the renal transplantation, the patient developed visual abnormalities, a headache, and paralysis. Then, he became unconscious. Magnetic resonance imaging of the brain demonstrated bilateral posterior vasogenic edema. Our diagnosis was posterior reversible encephalopathy syndrome due to TAC neurotoxicity. After converting TAC to reduced cyclosporine and everolimus, the symptoms rapidly disappeared. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ueda</LastName>
<ForeName>Norichika</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>The Department of Urology, Hyogo Prefectual Nishinomiya Hospital.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kawamura</LastName>
<ForeName>Masataka</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>The Department of Urology, Hyogo Prefectual Nishinomiya Hospital.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nakazawa</LastName>
<ForeName>Shigeaki</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>The Department of Urology, Hyogo Prefectual Nishinomiya Hospital.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hirai</LastName>
<ForeName>Toshiaki</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>The Department of Urology, Hyogo Prefectual Nishinomiya Hospital.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kishikawa</LastName>
<ForeName>Hidefumi</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>The Department of Urology, Hyogo Prefectual Nishinomiya Hospital.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nishimura</LastName>
<ForeName>Kenji</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>The Department of Urology, Hyogo Prefectual Nishinomiya Hospital.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>jpn</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>Hinyokika Kiyo</MedlineTA>
<NlmUniqueID>0421145</NlmUniqueID>
<ISSNLinking>0018-1994</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016030">Kidney Transplantation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019520">Living Donors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054038">Posterior Leukoencephalopathy Syndrome</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24999245</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>11</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1872-8421</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>274</Volume>
<Issue>1-2</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Journal of neuroimmunology</Title>
<ISOAbbreviation>J. Neuroimmunol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy.</ArticleTitle>
<Pagination>
<MedlinePgn>149-54</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jneuroim.2014.06.010</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0165-5728(14)00181-7</ELocationID>
<Abstract>
<AbstractText>To investigate whether multiple sclerosis (MS) patients with and without cerebrospinal fluid (CSF) oligoclonal immunoglobulin G bands (OCB) differ in brain atrophy. Twenty-eight OCB-negative and thirty-five OCB-positive patients were included. Larger volumes of total CSF and white matter (WM) lesions; smaller gray matter (GM) volume in the basal ganglia, diencephalon, cerebellum, and hippocampus; and smaller WM volume in corpus callosum, periventricular-deep WM, brainstem, and cerebellum, were observed in OCB-positives. OCB-negative patients, known to differ genetically from OCB-positives, are characterized by less global and regional brain atrophy. This finding supports the notion that OCB-negative MS patients may represent a clinically relevant MS subgroup. </AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ferreira</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics (Karolinska Institutet), Novum 5th floor, 141 86 Stockholm, Sweden. Electronic address: daniel.ferreira.padilla@ki.se.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Voevodskaya</LastName>
<ForeName>Olga</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics (Karolinska Institutet), Novum 5th floor, 141 86 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Imrell</LastName>
<ForeName>Kerstin</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Neuroscience (Karolinska Institutet), Center for Molecular Medicine (CMM), L8:00, 171 76, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stawiarz</LastName>
<ForeName>Leszek</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Neuroscience (Karolinska Institutet), Center for Molecular Medicine (CMM), L8:00, 171 76, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Spulber</LastName>
<ForeName>Gabriela</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics (Karolinska Institutet), Novum 5th floor, 141 86 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wahlund</LastName>
<ForeName>Lars-Olof</ForeName>
<Initials>LO</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics (Karolinska Institutet), Novum 5th floor, 141 86 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hillert</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Neuroscience (Karolinska Institutet), Center for Molecular Medicine (CMM), L8:00, 171 76, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Westman</LastName>
<ForeName>Eric</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics (Karolinska Institutet), Novum 5th floor, 141 86 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Karrenbauer</LastName>
<ForeName>Virginija Danylait</ForeName>
<Initials>VD</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Neuroscience (Karolinska Institutet), Center for Molecular Medicine (CMM), L8:00, 171 76, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>J Neuroimmunol</MedlineTA>
<NlmUniqueID>8109498</NlmUniqueID>
<ISSNLinking>0165-5728</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D043025">Oligoclonal Bands</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001284">Atrophy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000134">cerebrospinal fluid</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001927">Brain Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000134">cerebrospinal fluid</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004185">Disability Evaluation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020528">Multiple Sclerosis, Chronic Progressive</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000134">cerebrospinal fluid</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020529">Multiple Sclerosis, Relapsing-Remitting</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000134">cerebrospinal fluid</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015999">Multivariate Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D043025">Oligoclonal Bands</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000134">cerebrospinal fluid</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Brain atrophy</Keyword>
<Keyword MajorTopicYN="N">Cerebrospinal fluid</Keyword>
<Keyword MajorTopicYN="N">MRI</Keyword>
<Keyword MajorTopicYN="N">Multiple Esclerosis</Keyword>
<Keyword MajorTopicYN="N">Multivariate analyses</Keyword>
<Keyword MajorTopicYN="N">Oligoclonal bands</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25181852</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>25</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0204-8043</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>56</Volume>
<Issue>2</Issue>
<PubDate>
<MedlineDate>2014 Apr-Jun</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Folia medica</Title>
<ISOAbbreviation>Folia Med (Plovdiv)</ISOAbbreviation>
</Journal>
<ArticleTitle>Myxopapillary ependymoma of filum terminale.</ArticleTitle>
<Pagination>
<MedlinePgn>133-5</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We report a case of 56-year-old patient suffering from myxopapillary ependymoma of filum terminale at the level of the fifth lumbar vertebra. The patient presented with progressive complaints of permanent pain in the anal and sacral region with duration of 8 months. When sneezing or attempting to do brisk movements, the pain irradiated to the posterior surface of the right thigh. Vertebral syndrome was absent. Neurological examination demonstrated no other abnormalities. Magnetic-resonance imaging showed intradural tumor of cauda equina at the level of the fifth lumbar vertebra. The present article discusses the role of MRI in the diagnosis of clinical cases presenting with atypical lumboradiculalgia. We have put an emphasis on the early diagnosis of myxopapillary ependymoma of filum terminale which has an impact on the surgical strategy and postoperative outcome.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Koev</LastName>
<ForeName>Ilian G</ForeName>
<Initials>IG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Poryazova</LastName>
<ForeName>Elena G</ForeName>
<Initials>EG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kitova</LastName>
<ForeName>Tania T</ForeName>
<Initials>TT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Miryanov</LastName>
<ForeName>Petar Zh</ForeName>
<Initials>PZh</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kitov</LastName>
<ForeName>Borislav D</ForeName>
<Initials>BD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Bulgaria</Country>
<MedlineTA>Folia Med (Plovdiv)</MedlineTA>
<NlmUniqueID>2984761R</NlmUniqueID>
<ISSNLinking>0204-8043</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002420">Cauda Equina</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004806">Ependymoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007150">Immunohistochemistry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008159">Lumbar Vertebrae</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013125">Spinal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25181910</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0001-5385</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>69</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Acta cardiologica</Title>
<ISOAbbreviation>Acta Cardiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Can we predict the non-response to cardiac resynchronization therapy?</ArticleTitle>
<Pagination>
<MedlinePgn>366-8</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Donal</LastName>
<ForeName>Erwan</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brunet</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Galli</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Belgium</Country>
<MedlineTA>Acta Cardiol</MedlineTA>
<NlmUniqueID>0370570</NlmUniqueID>
<ISSNLinking>0001-5385</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biological Markers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>114471-18-0</RegistryNumber>
<NameOfSubstance UI="D020097">Natriuretic Peptide, Brain</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015415">Biological Markers</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D058406">Cardiac Resynchronization Therapy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019317">Evidence-Based Medicine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006329">Heart Conduction System</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006333">Heart Failure</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020097">Natriuretic Peptide, Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011237">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013318">Stroke Volume</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017211">Treatment Failure</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25181925</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0001-5385</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>69</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Acta cardiologica</Title>
<ISOAbbreviation>Acta Cardiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Contemporary imaging assessment of a ruptured"windsock" aneurysm of the sinus of Valsalva.</ArticleTitle>
<Pagination>
<MedlinePgn>458-60</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Timmermans</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hofkens</LastName>
<ForeName>Pieter-Jan</ForeName>
<Initials>PJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Meyns</LastName>
<ForeName>Bart</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bogaert</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Budts</LastName>
<ForeName>Werner</ForeName>
<Initials>W</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Belgium</Country>
<MedlineTA>Acta Cardiol</MedlineTA>
<NlmUniqueID>0370570</NlmUniqueID>
<ISSNLinking>0001-5385</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001014">Aortic Aneurysm</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001019">Aortic Rupture</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004452">Echocardiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012850">Sinus of Valsalva</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014656">Vascular Surgical Procedures</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25183593</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2049-4408</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>96-B</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>The bone &amp; joint journal</Title>
<ISOAbbreviation>Bone Joint J</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of opening-wedge high tibial osteotomy on the three-dimensional kinematics of the knee.</ArticleTitle>
<Pagination>
<MedlinePgn>1214-21</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1302/0301-620X.96B9.32522</ELocationID>
<Abstract>
<AbstractText>Although it is clear that opening-wedge high tibial osteotomy (HTO) changes alignment in the coronal plane, which is its objective, it is not clear how this procedure affects knee kinematics throughout the range of joint movement and in other planes. Our research question was: how does opening-wedge HTO change three-dimensional tibiofemoral and patellofemoral kinematics in loaded flexion in patients with varus deformity?Three-dimensional kinematics were assessed over 0 to 60 of loaded flexion using an MRI method before and after opening-wedge HTO in a cohort of 13 men (14 knees). Results obtained from an iterative statistical model found that at six and 12 months after operation, opening-wedge HTO caused increased anterior translation of the tibia (mean 2.6 mm, p &lt; 0.001), decreased proximal translation of the patella (mean -2.2 mm, p &lt; 0.001), decreased patellar spin (mean -1.4, p &lt; 0.05), increased patellar tilt (mean 2.2, p &lt; 0.05) and changed three other parameters. The mean Western Ontario and McMaster Universities Arthritis Index improved significantly (p &lt; 0.001) from 49.6 (standard deviation (sd) 16.4) pre-operatively to a mean of 28.2 (sd 16.6) at six months and a mean of 22.5 (sd 14.4) at 12 months. The three-dimensional kinematic changes found may be important in explaining inconsistency in clinical outcomes, and suggest that measures in addition to coronal plane alignment should be considered.</AbstractText>
<CopyrightInformation>2014 The British Editorial Society of Bone &amp; Joint Surgery.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>d'Entremont</LastName>
<ForeName>A G</ForeName>
<Initials>AG</Initials>
<AffiliationInfo>
<Affiliation>University of British Columbia, Centre for Hip Health and Mobility, 2635 Laurel Street, Vancouver BC, V5Z 1M9, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McCormack</LastName>
<ForeName>R G</ForeName>
<Initials>RG</Initials>
<AffiliationInfo>
<Affiliation>University of British Columbia, 65 Richmond St. Suite 102, New Westminster, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Horlick</LastName>
<ForeName>S G D</ForeName>
<Initials>SG</Initials>
<AffiliationInfo>
<Affiliation>University of British Columbia, 500-1144 Burrard St, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stone</LastName>
<ForeName>T B</ForeName>
<Initials>TB</Initials>
<AffiliationInfo>
<Affiliation>Fraser Orthopedic Institute, 403-233 Nelson's Crescent, New Westminster, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Manzary</LastName>
<ForeName>M M</ForeName>
<Initials>MM</Initials>
<AffiliationInfo>
<Affiliation>John Hopkins Aramco Health Care Center, P O Box 11348, Dhahran 31311, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wilson</LastName>
<ForeName>D R</ForeName>
<Initials>DR</Initials>
<AffiliationInfo>
<Affiliation>University of British Columbia, Centre for Hip Health and Mobility, 2635 Laurel Street, Vancouver BC, V5Z 1M9, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Bone Joint J</MedlineTA>
<NlmUniqueID>101599229</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001696">Biomechanical Phenomena</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D060750">Bone Anteversion</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007719">Knee Joint</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015233">Models, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020370">Osteoarthritis, Knee</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010027">Osteotomy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016059">Range of Motion, Articular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016474">Weight-Bearing</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">High tibial osteotomy</Keyword>
<Keyword MajorTopicYN="N">Kinematics</Keyword>
<Keyword MajorTopicYN="N">Knee</Keyword>
<Keyword MajorTopicYN="N">MRI</Keyword>
<Keyword MajorTopicYN="N">WOMAC</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25180999</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1439-4413</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>139</Volume>
<Issue>37</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Deutsche medizinische Wochenschrift (1946)</Title>
<ISOAbbreviation>Dtsch. Med. Wochenschr.</ISOAbbreviation>
</Journal>
<ArticleTitle>[New imaging procedures in rheumatology: from bench to bedside].</ArticleTitle>
<Pagination>
<MedlinePgn>1835-41</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0034-1370280</ELocationID>
<Abstract>
<AbstractText>Modern imaging procedures play an import role in diagnostic and therapy-control in rheumatic diseases. Reasons are the continuous development, the evaluation and the implementation in local / international guidelines and classification criteria. According to new therapeutic goals and the aim of clinical and radiological remission the early diagnosis and sufficient therapy-control is unalterable. The ultrasound is today an inherent tool in the early diagnosis of joint- and vascular diseases and is used comprehensively in rheumatic diseases. Beside the highly sensitive detection of inflammation the MRI might depict bone erosions and bone marrow oedema, which is highly predictive for the development of erosions, clearly earlier than conventional x-rays. Due to its advantages the MRI is used frequently in the early diagnosis of spondyloarthritis (ASAS-guidelines). Moreover the capillary microscopy is - due to the rapid performance, the absence of radiation and the high sensitivity - applied in the early diagnosis and therapy-control of connective tissue diseases (e.g systemic sclerosis). New innovative imaging technics find increasing acceptance in the diagnostic algorithm in rheumatic disease. Hence the DECT can detect monosodium urate (MSU) crystals without the need of a joint puncture. Hybrid imaging technics like PET-CT / PET-MRI combine the high sensitivity of the PET and the accurate solution of the CT / MRI. These advantages lead to increasing importance in diagnostic imaging. </AbstractText>
<CopyrightInformation>Georg Thieme Verlag KG Stuttgart  New York.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sewerin</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Poliklinik fr Rheumatologie, Medizinische Fakultt, Heinrich-Heine Universitt Dsseldorf.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ostendorf</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Poliklinik fr Rheumatologie, Medizinische Fakultt, Heinrich-Heine Universitt Dsseldorf.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Neue bildgebende Verfahren in der Rheumatologie: From bench to bedside.</VernacularTitle>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>09</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Dtsch Med Wochenschr</MedlineTA>
<NlmUniqueID>0006723</NlmUniqueID>
<ISSNLinking>0012-0472</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018501">Antirheumatic Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001172">Arthritis, Rheumatoid</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002196">Capillaries</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003952">Diagnostic Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D042241">Early Diagnosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013700">Giant Cell Arteritis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006073">Gout</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009262">Nails</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000098">blood supply</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D061848">Optical Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011111">Polymyalgia Rheumatica</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012216">Rheumatic Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012595">Scleroderma, Systemic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013167">Spondylitis, Ankylosing</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015899">Tomography, Emission-Computed, Single-Photon</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018615">Ultrasonography, Doppler, Color</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24395136</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>01</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1435-165X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>23</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>European child &amp; adolescent psychiatry</Title>
<ISOAbbreviation>Eur Child Adolesc Psychiatry</ISOAbbreviation>
</Journal>
<ArticleTitle>Striatal volume deficits in children with ADHD who present a poor response to methylphenidate.</ArticleTitle>
<Pagination>
<MedlinePgn>805-12</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s00787-013-0510-y</ELocationID>
<Abstract>
<AbstractText>Methylphenidate (MPH) is the first choice of medical treatment for attention-deficit/hyperactivity disorder (ADHD). Its mechanism of action is to inhibit the reuptake of dopamine and noradrenaline mainly in the region of the striatum. It has been estimated that 10-30 % of patients with ADHD do not respond adequately to MPH. The aim of this study was to evaluate whether striatal differences exist between good and poor responders to MPH. The sample included 27 treatment-nave children with ADHD between the ages of 6 and 14. MPH administration started 1 day after the MRI acquisition. After a month, psychiatrists established the good or poor response to treatment according to clinical criteria. MRI images were analyzed using a technique based on regions of interest applied specifically to the caudate and accumbens nuclei. Sixteen patients showed good response to MPH and 11 a poor one. Regions of interest analysis showed that good responders had a higher concentration of gray matter in the head of both caudate nuclei and the right nucleus accumbens. Furthermore, a significant correlation was found between caudate and accumbens nuclei volume and the Conners' Parent Rating Scale and Continuous Performance Test improvement. These results support the hypothesis of the involvement of the caudate and accumbens nuclei in MPH response and in ADHD pathophysiology.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Moreno</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Unitat de Recerca en Neurocincia Cognitiva (Departament de Psiquiatria i Medicina Legal), Universitat Autnoma de Barcelona, Campus de Bellaterra, 08193, Barcelona, Spain, ana.moreno.alcazar@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Du</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hoekzema</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Picado</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Martn</LastName>
<ForeName>L M</ForeName>
<Initials>LM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fauquet</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vives-Gilabert</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bulbena</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vilarroya</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D018848">Controlled Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>01</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Eur Child Adolesc Psychiatry</MedlineTA>
<NlmUniqueID>9212296</NlmUniqueID>
<ISSNLinking>1018-8827</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000697">Central Nervous System Stimulants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>207ZZ9QZ49</RegistryNumber>
<NameOfSubstance UI="D008774">Methylphenidate</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001289">Attention Deficit Disorder with Hyperactivity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000697">Central Nervous System Stimulants</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002540">Cerebral Cortex</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003342">Corpus Striatum</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008774">Methylphenidate</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009929">Organ Size</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010290">Parents</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D013030">Spain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24963126</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1535-5667</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>55</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</Title>
<ISOAbbreviation>J. Nucl. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>PET/MR imaging and optical imaging of metastatic rhabdomyosarcoma in mice.</ArticleTitle>
<Pagination>
<MedlinePgn>1545-51</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2967/jnumed.114.138578</ELocationID>
<Abstract>
<AbstractText Label="UNLABELLED">The combination of PET and MR imaging synergizes molecular and morphologic information, allowing better diagnosis in cancer patients. The diagnosis of tumor recurrence in rhabdomyosarcoma is extremely challenging and could be improved with PET/MR imaging. The aim of this study was to validate PET/MR imaging in a disseminated rhabdomyosarcoma mouse model.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">One million alveolar (Rh30) and embryonal (RD) rhabdomyosarcoma cells with stably transfected mCherry and Gaussia luciferase were injected intraperitoneally into NOD/LtSz-scid-IL2Rnull mice. Nine animals were treated with vincristine (0.75 g/g/d). Tumor growth was monitored on the basis of serum luciferase activity, optical imaging (OI) of the fluorescent protein mCherry, and sequential PET/MR imaging with 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) and (18)F-FDG. Immunohistochemical Ki-67 and glucose transporter 1 analysis was used to evaluate tumor cell density and proliferative and metabolic activity.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The injection of rhabdomyosarcoma cells led to intraperitoneal tumor growth in 34 of 37 mice (Rh30) and 4 of 9 animals (RD). OI revealed inconsistent results for tumors located near the liver. The detection of tumors in the peritoneal cavity was exclusively possible with sequential PET/MR imaging. PET studies with (18)F-FLT MR imaging were more reliable than (18)F-FDG comparing the tracer uptake and correlation with tumor weight. Treatment with vincristine led to reduced tumor growth, which was efficiently detected with (18)F-FDG PET and MR imaging. Total tumor burden as estimated by PET/MR imaging correlated with the serum luciferase activity.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We established a unique model of metastatic rhabdomyosarcoma with a high frequency of tumor occurrence and easy monitoring of the tumor growth based on reporter gene expression. The accurate detection of rhabdomyosarcoma requires high soft-tissue contrast provided by the MR imaging and high tracer uptake for PET, which was achieved with (18)F-FLT as the tracer before and (18)F-FDG after treatment with vincristine. PET/MR imaging allows improved diagnosis of experimental rhabdomyosarcoma and therefore might influence clinical therapeutic decisions in the future.</AbstractText>
<CopyrightInformation> 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Armeanu-Ebinger</LastName>
<ForeName>Sorin</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatric Surgery and Urology, University Children's Hospital, Eberhard Karls University Tbingen, Tbingen, Germany armeanu@uni-tuebingen.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Griessinger</LastName>
<ForeName>Christoph M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>Department of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Eberhard Karls University Tbingen, Tbingen, Germany; and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Herrmann</LastName>
<ForeName>Delia</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatric Surgery and Urology, University Children's Hospital, Eberhard Karls University Tbingen, Tbingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fuchs</LastName>
<ForeName>Jrg</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatric Surgery and Urology, University Children's Hospital, Eberhard Karls University Tbingen, Tbingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kneilling</LastName>
<ForeName>Manfred</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Eberhard Karls University Tbingen, Tbingen, Germany; and Department of Dermatology, Eberhard Karls University Tbingen, Tbingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pichler</LastName>
<ForeName>Bernd J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Eberhard Karls University Tbingen, Tbingen, Germany; and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Seitz</LastName>
<ForeName>Guido</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatric Surgery and Urology, University Children's Hospital, Eberhard Karls University Tbingen, Tbingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Nucl Med</MedlineTA>
<NlmUniqueID>0217410</NlmUniqueID>
<ISSNLinking>0161-5505</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015224">Dideoxynucleosides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0Z5B2CJX4D</RegistryNumber>
<NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>PG53R0DWDQ</RegistryNumber>
<NameOfSubstance UI="C002854">alovudine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015224">Dideoxynucleosides</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019788">Fluorodeoxyglucose F18</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019275">Radiopharmaceuticals</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012208">Rhabdomyosarcoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000556">secondary</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">18F-FDG</Keyword>
<Keyword MajorTopicYN="N">18F-FLT</Keyword>
<Keyword MajorTopicYN="N">PET/MRI</Keyword>
<Keyword MajorTopicYN="N">combination</Keyword>
<Keyword MajorTopicYN="N">luciferase</Keyword>
<Keyword MajorTopicYN="N">mCherry</Keyword>
<Keyword MajorTopicYN="N">metastasis</Keyword>
<Keyword MajorTopicYN="N">rhabdomyosarcoma</Keyword>
<Keyword MajorTopicYN="N">xenograft</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25071098</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1535-5667</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>55</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</Title>
<ISOAbbreviation>J. Nucl. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>18F-FDG PET and MR imaging associations across a spectrum of pediatric brain tumors: a report from the pediatric brain tumor consortium.</ArticleTitle>
<Pagination>
<MedlinePgn>1473-80</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2967/jnumed.114.139626</ELocationID>
<Abstract>
<AbstractText Label="UNLABELLED">The purpose of this study was to describe (18)F-FDG uptake across a spectrum of pediatric brain tumors and correlate (18)F-FDG PET with MR imaging variables, progression-free survival (PFS), and overall survival (OS).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective analysis was conducted of children enrolled in phase I/II clinical trials through the Pediatric Brain Tumor Consortium from August 2000 to June 2010. PET variables were summarized within diagnostic categories using descriptive statistics. Associations of PET with MR imaging variables and PFS and OS by tumor types were evaluated.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Baseline (18)F-FDG PET was available in 203 children; 66 had newly diagnosed brain tumors, and 137 had recurrent/refractory brain tumors before enrolling in a Pediatric Brain Tumor Consortium trial. MR imaging was performed within 2 wk of PET and before therapy in all cases. The (18)F-FDG uptake pattern and MR imaging contrast enhancement (CE) varied by tumor type. On average, glioblastoma multiforme and medulloblastoma had uniform, intense uptake throughout the tumor, whereas brain stem gliomas (BSGs) had low uptake in less than 50% of the tumor and ependymoma had low uptake throughout the tumor. For newly diagnosed BSG, correlation of (18)F-FDG uptake with CE portended reduced OS (P = 0.032); in refractory/recurrent BSG, lack of correlation between (18)F-FDG uptake and CE suggested decreased PFS (P = 0.023). In newly diagnosed BSG for which more than 50% of the tumor had (18)F-FDG uptake, there was a suggestion of lower apparent diffusion coefficient (P = 0.061) and decreased PFS (P = 0.065).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">(18)F-FDG PET and MR imaging showed a spectrum of patterns depending on tumor type. In newly diagnosed BSG, the correlation of (18)F-FDG uptake and CE suggested decreased OS, likely related to more aggressive disease. When more than 50% of the tumor had (18)F-FDG uptake, the apparent diffusion coefficient was lower, consistent with increased cellularity. In refractory/recurrent BSG, poor correlation between (18)F-FDG uptake and CE was associated with decreased PFS, which may reflect concurrent tissue breakdown at sites of treated disease and development of new sites of (18)F-FDG-avid malignancy.</AbstractText>
<CopyrightInformation> 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zukotynski</LastName>
<ForeName>Katherine</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Imaging, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada Department of Radiology, Harvard Medical School, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fahey</LastName>
<ForeName>Frederic</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Harvard Medical School, Boston, Massachusetts Department of Radiology, Boston Children's Hospital, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kocak</LastName>
<ForeName>Mehmet</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kun</LastName>
<ForeName>Larry</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boyett</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fouladi</LastName>
<ForeName>Maryam</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Hematology/Oncology, Cincinnati Children's Medical Center, Cincinnati, Ohio.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vajapeyam</LastName>
<ForeName>Sridhar</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Harvard Medical School, Boston, Massachusetts Department of Radiology, Boston Children's Hospital, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Treves</LastName>
<ForeName>Ted</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Harvard Medical School, Boston, Massachusetts Department of Radiology, Boston Children's Hospital, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Poussaint</LastName>
<ForeName>Tina Y</ForeName>
<Initials>TY</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Harvard Medical School, Boston, Massachusetts Department of Radiology, Boston Children's Hospital, Boston, Massachusetts tinayoung.poussaint@childrens.harvard.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>U01 CA81457</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Nucl Med</MedlineTA>
<NlmUniqueID>0217410</NlmUniqueID>
<ISSNLinking>0161-5505</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0Z5B2CJX4D</RegistryNumber>
<NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000531">radionuclide imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019788">Fluorodeoxyglucose F18</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005910">Glioma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000531">radionuclide imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019275">Radiopharmaceuticals</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">18F-FDG PET</Keyword>
<Keyword MajorTopicYN="N">MR diffusion</Keyword>
<Keyword MajorTopicYN="N">brain tumor</Keyword>
<Keyword MajorTopicYN="N">pediatric</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24535407</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1476-5551</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Leukemia</Title>
<ISOAbbreviation>Leukemia</ISOAbbreviation>
</Journal>
<ArticleTitle>Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma.</ArticleTitle>
<Pagination>
<MedlinePgn>1902-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/leu.2014.75</ELocationID>
<Abstract>
<AbstractText>Previous studies demonstrated the relevance of focal lesions (FL) in whole-body magnetic resonance imaging (wb-MRI) at the initial workup of patients with smoldering multiple myeloma (SMM). The aim of this study was to assess the effects of longitudinal wb-MRIs on progression into multiple myeloma (MM). Sixty-three patients with SMM were analyzed who received at least two wb-MRIs for follow-up before progression into MM. Radiological progressive disease (MRI-PD) was defined as detection of new FL or increase in diameter of existing FL and a novel or progressive diffuse infiltration. Radiological stable disease (MRI-SD) was defined by no change compared with the prior MRI. Patients were followed-up every 3-6 months, including a serological and clinical evaluation. One Hundred and eighty-two wb-MRIs were analyzed. MRI-PD occurred in 31 patients (49%), and 25 (40%) patients developed MM. MRI-PD was highly significantly associated with progression into MM, regardless of findings at the initial MRI. In multivariate analysis, MRI-PD remained a risk factor, independent of relevant baseline parameters like serum monoclonal protein or 95% aberrant plasma cells in the bone marrow. Patients with MRI-SD had no higher risk of progression, even when FL were present at the initial MRI. Therefore, MRI is suitable for the follow-up of patients with SMM. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Merz</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany [2] Department of Radiology, German Cancer Research Center, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hielscher</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wagner</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, German Cancer Research Center, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sauer</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shah</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Raab</LastName>
<ForeName>M S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Department of Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jauch</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Human Genetics, University Hospital of Heidelberg, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Neben</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hose</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Egerer</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Weber</LastName>
<ForeName>M A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Department of Diagnostic and Interventional Radiology, University Hospital of Heidelberg, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Delorme</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, German Cancer Research Center, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goldschmidt</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany [2] National Center for Tumor Diseases, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hillengass</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>1] Department of Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany [2] Department of Radiology, German Cancer Research Center, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>02</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Leukemia</MedlineTA>
<NlmUniqueID>8704895</NlmUniqueID>
<ISSNLinking>0887-6924</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009101">Multiple Myeloma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011237">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016016">Proportional Hazards Models</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25180856</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>14</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1121-7138</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>37</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>The new microbiologica</Title>
<ISOAbbreviation>New Microbiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Chronic neuroborreliosis by B. garinii: an unusual case presenting with epilepsy and multifocal brain MRI lesions.</ArticleTitle>
<Pagination>
<MedlinePgn>393-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Late/chronic Lyme neuroborreliosis (LNB) represents a challenging entity whose diagnosis requires a combination of clinical and laboratory findings, surrounded by much controversy. Here we describe a patient who had a peculiar form of late LNB with CNS lesions shown by magnetic resonance imaging (MRI), and epileptic seizures, etiologically diagnosed by conventional and molecular methods. The current case provides evidence that patients presenting with epileptic seizures and MRI-detected multifocal lesions, particularly when a facial palsy has also occurred, should raise the suspicion of LNB, as this diagnosis has important implications for treatment and prognosis. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Matera</LastName>
<ForeName>Giovanni</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Institute of Microbiology, Department of Health Sciences, "Magna Graecia" University, Catanzaro, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Labate</LastName>
<ForeName>Angelo</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Quirino</LastName>
<ForeName>Angela</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lamberti</LastName>
<ForeName>Angelo G</ForeName>
<Initials>AG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Borz</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Barreca</LastName>
<ForeName>Giorgio S</ForeName>
<Initials>GS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mumoli</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Peronace</LastName>
<ForeName>Cinzia</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Giancotti</LastName>
<ForeName>Aida</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gambardella</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Foc</LastName>
<ForeName>Alfredo</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Quattrone</LastName>
<ForeName>Aldo</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>New Microbiol</MedlineTA>
<NlmUniqueID>9516291</NlmUniqueID>
<ISSNLinking>1121-7138</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000907">Antibodies, Bacterial</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000907">Antibodies, Bacterial</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015748">Borrelia burgdorferi Group</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000302">isolation &amp; purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002908">Chronic Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004827">Epilepsy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020852">Lyme Neuroborreliosis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25157008</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1098-4275</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>134</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Pediatrics</Title>
<ISOAbbreviation>Pediatrics</ISOAbbreviation>
</Journal>
<ArticleTitle>Subdural hemorrhage and hypoxia in infants with congenital heart disease.</ArticleTitle>
<Pagination>
<MedlinePgn>e773-81</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1542/peds.2013-3903</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">It has been suggested that there is a causal relationship between hypoxia and subdural hemorrhage (SDH) in infancy. The purpose of this study was to review the incidence of SDH in infants with congenital heart disease and explore the relationship between SDH and hypoxia.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Review of data collected for a prospective longitudinal cohort study of infants undergoing surgery for congenital heart disease in New Zealand and Australia. Infants underwent serial MRI scans of the brain in the first 3 months of life. All oxygen saturation recordings and MRI results were extracted and infants assigned to categories by degree of hypoxia. The data were then examined for any statistically significant relationship between hypoxia and SDH.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred fifty-two infants underwent MRI scans, and 66 (43%) had 145 loci of SDH. New SDH was seen in 12 infants after cardiac surgery. Of the loci of SDH, 63 (43%) were supratentorial, and most of these were interhemispheric, parietal, or temporal. SDH present on the first MRI persisted beyond 28 days of life in 8 infants. There was no demonstrable relationship between SDH and hypoxia.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Asymptomatic SDH is common in young infants with congenital heart disease, at a frequency similar to that of those without congenital heart disease. These SDHs may occur in locations where they occur in abusive head trauma, but they are typically small and resolve within 3 months of birth. We were unable to demonstrate any association between hypoxia and SDH in this cohort.</AbstractText>
<CopyrightInformation>Copyright  2014 by the American Academy of Pediatrics.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kelly</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Te Puaruruhau (Child Protection Team), Department of Pediatrics, Faculty of Medical and Health Sciences, University of Auckland, New Zealand; patrickk@adhb.govt.nz.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hayman</LastName>
<ForeName>Rebecca</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Children's Emergency Department.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shekerdemian</LastName>
<ForeName>Lara S</ForeName>
<Initials>LS</Initials>
<AffiliationInfo>
<Affiliation>Section of Critical Care Medicine, Texas Children's Hospital, Houston, Texas;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reed</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Children's Research Centre, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hope</LastName>
<ForeName>Ayton</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Neuroradiology, Auckland City Hospital, Auckland, New Zealand;</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gunn</LastName>
<ForeName>Julia</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Departments of Neonatal Medicine, and Murdoch Children's Research Institute, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Coleman</LastName>
<ForeName>Lee</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Radiology, The Royal Children's Hospital, Melbourne, Australia; and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Beca</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Pediatric ICU, Starship Children's Hospital, Auckland, New Zealand;</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Pediatrics</MedlineTA>
<NlmUniqueID>0376422</NlmUniqueID>
<ISSNLinking>0031-4005</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000860">Anoxia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D001315">Australia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015331">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006330">Heart Defects, Congenital</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006408">Hematoma, Subdural</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008137">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D009520">New Zealand</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">abusive head trauma</Keyword>
<Keyword MajorTopicYN="N">hypoxia</Keyword>
<Keyword MajorTopicYN="N">neonates</Keyword>
<Keyword MajorTopicYN="N">subdural hemorrhage</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23275271</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>23</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1537-453X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>37</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>American journal of clinical oncology</Title>
<ISOAbbreviation>Am. J. Clin. Oncol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Breast magnetic resonance imaging alters patient selection for accelerated partial breast irradiation.</ArticleTitle>
<Pagination>
<MedlinePgn>248-54</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/COC.0b013e318277d7c8</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine whether pretreatment contrast-enhanced breast magnetic resonance imaging (MRI) alters patient selection for accelerated partial breast irradiation (APBI).</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Women aged 40 years or older with unifocal invasive or intraductal carcinoma 2.5 cm on physical examination, mammography, and ultrasound (US) were evaluated with breast MRI before enrollment on an APBI trial using single-fraction intraoperative radiotherapy (IORT) or fractionated 3-dimensional conformal radiotherapy. Abnormal MRI findings were evaluated with US-guided or MRI-guided biopsy.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Between December 2002 and March 2005, 51 women (median age=61 y; range, 40 to 83 y) who met inclusion criteria underwent breast MRI before APBI. MRI demonstrated limited disease in 41 patients (80.4%): 34 received APBI using IORT (22) or 3DCRT (12), whereas 7 elected standard whole-breast radiotherapy. Ten of the 51 patients (19.6%) had indeterminate or suspicious enhancement patterns on MRI. Five of these 10 (9.8% of MRI cohort) underwent US-guided or MRI-guided biopsy revealing normal breast tissue without atypia: 3 were treated with APBI using IORT (5.9% of MRI cohort) and 2 underwent standard breast conservation therapy (3.9% of MRI cohort). The remaining 5 patients (9.8% of MRI cohort) had MRI findings revealing previously unsuspected pectoral fascia involvement (1), multifocal disease (3), or multicentric disease (1): 2 were treated with standard breast conservation therapy, whereas 3 underwent mastectomy without adjuvant radiotherapy.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Pretreatment breast MRI altered patient selection for APBI by identifying additional disease in 9.8% of the candidates, all of whom fit into the "cautionary" or "unsuitable" categories as defined by the American Society for Radiation Oncology APBI consensus guidelines. The clinical significance of these findings will be clarified with the results of ongoing randomized trials of APBI that do not incorporate breast MRI as part of the selection criteria.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Horst</LastName>
<ForeName>Kathleen C</ForeName>
<Initials>KC</Initials>
<AffiliationInfo>
<Affiliation>Departments of *Radiation Oncology Diagnostic Radiology Surgery, Stanford University, Stanford, CA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ikeda</LastName>
<ForeName>Debra M</ForeName>
<Initials>DM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fero</LastName>
<ForeName>Katherine E</ForeName>
<Initials>KE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Daniel</LastName>
<ForeName>Bruce L</ForeName>
<Initials>BL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Goffinet</LastName>
<ForeName>Don R</ForeName>
<Initials>DR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dirbas</LastName>
<ForeName>Frederick M</ForeName>
<Initials>FM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Clin Oncol</MedlineTA>
<NlmUniqueID>8207754</NlmUniqueID>
<ISSNLinking>0277-3732</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001943">Breast Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000532">radiotherapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019583">Dose Fractionation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005189">False Positive Reactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D061705">Image-Guided Biopsy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007432">Intraoperative Period</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015411">Mastectomy, Modified Radical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015412">Mastectomy, Segmental</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009367">Neoplasm Staging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D018579">Patient Selection</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018714">Radiotherapy, Adjuvant</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D020266">Radiotherapy, Conformal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016217">Ultrasonography, Mammary</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25187586</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>29</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1535-1386</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>96</Volume>
<Issue>17</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of bone and joint surgery. American volume</Title>
<ISOAbbreviation>J Bone Joint Surg Am</ISOAbbreviation>
</Journal>
<ArticleTitle>Cement arthroplasty for ankle joint destruction.</ArticleTitle>
<Pagination>
<MedlinePgn>1468-75</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2106/JBJS.M.01280</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The aim of this study was to investigate the outcomes of cement arthroplasty used as a primary salvage procedure to treat ankle joint destruction.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This study included sixteen patients who underwent primary cement arthroplasty from May 2004 to March 2012 because of an ankle disorder, including intractable infection, nonunion, or a large bone defect or tumor. The mean age of the patients was fifty-seven years (range, twenty-three to seventy-four years), and the mean follow-up period was thirty-nine months (range, fourteen to 100 months). The cement spacer position, cement breakage, osteolysis around the inserted cement, and alignment of the joint were evaluated radiographically. American Orthopaedic Foot &amp; Ankle Society (AOFAS) scores and visual analogue scale (VAS) pain scores were recorded preoperatively and at the time of final follow-up. Functional questionnaires were used to assess the duration for which the patient could walk continuously, use of walking aids, sports activity, consumption of pain medication, and the patient's subjective assessment of the percentage of overall improvement compared with before the cement arthroplasty.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The cement spacer was retained without breakage for a mean of thirty-nine months (range, fourteen to 100 months). Osteolysis around the cement was observed in one patient at seventy-eight months, and subluxation developed in one patient. The mean AOFAS and VAS pain scores improved from 39 (range, 11 to 71) preoperatively to 70 (range, 47 to 88) postoperatively (p = 0.001) and from 8 (range, 4 to 9) to 3 (range, 1 to 7) (p = 0.001), respectively. At the final follow-up evaluation, nine of the sixteen patients did not require walking aids, ten used no pain medication, and nine were able to walk continuously for more than an hour. One patient complained of persistent pain and was considered to have had a failure of the procedure.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Primary cement arthroplasty might be a treatment option for advanced ankle destruction in elderly and less active patients.</AbstractText>
<AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.</AbstractText>
<CopyrightInformation>Copyright  2014 by The Journal of Bone and Joint Surgery, Incorporated.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Ho-Seong</ForeName>
<Initials>HS</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Foot and Ankle Surgery, Asan Medical Center, University of Ulsan, College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, South Korea. E-mail address for H.-S. Lee: hosng@amc.seoul.kr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ahn</LastName>
<ForeName>Ji-Yong</ForeName>
<Initials>JY</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Foot and Ankle Surgery, Asan Medical Center, University of Ulsan, College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, South Korea. E-mail address for H.-S. Lee: hosng@amc.seoul.kr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Jong-Seok</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Foot and Ankle Surgery, Asan Medical Center, University of Ulsan, College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, South Korea. E-mail address for H.-S. Lee: hosng@amc.seoul.kr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Jun-Young</ForeName>
<Initials>JY</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Foot and Ankle Surgery, Chosun University School of Medicine, Gwangju, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jeong</LastName>
<ForeName>Jae-Jung</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Foot and Ankle Surgery, The Catholic University of Korea, Daejeon St. Mary's Hospital, Daeheung-dong, jung-gu, Daejeon, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Choi</LastName>
<ForeName>Young Rak</ForeName>
<Initials>YR</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Foot and Ankle Surgery, CHA Bundang Medical Center, CHA University, Bundang-gu, Seongnam-si, Gyeonggi-do, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Bone Joint Surg Am</MedlineTA>
<NlmUniqueID>0014030</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001843">Bone Cements</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Bone Joint Surg Am. 2014 Sep 3;96(17):e152</RefSource>
<PMID Version="1">25187596</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000843">Ankle Joint</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001178">Arthroplasty</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001843">Bone Cements</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001859">Bone Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002484">Cementation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015331">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007592">Joint Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010003">Osteoarthritis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010147">Pain Measurement</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010149">Pain, Postoperative</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D061214">Patient Safety</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016059">Range of Motion, Articular</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25187589</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>29</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1535-1386</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>96</Volume>
<Issue>17</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of bone and joint surgery. American volume</Title>
<ISOAbbreviation>J Bone Joint Surg Am</ISOAbbreviation>
</Journal>
<ArticleTitle>Primary epiphyseal osteomyelitis caused by mycobacterium species in otherwise healthy toddlers.</ArticleTitle>
<Pagination>
<MedlinePgn>e145</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2106/JBJS.M.01186</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Mycobacterial osteomyelitis involving only the epiphysis of a long bone is extremely rare, and its clinical and radiographic features remain unclear. The purpose of this study was to characterize mycobacterial epiphyseal osteomyelitis and to identify differences between its features and those reported for epiphyseal osteomyelitis caused by bacteria or unidentified pathogens.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively reviewed the cases of eight children (five males and three females) who presented at a median age of nineteen months (range, twelve to twenty-five months). Clinical findings were compiled. Radiographs and magnetic resonance imaging (MRI) were used to determine local spread of the abscess outside the epiphysis during the disease course. At the time of the latest follow-up evaluation, the presence of limited joint mobility or growth disturbance was determined. Physeal damage was evaluated with use of MRI.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Pathogens were identified through multiplex polymerase chain reaction. Mycobacterium bovis bacille Calmette-Gurin (BCG, Tokyo-172 strain) was identified in four patients; Mycobacterium tuberculosis, in three patients; and nontuberculous mycobacterium, in one patient. The lesion was located at the distal femoral epiphysis in six patients, at the proximal tibial epiphysis in one patient, and at the proximal humeral epiphysis in one patient. The abscess was confined to the epiphysis at the time of initial presentation but, over time, extended outside the epiphysis in seven cases. The lesion was initially located in the cartilaginous epiphysis in two patients, which could be diagnosed only on MRI. Seven patients worsened despite surgical drainage and medication, and five required additional surgery. At follow-up at a mean of 4.1 years (range, 1.3 to 7.8 years), focal physeal damage was evident in five patients, and clinical growth disturbance was evident in one patient.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In contrast to the reported benign features of epiphyseal osteomyelitis caused by bacteria or unidentified pathogens, mycobacterial epiphyseal osteomyelitis seems to have an unfavorable clinical course that tends to lead to physeal damage. MRI is useful for early diagnosis of a cartilaginous lesion and evaluation of abscess spread and physeal damage.</AbstractText>
<AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.</AbstractText>
<CopyrightInformation>Copyright  2014 by The Journal of Bone and Joint Surgery, Incorporated.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yoo</LastName>
<ForeName>Won Joon</ForeName>
<Initials>WJ</Initials>
<AffiliationInfo>
<Affiliation>Divisions of Pediatric Orthopaedics (W.J.Y., I.H.C., T-J.C., and M.H.S.), Radiology (J.-E.C.), and Pediatrics (E.C. and H.J.L.), Seoul National University Children's Hospital, 101 Daehak-ro, Jongno-gu, 110-744 Seoul, South Korea. E-mail address for I.H. Choi: inhoc@snu.ac.kr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Choi</LastName>
<ForeName>In Ho</ForeName>
<Initials>IH</Initials>
<AffiliationInfo>
<Affiliation>Divisions of Pediatric Orthopaedics (W.J.Y., I.H.C., T-J.C., and M.H.S.), Radiology (J.-E.C.), and Pediatrics (E.C. and H.J.L.), Seoul National University Children's Hospital, 101 Daehak-ro, Jongno-gu, 110-744 Seoul, South Korea. E-mail address for I.H. Choi: inhoc@snu.ac.kr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yun</LastName>
<ForeName>Yeo-Hon</ForeName>
<Initials>YH</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopedic Surgery, Ewha Womans University Mok-Dong Hospital, 1071 Anyangcheon-ro, Yangcheon-gu, 158-710 Seoul, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cho</LastName>
<ForeName>Tae-Joon</ForeName>
<Initials>TJ</Initials>
<AffiliationInfo>
<Affiliation>Divisions of Pediatric Orthopaedics (W.J.Y., I.H.C., T-J.C., and M.H.S.), Radiology (J.-E.C.), and Pediatrics (E.C. and H.J.L.), Seoul National University Children's Hospital, 101 Daehak-ro, Jongno-gu, 110-744 Seoul, South Korea. E-mail address for I.H. Choi: inhoc@snu.ac.kr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cheon</LastName>
<ForeName>Jung-Eun</ForeName>
<Initials>JE</Initials>
<AffiliationInfo>
<Affiliation>Divisions of Pediatric Orthopaedics (W.J.Y., I.H.C., T-J.C., and M.H.S.), Radiology (J.-E.C.), and Pediatrics (E.C. and H.J.L.), Seoul National University Children's Hospital, 101 Daehak-ro, Jongno-gu, 110-744 Seoul, South Korea. E-mail address for I.H. Choi: inhoc@snu.ac.kr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Song</LastName>
<ForeName>Mi Hyun</ForeName>
<Initials>MH</Initials>
<AffiliationInfo>
<Affiliation>Divisions of Pediatric Orthopaedics (W.J.Y., I.H.C., T-J.C., and M.H.S.), Radiology (J.-E.C.), and Pediatrics (E.C. and H.J.L.), Seoul National University Children's Hospital, 101 Daehak-ro, Jongno-gu, 110-744 Seoul, South Korea. E-mail address for I.H. Choi: inhoc@snu.ac.kr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chung</LastName>
<ForeName>Chin Youb</ForeName>
<Initials>CY</Initials>
<AffiliationInfo>
<Affiliation>Departments of Orthopedic Surgery (C.Y.C. and M.S.P.) and Laboratory Medicine (K.U.P.), Seoul National University Bundang Hospital, 82 Gumi-ro, 173 Beon-gil, Bundang-gu, 463-707 Seongnam, Gyeonggi-do, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Park</LastName>
<ForeName>Moon Seok</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Departments of Orthopedic Surgery (C.Y.C. and M.S.P.) and Laboratory Medicine (K.U.P.), Seoul National University Bundang Hospital, 82 Gumi-ro, 173 Beon-gil, Bundang-gu, 463-707 Seongnam, Gyeonggi-do, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Choi</LastName>
<ForeName>Eunhwa</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Divisions of Pediatric Orthopaedics (W.J.Y., I.H.C., T-J.C., and M.H.S.), Radiology (J.-E.C.), and Pediatrics (E.C. and H.J.L.), Seoul National University Children's Hospital, 101 Daehak-ro, Jongno-gu, 110-744 Seoul, South Korea. E-mail address for I.H. Choi: inhoc@snu.ac.kr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Hoan Jong</ForeName>
<Initials>HJ</Initials>
<AffiliationInfo>
<Affiliation>Divisions of Pediatric Orthopaedics (W.J.Y., I.H.C., T-J.C., and M.H.S.), Radiology (J.-E.C.), and Pediatrics (E.C. and H.J.L.), Seoul National University Children's Hospital, 101 Daehak-ro, Jongno-gu, 110-744 Seoul, South Korea. E-mail address for I.H. Choi: inhoc@snu.ac.kr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Park</LastName>
<ForeName>Kyoung Un</ForeName>
<Initials>KU</Initials>
<AffiliationInfo>
<Affiliation>Departments of Orthopedic Surgery (C.Y.C. and M.S.P.) and Laboratory Medicine (K.U.P.), Seoul National University Bundang Hospital, 82 Gumi-ro, 173 Beon-gil, Bundang-gu, 463-707 Seongnam, Gyeonggi-do, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Bone Joint Surg Am</MedlineTA>
<NlmUniqueID>0014030</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000995">Antitubercular Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000038">Abscess</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000367">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000995">Antitubercular Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015331">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003131">Combined Modality Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004322">Drainage</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004838">Epiphyses</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006132">Growth Plate</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009164">Mycobacterium Infections</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009163">Mycobacterium bovis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000302">isolation &amp; purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009169">Mycobacterium tuberculosis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000302">isolation &amp; purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010019">Osteomyelitis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D035583">Rare Diseases</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25005878</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1559-7016</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>34</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</Title>
<ISOAbbreviation>J. Cereb. Blood Flow Metab.</ISOAbbreviation>
</Journal>
<ArticleTitle>Tissue oxygen saturation mapping with magnetic resonance imaging.</ArticleTitle>
<Pagination>
<MedlinePgn>1550-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/jcbfm.2014.116</ELocationID>
<Abstract>
<AbstractText>A quantitative estimate of cerebral blood oxygen saturation is of critical importance in the investigation of cerebrovascular disease. While positron emission tomography can map in vivo the oxygen level in blood, it has limited availability and requires ionizing radiation. Magnetic resonance imaging (MRI) offers an alternative through the blood oxygen level-dependent contrast. Here, we describe an in vivo and non-invasive approach to map brain tissue oxygen saturation (StO2) with high spatial resolution. StO2 obtained with MRI correlated well with results from blood gas analyses for various oxygen and hematocrit challenges. In a stroke model, the hypoxic areas delineated in vivo by MRI spatially matched those observed ex vivo by pimonidazole staining. In a model of diffuse traumatic brain injury, MRI was able to detect even a reduction in StO2 that was too small to be detected by histology. In a F98 glioma model, MRI was able to map oxygenation heterogeneity. Thus, the MRI technique may improve our understanding of the pathophysiology of several brain diseases involving impaired oxygenation. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Christen</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>1] Inserm, U836, Grenoble, France [2] Universit Grenoble Alpes, Grenoble Institut des Neurosciences, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bouzat</LastName>
<ForeName>Pierre</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>1] Inserm, U836, Grenoble, France [2] Universit Grenoble Alpes, Grenoble Institut des Neurosciences, Grenoble, France [3] CHU Grenoble, Ple d'Anesthsie-Ranimation, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pannetier</LastName>
<ForeName>Nicolas</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>1] Inserm, U836, Grenoble, France [2] Universit Grenoble Alpes, Grenoble Institut des Neurosciences, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Coquery</LastName>
<ForeName>Nicolas</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>1] Inserm, U836, Grenoble, France [2] Universit Grenoble Alpes, Grenoble Institut des Neurosciences, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moisan</LastName>
<ForeName>Anack</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>1] Inserm, U836, Grenoble, France [2] Universit Grenoble Alpes, Grenoble Institut des Neurosciences, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lemasson</LastName>
<ForeName>Benjamin</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>1] Inserm, U836, Grenoble, France [2] Universit Grenoble Alpes, Grenoble Institut des Neurosciences, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thomas</LastName>
<ForeName>Sbastien</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>1] Inserm, U836, Grenoble, France [2] Universit Grenoble Alpes, Grenoble Institut des Neurosciences, Grenoble, France [3] CHU Grenoble, Ple d'Anesthsie-Ranimation, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Grillon</LastName>
<ForeName>Emmanuelle</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>1] Inserm, US 017, Grenoble, France [2] Universit Grenoble Alpes, IRMaGe, Grenoble, France [3] CHU Grenoble, IRMaGe, Grenoble, France [4] CNRS, UMS 3552, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Detante</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>1] Inserm, U836, Grenoble, France [2] Universit Grenoble Alpes, Grenoble Institut des Neurosciences, Grenoble, France [3] CHU Grenoble, Service de Neurologie, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rmy</LastName>
<ForeName>Chantal</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>1] Inserm, U836, Grenoble, France [2] Universit Grenoble Alpes, Grenoble Institut des Neurosciences, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Payen</LastName>
<ForeName>Jean-Franois</ForeName>
<Initials>JF</Initials>
<AffiliationInfo>
<Affiliation>1] Inserm, U836, Grenoble, France [2] Universit Grenoble Alpes, Grenoble Institut des Neurosciences, Grenoble, France [3] CHU Grenoble, Ple d'Anesthsie-Ranimation, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barbier</LastName>
<ForeName>Emmanuel Luc</ForeName>
<Initials>EL</Initials>
<AffiliationInfo>
<Affiliation>1] Inserm, U836, Grenoble, France [2] Universit Grenoble Alpes, Grenoble Institut des Neurosciences, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Cereb Blood Flow Metab</MedlineTA>
<NlmUniqueID>8112566</NlmUniqueID>
<ISSNLinking>0271-678X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>S88TT14065</RegistryNumber>
<NameOfSubstance UI="D010100">Oxygen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001784">Blood Gas Analysis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001930">Brain Injuries</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004195">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010100">Oxygen</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011916">Rats, Inbred F344</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017208">Rats, Wistar</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020521">Stroke</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000530">radiography</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4158672 [Available on 09/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25186756</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1529-2401</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>34</Volume>
<Issue>36</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title>
<ISOAbbreviation>J. Neurosci.</ISOAbbreviation>
</Journal>
<ArticleTitle>Interindividual variation in fornix microstructure and macrostructure is related to visual discrimination accuracy for scenes but not faces.</ArticleTitle>
<Pagination>
<MedlinePgn>12121-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1523/JNEUROSCI.0026-14.2014</ELocationID>
<Abstract>
<AbstractText>Transection of the nonhuman primate fornix has been shown to impair learning of configurations of spatial features and object-in-scene memory. Although damage to the human fornix also results in memory impairment, it is not known whether there is a preferential involvement of this white-matter tract in spatial learning, as implied by animal studies. Diffusion-weighted MR images were obtained from healthy participants who had completed versions of a task in which they made rapid same/different discriminations to two categories of highly visually similar stimuli: (1) virtual reality scene pairs; and (2) face pairs. Diffusion-MRI measures of white-matter microstructure [fractional anisotropy (FA) and mean diffusivity (MD)] and macrostructure (tissue volume fraction, f) were then extracted from the fornix of each participant, which had been reconstructed using a deterministic tractography protocol. Fornix MD and f measures correlated with scene, but not face, discrimination accuracy in both discrimination tasks. A complementary voxelwise analysis using tract-based spatial statistics suggested the crus of the fornix as a focus for this relationship. These findings extend previous reports of spatial learning impairments after fornix transection in nonhuman primates, critically highlighting the fornix as a source of interindividual variation in scene discrimination in humans. </AbstractText>
<CopyrightInformation>Copyright  2014 Postans et al.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Postans</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Wales Institute of Cognitive Neuroscience, Cardiff University Brain Research Imaging Centre, School of Psychology, and Neuroscience and Mental Health Research Institute, Cardiff University, CF10 3AT, United Kingdom, and PostansM@cardiff.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hodgetts</LastName>
<ForeName>Carl J</ForeName>
<Initials>CJ</Initials>
<AffiliationInfo>
<Affiliation>Wales Institute of Cognitive Neuroscience, Cardiff University Brain Research Imaging Centre, School of Psychology, and Neuroscience and Mental Health Research Institute, Cardiff University, CF10 3AT, United Kingdom, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mundy</LastName>
<ForeName>Matthew E</ForeName>
<Initials>ME</Initials>
<AffiliationInfo>
<Affiliation>School of Psychology and Psychiatry, Monash University, Clayton, Victoria 3800, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jones</LastName>
<ForeName>Derek K</ForeName>
<Initials>DK</Initials>
<AffiliationInfo>
<Affiliation>Wales Institute of Cognitive Neuroscience, Cardiff University Brain Research Imaging Centre, School of Psychology, and Neuroscience and Mental Health Research Institute, Cardiff University, CF10 3AT, United Kingdom, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lawrence</LastName>
<ForeName>Andrew D</ForeName>
<Initials>AD</Initials>
<AffiliationInfo>
<Affiliation>Wales Institute of Cognitive Neuroscience, Cardiff University Brain Research Imaging Centre, School of Psychology, and Neuroscience and Mental Health Research Institute, Cardiff University, CF10 3AT, United Kingdom, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Graham</LastName>
<ForeName>Kim S</ForeName>
<Initials>KS</Initials>
<AffiliationInfo>
<Affiliation>Wales Institute of Cognitive Neuroscience, Cardiff University Brain Research Imaging Centre, School of Psychology, and Neuroscience and Mental Health Research Institute, Cardiff University, CF10 3AT, United Kingdom, and.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>BB/I007091/1</GrantID>
<Agency>Biotechnology and Biological Sciences Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>G1002149</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Neurosci</MedlineTA>
<NlmUniqueID>8102140</NlmUniqueID>
<ISSNLinking>0270-6474</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2005 Nov 2;25(44):10239-46</RefSource>
<PMID Version="1">16267231</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Geriatr Psychiatry. 2005 Dec;13(12):1092-9</RefSource>
<PMID Version="1">16319302</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2006 Jul 15;31(4):1487-505</RefSource>
<PMID Version="1">16624579</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2006 Jul 19;26(29):7547-54</RefSource>
<PMID Version="1">16855082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hippocampus. 2007;17(5):396-411</RefSource>
<PMID Version="1">17372974</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2007 Jul 1;36(3):630-44</RefSource>
<PMID Version="1">17481925</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychologia. 2007 Oct 1;45(13):2963-74</RefSource>
<PMID Version="1">17658561</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2007 Nov 21;27(47):12868-73</RefSource>
<PMID Version="1">18032659</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2008 Apr 15;40(3):1044-55</RefSource>
<PMID Version="1">18295509</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2008 Aug 15;42(2):617-25</RefSource>
<PMID Version="1">18583153</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychology. 2008 Sep;22(5):658-68</RefSource>
<PMID Version="1">18763885</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Q J Exp Psychol (Hove). 2008 Oct;61(10):1441-71</RefSource>
<PMID Version="1">18671169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2009 Jan 1;44(1):83-98</RefSource>
<PMID Version="1">18501637</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2009 Jan;12(1):29-31</RefSource>
<PMID Version="1">19029889</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Behav Brain Res. 2009 Jul 19;201(1):192-7</RefSource>
<PMID Version="1">19428633</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2009 Sep;62(3):717-30</RefSource>
<PMID Version="1">19623619</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hippocampus. 2005;15(6):782-97</RefSource>
<PMID Version="1">16010661</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1999 Sep;42(3):515-25</RefSource>
<PMID Version="1">10467296</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Behav Neurosci. 2004 Feb;118(1):138-49</RefSource>
<PMID Version="1">14979790</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2009 Nov 25;29(47):14987-92</RefSource>
<PMID Version="1">19940194</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2002 Jan;15(2):365-74</RefSource>
<PMID Version="1">11849302</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychologia. 2010 Mar;48(4):831-53</RefSource>
<PMID Version="1">20074580</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychologia. 2010 Jul;48(8):2370-84</RefSource>
<PMID Version="1">20206190</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2011 Mar 15;55(2):500-7</RefSource>
<PMID Version="1">21168517</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Brain Mapp. 2011 Mar;32(3):461-79</RefSource>
<PMID Version="1">21319270</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2011 Feb 16;31(7):2624-9</RefSource>
<PMID Version="1">21325530</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2011 Jul 27;31(30):10937-47</RefSource>
<PMID Version="1">21795544</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2011 Sep 14;31(37):13236-45</RefSource>
<PMID Version="1">21917806</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2012 Jan 16;59(2):1394-403</RefSource>
<PMID Version="1">21924365</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2012 Jul 16;61(4):1213-25</RefSource>
<PMID Version="1">22525876</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Psychiatry. 2012 Aug 15;72(4):296-302</RefSource>
<PMID Version="1">22386005</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Front Neural Circuits. 2013;7:35</RefSource>
<PMID Version="1">23493515</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2013 Jun;73:239-54</RefSource>
<PMID Version="1">22846632</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2013 Jun 19;33(25):10490-502</RefSource>
<PMID Version="1">23785161</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2013 Jun 19;78(6):1127-37</RefSource>
<PMID Version="1">23791201</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2013 Jul 31;33(31):12844-50</RefSource>
<PMID Version="1">23904619</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2013 Aug 14;33(33):13251-8</RefSource>
<PMID Version="1">23946384</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2003 Sep;126(Pt 9):2093-107</RefSource>
<PMID Version="1">12821517</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>NMR Biomed. 2002 Nov-Dec;15(7-8):435-55</RefSource>
<PMID Version="1">12489094</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Behav Brain Sci. 1999 Jun;22(3):425-44; discussion 444-89</RefSource>
<PMID Version="1">11301518</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001931">Brain Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004192">Discrimination (Psychology)</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005145">Face</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020712">Fornix, Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007858">Learning</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D010364">Pattern Recognition, Visual</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4152609</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">discrimination learning</Keyword>
<Keyword MajorTopicYN="N">fornix</Keyword>
<Keyword MajorTopicYN="N">hippocampus</Keyword>
<Keyword MajorTopicYN="N">scene discrimination</Keyword>
<Keyword MajorTopicYN="N">tractography</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24812077</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1097-6817</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>151</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery</Title>
<ISOAbbreviation>Otolaryngol Head Neck Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Perplexing lesions of the sinonasal cavity and skull base: IgG4-related and similar inflammatory diseases.</ArticleTitle>
<Pagination>
<MedlinePgn>496-502</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1177/0194599814533648</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">IgG4-related disease (IgG4RD) causing sinonasal and skull base pathology is uncommonly described. We present a series of suspected IgG4RD patients, with a pertinent review of the literature to highlight diagnostic challenges.</AbstractText>
<AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Case series.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Academic tertiary care center.</AbstractText>
<AbstractText Label="SUBJECTS AND METHODS" NlmCategory="METHODS">Case series of patients with IgG4RD or suspected IgG4RD involving the sinonasal cavity and skull base.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We present 4 patients with atypical sinonasal and/or skull base disease who were noted to have IgG4-positive plasma cell infiltration on immunohistochemistry of biopsy specimens. IgG4RD, a recently described entity affecting multiple organs, is characterized by lymphoplasmacytic infiltration and often elevated serum IgG4. IgG4RD can masquerade as malignancy or infection but responds to glucocorticosteroid and immunosuppressant therapy. IgG4RD has been infrequently reported presenting as sinonasal or skull base lesions, and definitive diagnostic criteria for these regions are not established. In our series, IgG4RD was suspected in all 4 patients, but only 1 met all current criteria for definitive diagnosis. All 4 patients, however, responded to corticosteroid therapy, and 1 was placed on long-term azathioprine.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">IgG4RD is rarely described in the sinonasal cavity and skull base, and specific diagnostic criteria for such disease have not been defined. We present a series of patients with IgG4-positive plasma cell inflammatory pathology who were suspected to have IgG4RD. Our series highlights diagnostic challenges associated with these patients. Tumefactive and destructive sinonasal-skull base lesions with a plasma cell-rich infiltrate should incite suspicion of IgG4RD, and immunohistochemistry for IgG4-positive plasma cells should be performed.</AbstractText>
<CopyrightInformation> American Academy of OtolaryngologyHead and Neck Surgery Foundation 2014.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cain</LastName>
<ForeName>Rachel B</ForeName>
<Initials>RB</Initials>
<AffiliationInfo>
<Affiliation>Department of Otolaryngology, Mayo Clinic, Phoenix, Arizona, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Colby</LastName>
<ForeName>Thomas V</ForeName>
<Initials>TV</Initials>
<AffiliationInfo>
<Affiliation>Department of Laboratory Medicine &amp; Pathology, Mayo Clinic, Phoenix, Arizona, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Balan</LastName>
<ForeName>Vijayan</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Hepatology, Mayo Clinic, Phoenix, Arizona, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Patel</LastName>
<ForeName>Naresh P</ForeName>
<Initials>NP</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurologic Surgery, Mayo Clinic, Phoenix, Arizona, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lal</LastName>
<ForeName>Devyani</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Otolaryngology, Mayo Clinic, Phoenix, Arizona, USA lal.devyani@mayo.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Otolaryngol Head Neck Surg</MedlineTA>
<NlmUniqueID>8508176</NlmUniqueID>
<ISSNLinking>0194-5998</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000305">Adrenal Cortex Hormones</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001327">Autoimmune Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001707">Biopsy, Needle</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007074">Immunoglobulin G</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007150">Immunohistochemistry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007249">Inflammation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010254">Paranasal Sinus Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010950">Plasma Cells</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012494">Sampling Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019291">Skull Base</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">IgG4</Keyword>
<Keyword MajorTopicYN="N">IgG4-related disease</Keyword>
<Keyword MajorTopicYN="N">autoimmune pancreatitis</Keyword>
<Keyword MajorTopicYN="N">plasma cell related inflammation</Keyword>
<Keyword MajorTopicYN="N">tumefactive fibroinflammatory lesion</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25189032</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>05</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0017-7768</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Harefuah</Title>
<ISOAbbreviation>Harefuah</ISOAbbreviation>
</Journal>
<ArticleTitle>[Lumbar nucleoplasty].</ArticleTitle>
<Pagination>
<MedlinePgn>407-10, 432</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Low back pain (LBP) is one of the common reasons for people to seek treatment from a physician. A familiar cause of LBP and radicular pain is disc bulge or protrusion. The treatment for this indication is diverse and suited to the type pathology and its severity. The treatment can be conservative ranging from a diversity of minimal invasive surgical methods to an open discectomy. The classification of disc herniation is based on the severity of the bulge, whereby the lowest degree is protrusion/ prolapse, then extrusion and the most severe level is sequestered disc. This classification is important when considering the treatment options. One of the known possible treatments for disc protrusion is Nucleoplasty or disc Coblation. This percutaneous surgical method is used to treat discogenic back pain and radicular pain. This method is based on reducing disc volume by using radio frequency energy. During the last decade, many medical centers worldwide used this procedure. In recent years, this method is rising in popuLarity due to its percutaneous approach, low complication rate, good results at the post surgical stage reflecting improvement in symptoms and facilitating rapid return to normal life. The accepted indications for Nucleoplastia are discogenic radicular pain, contained disc herniation according to an MRI scan with intact annulus fibrosus, insufficient response to conservative treatment and absence of a medical emergency as in the case of Cauda Equina syndrome. Patient selection according to those parameters is very important. Today this surgical method is still controversial. In recent years many studies regarding Nucleoplasty have been published, although more research is necessary in order to evaluate long term results and tailor it to the appropriate patient and pathology.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Keren</LastName>
<ForeName>Amit</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Berkovich</LastName>
<ForeName>Yaron</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Merom</LastName>
<ForeName>Lior</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>heb</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Israel</Country>
<MedlineTA>Harefuah</MedlineTA>
<NlmUniqueID>0034351</NlmUniqueID>
<ISSNLinking>0017-7768</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007405">Intervertebral Disc Displacement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017116">Low Back Pain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008159">Lumbar Vertebrae</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019060">Minimally Invasive Surgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010146">Pain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018579">Patient Selection</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25188619</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>05</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1541-8243</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>107</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Southern medical journal</Title>
<ISOAbbreviation>South. Med. J.</ISOAbbreviation>
</Journal>
<ArticleTitle>Successful use of intravenous dexmedetomidine for magnetic resonance imaging sedation in autistic children.</ArticleTitle>
<Pagination>
<MedlinePgn>559-64</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.14423/SMJ.0000000000000160</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Autism and autism spectrum disorders (A/ASD) represent a family of neurodevelopmental conditions that are associated with overactive, difficult-to-control behaviors. Sedating these patients for magnetic resonance imaging (MRI) poses challenges. Children with A/ASD were examined against clinical controls to determine the effectiveness and safety of intravenous (IV) dexmedetomidine for deep sedation.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The quality assurance data on all of the children who received IV dexmedetomidine sedation for MRI between July 2007 and December 2012 were reviewed. Patients in both groups were sedated by an intensivist-based team with a standard plan of 2 g/kg IV dexmedetomidine administered for 10 minutes followed by an infusion of 1 gkg(-1) hour(-1). The amount of IV dexmedetomidine was titrated to the deep level of sedation. A total of 56 patients in the A/ASD group and 107 in the control group were sedated with no reported sedation failures. Sedation parameters were compared between the A/ASD and control groups using analysis of covariance models, controlling for age, sex, and weight.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Children in the A/ASD group were predominantly male (73%) and older (6.1  0.3 years) than children in the control group (56%; 5.0  0.2 years; P &lt; 0.05 for both). Procedure time was significantly shorter for patients in the A/ASD group than in control patients (34.6  2.4 vs 44.3  1.6 minutes; P &lt; 0.05). The A/ASD and control groups required a similar IV bolus of dexmedetomidine (2.6 g/kg  0.1 vs 2.4 g/kg  0.10; P = 0.29), with a significantly lower infusion dose in the A/ASD group (0.74 g/kg  0.05 vs 0.89 g/kg  0.03; P &lt; 0.05). Heart rates were similar in the A/ASD group and the control group (67.0 beats per minute  1.6 vs 69.3  1.1 beats per minute; P = 0.250). There were no complications. Recovery time was approximately 7 minutes longer in the A/ASD group than in the control group, but this was nonsignificant (101.2  3.5 minutes vs 94.2  2.4 minutes; P = 0.12). Analyses were performed using analysis of covariance methods and generalized linear models to control for age, sex, and weight.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Children with A/ASD can be successfully sedated for MRIs with IV dexmedetomidine without complications.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ahmed</LastName>
<ForeName>Sheikh Sohail</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Pediatrics, Riley Hospital for Children at Indiana University Health, Indiana University School of Medicine, and the Department of Biostatistics, Indiana University School of Medicine, Indianapolis.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Unland</LastName>
<ForeName>Tamara</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Pediatrics, Riley Hospital for Children at Indiana University Health, Indiana University School of Medicine, and the Department of Biostatistics, Indiana University School of Medicine, Indianapolis.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Slaven</LastName>
<ForeName>James E</ForeName>
<Initials>JE</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Pediatrics, Riley Hospital for Children at Indiana University Health, Indiana University School of Medicine, and the Department of Biostatistics, Indiana University School of Medicine, Indianapolis.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nitu</LastName>
<ForeName>Mara E</ForeName>
<Initials>ME</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Pediatrics, Riley Hospital for Children at Indiana University Health, Indiana University School of Medicine, and the Department of Biostatistics, Indiana University School of Medicine, Indianapolis.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rigby</LastName>
<ForeName>Mark R</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Pediatrics, Riley Hospital for Children at Indiana University Health, Indiana University School of Medicine, and the Department of Biostatistics, Indiana University School of Medicine, Indianapolis.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>South Med J</MedlineTA>
<NlmUniqueID>0404522</NlmUniqueID>
<ISSNLinking>0038-4348</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>67VB76HONO</RegistryNumber>
<NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>South Med J. 2014 Sep;107(9):565-6</RefSource>
<PMID Version="1">25188620</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D061605">Administration, Intravenous</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001321">Autistic Disorder</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001794">Blood Pressure</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016292">Conscious Sedation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020927">Dexmedetomidine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006339">Heart Rate</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006993">Hypnotics and Sedatives</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25188620</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>05</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1541-8243</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>107</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Southern medical journal</Title>
<ISOAbbreviation>South. Med. J.</ISOAbbreviation>
</Journal>
<ArticleTitle>Commentary on "Successful use of intravenous dexmedetomidine for magnetic resonance imaging sedation in autistic children".</ArticleTitle>
<Pagination>
<MedlinePgn>565-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.14423/SMJ.0000000000000161</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lumeng</LastName>
<ForeName>Julie C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>From the Center for Human Growth and Development, University of Michigan, Ann Arbor.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>South Med J</MedlineTA>
<NlmUniqueID>0404522</NlmUniqueID>
<ISSNLinking>0038-4348</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>67VB76HONO</RegistryNumber>
<NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>South Med J. 2014 Sep;107(9):559-64</RefSource>
<PMID Version="1">25188619</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001321">Autistic Disorder</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016292">Conscious Sedation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020927">Dexmedetomidine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006993">Hypnotics and Sedatives</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25175347</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1537-6605</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>95</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>4</Day>
</PubDate>
</JournalIssue>
<Title>American journal of human genetics</Title>
<ISOAbbreviation>Am. J. Hum. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Mutations in APOPT1, encoding a mitochondrial protein, cause cavitating leukoencephalopathy with cytochrome c oxidase deficiency.</ArticleTitle>
<Pagination>
<MedlinePgn>315-25</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajhg.2014.08.003</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0002-9297(14)00347-4</ELocationID>
<Abstract>
<AbstractText>Cytochrome c oxidase (COX) deficiency is a frequent biochemical abnormality in mitochondrial disorders, but a large fraction of cases remains genetically undetermined. Whole-exome sequencing led to the identification of APOPT1 mutations in two Italian sisters and in a third Turkish individual presenting severe COX deficiency. All three subjects presented a distinctive brain MRI pattern characterized by cavitating leukodystrophy, predominantly in the posterior region of the cerebral hemispheres. We then found APOPT1 mutations in three additional unrelated children, selected on the basis of these particular MRI features. All identified mutations predicted the synthesis of severely damaged protein variants. The clinical features of the six subjects varied widely from acute neurometabolic decompensation in late infancy to subtle neurological signs, which appeared in adolescence; all presented a chronic, long-surviving clinical course. We showed that APOPT1 is targeted to and localized within mitochondria by an N-terminal mitochondrial targeting sequence that is eventually cleaved off from the mature protein. We then showed that APOPT1 is virtually absent in fibroblasts cultured in standard conditions, but its levels increase by inhibiting the proteasome or after oxidative challenge. Mutant fibroblasts showed reduced amount of COX holocomplex and higher levels of reactive oxygen species, which both shifted toward control values by expressing a recombinant, wild-type APOPT1 cDNA. The shRNA-mediated knockdown of APOPT1 in myoblasts and fibroblasts caused dramatic decrease in cell viability. APOPT1 mutations are responsible for infantile or childhood-onset mitochondrial disease, hallmarked by the combination of profound COX deficiency with a distinctive neuroimaging presentation. </AbstractText>
<CopyrightInformation>Copyright  2014 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Melchionda</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Unit of Molecular Neurogenetics, Foundation IRCCS Institute of Neurology Besta, 20126 Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Haack</LastName>
<ForeName>Tobias B</ForeName>
<Initials>TB</Initials>
<AffiliationInfo>
<Affiliation>Institute of Human Genetics, Technische Universitt Mnchen, Munich 81675, Germany; Institute of Human Genetics, Helmholtz Zentrum Mnchen, Neuherberg 85764, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hardy</LastName>
<ForeName>Steven</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Wellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abbink</LastName>
<ForeName>Truus E M</ForeName>
<Initials>TE</Initials>
<AffiliationInfo>
<Affiliation>Departments of Child Neurology and Functional Genomics, Neuroscience Campus Amsterdam, VU University and VU University Medical Center, Amsterdam 1081 HV, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fernandez-Vizarra</LastName>
<ForeName>Erika</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>MRC Mitochondrial Biology Unit, Cambridge CB2 0XY, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lamantea</LastName>
<ForeName>Eleonora</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Unit of Molecular Neurogenetics, Foundation IRCCS Institute of Neurology Besta, 20126 Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marchet</LastName>
<ForeName>Silvia</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Unit of Molecular Neurogenetics, Foundation IRCCS Institute of Neurology Besta, 20126 Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Morandi</LastName>
<ForeName>Lucia</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Neuromuscular Diseases and Neuroimmunology Unit, Foundation IRCCS Institute of Neurology Besta, 20133 Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moggio</LastName>
<ForeName>Maurizio</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Neuromuscular Unit, Department of Neurology, Centro Dino Ferrari, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, 20122 Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Carrozzo</LastName>
<ForeName>Rosalba</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Unit of Neuromuscular Disorders, Laboratory of Molecular Medicine, Bambino Gesu' Children's Research Hospital, 00165 Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Torraco</LastName>
<ForeName>Alessandra</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Unit of Neuromuscular Disorders, Laboratory of Molecular Medicine, Bambino Gesu' Children's Research Hospital, 00165 Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Diodato</LastName>
<ForeName>Daria</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Unit of Molecular Neurogenetics, Foundation IRCCS Institute of Neurology Besta, 20126 Milan, Italy; Unit of Neuromuscular Disorders, Laboratory of Molecular Medicine, Bambino Gesu' Children's Research Hospital, 00165 Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Strom</LastName>
<ForeName>Tim M</ForeName>
<Initials>TM</Initials>
<AffiliationInfo>
<Affiliation>Institute of Human Genetics, Technische Universitt Mnchen, Munich 81675, Germany; Institute of Human Genetics, Helmholtz Zentrum Mnchen, Neuherberg 85764, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Meitinger</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Institute of Human Genetics, Technische Universitt Mnchen, Munich 81675, Germany; Institute of Human Genetics, Helmholtz Zentrum Mnchen, Neuherberg 85764, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tekturk</LastName>
<ForeName>Pinar</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, 34098 Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yapici</LastName>
<ForeName>Zuhal</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, 34098 Istanbul, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Al-Murshedi</LastName>
<ForeName>Fathiya</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Genetic and Developmental Medicine Clinic, Sultan Qaboos University Hospital, Muscat 123, Oman.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stevens</LastName>
<ForeName>Ren</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Paediatrics, CHC Clinique de l'Esprance at Lige, Lige 4000, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rodenburg</LastName>
<ForeName>Richard J</ForeName>
<Initials>RJ</Initials>
<AffiliationInfo>
<Affiliation>Nijmegen Center for Mitochondrial Disorders, Laboratory for Genetic, Endocrine, and Metabolic Disorders, Department of Pediatrics, Radboud University Medical Center, 9101 Nijmegen, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lamperti</LastName>
<ForeName>Costanza</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Unit of Molecular Neurogenetics, Foundation IRCCS Institute of Neurology Besta, 20126 Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ardissone</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Child Neurology, Foundation IRCCS Institute of Neurology Besta, 20133 Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moroni</LastName>
<ForeName>Isabella</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Department of Child Neurology, Foundation IRCCS Institute of Neurology Besta, 20133 Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Uziel</LastName>
<ForeName>Graziella</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Child Neurology, Foundation IRCCS Institute of Neurology Besta, 20133 Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Prokisch</LastName>
<ForeName>Holger</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Institute of Human Genetics, Technische Universitt Mnchen, Munich 81675, Germany; Institute of Human Genetics, Helmholtz Zentrum Mnchen, Neuherberg 85764, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taylor</LastName>
<ForeName>Robert W</ForeName>
<Initials>RW</Initials>
<AffiliationInfo>
<Affiliation>Wellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, The Medical School, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bertini</LastName>
<ForeName>Enrico</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Unit of Neuromuscular Disorders, Laboratory of Molecular Medicine, Bambino Gesu' Children's Research Hospital, 00165 Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van der Knaap</LastName>
<ForeName>Marjo S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Departments of Child Neurology and Functional Genomics, Neuroscience Campus Amsterdam, VU University and VU University Medical Center, Amsterdam 1081 HV, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ghezzi</LastName>
<ForeName>Daniele</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Unit of Molecular Neurogenetics, Foundation IRCCS Institute of Neurology Besta, 20126 Milan, Italy. Electronic address: dghezzi@instituto-besta.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zeviani</LastName>
<ForeName>Massimo</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Unit of Molecular Neurogenetics, Foundation IRCCS Institute of Neurology Besta, 20126 Milan, Italy; MRC Mitochondrial Biology Unit, Cambridge CB2 0XY, UK. Electronic address: mdz21@mrc-mbu.cam.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>MC_UP_1002/1</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Hum Genet</MedlineTA>
<NlmUniqueID>0370475</NlmUniqueID>
<ISSNLinking>0002-9297</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051017">Apoptosis Regulatory Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D024101">Mitochondrial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.9.3.1</RegistryNumber>
<NameOfSubstance UI="D003576">Electron Transport Complex IV</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051017">Apoptosis Regulatory Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D030401">Cytochrome-c Oxidase Deficiency</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003576">Electron Transport Complex IV</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005347">Fibroblasts</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056784">Leukoencephalopathies</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000201">enzymology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008928">Mitochondria</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D024101">Mitochondrial Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009154">Mutation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D032446">Myoblasts</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4157140 [Available on 03/04/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25193908</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>24</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1319-2442</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>25</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia</Title>
<ISOAbbreviation>Saudi J Kidney Dis Transpl</ISOAbbreviation>
</Journal>
<ArticleTitle>Unusual presentation of aortic dissection: post-coital acute paraplegia with renal failure.</ArticleTitle>
<Pagination>
<MedlinePgn>1059-61</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We report the case of a 45-year-old chronic smoker who presented with acute paraplegia occurring during coitus and subsequently developed acute renal failure (ARF) requiring dialysis. He had absent peripheral pulses in the lower limbs with evidence of acute ischemia. Doppler study showed dissecting aneurysm of thoracic aorta, thrombotic occlusion of the distal aorta from L1 level up to bifurcation and occlusion of the right renal artery by a thrombus that was confirmed by magnetic resonance imaging of the spine. He was not subjected to any vascular intervention as his lower limbs were not salvageable due to delay in the diagnosis. Post-coital aortic dissection and aortic dissection presenting with acute paraplegia and ARF are very rare. This is probably the first case report with post-coital acute aortic dissection presenting with paraplegia and ARF. This case emphasizes the importance of a careful examination of peripheral pulses in patients presenting with ARF and paraplegia. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Galabada</LastName>
<ForeName>Dinith P</ForeName>
<Initials>DP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nazar</LastName>
<ForeName>Abdul L M</ForeName>
<Initials>AL</Initials>
<AffiliationInfo>
<Affiliation>Nephrology and Transplant Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Saudi Arabia</Country>
<MedlineTA>Saudi J Kidney Dis Transpl</MedlineTA>
<NlmUniqueID>9436968</NlmUniqueID>
<ISSNLinking>1319-2442</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058186">Acute Kidney Injury</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000784">Aneurysm, Dissecting</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017545">Aortic Aneurysm, Thoracic</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D003075">Coitus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017809">Fatal Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006439">Hemodynamics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010264">Paraplegia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012078">Renal Artery Obstruction</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006435">Renal Dialysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012907">Smoking</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013927">Thrombosis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23111214</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Hemodynamic derangements with hydrogen peroxide instillation in neurosurgery: need for awareness among anesthesiologists and surgeons.</ArticleTitle>
<Pagination>
<MedlinePgn>e388-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2012.10.070</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(12)01244-2</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gyanesh</LastName>
<ForeName>Prakhar</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Sanjay Gandhi Postgraduate Institute, Lucknow, India. Electronic address: prakhargyan@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Haldar</LastName>
<ForeName>Rudrashish</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Sanjay Gandhi Postgraduate Institute, Lucknow, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2012</Year>
<Month>10</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016877">Oxidants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>BBX060AN9V</RegistryNumber>
<NameOfSubstance UI="D006861">Hydrogen Peroxide</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000758">Anesthesia</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002530">Cerebellopontine Angle</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003399">Craniotomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006439">Hemodynamics</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006487">Hemostasis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006861">Hydrogen Peroxide</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008579">Meningioma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009493">Neurosurgery</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016877">Oxidants</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010820">Physicians</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23182733</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>A new thrombosis model of the superior sagittal sinus involving cortical veins.</ArticleTitle>
<Pagination>
<MedlinePgn>169-74</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2012.11.062</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(12)01362-9</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Patients with cerebral sinus and cortical venous thrombosis develop venous infarcts in approximately 50% of cases, resulting in serious clinical symptoms. An animal model is needed to further clarify the underlying mechanisms and consequences surrounding cerebral venous sinus thrombosis, particularly for severe ones.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Adult male Sprague-Dawley rats were used to develop a new superior sagittal sinus thrombosis model involving cortical veins. The superior sagittal sinus was exposed and ligated. A microcatheter was inserted into the sinus, then both common carotid arteries were temporary occluded to reduce cerebral blood flow, and thrombin was injected into the sinus. Twenty-four hours later, after evaluating neurological function and obtaining a magnetic resonance imaging, animals were sacrificed and data pertaining to brain water content, infarct volume, and tissue histology was collected.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Superior sagittal sinus thrombosis and brain infarction were detected in all rats (100%). Hemorrhagic infarction, when present, and brain edema were observed in the brain parenchyma of the parietal lobe. The rate of hemorrhage was 59%, which is similar to that seen clinically in patients with superior sagittal sinus thrombosis. Brain edema, as measured by brain water content percentage, was significantly increased in thrombosed animals compared with sham-operated animals (80.8%  0.55% vs. 78.8%  0.14%, P &lt; 0.05). Infarct volumes were 53.02  7.91 mm(3).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We suggest that our modified model of superior sagittal sinus thrombosis, involving cortical veins, is suitable for the study of its underlying mechanisms, as well as therapeutic approaches directed at the disease.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Guangwen</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Cerebrovascular Diseases Research Institute, Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zeng</LastName>
<ForeName>Xianwei</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Affiliated Hospital of Weifang Medical College, Weifang, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ji</LastName>
<ForeName>Tailing</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Affiliated Hospital of Weifang Medical College, Weifang, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fredrickson</LastName>
<ForeName>Vance</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurological Surgery, Wayne State University School of Medicine, Detroit, Michigan, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Tony</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurological Surgery, Wayne State University School of Medicine, Detroit, Michigan, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hussain</LastName>
<ForeName>Mohammed</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurological Surgery, Wayne State University School of Medicine, Detroit, Michigan, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ren</LastName>
<ForeName>Changhong</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Institute of Hypoxia Medicine, Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Jian</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sikhram</LastName>
<ForeName>Chaitanya</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurological Surgery, Wayne State University School of Medicine, Detroit, Michigan, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ding</LastName>
<ForeName>Yuchuan</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurological Surgery, Wayne State University School of Medicine, Detroit, Michigan, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ji</LastName>
<ForeName>Xunming</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China. Electronic address: jixm@ccmu.edu.cn.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2012</Year>
<Month>11</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004396">Coloring Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013778">Tetrazolium Salts</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7OL20RET2I</RegistryNumber>
<NameOfSubstance UI="C009591">triphenyltetrazolium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):50-3</RefSource>
<PMID Version="1">23920298</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e61-3</RefSource>
<PMID Version="1">23333987</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001834">Body Water</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001929">Brain Edema</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057785">Catheters</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002544">Cerebral Infarction</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002550">Cerebral Veins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002560">Cerebrovascular Circulation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004396">Coloring Agents</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004195">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020300">Intracranial Hemorrhages</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009460">Neurologic Examination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010296">Parietal Lobe</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017207">Rats, Sprague-Dawley</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020225">Sagittal Sinus Thrombosis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013778">Tetrazolium Salts</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cortical vein</Keyword>
<Keyword MajorTopicYN="N">Hemorrhage</Keyword>
<Keyword MajorTopicYN="N">Infarction</Keyword>
<Keyword MajorTopicYN="N">Superior sagittal sinus</Keyword>
<Keyword MajorTopicYN="N">Thrombosis</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23202581</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>A rare case of recurrent frontal osteoma complicated by mucopyocele with an unusual organism, Moraxella catarrhalis.</ArticleTitle>
<Pagination>
<MedlinePgn>240.e13-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2012.11.064</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(12)01364-2</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We report a rare case of recurrent frontal osteoma complicated by mucopyocele and intracranial abscess. Furthermore, we report an unusual organism, Moraxella catarrhalis, as the infectious agent. Finally, we demonstrate that endovascular embolization may be part of the treatment paradigm of frontal osteomas in selected cases.</AbstractText>
<AbstractText Label="CASE DESCRIPTION" NlmCategory="METHODS">A 71-year-old man with a previous history of craniotomy presented to the emergency room with 24 hours of headache episodes, confusion, lethargy, and spells of low-grade fever. Imaging and angiography revealed a complex frontal lesion involving the frontoethmoidal sinuses that extended into the medial orbit and anterior skull base with multiple feeding vessels from the middle meningeal artery. The initial diagnosis of recurrent meningioma was made based on imaging data. The patient underwent partial angiographic embolization of the lesion followed by microneurosurgical complete resection. Pathology revealed a synchronous presentation of an osteoma and mucopyocele with intracranial abscess caused by M.catarrhalis.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Synchronous presentation of a frontal osteoma with mucopyocele is a rare event. However, the case of a recurrent osteoma complicated by infection with M.catarrhalis has not been reported in the literature, nor a treatment paradigm that included preoperative partial endovascular embolization.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ramakrishna</LastName>
<ForeName>Rohan</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Departments of Neurological Surgery and Pathology, University of Washington, Seattle, Washington, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nair</LastName>
<ForeName>M Nathan</ForeName>
<Initials>MN</Initials>
<AffiliationInfo>
<Affiliation>Departments of Neurological Surgery and Pathology, University of Washington, Seattle, Washington, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huber</LastName>
<ForeName>Bertrand</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Departments of Neurological Surgery and Pathology, University of Washington, Seattle, Washington, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sekhar</LastName>
<ForeName>Laligam N</ForeName>
<Initials>LN</Initials>
<AffiliationInfo>
<Affiliation>Departments of Neurological Surgery and Pathology, University of Washington, Seattle, Washington, USA. Electronic address: lsekhar@u.washington.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2012</Year>
<Month>11</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001922">Brain Abscess</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002533">Cerebral Angiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004621">Embolization, Therapeutic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005094">Exophthalmos</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018810">Magnetic Resonance Angiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008579">Meningioma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001936">Moraxella (Branhamella) catarrhalis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D045828">Moraxellaceae Infections</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009078">Mucocele</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010016">Osteoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010255">Paranasal Sinus Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012907">Smoking</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Abscess</Keyword>
<Keyword MajorTopicYN="N">Angiography</Keyword>
<Keyword MajorTopicYN="N">Infection</Keyword>
<Keyword MajorTopicYN="N">Meningioma</Keyword>
<Keyword MajorTopicYN="N">Mucocele</Keyword>
<Keyword MajorTopicYN="N">Mucopyocele</Keyword>
<Keyword MajorTopicYN="N">Osteoma</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23313261</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Real-time ultrasound monitoring during intracranial needle biopsies: operative results and detection of complications in 100 cases.</ArticleTitle>
<Pagination>
<MedlinePgn>202-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.01.019</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)00068-5</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Intraoperative ultrasound displays dynamic processes intraoperatively. Performing burr-hole biopsies under a real-time visual control is an interesting option for the neurosurgeon. However, the percentage of conclusive diagnoses obtained by this technique and the rate of complications must be evaluated in a larger series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">One hundred consecutive intracranial biopsies were analyzed. Through a burr hole, the lesion was localized by ultrasonography, and the planned needle trajectory was superimposed onto the image. Intracranial vessels were imaged by Doppler flow signals. Biopsies were taken in a mean depth of 41 mm (maximal 65 mm) from different parts of each tumor.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-six lesions involved the corpus callosum, 16 lesions were located deeply within the white matter, five in the internal capsule, and one in the upper brainstem. There were three cerebellar and 17 temporal lesions. Ten tumors did not exceed a diameter of 15 mm in any plane. The mean time interval from skin incision to the end of suturing was 45 minutes, and the mean time from the surgeons entering the operating theater to leaving the theater was 63 minutes. In 95% of the lesions, a diagnosis could be established. Transient neurologic deficits occurred in five patients, which were permanent in three. In 42 patients without postoperative neurological symptoms, postoperative computed tomography scans were obtained within 24 hours; a visible hemorrhage occurred in eight (19%), six of which were seen intraoperatively.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">When intraoperative ultrasound-navigated biopsies were used they obtained a similar percentage of conclusive diagnoses as stereotactic biopsies. The complication rate is comparable as well. Emerging intracranial complications such as hemorrhages can be observed. However, their incidence cannot be decreased.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Allouch</LastName>
<ForeName>Hassan</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Zentralklinik, Bad Berka, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pfeifenbring</LastName>
<ForeName>Sabine</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Institute of Neuropathology, University Medical Center, Georg August University, Gttingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Behnke-Mursch</LastName>
<ForeName>Julianne</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Zentralklinik, Bad Berka, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Halatsch</LastName>
<ForeName>Marc-Eric</ForeName>
<Initials>ME</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, University of Ulm, Ulm, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mursch</LastName>
<ForeName>Kay</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Zentralklinik, Bad Berka, Germany. Electronic address: kay.mursch@zentralklinik.de.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>01</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):60-2</RefSource>
<PMID Version="1">23523682</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000768">Anesthesia, General</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001707">Biopsy, Needle</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001927">Brain Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004388">Dura Mater</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013238">Stereotaxic Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018084">Ultrasonography, Interventional</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Biopsy</Keyword>
<Keyword MajorTopicYN="N">Brain neoplasm</Keyword>
<Keyword MajorTopicYN="N">Complications</Keyword>
<Keyword MajorTopicYN="N">Histopathology</Keyword>
<Keyword MajorTopicYN="N">Stereotaxy</Keyword>
<Keyword MajorTopicYN="N">Ultrasonography</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23314030</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Surgically induced SMART syndrome: case report and review of the literature.</ArticleTitle>
<Pagination>
<MedlinePgn>240.e7-12</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.01.028</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)00089-2</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Strokelike migraine attack after radiation therapy is a recently described clinical entity characterized by transient hemispheric dysfunction manifesting as, but not limited to, visuospatial deficits, confusion, hemisensory deficits, hemiparesis, aphasia, seizures, and, most prominently, headache in patients with a history of remote external beam radiation therapy to the brain. The radiographic hallmark on magnetic resonance imaging is the presence of transient, diffuse, unilateral gadolinium enhancement of the cortex with white matter sparing, usually corresponding to the previous radiation field.</AbstractText>
<AbstractText Label="CASE DESCRIPTION" NlmCategory="METHODS">We present a case of strokelike migraine attacks after radiation therapy syndrome diagnosed immediately following a craniotomy and temporal lobectomy for recurrent metastatic tumor resection after prior gamma knife radiosurgery and whole-brain radiation therapy.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">SMART syndrome should be considered in the differential diagnosis of postsurgical patients with remote history of cranial irradiation and significant, new transient neurologic deficits not explainable by any other mechanism. It is possible that manipulation of the trigeminal ganglion, or the dura of the Meckel cave, contributed to triggering the manifestations of this syndrome in our patient during the immediate postoperative period.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Maloney</LastName>
<ForeName>Patrick R</ForeName>
<Initials>PR</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Mayo Clinic, College of Medicine, Rochester, Minnesota, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rabinstein</LastName>
<ForeName>Alejandro A</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Mayo Clinic, College of Medicine, Rochester, Minnesota, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Daniels</LastName>
<ForeName>David J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Mayo Clinic, College of Medicine, Rochester, Minnesota, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Link</LastName>
<ForeName>Michael J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Mayo Clinic, College of Medicine, Rochester, Minnesota, USA. Electronic address: link.michael@mayo.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>01</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7S5I7G3JQL</RegistryNumber>
<NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e193-4</RefSource>
<PMID Version="1">23376390</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000230">Adenocarcinoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D038481">Anterior Temporal Lobectomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000893">Anti-Inflammatory Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000971">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001943">Breast Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003399">Craniotomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003907">Dexamethasone</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006261">Headache</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008175">Lung Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000556">secondary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015412">Mastectomy, Segmental</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008881">Migraine Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009422">Nervous System Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011832">Radiation Injuries</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016634">Radiosurgery</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013577">Syndrome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Radiation</Keyword>
<Keyword MajorTopicYN="N">SMART syndrome</Keyword>
<Keyword MajorTopicYN="N">Trigeminovascular system</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23369940</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Orbital congestion complicating treatment of cerebral vascular anomalies.</ArticleTitle>
<Pagination>
<MedlinePgn>239.e13-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.01.093</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)00192-7</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The decision between conservative management and invasive treatment of juxtaorbital intracranial vascular anomalies can be challenging. Whereas arteriovenous malformations (AVMs) can lead to vision loss and are potentially life-threatening if they rupture, invasive endovascular and surgical procedures also carry risks.</AbstractText>
<AbstractText Label="CASE DESCRIPTIONS" NlmCategory="METHODS">Two patients developed blinding orbital congestion soon after they were treated successfully for cerebral vascular anomalies. The first patient, a 36 year-old man, underwent partial embolization followed by resection of a congenital frontal-lobe AVM. The second patient, a 62 year-old woman, underwent embolization of a periorbital/skull base dural arteriovenous malformation. After intervention, both patients developed unilateral vision loss proptosis, chemosis, complete ophthalmoplegia, and increased intraocular pressure. The first patient suffered from acute orbital compartment syndrome in the absence of any acute localized hemorrhage or thrombosis. The second patient experienced refractory acute glaucoma from orbital congestion, secondary hyphema, and angle closure caused by superior ophthalmic vein and cavernous sinus thromboses.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These cases highlight the potential for orbital congestion to worsen acutely after invasive treatment of juxtaorbital cerebral vascular anomalies and suggest diverse mechanisms of resultant visual and orbital compromise. The first case represents the first report of orbital compartment syndrome after resection of a congenital AVM.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Levin</LastName>
<ForeName>Marc H</ForeName>
<Initials>MH</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: marc.levin@uphs.upenn.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moss</LastName>
<ForeName>Heather E</ForeName>
<Initials>HE</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pineles</LastName>
<ForeName>Stacy L</ForeName>
<Initials>SL</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bagley</LastName>
<ForeName>Linda J</ForeName>
<Initials>LJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heuer</LastName>
<ForeName>Gregory G</ForeName>
<Initials>GG</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zager</LastName>
<ForeName>Eric L</ForeName>
<Initials>EL</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Balcer</LastName>
<ForeName>Laura J</ForeName>
<Initials>LJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Galetta</LastName>
<ForeName>Steven L</ForeName>
<Initials>SL</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vagefi</LastName>
<ForeName>M Reza</ForeName>
<Initials>MR</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K12 EY021475</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>01</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e189-90</RefSource>
<PMID Version="1">24103550</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e191-2</RefSource>
<PMID Version="1">23474182</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001766">Blindness</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002533">Cerebral Angiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003399">Craniotomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004322">Drainage</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004621">Embolization, Therapeutic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005901">Glaucoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002538">Intracranial Arteriovenous Malformations</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015835">Ocular Motility Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009901">Optic Nerve Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009915">Orbit</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014792">Visual Acuity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS468245 [Available on 07/01/15]</OtherID>
<OtherID Source="NLM">PMC3766429 [Available on 07/01/15]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Arteriovenous malformation</Keyword>
<Keyword MajorTopicYN="N">Dural arteriovenous fistula</Keyword>
<Keyword MajorTopicYN="N">Orbital compartment syndrome</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23385448</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report.</ArticleTitle>
<Pagination>
<MedlinePgn>195-201</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.01.127</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)00264-7</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Single fraction stereotactic radiosurgery (SRS) is a common adjuvant therapy for hormonally active pituitary adenomas when surgical resection fails to control tumor growth or normalize hypersecretory activity. Marginal doses of 20-24 Gy are used at many centers and here we report our outcome data in patients treated with a higher marginal dose of 35 Gy.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Thirty-one patients with secretory pituitary adenomas (adrenocorticotropic hormone, n = 15; growth hormone, n = 13; prolactin, n = 2; thyroid-stimulating hormone, n = 1) were treated with 35 Gy to the 50% isodose line, and had a mean follow-up time of 40.2 months (range = 12-96). All patients were evaluated post-SRS for time to hormonal normalization, time to relapse, as well as incidence and time course of radiation-induced hypopituitarism and cranial neuropathies.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Initial normalization of hypersecretion was achieved in 22 patients (70%) with a median time to remission of 17.7 months. After initial hormonal remission, 7 patients (32%) experienced an endocrine relapse, with a mean time to relapse of 21 months. New endocrine deficiency within any of the five major hormonal axes occurred in 10 patients (32%). One patient (3%) developed new-onset unilateral optic nerve pallor within the temporal field 3 years after SRS. Three patients (10%) reported transient new or increasing frontal headaches of unclear etiology following their procedures.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Time to endocrine remission was more rapid in patients treated with 35 Gy, as compared to previously reported literature using marginal doses of 20-24 Gy. Rates of endocrine remission and relapse, post-SRS hypopituitarism, and radiation-induced sequelae were not increased following higher dose treatment.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Grant</LastName>
<ForeName>Ryan A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Yale University School of Medicine and Yale-New Haven Medical Center, New Haven, Connecticut, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Whicker</LastName>
<ForeName>Margaret</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Yale University School of Medicine and Yale-New Haven Medical Center, New Haven, Connecticut, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lleva</LastName>
<ForeName>Ranee</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Section of Endocrinology, Yale University School of Medicine and Yale-New Haven Medical Center, New Haven, Connecticut, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Knisely</LastName>
<ForeName>Jonathan P S</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Hofstra North Shore-LIJ School of Medicine, Manhasset, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Inzucchi</LastName>
<ForeName>Silvio E</ForeName>
<Initials>SE</Initials>
<AffiliationInfo>
<Affiliation>Section of Endocrinology, Yale University School of Medicine and Yale-New Haven Medical Center, New Haven, Connecticut, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chiang</LastName>
<ForeName>Veronica L</ForeName>
<Initials>VL</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Yale University School of Medicine and Yale-New Haven Medical Center, New Haven, Connecticut, USA. Electronic address: veronica.chiang@yale.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>02</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010907">Pituitary Hormones</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e75-6</RefSource>
<PMID Version="1">23459276</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):58-9</RefSource>
<PMID Version="1">23500123</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e71-3</RefSource>
<PMID Version="1">23459278</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000236">Adenoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004307">Dose-Response Relationship, Radiation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007018">Hypopituitarism</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053208">Kaplan-Meier Estimate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009364">Neoplasm Recurrence, Local</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009900">Optic Nerve</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010907">Pituitary Hormones</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010911">Pituitary Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016634">Radiosurgery</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016019">Survival Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">35 Gy</Keyword>
<Keyword MajorTopicYN="N">Gamma-knife surgery</Keyword>
<Keyword MajorTopicYN="N">Optic apparatus</Keyword>
<Keyword MajorTopicYN="N">Optic nerves</Keyword>
<Keyword MajorTopicYN="N">Pituitary adenoma</Keyword>
<Keyword MajorTopicYN="N">Stereotactic radiosurgery</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23403355</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>The transplanum transtuberculum approaches for suprasellar and sellar-suprasellar lesions: avoidance of cerebrospinal fluid leak and lessons learned.</ArticleTitle>
<Pagination>
<MedlinePgn>186-95</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.02.032</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)00297-0</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To present a large series of patients and examine the learning curve of the endonasal endoscopic transplanum, transtuberculum approach for primarily suprasellar or sellar-suprasellar tumors.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We identified 122 patients who underwent 126 surgeries using the transplanum, transtuberculum approach. Extent of resection was determined with volumetric analysis of magnetic resonance imagings. Results concerning vision, endocrine function, and complications were noted.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Average tumor volume was 14 cm(3). The most frequent pathologies were pituitary macroadenoma (51.6%), craniopharyngioma (20.6%), and meningioma (15.9%). A total of 73% patients presented with visual compromise. Rates of gross total resection (GTR) and near total resection for the group as a whole were 58.1% and 13.7%, and for the patients in whom GTR was intended (n = 90), rates of GTR and near total resection were 77.5% and 12.5% for a total of 90%. Extent of resection in this group was 97.6%. Vision improved in 52.4% and deteriorated in 4.8%. Favorable endocrine outcome occurred in 63.5%. The cerebrospinal fluid leak rate was 3.1% for the series as a whole. It improved from 6.3% in the first half of the series to 0 in the second half. Leak rates varied with technique from 11% (fat graft only) to 4.2% (gasket seal only) to 1.8% (fat plus nasoseptal flap) to 0 (gasket plus nasoseptal flap). The rate of other complications was 14.3% in the first half of the series and 1.6% in the second half. There was one infection (0.8%).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The endonasal endoscopic transtuberculum transplanum approach is a safe and effective minimal access approach to midline pathology in the suprasellar cistern.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mascarenhas</LastName>
<ForeName>Lino</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Brain and Spine Center, Brain and Mind Research Institute, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moshel</LastName>
<ForeName>Yaron A</ForeName>
<Initials>YA</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Brain and Spine Center, Brain and Mind Research Institute, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bayad</LastName>
<ForeName>Fatema</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Brain and Spine Center, Brain and Mind Research Institute, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Szentirmai</LastName>
<ForeName>Oszkar</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Brain and Spine Center, Brain and Mind Research Institute, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Salek</LastName>
<ForeName>Al Amin</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Brain and Spine Center, Brain and Mind Research Institute, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leng</LastName>
<ForeName>Lewis Z</ForeName>
<Initials>LZ</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Brain and Spine Center, Brain and Mind Research Institute, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hofstetter</LastName>
<ForeName>Christoph P</ForeName>
<Initials>CP</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Brain and Spine Center, Brain and Mind Research Institute, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Placantonakis</LastName>
<ForeName>Dimitris G</ForeName>
<Initials>DG</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Brain and Spine Center, Brain and Mind Research Institute, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tsiouris</LastName>
<ForeName>Apostolos J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Brain and Spine Center, Brain and Mind Research Institute, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Anand</LastName>
<ForeName>Vijay K</ForeName>
<Initials>VK</Initials>
<AffiliationInfo>
<Affiliation>Department of Otolaryngology, Brain and Spine Center, Brain and Mind Research Institute, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schwartz</LastName>
<ForeName>Theodore H</ForeName>
<Initials>TH</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Brain and Spine Center, Brain and Mind Research Institute, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York, USA; Department of Neurology and Neuroscience, Brain and Spine Center, Brain and Mind Research Institute, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York, USA; Department of Otolaryngology, Brain and Spine Center, Brain and Mind Research Institute, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York, USA. Electronic address: schwarh@med.cornell.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>02</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e65-6</RefSource>
<PMID Version="1">23500340</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):56-7</RefSource>
<PMID Version="1">23542393</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e67-9</RefSource>
<PMID Version="1">23542388</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D065634">Cerebrospinal Fluid Leak</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002559">Cerebrospinal Fluid Rhinorrhea</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004724">Endoscopy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059032">Learning Curve</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019060">Minimally Invasive Surgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009296">Nasal Cavity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018365">Neoplasm, Residual</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009422">Nervous System Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010901">Pituitary Function Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010911">Pituitary Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019291">Skull Base</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014786">Vision Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Craniopharyngioma</Keyword>
<Keyword MajorTopicYN="N">Endonasal transsphenoidal approach</Keyword>
<Keyword MajorTopicYN="N">Meningioma</Keyword>
<Keyword MajorTopicYN="N">Planum sphenoidale</Keyword>
<Keyword MajorTopicYN="N">Rathke cleft cyst</Keyword>
<Keyword MajorTopicYN="N">Skull base</Keyword>
<Keyword MajorTopicYN="N">Tuberculum sellae</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23416769</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>A comparison of cell-cycle markers in skull base and sacral chordomas.</ArticleTitle>
<Pagination>
<MedlinePgn>e311-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.01.131</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)00319-7</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Despite refinement of surgical techniques and adjuvant radiotherapy, the prognosis for patients with a chordoma remains poor. Identification of prognostic factors related to tumor biology might improve this assessment and result in molecular markers for targeted therapy. Limited studies have been performed to unravel the impact of cell-cycle markers in chordoma, and those performed have shown inconclusive results. In the current study, we aimed to discover the impact of cyclin-dependent kinase 4 (CDK4) expression and its relation to prognosis and other cell-cycle markers in chordoma.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Twenty-five human formalin-fixed, paraffin-embedded chordoma specimens were examined by immunohistochemistry for the expression of CDK4, protein 53 (p53), and murine double minute 2 (MDM2). The MIB-1 labeling index and mitotic index were used for the examination of proliferation. We collected detailed demographic and clinical data.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Overexpression of CDK4, p53, and MDM2 was found in five (20%), seven (28%), and 14 (56%) of the cases, respectively. All three cell-cycle markers showed a significant correlation with MIB1 labeling index. Expression of CDK4 (P = 0.02) and p53 (P &lt; 0.01) were both significantly correlated with poor overall survival. Also, histologically observed necrosis (P &lt; 0.05) and a dedifferentiated tumor subtype (P &lt; 0.01) were related to adverse patient outcome.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results show that the expression of CDK4 and p53 are related to cell proliferation capacity and worse outcome in patients with chordoma.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yakkioui</LastName>
<ForeName>Youssef</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands; Department of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands; European Graduate School of Neuroscience, Maastricht, The Netherlands; School for Oncology and Developmental Biology, Maastricht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Temel</LastName>
<ForeName>Yasin</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands; Department of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands; European Graduate School of Neuroscience, Maastricht, The Netherlands. Electronic address: y.temel@maastrichtuniversity.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Creytens</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>School for Oncology and Developmental Biology, Maastricht, The Netherlands; Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jahanshahi</LastName>
<ForeName>Ali</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands; Department of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands; European Graduate School of Neuroscience, Maastricht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fleischeuer</LastName>
<ForeName>Ruth</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Sint Elisabeth Hospital, Tilburg, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Santegoeds</LastName>
<ForeName>Ren G C</ForeName>
<Initials>RG</Initials>
<AffiliationInfo>
<Affiliation>Department of Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands; European Graduate School of Neuroscience, Maastricht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Van Overbeeke</LastName>
<ForeName>Jacobus J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands; Department of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands; European Graduate School of Neuroscience, Maastricht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>02</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019394">Ki-67 Antigen</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014408">Tumor Markers, Biological</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016159">Tumor Suppressor Protein p53</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.22</RegistryNumber>
<NameOfSubstance UI="D051358">Cyclin-Dependent Kinase 4</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 6.3.2.19</RegistryNumber>
<NameOfSubstance UI="C497207">Mdm2 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 6.3.2.19</RegistryNumber>
<NameOfSubstance UI="D051736">Proto-Oncogene Proteins c-mdm2</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e135-7</RefSource>
<PMID Version="1">23380279</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018797">Cell Cycle Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002817">Chordoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016001">Confidence Intervals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051358">Cyclin-Dependent Kinase 4</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007150">Immunohistochemistry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053208">Kaplan-Meier Estimate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019394">Ki-67 Antigen</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016612">Paraffin Embedding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051736">Proto-Oncogene Proteins c-mdm2</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012445">Sacrococcygeal Region</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019292">Skull Base Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013125">Spinal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016019">Survival Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014408">Tumor Markers, Biological</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016159">Tumor Suppressor Protein p53</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Chordoma</Keyword>
<Keyword MajorTopicYN="N">Cyclin-dependent kinase 4</Keyword>
<Keyword MajorTopicYN="N">MIB-1</Keyword>
<Keyword MajorTopicYN="N">Mouse double murine 2</Keyword>
<Keyword MajorTopicYN="N">Survival</Keyword>
<Keyword MajorTopicYN="N">p53</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23428375</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Military rank and the symptoms of lumbar disc herniation in young Korean soldiers.</ArticleTitle>
<Pagination>
<MedlinePgn>e9-e14</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.02.056</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)00342-2</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">There are many factors associated with the symptom presentation of lumbar disc herniation (LDH). However, there are only few reports regarding the clinical feature of LDH in military medicine. The objective of this study is to determine the factors that affected the symptoms of LDH in young Korean soldiers.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">One hundred thirty male soldiers, diagnosed with LDH, were enrolled in this study. They were divided into four groups, according to their military ranks: private, private first class, corporal, and sergeant. The visual analog scale for low back pain (VAS-LBP), the VAS for leg pain (VAS-LP), and the Oswestry Disability Index (ODI) were evaluated. The education level and military rank were also reviewed and their relationship with the degree of symptoms was investigated.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean age for the male subjects enrolled was 20.7  1.2. The mean VAS-LBP, VAS-LP, and ODI were 6.6%  1.7%, 7.1%  1.9%, and 46.0%  16.3%, respectively. There was no statistically significant relationship between the degree of symptoms and the radiologic findings. However, the military rank had an inverse correlation with the VAS scores and the ODI (P &lt; 0.05).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our data showed that the military rank was associated with the symptom presentation of LDH and reflected the characteristics of military life.</AbstractText>
<CopyrightInformation>Crown Copyright  2014. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kang</LastName>
<ForeName>Suk Hyung</ForeName>
<Initials>SH</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Spine Center, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University, Chuncheon, Korea. Electronic address: nscharisma@hanmail.net.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Jin Seo</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Spine Center, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University, Chuncheon, Korea. Electronic address: yiyaseo@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cho</LastName>
<ForeName>Yong Jun</ForeName>
<Initials>YJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Spine Center, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University, Chuncheon, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Park</LastName>
<ForeName>Seung Won</ForeName>
<Initials>SW</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Chung-Ang University College of Medicine, Dongjak, Seoul, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ko</LastName>
<ForeName>Kwang Pil</ForeName>
<Initials>KP</Initials>
<AffiliationInfo>
<Affiliation>Department of Preventive Medicine, Gachon University of Medicine and Science, Guwol 1-dong, Namdong-gu, Inchon, Korea.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>02</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e159-61</RefSource>
<PMID Version="1">23924968</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e157-8</RefSource>
<PMID Version="1">23920288</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017677">Age Distribution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004185">Disability Evaluation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004522">Educational Status</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007405">Intervertebral Disc Displacement</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017116">Low Back Pain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008159">Lumbar Vertebrae</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008889">Military Personnel</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010147">Pain Measurement</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D056910">Republic of Korea</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012959">Socioeconomic Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Correlation study</Keyword>
<Keyword MajorTopicYN="N">Lumbar disc herniation</Keyword>
<Keyword MajorTopicYN="N">Social class</Keyword>
<Keyword MajorTopicYN="N">Worker's compensation</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23438971</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Intraoperative coregistration of magnetic resonance imaging, positron emission tomography, and electrocorticographic data for neocortical lesional epilepsies may improve the localization of the epileptogenic focus: a pilot study.</ArticleTitle>
<Pagination>
<MedlinePgn>110-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.02.057</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)00343-4</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To objectively mark out abnormal areas of magnetic resonance imaging (MRI), positron emission tomography (PET), and electrocorticography (ECoG) using neuronavigation so as to 1) enhance the accuracy of margins of the epileptogenic zone and 2) understand the relationships of all the three modalities with each other.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A prospective study was conducted of 37 patients with intractable epilepsy due to lesional, neocortical pathologies from noneloquent areas. Prior to surgery, fusion and transfer of MRI and PET images onto a neuronavigation system was performed. At surgery, this was correlated to intraoperative ECoG using the electrode as referential points. An objective score was created for every electrode point that was correlated with MRI and PET abnormality at the point. The extent of surgical resection was mapped out using these data.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">From a total of the data recorded from 1280 electrode points, 23.5% were located over the lesion. In addition, over the lesions, 93% of PET and 66% of ECoG points were abnormal. Over the perilesional areas, 43% of PET and 45% of ECoG points were abnormal. Using these data for surgery, both lesional and perileisonal areas were resected; 33/37 patients had good outcome (25 Engel I, 8 Engel II) (mean follow-up: 23.6  3.2 months; range 18-31 months).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Multimodal imaging and ECoG using this method seems to provide a better objective localization of the epileptogenic foci.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chandra</LastName>
<ForeName>Sarat P</ForeName>
<Initials>SP</Initials>
<AffiliationInfo>
<Affiliation>Neurosciences Center, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bal</LastName>
<ForeName>C S</ForeName>
<Initials>CS</Initials>
<AffiliationInfo>
<Affiliation>Neurosciences Center, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jain</LastName>
<ForeName>Shailesh</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Neurosciences Center, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Joshua</LastName>
<ForeName>Shejoy P</ForeName>
<Initials>SP</Initials>
<AffiliationInfo>
<Affiliation>Neurosciences Center, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gaikwad</LastName>
<ForeName>Shailesh</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Neurosciences Center, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Garg</LastName>
<ForeName>Ajay</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Neurosciences Center, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ansari</LastName>
<ForeName>Abuzar</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Neurosciences Center, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nehra</LastName>
<ForeName>Ashima</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Neurosciences Center, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sarkar</LastName>
<ForeName>Chitra</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Neurosciences Center, All India Institute of Medical Sciences, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tripathi</LastName>
<ForeName>Manjari</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Neurosciences Center, All India Institute of Medical Sciences, New Delhi, India. Electronic address: manjari2tripathi@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>02</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0Z5B2CJX4D</RegistryNumber>
<NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001931">Brain Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003627">Data Interpretation, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004827">Epilepsy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019788">Fluorodeoxyglucose F18</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019579">Neocortex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010865">Pilot Projects</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019275">Radiopharmaceuticals</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Coregistration</Keyword>
<Keyword MajorTopicYN="N">Electrocorticography</Keyword>
<Keyword MajorTopicYN="N">Intraoperative</Keyword>
<Keyword MajorTopicYN="N">Lesional epilepsy</Keyword>
<Keyword MajorTopicYN="N">Multimodal imaging</Keyword>
<Keyword MajorTopicYN="N">Neocortical epilepsy</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23563303</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparative proteomic tissue analysis in patients with ossification of the posterior longitudinal ligament.</ArticleTitle>
<Pagination>
<MedlinePgn>e353-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.03.033</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)00480-4</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The ossification of the posterior longitudinal ligament (OPLL) involves the ligament that lines the posterior surface of the spinal vertebral bodies. Hormonal and metabolic factors as well as hereditary factors have been proposed to be involved in pathologic ligamentous OPLL. However, there are currently no definitive serological biomarkers for OPLL that might be used to achieve a more convenient and economic diagnosis. To find an easier and simpler diagnostic method and to identify pathogenic proteins associated with OPLL, we assessed PLL tissues from patients with OPLL for proteomic alterations.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">OPLL tissues were collected from 12 patients with OPLL, and non-OPLL tissues were collected from 12 healthy subjects without OPLL. To minimize individual variations, we matched the sex and age of the patients in the healthy and OPLL groups. The two-dimensional electrophoresis patterns of tissue from 12 OPLL patients and 12 healthy subjects were compared.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We found 25 proteins that were significantly and consistently different on the two-dimensional electrophoresis gels between the group of ossified PLL tissues from the patients with OPLL and the group of nonossified PLL tissues from the healthy subjects. Among them, 21 proteins were up-regulated in the patients with OPLL, whereas the remaining four proteins were down-regulated.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The information obtained via this proteomic analysis will be very useful in understanding the pathophysiology of OPLL as well as in finding protein candidates to serve as new diagnostic biomarkers of OPLL.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Oh</LastName>
<ForeName>Young-Min</ForeName>
<Initials>YM</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Research Institute of Clinical Medicine, Chonbuk National University Medical School and Hospital, Jeonju, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Woo-Jong</ForeName>
<Initials>WJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Research Institute of Clinical Medicine, Chonbuk National University Medical School and Hospital, Jeonju, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Min-Gul</ForeName>
<Initials>MG</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, Research Institute of Clinical Medicine, Chonbuk National University Medical School and Hospital, Jeonju, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ma</LastName>
<ForeName>Tian-Ze</ForeName>
<Initials>TZ</Initials>
<AffiliationInfo>
<Affiliation>Department of Hematology, Yambian University Hospital, Yanji Jilin, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kwak</LastName>
<ForeName>Yong-Geun</ForeName>
<Initials>YG</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, Research Institute of Clinical Medicine, Chonbuk National University Medical School and Hospital, Jeonju, Korea. Electronic address: ygkwak@jbnu.ac.kr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eun</LastName>
<ForeName>Jong-Pil</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Research Institute of Clinical Medicine, Chonbuk National University Medical School and Hospital, Jeonju, Korea. Electronic address: spineeun@jbnu.ac.kr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>04</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biological Markers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.21.4</RegistryNumber>
<NameOfSubstance UI="D014357">Trypsin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015415">Biological Markers</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015536">Down-Regulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015180">Electrophoresis, Gel, Two-Dimensional</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006868">Hydrolysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017887">Ossification of Posterior Longitudinal Ligament</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D040901">Proteomics</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016622">Silver Staining</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019032">Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014357">Trypsin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015854">Up-Regulation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Biomarker</Keyword>
<Keyword MajorTopicYN="N">Enthesopathy</Keyword>
<Keyword MajorTopicYN="N">Mass spectrometry</Keyword>
<Keyword MajorTopicYN="N">Ossification of posterior longitudinal ligament</Keyword>
<Keyword MajorTopicYN="N">Proteomics</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23851213</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Surgical decompression for optic neuropathy from carotid artery ectasia: case report with technical considerations.</ArticleTitle>
<Pagination>
<MedlinePgn>239.e9-12</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.06.023</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)00770-5</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Symptomatic compression of the optic nerve (ON) through its intracranial course or within the orbit may occur at several locations by abnormalities of adjacent soft tissue, bony, or vascular structures. Compressive optic neuropathy secondary to vascular ectasia is a rare phenomenon.</AbstractText>
<AbstractText Label="CASE DESCRIPTION" NlmCategory="METHODS">An adult male patient presented with a several month history of monocular visual loss. Imaging demonstrated compression of the ipsilateral ON by an ectatic carotid artery. Magnetic resonance imaging, ophthalmologic examination, and cerebral angiography did not demonstrate an alternative etiology of his visual loss. Conservative management was recommended; however, the patient's vision deteriorated further and pterional craniotomy was offered. Intraoperative examination demonstrated a distal origin of the ophthalmic artery that was bulging into, and pulsating against, the adjacent ON. Anterior clinoidectomy, falciform ligament transection, and sponge padding of the ON were then performed. The patient's visual loss improved rapidly postoperatively and at 1 month follow-up the patient exhibited normal visual fields on ophthalmologic testing.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We present a patient with severe monocular visual loss and significant anatomic displacement of the ON by an ectatic internal carotid artery-ophthalmic artery complex with dramatic and rapid visual improvement after surgical decompression. Complete untethering of the nerve and total cessation of transmitted pulsatility may not be necessary for symptomatic improvement. Optic nerve contact or displacement by the ipsilateral carotid artery is common in asymptomatic patients, therefore ruling out other etiologies of monocular visual loss before surgical decompression is paramount.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fargen</LastName>
<ForeName>Kyle M</ForeName>
<Initials>KM</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, University of Florida, Gainesville, Florida, USA. Electronic address: kyle.fargen@neurosurgery.ufl.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Blackburn</LastName>
<ForeName>Spiros</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, University of Florida, Gainesville, Florida, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>07</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002340">Carotid Artery Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002533">Cerebral Angiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003399">Craniotomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019299">Decompression, Surgical</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004108">Dilatation, Pathologic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009901">Optic Nerve Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011014">Pneumonia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D029424">Pulmonary Disease, Chronic Obstructive</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020127">Recovery of Function</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014786">Vision Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014785">Vision, Ocular</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Internal carotid artery</Keyword>
<Keyword MajorTopicYN="N">Microvascular decompression</Keyword>
<Keyword MajorTopicYN="N">Optic nerve</Keyword>
<Keyword MajorTopicYN="N">Optic neuropathy</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23851228</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Irregular neointimal lining with prominent proliferative activity after carotid patch angioplasty: an autopsy case report.</ArticleTitle>
<Pagination>
<MedlinePgn>240.e1-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.06.022</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)00769-9</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Although the healing response after carotid balloon injury and carotid patch angioplasty injury has been well-documented in animal models, there is limited information about this process after carotid endarterectomy (CEA) in human patients.</AbstractText>
<AbstractText Label="CASE DESCRIPTION" NlmCategory="METHODS">We describe the autopsy results of a 79-year-old man who died 18 days after CEA with patch angioplasty. The treated carotid artery had an adequate luminal diameter. Elastica-Masson staining revealed that the treated portion was covered with neointima but the patch graft was exposed to the arterial lumen at 18 days after CEA. Immunohistochemistry staining for alpha-smooth muscle actin (-SMA), von-Willebrand factor, and vascular endothelial growth factor receptor-2 revealed that the neointima was mainly composed of -SMA-positive cells. In addition, the -SMA-rich neointima had many more Ki-67-positive cells than did the internal carotid artery intima in the area beyond the CEA-treated portion.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This case report is the first to describe an entire carotid artery specimen in the acute stage after CEA with patch angioplasty. These findings suggest that an -SMA-rich neointima with prominent proliferative activity covers the inner surface of the treated carotid artery, but patch grafts are left uncovered. The intrinsic arterial wall may have an important role in intimal regeneration after CEA, although the nature of the neointima and the mechanism by which it regulates proliferative activity remain unclarified.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ito</LastName>
<ForeName>Masaki</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Otaru Municipal Medical Center, Otaru, Japan. Electronic address: masakiitou-nsu@umin.ac.jp.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Niiya</LastName>
<ForeName>Yoshimasa</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Otaru Municipal Medical Center, Otaru, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Uchino</LastName>
<ForeName>Haruto</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Otaru Municipal Medical Center, Otaru, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nakayama</LastName>
<ForeName>Naoki</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mabuchi</LastName>
<ForeName>Shoji</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Otaru Municipal Medical Center, Otaru, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Houkin</LastName>
<ForeName>Kiyohiro</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>07</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C541116">ACTA2 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000199">Actins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019394">Ki-67 Antigen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000199">Actins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017130">Angioplasty</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001344">Autopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002339">Carotid Arteries</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002343">Carotid Artery, Internal</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002533">Cerebral Angiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017809">Fatal Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007150">Immunohistochemistry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019394">Ki-67 Antigen</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058426">Neointima</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Carotid endarterectomy</Keyword>
<Keyword MajorTopicYN="N">Neointima</Keyword>
<Keyword MajorTopicYN="N">Regeneration</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23871813</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.</ArticleTitle>
<Pagination>
<MedlinePgn>e277-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.07.002</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)00773-0</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">With the use of fluorescence-guided resection with 5-aminolevulinic acid (5-ALA), the rate of complete resection of the contrast-enhancing part of malignant gliomas could be increased from 36% to 65%. Because the visualization of 5-ALA-induced fluorescence depends on a sufficient exposure to fluorescent light, residual tumor tissue in deep-seated resection cavities might not be detected. In addition, subcortical parts of a large spherical tumor might not be visualized, owing to a tangential position at the periphery of the microscopic field. With the availability of a specially designed endoscope with the capability to visualize 5-ALA fluorescence, we investigated the impact of this new technique on the visualization of residual glioma tissue.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A standard dose of 5-ALA 20 mg/kg was administered to 9 patients with deep-seated contrast-enhancing brain tumors 3 hours before surgery. A standard surgical exposure was performed and supplemented by the use of a specially designed endoscope with an option of 5-ALA fluorescence guidance. After microscopic visualization of the surgical cavity, endoscopic visualization was employed. If additional fluorescence tissue was detected, microscopic visualization was performed. Detected remnants of the tumor were removed and evaluated by histologic examination.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In all cases, fluorescence-guided endoscopic visualization identified 5-ALA-positive tissue not sufficiently exposed by conventional microscopic visualization. In 8 patients, histopathologic examination confirmed residual tumor tissue; in 1 patient, the endoscopic visualized tissue was classified as radiation necrosis. In this patient, the tumor was completely ALA negative microscopically.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">As an additional instrument, fluorescence-guided endoscopic visualization might help to overcome technical limitations of the conventional microscopic exposure of 5-ALA-positive tumor tissue. The false-positive 5-ALA tissue indicates that endoscopic visualization may overestimate the amount of tumor, so further analyses to ascertain the sensitivity and specificity of this technique are required.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rapp</LastName>
<ForeName>Marion</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Heinrich Heine University of Duesseldorf, Duesseldorf, Germany. Electronic address: marion.rapp@uni-duesseldorf.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kamp</LastName>
<ForeName>Marcel</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Heinrich Heine University of Duesseldorf, Duesseldorf, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Steiger</LastName>
<ForeName>Hans-Jakob</ForeName>
<Initials>HJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Heinrich Heine University of Duesseldorf, Duesseldorf, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sabel</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Heinrich Heine University of Duesseldorf, Duesseldorf, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>07</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017319">Photosensitizing Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>88755TAZ87</RegistryNumber>
<NameOfSubstance UI="D000622">Aminolevulinic Acid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e117-8</RefSource>
<PMID Version="1">23920307</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000622">Aminolevulinic Acid</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002540">Cerebral Cortex</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003287">Contrast Media</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003399">Craniotomy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004724">Endoscopy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005189">False Positive Reactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005453">Fluorescence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005910">Glioma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017319">Photosensitizing Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D025321">Surgery, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">5-Aminolevulinic acid (5-ALA)</Keyword>
<Keyword MajorTopicYN="N">Endoscope</Keyword>
<Keyword MajorTopicYN="N">Fluorescence-guided surgery</Keyword>
<Keyword MajorTopicYN="N">Malignant glioma</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23891581</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Curvularia abscess of the brainstem.</ArticleTitle>
<Pagination>
<MedlinePgn>241.e9-13</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.07.014</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)00828-0</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To present a unique case of a brainstem Curvularia fungal infection and review the diagnosis and management of this rare phenomenon.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A 33-year-old immunocompetent African American male presented with 2 weeks of headache, nausea, and vomiting in a setting of a recent 20-lb weight loss. Neurological examination was positive for multiple cranial nerve palsies, hemisensory loss, and gait instability. Magnetic resonance imaging demonstrated an enhancing medullary lesion.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Metastatic and infectious workup revealed a left lung lesion, which on subsequent biopsy was positive for a granuloma yielding no further clues to the etiology of the brainstem lesion. On surgical exploration of the cranial lesion, a puss-filed, encapsulated lesion was encountered that was tightly adherent to the brainstem. Intraoperative biopsy of the lesion capsule was initially negative but on postoperative day 9, fungal hyphae were encountered identified on morphology as Curvularia species. The patient was started on triple antifungal therapy but necessitated a second surgery for lesion debulking and drainage. The patient was discharged home 10 weeks after initial presentation. At the 13-months follow-up the patient is doing very well and his neurological examination continues to improve.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This is the first reported case of a brainstem Curvularia infection. This case highlights the importance of an aggressive surgical and antibiotic therapy in the treatment of central nervous system Curvularia infections. There appears to be a strong relationship between heavy marijuana use and Curvularia infection, producing lung granulomas that may extend to other organs such as the central nervous system of immunocompetent patients.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Skovrlj</LastName>
<ForeName>Branko</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Mount Sinai School of Medicine, New York City, New York, USA. Electronic address: skovrlj.branko@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Haghighi</LastName>
<ForeName>Maryam</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>School of Medicine, Karolinska Institutet, Hagalund, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smethurst</LastName>
<ForeName>Mark E</ForeName>
<Initials>ME</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, James J. Peters VA Medical Center, Bronx, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Caridi</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Mount Sinai School of Medicine, New York City, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bederson</LastName>
<ForeName>Joshua B</ForeName>
<Initials>JB</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Mount Sinai School of Medicine, New York City, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>07</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000935">Antifungal Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011743">Pyrimidines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014230">Triazoles</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>JFU09I87TR</RegistryNumber>
<NameOfSubstance UI="D065819">Voriconazole</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000935">Antifungal Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001203">Ascomycota</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001922">Brain Abscess</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001933">Brain Stem</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020314">Central Nervous System Fungal Infections</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003389">Cranial Nerve Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006261">Headache</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008881">Migraine Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009422">Nervous System Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009460">Neurologic Examination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010292">Paresthesia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011743">Pyrimidines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014230">Triazoles</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D065819">Voriconazole</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Brainstem</Keyword>
<Keyword MajorTopicYN="N">Curvularia abscess</Keyword>
<Keyword MajorTopicYN="N">Fungal central nervous system infection</Keyword>
<Keyword MajorTopicYN="N">Phaeohyphomycosis</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23948651</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Hand-Schller-Christian disease associated with symptomatic cavum septi pellucidi cyst in an adult with a 10-year follow-up.</ArticleTitle>
<Pagination>
<MedlinePgn>e396-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.08.008</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)00969-8</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Yong</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Shandong Cancer Hospital, Jinan, People's Republic of China. Electronic address: doctorwy@163.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Li</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, The People's Hospital of ZhangQiu, Jinan, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gao</LastName>
<ForeName>Ye</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, The People's Hospital of ZhangQiu, Jinan, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tao</LastName>
<ForeName>Rongjie</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Shandong Cancer Hospital, Jinan, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>08</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000972">Antineoplastic Agents, Phytogenic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>57-22-7</RegistryNumber>
<NameOfSubstance UI="D014750">Vincristine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>VB0R961HZT</RegistryNumber>
<NameOfSubstance UI="D011241">Prednisone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000893">Anti-Inflammatory Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000972">Antineoplastic Agents, Phytogenic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003131">Combined Modality Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015653">Cystectomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003560">Cysts</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003919">Diabetes Insipidus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005094">Exophthalmos</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006646">Histiocytosis, Langerhans-Cell</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007150">Immunohistochemistry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011241">Prednisone</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012688">Septum Pellucidum</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013577">Syndrome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014750">Vincristine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23994073</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Giant pituitary adenomas: surgical outcomes of 50 cases operated on by the endonasal endoscopic approach.</ArticleTitle>
<Pagination>
<MedlinePgn>e281-90</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.08.028</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)01049-8</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To present our experience with the surgical management of giant pituitary adenomas in a series of 50 cases operated on by an endoscopic endonasal approach.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective data analysis of all patients who underwent transsphenoidal endonasal endoscopic surgery at the General Hospital of Fortaleza, Brazil, between January 1998 and November 2011 was performed. Patients who presented with pituitary adenomas larger than 4 cm were included in the study. Analysis of factors related to the choice of the operative approach, hormonal and visual status, extent of resection, tumor control rates, clinical outcome, and complications were evaluated.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty cases (10.41%) matched our inclusion criteria. Nonfunctioning tumors were present in 42 patients (84%); among functioning adenomas, five patients (10%) had growth hormone-secreting adenomas, and three patients (6%) had prolactinomas. Total removal of the tumor occurred in 19 cases (38%), near-total removal in 9 cases (18%), and partial removal in 22 cases (44%). Postoperative cerebrospinal fluid leaks occurred in four cases (8%). Postoperative diabetes insipidus was present in 10% and new anterior pituitary insufficiency affecting one axis or more than one axis was observed in 22% and 14%, respectively. The presence of Knosp score 3 was associated with subtotal resection. Patients harboring hormonally active adenomas were submitted to adjuvant medical therapy for long-term clinical control. Vision improved in 38 patients (76%), with only one case of visual deterioration reported.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Transsphenoidal endoscopic endonasal surgery may provide effective treatment for patients with giant adenomas when performed by a surgical team that specializes in pituitary surgery. In cases in which total resection by the endoscopic approach may be associated with important complications, we advocate the use of partial resections followed by adjuvant drug therapy or radiotherapy. In cases of progressive enlargement of residual lesions, a second endoscopic debulking of the tumor may be considered for control of the disease.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gondim</LastName>
<ForeName>Jackson A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Hospital Geral de Fortaleza, Fortaleza-CE, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Almeida</LastName>
<ForeName>Joo Paulo C</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Universidade Estadual de Campinas, Campinas-SP, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Albuquerque</LastName>
<ForeName>Lucas Alverne F</ForeName>
<Initials>LA</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Santa Casa de Belo Horizonte, Belo Horizonte-MG, Brazil. Electronic address: lucasalverne@yahoo.com.br.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gomes</LastName>
<ForeName>Erika F</ForeName>
<Initials>EF</Initials>
<AffiliationInfo>
<Affiliation>Department of Ear, Nose and Throat Surgery, Hospital Geral de Fortaleza, Fortaleza-CE, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schops</LastName>
<ForeName>Michele</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Universidade Federal do Cear, Fortaleza-CE, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>08</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010907">Pituitary Hormones</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e119-20</RefSource>
<PMID Version="1">24036341</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e121-4</RefSource>
<PMID Version="1">24121298</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000236">Adenoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003131">Combined Modality Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004724">Endoscopy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009296">Nasal Cavity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059906">Neuroimaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010907">Pituitary Hormones</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010911">Pituitary Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019106">Postoperative Hemorrhage</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019291">Skull Base</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Adenoma</Keyword>
<Keyword MajorTopicYN="N">Endoscopy</Keyword>
<Keyword MajorTopicYN="N">Giant</Keyword>
<Keyword MajorTopicYN="N">Pituitary</Keyword>
<Keyword MajorTopicYN="N">Transsphenoidal</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24056222</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Prenatal diagnosis of hemimegalencephaly.</ArticleTitle>
<Pagination>
<MedlinePgn>241.e5-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.09.028</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)01210-2</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In recent literature, there have been case reports of prenatal diagnosis of hemimegalencephaly, an extremely rare entity characterized by enlargement of all or portions of 1 cerebral hemisphere and intractable seizures. A unique case is presented of hemimegalencephaly of a fetus diagnosed in utero.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A 27-year-old woman presented at 32 weeks' gestation for fetal magnetic resonance imaging after an abnormal fetal ultrasound. Fetal magnetic resonance imaging showed hemimegalencephaly of the left cerebral hemisphere with abnormal gyration.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The patient was born via cesarean section at 39 weeks' gestation. He had continuous infantile spasms and partial-onset seizures starting on day 1 of life, and electroencephalography showed burst suppression. The patient's seizures were initially managed with antiepileptics, prednisolone, and a ketogenic diet; however, he was hospitalized multiple times because of status epilepticus. At 6 months of age, he underwent a successful anatomic left hemispherectomy.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In utero diagnosis of complex developmental brain anomalies allows a multidisciplinary approach to provide optimal prenatal patient treatment and parental counseling.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lang</LastName>
<ForeName>Shih-Shan</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Hospital of the University of Pennsylvania, USA; Division of Neurosurgery, Center for Fetal Diagnosis and Treatment, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Electronic address: shihshan.lang@uphs.upenn.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goldberg</LastName>
<ForeName>Ethan</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurology, Center for Fetal Diagnosis and Treatment, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zarnow</LastName>
<ForeName>Deborah</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Center for Fetal Diagnosis and Treatment, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Johnson</LastName>
<ForeName>Mark P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, Center for Fetal Diagnosis and Treatment, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Storm</LastName>
<ForeName>Phillip B</ForeName>
<Initials>PB</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Hospital of the University of Pennsylvania, USA; Division of Neurosurgery, Center for Fetal Diagnosis and Treatment, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heuer</LastName>
<ForeName>Gregory G</ForeName>
<Initials>GG</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Hospital of the University of Pennsylvania, USA; Division of Neurosurgery, Center for Fetal Diagnosis and Treatment, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>09</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D038481">Anterior Temporal Lobectomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002585">Cesarean Section</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005333">Fetus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D038421">Hemispherectomy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007231">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054220">Malformations of Cortical Development</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011296">Prenatal Diagnosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012640">Seizures</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013226">Status Epilepticus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cortical dysplasia</Keyword>
<Keyword MajorTopicYN="N">Fetal imaging</Keyword>
<Keyword MajorTopicYN="N">Hemimegalencephaly</Keyword>
<Keyword MajorTopicYN="N">Hemispherectomy</Keyword>
<Keyword MajorTopicYN="N">MRI</Keyword>
<Keyword MajorTopicYN="N">Neuronal migration</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24076052</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>12</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Identifying better surgical candidates among recursive partitioning analysis class 2 patients who underwent surgery for intracranial metastases.</ArticleTitle>
<Pagination>
<MedlinePgn>e267-75</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.08.031</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)01052-8</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The management of patients with brain metastases is typically dependent on their prognosis. Recursive partitioning analysis (RPA) is the most commonly used method for prognosticating survival, but has limitations for patients in the intermediate class. The aims of this study were to ascertain preoperative risk factors associated with survival, develop a preoperative prognostic grading system, and evaluate the utility of this system in predicting survival for RPA class 2 patients.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Adult patient who underwent intracranial metastatic tumor surgery at an academic tertiary care institution from 1997 to 2011 were retrospectively reviewed. Multivariate proportional hazards regression analysis was used to identify preoperative factors associated with survival. The identified associations were then used to develop a grading system. Survival as a function of time was plotted using the Kaplan-Meier method, and survival rates were compared using log-rank analyses.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 421 (59%) of 708 patients were RPA class 2. The preoperative factors found to be associated with poorer survival were: male gender (P &lt; 0.0001), motor deficit (P = 0.0007), cognitive deficit (P = 0.0004), nonsolitary metastases (P = 0.002), and tumor size &gt;2 cm (P = 0.003). Patients having 0-1, 2, and 3-5 of these variables were assigned a preoperative grade of A, B, and C, respectively. Patients with a preoperative grade of A, B, and C had a median survival of 17.0, 10.3, and 7.3 months, respectively. These grades had distinct survival times (P &lt; 0.05).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The present study devised a preoperative grading system that may provide prognostic information for RPA class 2 patients, which may also guide medical and surgical therapies before any intervention is pursued.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chaichana</LastName>
<ForeName>Kaisorn L</ForeName>
<Initials>KL</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA. Electronic address: Kaisorn@jhmi.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Acharya</LastName>
<ForeName>Shami</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Flores</LastName>
<ForeName>Mariana</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wijesekera</LastName>
<ForeName>Olindi</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rigamonti</LastName>
<ForeName>Daniele</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Weingart</LastName>
<ForeName>Jon D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Olivi</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bettegowda</LastName>
<ForeName>Chetan</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gallia</LastName>
<ForeName>Gary L</ForeName>
<Initials>GL</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brem</LastName>
<ForeName>Henry</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lim</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Quinones-Hinojosa</LastName>
<ForeName>Alfredo</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA. Electronic address: aquinon2@jhmi.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 CA006973</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>09</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):801-9</RefSource>
<PMID Version="1">16904847</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):650-5</RefSource>
<PMID Version="1">22795806</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1155-61</RefSource>
<PMID Version="1">10725626</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Neurosci. 2003 Mar;10(2):190-4</RefSource>
<PMID Version="1">12637047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimaging Clin N Am. 2003 May;13(2):237-50, x-xi</RefSource>
<PMID Version="1">13677804</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):218-24</RefSource>
<PMID Version="1">15337559</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Surg Neurol. 1984 Apr;21(4):377-84</RefSource>
<PMID Version="1">6701773</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosurgery. 1989 Jun;24(6):798-805</RefSource>
<PMID Version="1">2473409</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 1990 Feb 22;322(8):494-500</RefSource>
<PMID Version="1">2405271</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Clin Oncol. 1990 Oct;13(5):427-32</RefSource>
<PMID Version="1">2220663</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosurg. 1995 Oct;83(4):605-16</RefSource>
<PMID Version="1">7674008</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 1996 Nov 15;56(22):5217-23</RefSource>
<PMID Version="1">8912860</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):745-51</RefSource>
<PMID Version="1">9128946</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer. 1997 Nov 1;80(9):1746-54</RefSource>
<PMID Version="1">9351543</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurooncol. 1998 Aug;39(1):91-4</RefSource>
<PMID Version="1">9760074</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 1998 Nov 4;280(17):1485-9</RefSource>
<PMID Version="1">9809728</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Clin Oncol. 2004 Oct;27(5):505-9</RefSource>
<PMID Version="1">15596921</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosurg. 2005 Feb;102(2):209-15</RefSource>
<PMID Version="1">15739546</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosurgery. 2005 May;56(5):1021-34; discussion 1021-34</RefSource>
<PMID Version="1">15854250</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer. 2005 Nov 15;104(10):2174-80</RefSource>
<PMID Version="1">16208705</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>World Neurosurg. 2013 Sep-Oct;80(3-4):351-8</RefSource>
<PMID Version="1">22484072</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):810-7</RefSource>
<PMID Version="1">17011454</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Cancer Res. 2007 Jun 15;13(12):3637-41</RefSource>
<PMID Version="1">17575228</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncologist. 2007 Jul;12(7):884-98</RefSource>
<PMID Version="1">17673619</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):510-4</RefSource>
<PMID Version="1">17931798</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Natl Compr Canc Netw. 2008 May;6(5):505-13; quiz 514</RefSource>
<PMID Version="1">18492462</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosurg. 2009 Jan;110(1):156-62</RefSource>
<PMID Version="1">18847342</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurooncol. 2009 Aug;94(1):103-10</RefSource>
<PMID Version="1">19255726</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1141-7</RefSource>
<PMID Version="1">19327899</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosurg Focus. 2009 Dec;27(6):E7</RefSource>
<PMID Version="1">19951060</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1486-92</RefSource>
<PMID Version="1">19619958</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):655-61</RefSource>
<PMID Version="1">19942357</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Surg Oncol. 2011 Feb;18(2):521-8</RefSource>
<PMID Version="1">20809176</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Surg Oncol. 2011 Jul;37(7):635-42</RefSource>
<PMID Version="1">21664097</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Strahlenther Onkol. 2012 Feb;188(2):143-7</RefSource>
<PMID Version="1">22234538</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Clin Oncol. 2012 Feb;9(2):79-86</RefSource>
<PMID Version="1">22143137</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cancer Res Clin Oncol. 2012 Jul;138(7):1239-47</RefSource>
<PMID Version="1">22441932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuro Oncol. 2012 Jul;14(7):910-8</RefSource>
<PMID Version="1">22544733</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Medicina (Kaunas). 2012;48(6):281-5</RefSource>
<PMID Version="1">22885360</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e111-3</RefSource>
<PMID Version="1">24129273</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e115-6</RefSource>
<PMID Version="1">24636934</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001707">Biopsy, Needle</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001929">Brain Edema</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000556">secondary</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053208">Kaplan-Meier Estimate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017567">Karnofsky Performance Status</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009362">Neoplasm Metastasis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D018579">Patient Selection</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013534">Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016019">Survival Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS565637</OtherID>
<OtherID Source="NLM">PMC3995859</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Breast</Keyword>
<Keyword MajorTopicYN="N">Gastrointestinal</Keyword>
<Keyword MajorTopicYN="N">Lung</Keyword>
<Keyword MajorTopicYN="N">Melanoma</Keyword>
<Keyword MajorTopicYN="N">Metastatic brain tumor</Keyword>
<Keyword MajorTopicYN="N">Prognosis</Keyword>
<Keyword MajorTopicYN="N">RPA</Keyword>
<Keyword MajorTopicYN="N">Recurrence</Keyword>
<Keyword MajorTopicYN="N">Renal</Keyword>
<Keyword MajorTopicYN="N">Surgery</Keyword>
<Keyword MajorTopicYN="N">Survival</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24076053</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Isolated cerebral aspergillosis in immunocompetent patients.</ArticleTitle>
<Pagination>
<MedlinePgn>e325-33</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2013.09.037</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(13)01225-4</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Isolated cerebral aspergillosis (ICA) traditionally has been associated with immunocompromised patients with dismal outcomes. Cases of ICA in immunocompetent patients are very rare and poorly described. We describe our experience of 5 immunocompetent patients with ICA and compare our experience with the literature.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">During the period 1996-2011, ICA was diagnosed in 5 otherwise healthy, immunocompetent patients at our institution. Medical records of the patients were reviewed with standardized data collection, including demographics, clinical presentation, radiologic features, histopathology results, treatment, and outcome.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">All 5 patients had radiologic evidence of cerebral disease, purely parenchymal in 4 patients and dural-based in 1 patient. Radiology showed the paranasal sinuses and lungs to be clear in all patients. All patients underwent resection with antifungal therapy. All patients were female with a mean age of 23 years (range, 13-36 years). Headache (n = 5) and seizures (n = 4) were the primary presenting manifestations. Brain magnetic resonance imaging was performed in 5 patients preoperatively, and computed tomography was performed preoperatively in 4 patients. The diagnosis was made by histopathology (n = 5) and fungal cultures (n = 3) of the excised mass. Surgical resection was performed in all patients followed by treatment with amphotericin B for 2-4 weeks then oral voriconazole for 6 months. Overall mortality was 20% (n = 1). Average follow-up period was 32 months (range, 12-51 months) with interval brain magnetic resonance imaging to document eradication.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">ICA in otherwise healthy immunocompetent hosts seems to have a more favorable prognosis than what is reported for immunocompromised hosts.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bokhari</LastName>
<ForeName>Rakan</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurosurgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baeesa</LastName>
<ForeName>Saleh</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurosurgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia. Electronic address: sbaeesa@kau.edu.sa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Al-Maghrabi</LastName>
<ForeName>Jaudah</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Madani</LastName>
<ForeName>Tariq</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>09</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000935">Antifungal Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e139-40</RefSource>
<PMID Version="1">24613669</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000935">Antifungal Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001228">Aspergillosis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002494">Central Nervous System Infections</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006261">Headache</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007121">Immunocompetence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010291">Paresis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Aspergillosis</Keyword>
<Keyword MajorTopicYN="N">Cerebral</Keyword>
<Keyword MajorTopicYN="N">Fungal infection</Keyword>
<Keyword MajorTopicYN="N">Immunocompetent hosts</Keyword>
<Keyword MajorTopicYN="N">Surgery</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24508595</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>When gross total resection of a glioblastoma is possible, how much resection should be achieved?</ArticleTitle>
<Pagination>
<MedlinePgn>e257-65</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2014.01.019</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(14)00083-7</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The efficacy of extensive resection on prolonging survival for patients with glioblastoma (GBM) is controversial because prior studies have included tumors with dissimilar resection capabilities. The true isolated effect of increasing resection on survival for GBM therefore remains unclear.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Adult patients who underwent surgery of an intracranial newly diagnosed GBM at an academic tertiary-care institution from 2007 to 2011 were reviewed. Preoperative images were reviewed by 3 neurosurgeons independently. Tumors considered amenable to gross total resection based on preoperative imaging by all neurosurgeons were included. Multivariate proportional hazards regression analysis was used to identify if an association existed between residual volume (RV) and extent of resection (EOR) with survival.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 292 patients with newly diagnosed GBM, 84 (29%) were amenable to gross total resection. The median (interquartile range) pre and postoperative tumor volumes were 27 (13.8-54.4) and 0.9 (0-2.7) cm(3), respectively. The mean percent resection was 91.7%  1.3%. In multivariate analysis, after controlling for age, functional status, and adjuvant therapies, RV (hazards ratio [HR] [95% confidence interval (CI)] = 1.114 [1.033-1.193], P = 0.006) and EOR (HR [95% CI] = 0.959 [0.934-0.985], P = 0.003) were each independently associated with survival. The RV and EOR with the greatest reduction in the risk of death was &lt;2 cm(3) and &gt;95%, respectively. Likewise, RV (HR [95% CI] = 1.085 [1.010-1.178], P = 0.01) and EOR (HR [95% CI] = 0.962 [0.930-0.998], P = 0.04) each remained independently associated with recurrence.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This is the first study to evaluate RV and EOR in a more uniform population of patients with tumors of similar surgical capabilities. This study shows that achieving a decreased RV and/or an increased EOR is independently associated with survival and recurrence in those patients with tumors with similar resection capacities.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chaichana</LastName>
<ForeName>Kaisorn L</ForeName>
<Initials>KL</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University School of Medicine, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA. Electronic address: Kaisorn@jhmi.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cabrera-Aldana</LastName>
<ForeName>Eibar Ernesto</ForeName>
<Initials>EE</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University School of Medicine, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jusue-Torres</LastName>
<ForeName>Ignacio</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University School of Medicine, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wijesekera</LastName>
<ForeName>Olindi</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University School of Medicine, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Olivi</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University School of Medicine, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rahman</LastName>
<ForeName>Maryam</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University School of Medicine, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Quinones-Hinojosa</LastName>
<ForeName>Alfredo</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Johns Hopkins University School of Medicine, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>02</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e105-7</RefSource>
<PMID Version="1">24802844</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e101-3</RefSource>
<PMID Version="1">24534058</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e109-10</RefSource>
<PMID Version="1">24813127</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059248">Chemoradiotherapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003287">Contrast Media</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005073">Evoked Potentials, Somatosensory</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005909">Glioblastoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009364">Neoplasm Recurrence, Local</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018365">Neoplasm, Residual</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015588">Observer Variation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010348">Patient Care Team</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018579">Patient Selection</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016019">Survival Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Extent of resection</Keyword>
<Keyword MajorTopicYN="N">GBM</Keyword>
<Keyword MajorTopicYN="N">Glioblastoma</Keyword>
<Keyword MajorTopicYN="N">Residual</Keyword>
<Keyword MajorTopicYN="N">Surgery</Keyword>
<Keyword MajorTopicYN="N">Survival</Keyword>
<Keyword MajorTopicYN="N">Volumetric</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24518886</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Smoking increases the risk of de novo intracranial aneurysms.</ArticleTitle>
<Pagination>
<MedlinePgn>e195-201</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2014.02.002</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(14)00130-2</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Case series have identified that de novo intracranial aneurysms occur. However, the risk for this occurrence has not been established. We examined the risk for the de novo intracranial aneurysm detection in a consecutive surgical case series.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A prospectively collected surgical database of intracranial aneurysms was retrospectively examined. Patients were analyzed if they were followed for more than 6 months postoperatively with angiography. Kaplan-Meier curve analysis of de novo aneurysms detection included the comparison of smoking vs. never smoked; those with and without a family history; single vs. multiple aneurysms at initial presentation; and original presentation with rupture vs. nonrupture.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 1366 surgically treated patients (1942 aneurysms), 472 patients (702 aneurysms) were followed with angiography for more than 6 months (average, 54 months). Thirty-three patients (6.99%) were detected to have de novo aneurysms. Multivariate analysis found a smoking history significantly increases the likelihood of de novo aneurysm detection. Kaplan-Meier analysis found the 5- and 10-year de novo aneurysm detection rate to be 4.21% (95% confidence interval [CI] 3.86-12.8) and 15% (95% CI 10-16), respectively. A smoking history increases the 5- and 10-year detection rate to 5.81% and 17% (hazard ratio 2.58; 95% CI 1.13-5.90) respectively. No increased risk was present for an initial presentation that included multiple aneurysms, a family history, or rupture.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">There is a 10-year de novo aneurysm detection rate of between 10% and 16% after surgery. Smoking increases the risk of de novo aneurysm detection. Consideration needs to be given to surveillance angiography after aneurysm treatment.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lai</LastName>
<ForeName>Leon Tat</ForeName>
<Initials>LT</Initials>
<AffiliationInfo>
<Affiliation>Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales, Australia. Electronic address: drleonlai@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Morgan</LastName>
<ForeName>Michael Kerin</ForeName>
<Initials>MK</Initials>
<AffiliationInfo>
<Affiliation>Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Patel</LastName>
<ForeName>Nirav J</ForeName>
<Initials>NJ</Initials>
<AffiliationInfo>
<Affiliation>Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>02</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e163-5</RefSource>
<PMID Version="1">24813126</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e79-80</RefSource>
<PMID Version="1">24680734</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015901">Angiography, Digital Subtraction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002533">Cerebral Angiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002532">Intracranial Aneurysm</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053208">Kaplan-Meier Estimate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018810">Magnetic Resonance Angiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012044">Regression Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012907">Smoking</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013345">Subarachnoid Hemorrhage</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016019">Survival Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">De novo aneurysm</Keyword>
<Keyword MajorTopicYN="N">Intracranial aneurysm</Keyword>
<Keyword MajorTopicYN="N">Kaplan-Meier</Keyword>
<Keyword MajorTopicYN="N">New aneurysm</Keyword>
<Keyword MajorTopicYN="N">Risk</Keyword>
<Keyword MajorTopicYN="N">Smoking</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24560709</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Management of low-grade gliomas: a review of patient-perceived quality of life and neurocognitive outcome.</ArticleTitle>
<Pagination>
<MedlinePgn>e299-309</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2014.02.033</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(14)00164-8</ELocationID>
<Abstract>
<AbstractText>Low-grade glioma (LGG) comprises nearly 20% of all central nervous system glial tumors, with approximately 2000-3000 patients diagnosed annually in the United States. Because of their infiltrative ability and aggressive nature, the average 10-year survival is 30% when &lt;90% of the tumor is resected. Since the 1970s, prognosis for LGGs has improved significantly. This improvement is primarily attributable to earlier diagnoses via magnetic resonance imaging scanning, increased awareness of the more favorable oligo component, technical advances in intraoperative neurosurgery, and stratification for young age. Using a number of prognostic factors, LGGs have been classified into low-risk and high-risk subgroups. Optimal therapy for patients with low-risk, supratentorial grade II glioma remains a highly controversial issue in the neuro-oncology community. The concerns regarding the toxicity of therapy often outweigh the benefits of delaying tumor progression. The recommendation for observation is made without full prospective understanding of the impact of radiologic tumor progression on the quality of life (QOL), neurocognitive function (NCF), seizure control, and functional status of these patients. We present a review of the current knowledge of the management of LGG with emphasis upon patient-reported outcomes of QOL, NCF, and seizure control. We also discuss current clinical trials with proposals to evaluate QOL, NCF, and seizure control in patients undergoing observation alone after newly diagnosed low-risk LGG or treatment options for those patients in the high-risk group.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shields</LastName>
<ForeName>Lisa B E</ForeName>
<Initials>LB</Initials>
<AffiliationInfo>
<Affiliation>Norton Neuroscience Institute and Norton Cancer Institute, Norton Healthcare, Louisville, Kentucky, USA. Electronic address: LBES@earthlink.net.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Choucair</LastName>
<ForeName>Ali K</ForeName>
<Initials>AK</Initials>
<AffiliationInfo>
<Affiliation>Norton Neuroscience Institute and Norton Cancer Institute, Norton Healthcare, Louisville, Kentucky, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>02</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e129-31</RefSource>
<PMID Version="1">24636936</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>World Neurosurg. 2014 Jul-Aug;82(1-2):e133-4</RefSource>
<PMID Version="1">24813129</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000970">Antineoplastic Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001931">Brain Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000532">radiotherapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003071">Cognition</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003131">Combined Modality Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005910">Glioma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000532">radiotherapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007167">Immunotherapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011788">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012640">Seizures</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Brain tumor</Keyword>
<Keyword MajorTopicYN="N">Cognitive function</Keyword>
<Keyword MajorTopicYN="N">Low-grade glioma</Keyword>
<Keyword MajorTopicYN="N">Quality of life</Keyword>
<Keyword MajorTopicYN="N">Seizures</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24780772</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1878-8750</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>82</Volume>
<Issue>1-2</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>World neurosurgery</Title>
<ISOAbbreviation>World Neurosurg</ISOAbbreviation>
</Journal>
<ArticleTitle>Aneurysm wall composition may determine rupture risk and endovascular treatment failure.</ArticleTitle>
<Pagination>
<MedlinePgn>8-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2014.04.063</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1878-8750(14)00446-X</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zammar</LastName>
<ForeName>Samer G</ForeName>
<Initials>SG</Initials>
<AffiliationInfo>
<Affiliation>Departments of Neurological Surgery and Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pines</LastName>
<ForeName>Andrew R</ForeName>
<Initials>AR</Initials>
<AffiliationInfo>
<Affiliation>Departments of Neurological Surgery and Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>El Tecle</LastName>
<ForeName>Najib E</ForeName>
<Initials>NE</Initials>
<AffiliationInfo>
<Affiliation>Departments of Neurological Surgery and Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>El Ahmadieh</LastName>
<ForeName>Tarek Y</ForeName>
<Initials>TY</Initials>
<AffiliationInfo>
<Affiliation>Departments of Neurological Surgery and Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McClendon</LastName>
<ForeName>Jamal</ForeName>
<Initials>J</Initials>
<Suffix>Jr</Suffix>
<AffiliationInfo>
<Affiliation>Departments of Neurological Surgery and Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Riachi</LastName>
<ForeName>Naji J</ForeName>
<Initials>NJ</Initials>
<AffiliationInfo>
<Affiliation>Departments of Neurological Surgery and Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bendok</LastName>
<ForeName>Bernard R</ForeName>
<Initials>BR</Initials>
<AffiliationInfo>
<Affiliation>Departments of Neurological Surgery and Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>04</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>World Neurosurg</MedlineTA>
<NlmUniqueID>101528275</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017542">Aneurysm, Ruptured</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019917">Blood Vessel Prosthesis Implantation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057510">Endovascular Procedures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002532">Intracranial Aneurysm</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D032389">Myocytes, Smooth Muscle</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017211">Treatment Failure</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25195301</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0022-9776</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>89</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Kekkaku : [Tuberculosis]</Title>
<ISOAbbreviation>Kekkaku</ISOAbbreviation>
</Journal>
<ArticleTitle>[Tenosynovitis confirmed by MRI during anti-tuberculous treatment suspected due to isoniazid--2 case reports and literature review].</ArticleTitle>
<Pagination>
<MedlinePgn>659-65</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The adverse effects of anti-tuberculosis agents is an important problem for treatment of tuberculosis. We report 2 possible cases of isoniazid-induced tenosynovitis. Case 1: A 49-year-old man with untreated diabetic mellitus presented with hypesthesia and difficulty grasping with his right hand 1 month after starting treatment of tuberculosis of the lung and pleuritis using isoniazid, rifampicin, ethambutol, and pyrazinamide. His symptoms were due to tenosynovitis, which was detected by magnetic resonance imaging. The clinical course and isoniazid challenge test revealed that the condition was related to isoniazid. After discontinuing isoniazid treatment, his symptoms gradually improved. Case 2: An 78-year-old man operated on for rectal cancer 3 weeks previously presented with edema and arthralgia of both hands 1 month after starting anti-tuberculosis treatment. His tuberculosis was diagnosed at preoperative screening tests for rectal cancer. Owing to a medical history of gout, pyrazinamide was discontinued. However, his symptoms did not improve. Magnetic resonance imaging revealed findings indicative of tenosynovitis. At the end of anti-tuberculosis treatment, his symptoms improved slightly within 6 months. Isoniazid-induced tenosynovitis and arthritis are rare adverse effects. However, they may be underestimated because the severity is variable. We suggest further investigations of the side effects of isoniazid using imaging techniques such as magnetic resonance imaging.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yamamoto</LastName>
<ForeName>Kei</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Takasaki</LastName>
<ForeName>Jin</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Morino</LastName>
<ForeName>Eriko</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kobayashi</LastName>
<ForeName>Nobuyuki</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sugiyama</LastName>
<ForeName>Haruto</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>jpn</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>Kekkaku</MedlineTA>
<NlmUniqueID>0422132</NlmUniqueID>
<ISSNLinking>0022-9776</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000995">Antitubercular Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>V83O1VOZ8L</RegistryNumber>
<NameOfSubstance UI="D007538">Isoniazid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000995">Antitubercular Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007538">Isoniazid</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013717">Tenosynovitis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014397">Tuberculosis, Pulmonary</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25195358</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>68</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medicinski arhiv</Title>
<ISOAbbreviation>Med Arh</ISOAbbreviation>
</Journal>
<ArticleTitle>Posterior reversible encephalopathy syndrome (PRES) as a complication of immunosuppressive therapy in renal transplantation in children.</ArticleTitle>
<Pagination>
<MedlinePgn>218-20</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Although kidney transplantation is by far the best method of renal replacement therapy, organ receiver is still not spared of eventual toxic consequences of drugs that are in charge of keeping the transplanted kidney functional. Both calcineurin inhibitors, of which tacrolimus more often, occasionally lead to neurotoxic side effects, mostly mild and reversible and dose-dependent in nature, but they can also be very severe or even fatal. It is very important to be aware of possible neurotoxic effects, to confirm them radiologically, and to prevent or reduce drug effects on nervous system. Sometimes the reduction of dose or substitution with another drug with similar mechanism effect is sufficient to terminate the neurotoxic effects of the drug and still not jeopardize the function of transplanted organ.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hodzic</LastName>
<ForeName>Emir</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brcic</LastName>
<ForeName>Majda</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Atic</LastName>
<ForeName>Mirza</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Halilcevic</LastName>
<ForeName>Alma</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jasarevic</LastName>
<ForeName>Amila</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Aleckovic-Halilovic</LastName>
<ForeName>Mirna</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Trojak</LastName>
<ForeName>Davor</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Atic</LastName>
<ForeName>Nedima</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zulic</LastName>
<ForeName>Snezana</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mehmedovic</LastName>
<ForeName>Zlatan</ForeName>
<Initials>Z</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Iveljic</LastName>
<ForeName>Ivana</ForeName>
<Initials>I</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Bosnia and Hercegovina</Country>
<MedlineTA>Med Arh</MedlineTA>
<NlmUniqueID>0400722</NlmUniqueID>
<ISSNLinking>0350-199X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>WM0HAQ4WNM</RegistryNumber>
<NameOfSubstance UI="D016559">Tacrolimus</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007166">Immunosuppressive Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016030">Kidney Transplantation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054038">Posterior Leukoencephalopathy Syndrome</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016559">Tacrolimus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25195396</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1438-3276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>156</Volume>
<Issue>14</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>MMW Fortschritte der Medizin</Title>
<ISOAbbreviation>MMW Fortschr Med</ISOAbbreviation>
</Journal>
<ArticleTitle>[Suspected seizure. Diagnosis is an indications process].</ArticleTitle>
<Pagination>
<MedlinePgn>31</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Stiefelhagen</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
<VernacularTitle>Verdacht auf Krampfanfall. Die Diagnostik ist ein Indizienprozess.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>MMW Fortschr Med</MedlineTA>
<NlmUniqueID>100893959</NlmUniqueID>
<ISSNLinking>1438-3276</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000927">Anticonvulsants</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003430">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004827">Epilepsy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008487">Medical History Taking</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018670">Monitoring, Ambulatory</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25135008</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1572-0241</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>109</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of gastroenterology</Title>
<ISOAbbreviation>Am. J. Gastroenterol.</ISOAbbreviation>
</Journal>
<ArticleTitle>ACG clinical guideline: the diagnosis and management of focal liver lesions.</ArticleTitle>
<Pagination>
<MedlinePgn>1328-47; quiz 1348</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/ajg.2014.213</ELocationID>
<Abstract>
<AbstractText>Focal liver lesions (FLL) have been a common reason for consultation faced by gastroenterologists and hepatologists. The increasing and widespread use of imaging studies has led to an increase in detection of incidental FLL. It is important to consider not only malignant liver lesions, but also benign solid and cystic liver lesions such as hemangioma, focal nodular hyperplasia, hepatocellular adenoma, and hepatic cysts, in the differential diagnosis. In this ACG practice guideline, the authors provide an evidence-based approach to the diagnosis and management of FLL. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Marrero</LastName>
<ForeName>Jorge A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>University of Texas at Southwestern, Dallas, Texas, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ahn</LastName>
<ForeName>Joseph</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Oregon Health and Science University, Portland, Oregon, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rajender Reddy</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>Americal College of Gastroenterology</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017065">Practice Guideline</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Gastroenterol</MedlineTA>
<NlmUniqueID>0421030</NlmUniqueID>
<ISSNLinking>0002-9270</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C536330">Polycystic liver disease</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000236">Adenoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001650">Bile Duct Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001653">Bile Ducts, Intrahepatic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006528">Carcinoma, Hepatocellular</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018281">Cholangiocarcinoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003560">Cysts</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004444">Echinococcosis, Hepatic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D020518">Focal Nodular Hyperplasia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006391">Hemangioma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D033162">Incidental Findings</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008107">Liver Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008113">Liver Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000556">secondary</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014463">Ultrasonography</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24916963</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1097-0142</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>120</Volume>
<Issue>18</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Cancer</Title>
<ISOAbbreviation>Cancer</ISOAbbreviation>
</Journal>
<ArticleTitle>Multiparametric MRI for prostate cancer: seeing is believing.</ArticleTitle>
<Pagination>
<MedlinePgn>2806-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/cncr.28787</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Warlick</LastName>
<ForeName>Christopher A</ForeName>
<Initials>CA</Initials>
<AffiliationInfo>
<Affiliation>Department of Urology, University of Minnesota, Minneapolis, Minnesota.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Cancer</MedlineTA>
<NlmUniqueID>0374236</NlmUniqueID>
<ISSNLinking>0008-543X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Cancer. 2014 Sep 15;120(18):2876-82</RefSource>
<PMID Version="1">24917122</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000230">Adenocarcinoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011471">Prostatic Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24917122</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1097-0142</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>120</Volume>
<Issue>18</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Cancer</Title>
<ISOAbbreviation>Cancer</ISOAbbreviation>
</Journal>
<ArticleTitle>Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer.</ArticleTitle>
<Pagination>
<MedlinePgn>2876-82</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/cncr.28790</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The Prostate Cancer Prevention Trial risk calculator for high-grade (PCPTHG) prostate cancer (CaP) was developed to improve the detection of clinically significant CaP. In this study, the authors compared the performance of the PCPTHG against multiparametric magnetic resonance imaging (MP-MRI) in predicting men at risk of CaP.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Men with an abnormal prostate-specific antigen (PSA) level or digital rectal examination (DRE) and a suspicious lesion on a 3-Tesla MP-MRI were enrolled prospectively. Three radiologists reviewed and graded all lesions on a 5-point Likert scale. Biopsy of suspicious lesion(s) was performed using a proprietary MRI/transrectal ultrasound fusion-guided prostate biopsy system, after which 12-core biopsy was performed. A genitourinary pathologist reviewed all pathology slides. The performance of PCPTHG was compared with that of MP-MRI in predicting clinically significant CaP.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 175 men who were eligible for analysis, 64.6% (113 of 175 men) were diagnosed with CaP, including 93 of 113 men (82.3%) who had clinically significant disease. Age, abnormal DRE, PSA, PSA density, prostate size, extraprostatic extension on MRI, apparent diffusion coefficient value, and MRI lesion size were identified as significant predictors of high-grade CaP (all P&lt;.05). The area under the receiver operating characteristic curve of PCPTHG for predicting high-grade CaP was 0.676 (95% confidence interval [CI], 0.592-0.751). By using a risk cutoff of 15% for biopsy as, proposed previously for high-grade CaP, sensitivity was 96.4%, specificity was 7.6%, and the false-positive rate was 51.1%. In contrast, the area under the receiver operating characteristic curve of MP-MRI for high-grade CaP was 0.769 (95% CI, 0.703-0.834), and it was 0.812 (95% CI, 0.754-0.869) for clinically significant CaP.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">MP-MRI outperforms PCPTHG in predicting clinically significant CaP, and its application may help select patients who will benefit from CaP diagnosis and treatment.</AbstractText>
<CopyrightInformation> 2014 American Cancer Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Salami</LastName>
<ForeName>Simpa S</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>The Arthur Smith Institute for Urology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park, New York; Department of Pathology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park, New York.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vira</LastName>
<ForeName>Manish A</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Turkbey</LastName>
<ForeName>Baris</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fakhoury</LastName>
<ForeName>Mathew</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yaskiv</LastName>
<ForeName>Oksana</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Villani</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ben-Levi</LastName>
<ForeName>Eran</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rastinehad</LastName>
<ForeName>Ardeshir R</ForeName>
<Initials>AR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Cancer</MedlineTA>
<NlmUniqueID>0374236</NlmUniqueID>
<ISSNLinking>0008-543X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>EC 3.4.21.77</RegistryNumber>
<NameOfSubstance UI="D017430">Prostate-Specific Antigen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Cancer. 2014 Sep 15;120(18):2806-9</RefSource>
<PMID Version="1">24916963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Nat Rev Urol. 2014 Aug;11(8):426</RefSource>
<PMID Version="1">24980200</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000230">Adenocarcinoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D062005">Biopsy, Large-Core Needle</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015331">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051517">Digital Rectal Examination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D060787">Neoplasm Grading</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009367">Neoplasm Staging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011322">Primary Prevention</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017430">Prostate-Specific Antigen</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011471">Prostatic Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012372">ROC Curve</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">nomogram</Keyword>
<Keyword MajorTopicYN="N">prostate cancer screening</Keyword>
<Keyword MajorTopicYN="N">prostate fusion biopsy</Keyword>
<Keyword MajorTopicYN="N">prostate imaging</Keyword>
<Keyword MajorTopicYN="N">risk calculator</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24706394</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1097-0215</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>135</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Nov</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>International journal of cancer. Journal international du cancer</Title>
<ISOAbbreviation>Int. J. Cancer</ISOAbbreviation>
</Journal>
<ArticleTitle>Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.</ArticleTitle>
<Pagination>
<MedlinePgn>2380-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/ijc.28877</ELocationID>
<Abstract>
<AbstractText>The aim of our study was to assess in which way different infiltration patterns of monoclonal plasma cell diseases in whole-body (wb) magnetic resonance imaging (MRI) are associated with clinical stages, plasma cell content in bone marrow samples and established serum markers of disease activity. Institutional review board approval was obtained. We performed wb-MRI in 547 consecutive, unselected and untreated patients with monoclonal gammopathy of undetermined significance (MGUS, n=138), smoldering myeloma (SMM, n=157) and multiple myeloma (MM, n=252) on two 1.5 T MRI-scanners with body array coils. The studies were evaluated in consensus by two experienced radiologists blinded to the diagnosis. We observed focal lesions in 23.9% (MGUS), 34.4% (SMM) and 81.3% (MM), respectively. A diffuse infiltration pattern was detected in 38.4%, 45.9% and 71%, respectively. The differences between all infiltration patterns were significant (p&lt;0.0001). The presence of focal lesions and the presence of a diffuse bone marrow infiltration was associated with an increased plasma cell percentage in bone marrow samples (median 22% vs. 14%, 26% vs. 10%, both p&lt;0.0001) and monoclonal protein concentration (median 18 g/dl vs. 13 g/dl, p=0.003, 20 g/dl vs. 11 g/dl, p&lt;0.0001). Further categorization of the diffuse infiltration patterns in wb-MRI into "salt-and-pepper," moderate and severe identified significant associations with M-protein (median g/dl for S+P/moderate/severe 23/18/25, p=0.04), plasma cell percentage in the bone marrow (median 25%/24%/40%, p=0.02), and age (median years 67/60/57, p&lt;0.0001). Bone marrow infiltration in wb-MRI is significantly different between the various stages of plasma cell disease and correlates well with established markers of disease activity.</AbstractText>
<CopyrightInformation> 2014 UICC.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kloth</LastName>
<ForeName>Jost K</ForeName>
<Initials>JK</Initials>
<AffiliationInfo>
<Affiliation>Department of Diagnostic and Interventional Radiology, University of Heidelberg, Heidelberg, Germany; Department of Radiology, German Cancer Research Center (dkfz), Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hillengass</LastName>
<ForeName>Jens</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Listl</LastName>
<ForeName>Karin</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kilk</LastName>
<ForeName>Kerstin</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hielscher</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Landgren</LastName>
<ForeName>Ola</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Delorme</LastName>
<ForeName>Stefan</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Goldschmidt</LastName>
<ForeName>Hartmut</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kauczor</LastName>
<ForeName>Hans-Ulrich</ForeName>
<Initials>HU</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Weber</LastName>
<ForeName>Marc-Andr</ForeName>
<Initials>MA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>04</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Int J Cancer</MedlineTA>
<NlmUniqueID>0042124</NlmUniqueID>
<ISSNLinking>0020-7136</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009194">Myeloma Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014408">Tumor Markers, Biological</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C085016">multiple myeloma M-proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001853">Bone Marrow</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018450">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008998">Monoclonal Gammopathy of Undetermined Significance</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009101">Multiple Myeloma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009194">Myeloma Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009367">Neoplasm Staging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010950">Plasma Cells</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014408">Tumor Markers, Biological</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D051598">Whole Body Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">correlation analysis</Keyword>
<Keyword MajorTopicYN="N">disease activity</Keyword>
<Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword>
<Keyword MajorTopicYN="N">monoclonal plasma cell disease</Keyword>
<Keyword MajorTopicYN="N">multiple myeloma</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24986746</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>27</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1879-355X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>90</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>International journal of radiation oncology, biology, physics</Title>
<ISOAbbreviation>Int. J. Radiat. Oncol. Biol. Phys.</ISOAbbreviation>
</Journal>
<ArticleTitle>3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy.</ArticleTitle>
<Pagination>
<MedlinePgn>181-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijrobp.2014.05.014</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0360-3016(14)00612-9</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate the utility of 3-dimensional magnetic resonance (3D-MR) proton spectroscopic imaging for treatment planning and its implications for early response assessment in glioblastoma multiforme.</AbstractText>
<AbstractText Label="METHODS AND MATERIALS" NlmCategory="METHODS">Eighteen patients with newly diagnosed, histologically confirmed glioblastoma had 3D-MR proton spectroscopic imaging (MRSI) along with T2 and T1 gadolinium-enhanced MR images at simulation and at boost treatment planning after 17 to 20 fractions of radiation therapy. All patients received standard radiation therapy (RT) with concurrent temozolomide followed by adjuvant temozolomide. Imaging for response assessment consisted of MR scans every 2 months. Progression-free survival was defined by the criteria of MacDonald et al. MRSI images obtained at initial simulation were analyzed for choline/N-acetylaspartate ratios (Cho/NAA) on a voxel-by-voxel basis with abnormal activity defined as Cho/NAA 2. These images were compared on anatomically matched MRSI data collected after 3 weeks of RT. Changes in Cho/NAA between pretherapy and third-week RT scans were tested using Wilcoxon matched-pairs signed rank tests and correlated with progression-free survival, radiation dose and location of recurrence using Cox proportional hazards regression.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">After a median follow-up time of 8.6 months, 50% of patients had experienced progression based on imaging. Patients with a decreased or stable mean or median Cho/NAA values had less risk of progression (P&lt;.01). Patients with an increase in mean or median Cho/NAA values at the third-week RT scan had a significantly greater chance of early progression (P&lt;.01). An increased Cho/NAA at the third-week MRSI scan carried a hazard ratio of 2.72 (95% confidence interval, 1.10-6.71; P=.03). Most patients received the prescription dose of RT to the Cho/NAA 2 volume, where recurrence most often occurred.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Change in mean and median Cho/NAA detected at 3 weeks was a significant predictor of early progression. The potential impact for risk-adaptive therapy based on early spectroscopic findings is suggested.</AbstractText>
<CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Muruganandham</LastName>
<ForeName>Manickam</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Clerkin</LastName>
<ForeName>Patrick P</ForeName>
<Initials>PP</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Brian J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Biostatistics, University of Iowa Hospitals and Clinics, Iowa City, Iowa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Anderson</LastName>
<ForeName>Carryn M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Morris</LastName>
<ForeName>Ann</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Capizzano</LastName>
<ForeName>Aristides A</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Magnotta</LastName>
<ForeName>Vincent</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McGuire</LastName>
<ForeName>Sarah M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Mark C</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bayouth</LastName>
<ForeName>John E</ForeName>
<Initials>JE</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Buatti</LastName>
<ForeName>John M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa. Electronic address: john-buatti@uiowa.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>1 U01 CA140206-01 A1</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 CA140206</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Int J Radiat Oncol Biol Phys</MedlineTA>
<NlmUniqueID>7603616</NlmUniqueID>
<ISSNLinking>0360-3016</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018906">Antineoplastic Agents, Alkylating</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014408">Tumor Markers, Biological</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>30KYC7MIAI</RegistryNumber>
<NameOfSubstance UI="D001224">Aspartic Acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7GR28W0FJI</RegistryNumber>
<NameOfSubstance UI="D003606">Dacarbazine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>85622-93-1</RegistryNumber>
<NameOfSubstance UI="C047246">temozolomide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>997-55-7</RegistryNumber>
<NameOfSubstance UI="C000179">N-acetylaspartate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>AU0V1LM3JT</RegistryNumber>
<NameOfSubstance UI="D005682">Gadolinium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>N91BDP6H0X</RegistryNumber>
<NameOfSubstance UI="D002794">Choline</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018906">Antineoplastic Agents, Alkylating</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001224">Aspartic Acid</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000031">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000532">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059248">Chemoradiotherapy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002794">Choline</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003287">Contrast Media</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003606">Dacarbazine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000031">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D018450">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018572">Disease-Free Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005682">Gadolinium</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005909">Glioblastoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000532">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009682">Magnetic Resonance Spectroscopy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016555">Matched-Pair Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009364">Neoplasm Recurrence, Local</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016016">Proportional Hazards Models</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011879">Radiotherapy Dosage</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014408">Tumor Markers, Biological</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS631604 [Available on 09/01/15]</OtherID>
<OtherID Source="NLM">PMC4183193 [Available on 09/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25015199</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>27</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1879-355X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>90</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>International journal of radiation oncology, biology, physics</Title>
<ISOAbbreviation>Int. J. Radiat. Oncol. Biol. Phys.</ISOAbbreviation>
</Journal>
<ArticleTitle>Feasibility of multimodal deformable registration for head and neck tumor treatment planning.</ArticleTitle>
<Pagination>
<MedlinePgn>85-93</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijrobp.2014.05.027</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0360-3016(14)00664-6</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To investigate the feasibility of using deformable registration in clinical practice to fuse MR and CT images of the head and neck for treatment planning.</AbstractText>
<AbstractText Label="METHOD AND MATERIALS" NlmCategory="METHODS">A state-of-the-art deformable registration algorithm was optimized, evaluated, and compared with rigid registration. The evaluation was based on manually annotated anatomic landmarks and regions of interest in both modalities. We also developed a multiparametric registration approach, which simultaneously aligns T1- and T2-weighted MR sequences to CT. This was evaluated and compared with single-parametric approaches.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Our results show that deformable registration yielded a better accuracy than rigid registration, without introducing unrealistic deformations. For deformable registration, an average landmark alignment of approximatively 1.7 mm was obtained. For all the regions of interest excluding the cerebellum and the parotids, deformable registration provided a median modified Hausdorff distance of approximatively 1 mm. Similar accuracies were obtained for the single-parameter and multiparameter approaches.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study demonstrates that deformable registration of head-and-neck CT and MR images is feasible, with overall a significanlty higher accuracy than for rigid registration.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fortunati</LastName>
<ForeName>Valerio</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Biomedical Imaging Group Rotterdam, Department of Medical Informatics and Radiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands. Electronic address: v.fortunati@erasmusmc.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Verhaart</LastName>
<ForeName>Ren F</ForeName>
<Initials>RF</Initials>
<AffiliationInfo>
<Affiliation>Hyperthermia Unit, Department of Radiation Oncology, Erasmus MC University Medical Center Cancer Institute, Rotterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Angeloni</LastName>
<ForeName>Francesco</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Istituto di Ricovero e Cura a Carattere Scientifico Foundation SDN for Research and High Education in Nuclear Diagnostics, Naples, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van der Lugt</LastName>
<ForeName>Aad</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Niessen</LastName>
<ForeName>Wiro J</ForeName>
<Initials>WJ</Initials>
<AffiliationInfo>
<Affiliation>Biomedical Imaging Group Rotterdam, Department of Medical Informatics and Radiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands; Faculty of Applied Sciences, Delft University of Technology, Delft, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Veenland</LastName>
<ForeName>Jifke F</ForeName>
<Initials>JF</Initials>
<AffiliationInfo>
<Affiliation>Biomedical Imaging Group Rotterdam, Department of Medical Informatics and Radiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Paulides</LastName>
<ForeName>Margarethus M</ForeName>
<Initials>MM</Initials>
<AffiliationInfo>
<Affiliation>Hyperthermia Unit, Department of Radiation Oncology, Erasmus MC University Medical Center Cancer Institute, Rotterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van Walsum</LastName>
<ForeName>Theo</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Biomedical Imaging Group Rotterdam, Department of Medical Informatics and Radiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D023362">Evaluation Studies</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Int J Radiat Oncol Biol Phys</MedlineTA>
<NlmUniqueID>7603616</NlmUniqueID>
<ISSNLinking>0360-3016</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D059925">Anatomic Landmarks</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005240">Feasibility Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006258">Head and Neck Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006979">Hyperthermia, Induced</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D064847">Multimodal Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015588">Observer Variation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056888">Patient Positioning</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011880">Radiotherapy Planning, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018709">Statistics, Nonparametric</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013813">Therapy, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25015200</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>27</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1879-355X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>90</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>International journal of radiation oncology, biology, physics</Title>
<ISOAbbreviation>Int. J. Radiat. Oncol. Biol. Phys.</ISOAbbreviation>
</Journal>
<ArticleTitle>Dosimetrically triggered adaptive intensity modulated radiation therapy for cervical cancer.</ArticleTitle>
<Pagination>
<MedlinePgn>147-54</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijrobp.2014.05.039</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0360-3016(14)00690-7</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The widespread use of intensity modulated radiation therapy (IMRT) for cervical cancer has been limited by internal target and normal tissue motion. Such motion increases the risk of underdosing the target, especially as planning margins are reduced in an effort to reduce toxicity. This study explored 2 adaptive strategies to mitigate this risk and proposes a new, automated method that minimizes replanning workload.</AbstractText>
<AbstractText Label="METHODS AND MATERIALS" NlmCategory="METHODS">Thirty patients with cervical cancer participated in a prospective clinical study and underwent pretreatment and weekly magnetic resonance (MR) scans over a 5-week course of daily external beam radiation therapy. Target volumes and organs at risk (OARs) were contoured on each of the scans. Deformable image registration was used to model the accumulated dose (the real dose delivered to the target and OARs) for 2 adaptive replanning scenarios that assumed a very small PTV margin of only 3 mm to account for setup and internal interfractional motion: (1) a preprogrammed, anatomy-driven midtreatment replan (A-IMRT); and (2) a dosimetry-triggered replan driven by target dose accumulation over time (D-IMRT).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Across all 30 patients, clinically relevant target dose thresholds failed for 8 patients (27%) if 3-mm margins were used without replanning. A-IMRT failed in only 3 patients and also yielded an additional small reduction in OAR doses at the cost of 30 replans. D-IMRT assured adequate target coverage in all patients, with only 23 replans in 16 patients.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A novel, dosimetry-triggered adaptive IMRT strategy for patients with cervical cancer can minimize the risk of target underdosing in the setting of very small margins and substantial interfractional motion while minimizing programmatic workload and cost.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lim</LastName>
<ForeName>Karen</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Liverpool Hospital, Sydney, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stewart</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kelly</LastName>
<ForeName>Valerie</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xie</LastName>
<ForeName>Jason</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brock</LastName>
<ForeName>Kristy K</ForeName>
<Initials>KK</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moseley</LastName>
<ForeName>Joanne</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cho</LastName>
<ForeName>Young-Bin</ForeName>
<Initials>YB</Initials>
<AffiliationInfo>
<Affiliation>Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fyles</LastName>
<ForeName>Anthony</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lundin</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>RaySearch Laboratories AB, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rehbinder</LastName>
<ForeName>Henrik</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>RaySearch Laboratories AB, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lf</LastName>
<ForeName>Johan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>RaySearch Laboratories AB, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jaffray</LastName>
<ForeName>David A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; Techna Institute for the Advancement of Technology for Health, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Milosevic</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada. Electronic address: mike.milosevic@rmp.uhn.ca.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Int J Radiat Oncol Biol Phys</MedlineTA>
<NlmUniqueID>7603616</NlmUniqueID>
<ISSNLinking>0360-3016</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012809">Colon, Sigmoid</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019583">Dose Fractionation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007421">Intestine, Small</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009068">Movement</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058958">Organs at Risk</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011880">Radiotherapy Planning, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D061089">Radiotherapy, Image-Guided</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050397">Radiotherapy, Intensity-Modulated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012007">Rectum</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047368">Tumor Burden</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001743">Urinary Bladder</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002583">Uterine Cervical Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000532">radiotherapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25015207</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>27</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1879-355X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>90</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>International journal of radiation oncology, biology, physics</Title>
<ISOAbbreviation>Int. J. Radiat. Oncol. Biol. Phys.</ISOAbbreviation>
</Journal>
<ArticleTitle>Fat composition changes in bone marrow during chemotherapy and radiation therapy.</ArticleTitle>
<Pagination>
<MedlinePgn>155-63</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijrobp.2014.05.041</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0360-3016(14)00692-0</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To quantify changes in bone marrow fat fraction and determine associations with peripheral blood cell counts.</AbstractText>
<AbstractText Label="METHODS AND MATERIALS" NlmCategory="METHODS">In this prospective study, 19 patients received either highly myelotoxic treatment (radiation therapy plus cisplatin, 5-fluorouracil mitomycin C [FU/MMC], or cisplatin/5-FU/cetuximab) or less myelotoxic treatment (capecitabine-radiation therapy or no concurrent chemotherapy). Patients underwent MR imaging and venipuncture at baseline, midtreatment, and posttreatment visits. We performed mixed effects modeling of the mean proton density fat fraction (PDFF[%]) by linear time, treatment, and vertebral column region (lumbar [L]4-sacral [S]2 vs thoracic [T]10-L3 vs cervical[C]3-T9), while controlling for cumulative mean dose and other confounders. Spearman rank correlations were performed by white blood cell (WBC) counts versus the differences in PDFF(%) before and after treatment.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Cumulative mean dose was associated with a 0.43% per Gy (P=.004) increase in PDFF(%). In the highly myelotoxic group, we observed significant changes in PDFF(%) per visit within L4-S2 (10.1%, P&lt;.001) and within T10-L3 (3.93%, P=.01), relative to the reference C3-T9. In the less myelotoxic group, we did not observe significant changes in PDFF(%) per visit according to region. Within L4-S2, we observed a significant difference between treatment groups in the change in PDFF(%) per visit (5.36%, P=.04). Rank correlations of the inverse log differences in WBC versus the differences in PDFF(%) overall and within T10-S2 ranged from 0.69 to 0.78 (P&lt;.05). Rank correlations of the inverse log differences in absolute neutrophil counts versus the differences in PDFF(%) overall and within L4-S2 ranged from 0.79 to 0.81 (P&lt;.05).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Magnetic resonance imaging fat quantification is sensitive to marrow composition changes that result from chemoradiation therapy. These changes are associated with peripheral blood cell counts. This study supports a rationale for bone marrow-sparing treatment planning to reduce the risk of hematologic toxicity.</AbstractText>
<CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Carmona</LastName>
<ForeName>Ruben</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pritz</LastName>
<ForeName>Jakub</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bydder</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of California San Diego Medical Center, San Diego, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gulaya</LastName>
<ForeName>Sachin</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhu</LastName>
<ForeName>He</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Williamson</LastName>
<ForeName>Casey W</ForeName>
<Initials>CW</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Welch</LastName>
<ForeName>Christian S</ForeName>
<Initials>CS</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of California San Diego Medical Center, San Diego, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vaida</LastName>
<ForeName>Florin</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Biostatistics and Bioinformatics, Department of Family and Preventive Medicine, University of California San Diego Medical Center, San Diego, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bydder</LastName>
<ForeName>Graeme</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of California San Diego Medical Center, San Diego, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mell</LastName>
<ForeName>Loren K</ForeName>
<Initials>LK</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California. Electronic address: lmell@ucsd.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>1R21CA162718-01</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 CA162718</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Int J Radiat Oncol Biol Phys</MedlineTA>
<NlmUniqueID>7603616</NlmUniqueID>
<ISSNLinking>0360-3016</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D061067">Antibodies, Monoclonal, Humanized</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0W860991D6</RegistryNumber>
<NameOfSubstance UI="D003841">Deoxycytidine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>33069-62-4</RegistryNumber>
<NameOfSubstance UI="D017239">Paclitaxel</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50SG953SK6</RegistryNumber>
<NameOfSubstance UI="D016685">Mitomycin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>6804DJ8Z9U</RegistryNumber>
<NameOfSubstance UI="C110904">capecitabine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>PQX0D8J21J</RegistryNumber>
<NameOfSubstance UI="C411189">cetuximab</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>Q20Q21Q62J</RegistryNumber>
<NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>U3P01618RT</RegistryNumber>
<NameOfSubstance UI="D005472">Fluorouracil</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000273">Adipose Tissue</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D061067">Antibodies, Monoclonal, Humanized</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000971">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001005">Anus Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001772">Blood Cell Count</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001853">Bone Marrow</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001854">Bone Marrow Cells</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002574">Cervical Vertebrae</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059248">Chemoradiotherapy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002945">Cisplatin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003841">Deoxycytidine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000031">analogs &amp; derivatives</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016889">Endometrial Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005472">Fluorouracil</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000031">analogs &amp; derivatives</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008159">Lumbar Vertebrae</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016685">Mitomycin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017239">Paclitaxel</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011471">Prostatic Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011879">Radiotherapy Dosage</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050397">Radiotherapy, Intensity-Modulated</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012004">Rectal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013131">Spine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013904">Thoracic Vertebrae</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002583">Uterine Cervical Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS612219 [Available on 09/01/15]</OtherID>
<OtherID Source="NLM">PMC4159416 [Available on 09/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25199330</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0021-4892</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>63</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Masui. The Japanese journal of anesthesiology</Title>
<ISOAbbreviation>Masui</ISOAbbreviation>
</Journal>
<ArticleTitle>[Case of respiratory arrest during intraoperative magnetic resonance imaging (iMRI) for awake craniotomy].</ArticleTitle>
<Pagination>
<MedlinePgn>907-10</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We had a neurosurgical patient who developed apnea during iMRI. She was suspected of obstructive sleep apnea. The tumor had a risk of motor aphasia, and therefore awake craniotomy with iMRI was planned. First, the patient was anesthetized and her airway was secured. After 11 minutes of termination of anesthetics, the patient regained consciousness. The level of consciousness was sufficient. Her respiration was stable with oxygen supply. Anesthetics were not given any more. She gradually became drowsy when the tasks were finished and tumor was removed, although she responded to verbal commands. During the second iMRI, capnogram showed flat line and peripheral oxygen saturation level dropped to 90%. Scanning was urgently stopped and the patient was intubated. The patient recovered without any neurological deficits the day after the surgery although the reason of respiratory arrest is still unknown. Awake craniotomy could be challenging because of unsecured airway with risks of vomitting, epileptic attacks or unstable level of consciousness. It is considered that the patient monitoring becomes more difficult when iMRI is performed because the patient's face cannot be obsereved directly. We should remember that conscious level as well as respiration pattern may change during operation.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kamata</LastName>
<ForeName>Kotoe</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wada</LastName>
<ForeName>Kosuke</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kinoshita</LastName>
<ForeName>Maho</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nomura</LastName>
<ForeName>Minoru</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ozaki</LastName>
<ForeName>Makoto</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>jpn</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>Masui</MedlineTA>
<NlmUniqueID>0413707</NlmUniqueID>
<ISSNLinking>0021-4892</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000758">Anesthesia</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D003399">Craniotomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007431">Intraoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016343">Monitoring, Intraoperative</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019990">Perioperative Care</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012119">Respiration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012131">Respiratory Insufficiency</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012306">Risk</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D025321">Surgery, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D014851">Wakefulness</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25202085</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>11</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1791-7530</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>34</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Anticancer research</Title>
<ISOAbbreviation>Anticancer Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Intracystic papillary carcinoma of the breast: a diagnostic challenge with major clinical impact.</ArticleTitle>
<Pagination>
<MedlinePgn>5017-20</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Intracystic papillary carcinoma (IPC) is a ductal carcinoma of papillary variety that develops in a cystic space surrounded by a fibrous capsule. It is a rare clinicopathological entity, the in situ or invasive character of which is difficult to establish, particularly on biopsy. The treatment is surgical and breast conservation depends on the tumor size. Lymph node exploration is still debated. The diagnosis of IPC is a challenge for the pathologist: the negativity of the basement membrane markers and of myoepithelial cells carries a risk of over-diagnosis on biopsy that can lead to over-treatment.</AbstractText>
<AbstractText Label="CASE REPORT" NlmCategory="METHODS">To illustrate this risk, we report the case of a breast mass of 8 cm; its biopsy evoked invasive papillary carcinoma (no hormone receptors and overexpression of Human Epidermal Receptor-2 (HER-2) and for which neoadjuvant chemotherapy associated with trastuzumab was firstly proposed.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The analysis of all anatomical radio-clinical data in a multidisciplinary context, however, allowed suspecting IPC, thus leading to first-line surgery (mastectomy with negative sentinel lymph nodes). With this diagnosis being confirmed on surgical specimen, no systemic treatment was then necessary. After 48 months, the patient is in complete remission.</AbstractText>
<CopyrightInformation>Copyright 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Akladios</LastName>
<ForeName>Cherif Y</ForeName>
<Initials>CY</Initials>
<AffiliationInfo>
<Affiliation>Obstetrics and Gynecology Unit, Hospital Hautepierre-University Hospital, Strasbourg, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Roedlich</LastName>
<ForeName>Marie-Nolle</ForeName>
<Initials>MN</Initials>
<AffiliationInfo>
<Affiliation>Breast Imaging Unit, Hospital Hautepierre-University Hospital, Strasbourg, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bretz-Grenier</LastName>
<ForeName>Marie-Franoise</ForeName>
<Initials>MF</Initials>
<AffiliationInfo>
<Affiliation>Breast Imaging Unit, Hospital Hautepierre-University Hospital, Strasbourg, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Croce</LastName>
<ForeName>Sabrina</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Hospital Hautepierre-University Hospital, Strasbourg, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mathelin</LastName>
<ForeName>Carole</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Breast Diseases Center, Hospital Hautepierre-University Hospital, Strasbourg, France karlicaro@noos.fr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Greece</Country>
<MedlineTA>Anticancer Res</MedlineTA>
<NlmUniqueID>8102988</NlmUniqueID>
<ISSNLinking>0250-7005</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001706">Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001940">Breast</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001943">Breast Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002291">Carcinoma, Papillary</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D060828">Induction Chemotherapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008327">Mammography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016217">Ultrasonography, Mammary</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Intracystic papillary carcinoma</Keyword>
<Keyword MajorTopicYN="N">human epidermal receptor 2</Keyword>
<Keyword MajorTopicYN="N">overtreatment</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25202096</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>11</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1791-7530</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>34</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Anticancer research</Title>
<ISOAbbreviation>Anticancer Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Surgical considerations for removal of giant tumor of the right adrenal.</ArticleTitle>
<Pagination>
<MedlinePgn>5087-90</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="BACKGROUND/AIM" NlmCategory="OBJECTIVE">Complete surgical removal is the only potentially curative approach for adrenal tumors. Our series of patients affected with giant right adrenal tumors, as well as the open surgical modalities used to obtain a complete tumor resection with safe vascular control were analyzed.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Nine patients (mean age=57 years) affected with a giant right adrenal tumor who underwent open surgical removal of the mass form the basis of the present analysis. A midline incision was performed. Large mobilization of the liver was performed to obtain good and safe exposure of the vascular pedicles.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">An en bloc R0 tumor resection was accomplished in all cases. Histology revealed an adrenal cortical carcinoma in all patients. No local recurrence was noted at a mean follow-up of 14 months.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Radical surgery is the only curative approach and is recommended for all patients, whenever technically feasible, through open access in cases of giant right adrenal carcinoma.</AbstractText>
<CopyrightInformation>Copyright 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pedull</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Pietro Valdoni Department of Surgery, Sapienza University of Rome, Rome, Italy giuseppe.pedulla@uniroma1.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sapienza</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Pietro Valdoni Department of Surgery, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Paliotta</LastName>
<ForeName>Annalisa</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Pietro Valdoni Department of Surgery, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Giordano</LastName>
<ForeName>Alessio</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Pietro Valdoni Department of Surgery, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Crocetti</LastName>
<ForeName>Daniele</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Pietro Valdoni Department of Surgery, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>DE Toma</LastName>
<ForeName>Giorgio</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Pietro Valdoni Department of Surgery, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Greece</Country>
<MedlineTA>Anticancer Res</MedlineTA>
<NlmUniqueID>8102988</NlmUniqueID>
<ISSNLinking>0250-7005</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000310">Adrenal Gland Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009362">Neoplasm Metastasis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047368">Tumor Burden</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Giant adrenal tumor</Keyword>
<Keyword MajorTopicYN="N">adrenalectomy</Keyword>
<Keyword MajorTopicYN="N">radical surgery</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25202108</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>11</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1791-7530</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>34</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Anticancer research</Title>
<ISOAbbreviation>Anticancer Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Fibroma of tendon sheath with 11q rearrangements.</ArticleTitle>
<Pagination>
<MedlinePgn>5159-62</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Fibroma of tendon sheath is an uncommon, benign fibroblastic tumor that usually occurs in the upper extremities of young and middle-aged adults. A clonal chromosomal aberration, t(2;11)(q31-32;q12), has been described in one case. We herein present a unique cytogenetic finding of fibroma of tendon sheath arising in the first web space of the right hand of a 38-year-old woman. Physical examination showed a 3.5-cm, firm, mobile, non-tender mass. Magnetic resonance imaging showed a well-defined soft tissue mass with iso- to slightly-low signal intensity relative to skeletal muscle on both T1- and T2-weighted sequences. Contrast-enhanced T1-weighted sequences demonstrated moderate patchy enhancement of the mass. A fibroma or giant cell tumor of tendon sheath was suggested, and the lesion was marginally excised. Histological examination confirmed the diagnosis of fibroma of tendon sheath. Cytogenetic analysis revealed a novel t(9;11)(p24;q13-14) translocation among other karyotypic abnormalities. The postoperative course was uneventful, and the patient is doing well without local recurrence two months after surgery. To the best of our knowledge, this is only the second report of fibroma of tendon sheath with clonal chromosomal abnormalities. </AbstractText>
<CopyrightInformation>Copyright 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nishio</LastName>
<ForeName>Jun</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan jnishio@cis.fukuoka-u.ac.jp.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Iwasaki</LastName>
<ForeName>Hiroshi</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nagatomo</LastName>
<ForeName>Masaya</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Naito</LastName>
<ForeName>Masatoshi</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Greece</Country>
<MedlineTA>Anticancer Res</MedlineTA>
<NlmUniqueID>8102988</NlmUniqueID>
<ISSNLinking>0250-7005</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D002880">Chromosomes, Human, Pair 11</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005350">Fibroma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013710">Tendons</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D014178">Translocation, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">11q</Keyword>
<Keyword MajorTopicYN="N">Fibroma of tendon sheath</Keyword>
<Keyword MajorTopicYN="N">collagenous fibroma</Keyword>
<Keyword MajorTopicYN="N">cytogenetics</Keyword>
<Keyword MajorTopicYN="N">desmoplastic fibroblastoma</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25199667</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1524-4539</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>130</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>9</Day>
</PubDate>
</JournalIssue>
<Title>Circulation</Title>
<ISOAbbreviation>Circulation</ISOAbbreviation>
</Journal>
<ArticleTitle>Detection of acute inflammatory myocarditis in Epstein Barr virus infection using hybrid 18F-fluoro-deoxyglucose-positron emission tomography/magnetic resonance imaging.</ArticleTitle>
<Pagination>
<MedlinePgn>925-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCULATIONAHA.114.011000</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>von Olshausen</LastName>
<ForeName>Gesa</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>From the Medizinische Klinik und Poliklinik (G.v.O., N.L., K.-L.L., T.I.) and Nuklearmedizinische Klinik und Poliklinik (F.H., M.S.), Klinikum rechts der Isar, Technische Universitt Mnchen, Munich, Germany; and DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany (K.-L.L.). gesavo@web.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hyafil</LastName>
<ForeName>Fabien</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>From the Medizinische Klinik und Poliklinik (G.v.O., N.L., K.-L.L., T.I.) and Nuklearmedizinische Klinik und Poliklinik (F.H., M.S.), Klinikum rechts der Isar, Technische Universitt Mnchen, Munich, Germany; and DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany (K.-L.L.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Langwieser</LastName>
<ForeName>Nicolas</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>From the Medizinische Klinik und Poliklinik (G.v.O., N.L., K.-L.L., T.I.) and Nuklearmedizinische Klinik und Poliklinik (F.H., M.S.), Klinikum rechts der Isar, Technische Universitt Mnchen, Munich, Germany; and DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany (K.-L.L.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Laugwitz</LastName>
<ForeName>Karl-Ludwig</ForeName>
<Initials>KL</Initials>
<AffiliationInfo>
<Affiliation>From the Medizinische Klinik und Poliklinik (G.v.O., N.L., K.-L.L., T.I.) and Nuklearmedizinische Klinik und Poliklinik (F.H., M.S.), Klinikum rechts der Isar, Technische Universitt Mnchen, Munich, Germany; and DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany (K.-L.L.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schwaiger</LastName>
<ForeName>Markus</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From the Medizinische Klinik und Poliklinik (G.v.O., N.L., K.-L.L., T.I.) and Nuklearmedizinische Klinik und Poliklinik (F.H., M.S.), Klinikum rechts der Isar, Technische Universitt Mnchen, Munich, Germany; and DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany (K.-L.L.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ibrahim</LastName>
<ForeName>Tareq</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>From the Medizinische Klinik und Poliklinik (G.v.O., N.L., K.-L.L., T.I.) and Nuklearmedizinische Klinik und Poliklinik (F.H., M.S.), Klinikum rechts der Isar, Technische Universitt Mnchen, Munich, Germany; and DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany (K.-L.L.).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Circulation</MedlineTA>
<NlmUniqueID>0147763</NlmUniqueID>
<ISSNLinking>0009-7322</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0Z5B2CJX4D</RegistryNumber>
<NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000208">Acute Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D057791">Cardiac Imaging Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020031">Epstein-Barr Virus Infections</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019788">Fluorodeoxyglucose F18</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D064847">Multimodal Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009205">Myocarditis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000821">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019275">Radiopharmaceuticals</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25200059</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>27</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1524-4539</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>130</Volume>
<Issue>11 Suppl 1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>9</Day>
</PubDate>
</JournalIssue>
<Title>Circulation</Title>
<ISOAbbreviation>Circulation</ISOAbbreviation>
</Journal>
<ArticleTitle>Cardiac tissue slice transplantation as a model to assess tissue-engineered graft thickness, survival, and function.</ArticleTitle>
<Pagination>
<MedlinePgn>S77-86</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCULATIONAHA.113.007920</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cell therapies offer the potential to improve cardiac function after myocardial infarction. Although injection of single-cell suspensions has proven safe, cell retention and survival rates are low. Tissue-engineered grafts allow cell delivery with minimal initial cell loss and mechanical support to the heart. However, graft performance cannot be easily compared, and optimal construct thickness, vascularization, and survival kinetics are unknown.</AbstractText>
<AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">Cardiac tissue slices (CTS) were generated by sectioning mouse hearts (n=40) expressing firefly luciferase and green fluorescent protein into slices of defined size and thickness using a vibrating blade microtome. Bioluminescence imaging of CTS transplanted onto hearts of immunodeficient mice demonstrated survival of 30% of transplanted cells. Cardiac slice perfusion was re-established within 3 days, likely through anastomosis of pre-existing vessels with the host vasculature and invasion of vessels from the host. Immunofluorescence showed a peak in cell death 3 days after transplantation and a gradual decline thereafter. MRI revealed preservation of contractile function and an improved ejection fraction 1 month after transplantation of CTS (282% CTS versus 222% control; P=0.05). Importantly, this effect was specific to CTS because transplantation of skeletal muscle tissue slices led to faster dilative remodeling and higher animal mortality.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In summary, this is the first study to use CTS as a benchmark to validate and model tissue-engineered graft studies. CTS transplantation improved cell survival, established reperfusion, and enhanced cardiac function after myocardial infarction. These findings also confirm that dilative remodeling can be attenuated by topical transplantation of CTS but not skeletal muscle tissue grafts.</AbstractText>
<CopyrightInformation> 2014 American Heart Association, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Riegler</LastName>
<ForeName>Johannes</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Division of Cardiology and Department of Radiology, Stanford Cardiovascular Institute (J.R., Q.S., J.C.W.), Department of Biochemistry (A.G.), and Department of Cardiothoracic Surgery (J.D.G.), Stanford University School of Medicine, CA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gillich</LastName>
<ForeName>Astrid</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Division of Cardiology and Department of Radiology, Stanford Cardiovascular Institute (J.R., Q.S., J.C.W.), Department of Biochemistry (A.G.), and Department of Cardiothoracic Surgery (J.D.G.), Stanford University School of Medicine, CA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shen</LastName>
<ForeName>Qi</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Division of Cardiology and Department of Radiology, Stanford Cardiovascular Institute (J.R., Q.S., J.C.W.), Department of Biochemistry (A.G.), and Department of Cardiothoracic Surgery (J.D.G.), Stanford University School of Medicine, CA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gold</LastName>
<ForeName>Joseph D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Division of Cardiology and Department of Radiology, Stanford Cardiovascular Institute (J.R., Q.S., J.C.W.), Department of Biochemistry (A.G.), and Department of Cardiothoracic Surgery (J.D.G.), Stanford University School of Medicine, CA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Joseph C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Medicine, Division of Cardiology and Department of Radiology, Stanford Cardiovascular Institute (J.R., Q.S., J.C.W.), Department of Biochemistry (A.G.), and Department of Cardiothoracic Surgery (J.D.G.), Stanford University School of Medicine, CA. joewu@stanford.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 EB009689</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 HL099776</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 HL099995</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Circulation</MedlineTA>
<NlmUniqueID>0147763</NlmUniqueID>
<ISSNLinking>0009-7322</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C485184">enhanced green fluorescent protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>147336-22-9</RegistryNumber>
<NameOfSubstance UI="D049452">Green Fluorescent Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.13.12.7</RegistryNumber>
<NameOfSubstance UI="D049409">Luciferases, Firefly</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000831">Animals, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053595">Embryonic Stem Cells</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000637">transplantation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017930">Genes, Reporter</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006085">Graft Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049452">Green Fluorescent Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006352">Heart Ventricles</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000637">transplantation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049409">Luciferases, Firefly</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016688">Mice, Inbred NOD</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016513">Mice, SCID</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008822">Mice, Transgenic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D023421">Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009200">Myocardial Contraction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009203">Myocardial Infarction</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009929">Organ Size</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D052097">Quadriceps Muscle</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011897">Random Allocation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D023822">Tissue Engineering</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016378">Tissue Transplantation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">cell transplantation</Keyword>
<Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword>
<Keyword MajorTopicYN="N">myocardial infarction</Keyword>
<Keyword MajorTopicYN="N">tissue engineering</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25200456</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1556-9519</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>52</Volume>
<Issue>8</Issue>
<PubDate>
<MedlineDate>2014 Sep-Oct</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Clinical toxicology (Philadelphia, Pa.)</Title>
<ISOAbbreviation>Clin Toxicol (Phila)</ISOAbbreviation>
</Journal>
<ArticleTitle>Subacute ascending numbness.</ArticleTitle>
<Pagination>
<MedlinePgn>905-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3109/15563650.2014.953170</ELocationID>
<Abstract>
<AbstractText>A 21-year-old male presented with two weeks of ascending numbness involving all 4 limbs, and imbalance when walking. Examination revealed diminished vibration and proprioception at the fingers, toes, and ankles, a high steppage gait and a positive Romberg sign. He had no weakness in any muscle groups. Laboratory data included vitamin B12 218 pg/mL (normal range: 200-800 pg/mL), homocysteine 87 mol/L (normal range: 2.2-13.2 mol/L), and non-reactive RPR. Magnetic resonance imaging of the cervical spine revealed abnormal T2-weighted hyperintensity along the posterior columns extending from C2 to C7. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Arshi</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, University of Southern California , Los Angeles, CA , USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shaw</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Clin Toxicol (Phila)</MedlineTA>
<NlmUniqueID>101241654</NlmUniqueID>
<ISSNLinking>1556-3650</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013287">Street Drugs</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0LVT1QZ0BA</RegistryNumber>
<NameOfSubstance UI="D006710">Homocysteine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>K50XQU1029</RegistryNumber>
<NameOfSubstance UI="D009609">Nitrous Oxide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>P6YC3EG204</RegistryNumber>
<NameOfSubstance UI="D014805">Vitamin B 12</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006710">Homocysteine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006987">Hypesthesia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019570">Inhalation Exposure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009609">Nitrous Oxide</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000633">toxicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011434">Proprioception</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013116">Spinal Cord</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013287">Street Drugs</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000633">toxicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014805">Vitamin B 12</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">CNS and psychological</Keyword>
<Keyword MajorTopicYN="N">CNS/Psychological</Keyword>
<Keyword MajorTopicYN="N">Metabolic</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25103267</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1552-5783</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>55</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Investigative ophthalmology &amp; visual science</Title>
<ISOAbbreviation>Invest. Ophthalmol. Vis. Sci.</ISOAbbreviation>
</Journal>
<ArticleTitle>Magic angle-enhanced MRI of fibrous microstructures in sclera and cornea with and without intraocular pressure loading.</ArticleTitle>
<Pagination>
<MedlinePgn>5662-72</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1167/iovs.14-14561</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The structure and biomechanics of the sclera and cornea are central to several eye diseases such as glaucoma and myopia. However, their roles remain unclear, partly because of limited noninvasive techniques to assess their fibrous microstructures globally, longitudinally, and quantitatively. We hypothesized that magic angle-enhanced magnetic resonance imaging (MRI) can reveal the structural details of the corneoscleral shell and their changes upon intraocular pressure (IOP) elevation.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Seven ovine eyes were extracted and fixed at IOP = 50 mm Hg to mimic ocular hypertension, and another 11 eyes were unpressurized. The sclera and cornea were scanned at different angular orientations relative to the main magnetic field inside a 9.4-Tesla MRI scanner. Relative MRI signal intensities and intrinsic transverse relaxation times (T2 and T2*) were determined to quantify the magic angle effect on the corneoscleral shells. Three loaded and eight unloaded tendon samples were scanned as controls.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">At magic angle, high-resolution MRI revealed distinct scleral and corneal lamellar fibers, and light/dark bands indicative of collagen fiber crimps in the sclera and tendon. Magic angle enhancement effect was the strongest in tendon and the least strong in cornea. Loaded sclera, cornea, and tendon possessed significantly higher T2 and T2* than unloaded tissues at magic angle.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Magic angle-enhanced MRI can detect ocular fibrous microstructures without contrast agents or coatings and can reveal their MR tissue property changes with IOP loading. This technique may open up new avenues for assessment of the biomechanical and biochemical properties of ocular tissues in aging and in diseases involving the corneoscleral shell.</AbstractText>
<CopyrightInformation>Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ho</LastName>
<ForeName>Leon C</ForeName>
<Initials>LC</Initials>
<AffiliationInfo>
<Affiliation>NeuroImaging Laboratory, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sigal</LastName>
<ForeName>Ian A</ForeName>
<Initials>IA</Initials>
<AffiliationInfo>
<Affiliation>UPMC Eye Center, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jan</LastName>
<ForeName>Ning-Jiun</ForeName>
<Initials>NJ</Initials>
<AffiliationInfo>
<Affiliation>UPMC Eye Center, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Squires</LastName>
<ForeName>Alexander</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Medical Robotics Lab, College of Engineering, University of Georgia, Athens, Georgia, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tse</LastName>
<ForeName>Zion</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Medical Robotics Lab, College of Engineering, University of Georgia, Athens, Georgia, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Ed X</ForeName>
<Initials>EX</Initials>
<AffiliationInfo>
<Affiliation>Department of Electrical and Electronic Engineering, The University of Hong Kong, Pokfulam, Hong Kong, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Seong-Gi</ForeName>
<Initials>SG</Initials>
<AffiliationInfo>
<Affiliation>NeuroImaging Laboratory, University of Pittsburgh, Pittsburgh, Pennsylvania, United States Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania, United States McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States Center for the Neural Basis of Cognition, University of Pittsburgh and Carnegie Mellon University, Pittsburgh, Pennsylvania, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schuman</LastName>
<ForeName>Joel S</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>UPMC Eye Center, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania, United States Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chan</LastName>
<ForeName>Kevin C</ForeName>
<Initials>KC</Initials>
<AffiliationInfo>
<Affiliation>NeuroImaging Laboratory, University of Pittsburgh, Pittsburgh, Pennsylvania, United States UPMC Eye Center, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania, United States Center for the Neural Basis of Cognition, University of Pittsburgh and Carnegie Mellon University, Pittsburgh, Pennsylvania, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30-EY008098</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 EY023966</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01-EY023966</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1-TR000005</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Invest Ophthalmol Vis Sci</MedlineTA>
<NlmUniqueID>7703701</NlmUniqueID>
<ISSNLinking>0146-0404</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>9007-34-5</RegistryNumber>
<NameOfSubstance UI="D003094">Collagen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003094">Collagen</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000648">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003315">Cornea</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000648">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007429">Intraocular Pressure</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D023421">Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008954">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012590">Sclera</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000648">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012756">Sheep</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4160095 [Available on 03/01/15]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">cornea</Keyword>
<Keyword MajorTopicYN="N">magic angle effect</Keyword>
<Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword>
<Keyword MajorTopicYN="N">ocular hypertension</Keyword>
<Keyword MajorTopicYN="N">sclera</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25155256</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>14</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-7897</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>28</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of anxiety disorders</Title>
<ISOAbbreviation>J Anxiety Disord</ISOAbbreviation>
</Journal>
<ArticleTitle>Cortical surface anatomy in pediatric patients with generalized anxiety disorder.</ArticleTitle>
<Pagination>
<MedlinePgn>717-23</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.janxdis.2014.07.012</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0887-6185(14)00112-1</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">It is established that pediatric patients with generalized anxiety disorder (GAD) exhibit functional abnormalities and altered gray matter volumes in neural structures that subserve emotional processing, yet there are no data regarding the surface anatomy of the cerebral cortex in youth with GAD.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Using an automated surface-based approach (FreeSurfer), cortical thickness was assessed node-by-node over the entire cerebral cortex in adolescents with GAD and no co-occurring major depressive disorder (n=13) and healthy subjects (n=19).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with healthy adolescents, youth with GAD exhibited increased cortical thickness in the right inferolateral and ventromedial prefrontal cortex (i.e., inferior frontal gyrus), the left inferior and middle temporal cortex as well as the right lateral occipital cortex. No relationships were observed between cortical thickness and the severity of anxiety symptoms in the significant regions that were identified in the vertex-wise analysis.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These findings suggest that, in adolescents with GAD, abnormalities in cortical thickness are present in an ensemble of regions responsible for fear learning, fear extinction, reflective functioning (e.g., mentalization), and regulation of the amygdala.</AbstractText>
<CopyrightInformation>Copyright  2014. Published by Elsevier Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Strawn</LastName>
<ForeName>Jeffrey R</ForeName>
<Initials>JR</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, College of Medicine, United States; Department of Pediatrics, Division of Child &amp; Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. Electronic address: strawnjr@uc.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>John Wegman</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, College of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dominick</LastName>
<ForeName>Kelli C</ForeName>
<Initials>KC</Initials>
<AffiliationInfo>
<Affiliation>Center for Imaging Research, University of Cincinnati, College of Medicine, Cincinnati, OH, United States; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, College of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Swartz</LastName>
<ForeName>Max S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, College of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wehry</LastName>
<ForeName>Anna M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, College of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Patino</LastName>
<ForeName>Luis R</ForeName>
<Initials>LR</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, College of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Strakowski</LastName>
<ForeName>Stephen M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, College of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Adler</LastName>
<ForeName>Caleb M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, College of Medicine, United States; Department of Pediatrics, Division of Child &amp; Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eliassen</LastName>
<ForeName>James C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Division of Child &amp; Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>DelBello</LastName>
<ForeName>Melissa P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, College of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01MH080973</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>J Anxiety Disord</MedlineTA>
<NlmUniqueID>8710131</NlmUniqueID>
<ISSNLinking>0887-6185</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000679">Amygdala</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001008">Anxiety Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002540">Cerebral Cortex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004644">Emotions</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005239">Fear</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017397">Prefrontal Cortex</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Adolescence</Keyword>
<Keyword MajorTopicYN="N">Cortical thickness</Keyword>
<Keyword MajorTopicYN="N">FreeSurfer</Keyword>
<Keyword MajorTopicYN="N">Generalized anxiety disorder (GAD)</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24780414</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1095-8673</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>191</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of surgical research</Title>
<ISOAbbreviation>J. Surg. Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Superparamagnetic iron oxide magnetic nanomaterial-labeled bone marrow mesenchymal stem cells for rat liver repair after hepatectomy.</ArticleTitle>
<Pagination>
<MedlinePgn>290-301</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jss.2014.03.064</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0022-4804(14)00344-8</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Superparamagnetic iron oxide magnetic nanomaterials (SPIO) are tracers used for treatment of central nervous and cardiovascular system complications in animal models. The present study investigated survival and proliferation of SPIO-labeled bone marrow mesenchymal stem cells (BMSCs) to determine their potential therapeutic value in liver repair.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Surface antigens of BMSCs were measured using flow cytometry. BMSCs viability, growth curve, and SPIO (0-100 g/mL) labeling rate were evaluated using trypan blue staining, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and Prussian blue staining, respectively. SPIO-labeled BMSCs were transplanted via liver or spleen injection in rats undergoing 70% hepatectomy. Distribution of SPIO-labeled BMSCs in liver and spleen, and liver repair were evaluated by magnetic resonance imaging (MRI), and serum alanine aminotransferase, aspartate aminotransferase, albumin, and total bilirubin levels.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">CD29(+)/CD90(+)/CD45(-) BMSCs were successfully isolated from rats. Labeling rate of SPIO in 25 g/mL was 94.9%. SPIO labeling did not affect BMSCs survival and proliferation. MRI showed that BMSCs colonized in the liver, whether via spleen or liver injection. Serum levels of alanine aminotransferase, aspartate aminotransferase, and total bilirubin in the transplanted rats were significantly lower than in the hepatectomy group at days 1, 3, and 7 after hepatectomy (all P &lt; 0.05), whereas serum albumin levels were significantly higher in the transplanted rats on posthepatectomy day 3 (both P &lt; 0.05). These indicators were not significantly different between the spleen and liver injection approaches.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">BMSCs transplantation via liver or spleen injection could significantly accelerate liver healing. In vivo MRI of SPIO-labeled BMSCs can be used to trace real-time liver healing during clinical treatment after hepatectomy.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Shiyu</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Yulin</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gao</LastName>
<ForeName>Chengshun</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesia, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Jing</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bao</LastName>
<ForeName>Haidong</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Zhongyu</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Department of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gong</LastName>
<ForeName>Peng</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China. Electronic address: doctorgongpeng@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>03</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Surg Res</MedlineTA>
<NlmUniqueID>0376340</NlmUniqueID>
<ISSNLinking>0022-4804</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005290">Ferric Compounds</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D058185">Magnetite Nanoparticles</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>1309-37-1</RegistryNumber>
<NameOfSubstance UI="C000499">ferric oxide</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049109">Cell Proliferation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002470">Cell Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005290">Ferric Compounds</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006498">Hepatectomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008115">Liver Regeneration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058185">Magnetite Nanoparticles</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D045164">Mesenchymal Stem Cell Transplantation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059630">Mesenchymal Stromal Cells</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017207">Rats, Sprague-Dawley</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bone marrow mesenchymal stem cells</Keyword>
<Keyword MajorTopicYN="N">Hepatectomy</Keyword>
<Keyword MajorTopicYN="N">Liver repair</Keyword>
<Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword>
<Keyword MajorTopicYN="N">Superparamagnetic iron oxide magnetic nanomaterials</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25085641</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1526-632X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>83</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>9</Day>
</PubDate>
</JournalIssue>
<Title>Neurology</Title>
<ISOAbbreviation>Neurology</ISOAbbreviation>
</Journal>
<ArticleTitle>A systematic study of topographical memory and posterior cerebral artery infarctions.</ArticleTitle>
<Pagination>
<MedlinePgn>996-1003</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000000780</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To estimate the prevalence of topographical memory impairment following posterior cerebral artery infarctions (PCAI) and define its anatomical correlations.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We recruited 15 patients (mean duration of 4 months postinfarct). We administered 2 sets of experimental tests to assess topographical memory: one set included 5 computerized tasks (CompT) and the other set consisted of one ecological topographical orientation test (EcolT) that included 4 tasks (i.e., map drawing, picture recognition and ordering, backward path). Fifteen healthy participants served as controls. Patients and controls underwent a volumetric T1 MRI brain scan. Brain lesions in patients were segmented, normalized, and correlated with performance.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Topographical memory impairments were evidenced in patients with PCAI using both group and individual analyses (50%), with more severe outcomes in patients with PCAI in the right hemisphere. CompT and EcolT were highly correlated, but the ecological test was more sensitive in revealing topographical memory impairments. Voxel-based lesion-symptom mapping demonstrated that 2 regions located in the cuneus and the calcarine sulcus correlated significantly with behavioral performance.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Topographical memory disorders following PCAI are reported in 50% of the patient population. Our results demonstrate the importance of developing and using dedicated batteries of topographical memory tests, in particular real-life tests, to identify such deficits.</AbstractText>
<CopyrightInformation> 2014 American Academy of Neurology.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Busigny</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Psychology (T.B.), Universit Catholique de Louvain, Louvain-la-Neuve, Belgium; Universit de Toulouse UPS &amp; Centre de Recherche Cerveau et Cognition (CNRS) (T.B., E.J.B., C.B.), Cerco, UMR 5549, Toulouse, France; Service de Neurologie et Ple Neurosciences (B.P., C.B., E.M., N.R., J.-F.A., F.C., J.P.), CHU de Toulouse, France; Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Universit de Toulouse UPS, UMR 825, CHU de Toulouse, France; and Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Inserm, UMR 825, CHU de Toulouse, Toulouse, France. busigny@cerco.ups-tlse.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pags</LastName>
<ForeName>Brengre</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Psychology (T.B.), Universit Catholique de Louvain, Louvain-la-Neuve, Belgium; Universit de Toulouse UPS &amp; Centre de Recherche Cerveau et Cognition (CNRS) (T.B., E.J.B., C.B.), Cerco, UMR 5549, Toulouse, France; Service de Neurologie et Ple Neurosciences (B.P., C.B., E.M., N.R., J.-F.A., F.C., J.P.), CHU de Toulouse, France; Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Universit de Toulouse UPS, UMR 825, CHU de Toulouse, France; and Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Inserm, UMR 825, CHU de Toulouse, Toulouse, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barbeau</LastName>
<ForeName>Emmanuel J</ForeName>
<Initials>EJ</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Psychology (T.B.), Universit Catholique de Louvain, Louvain-la-Neuve, Belgium; Universit de Toulouse UPS &amp; Centre de Recherche Cerveau et Cognition (CNRS) (T.B., E.J.B., C.B.), Cerco, UMR 5549, Toulouse, France; Service de Neurologie et Ple Neurosciences (B.P., C.B., E.M., N.R., J.-F.A., F.C., J.P.), CHU de Toulouse, France; Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Universit de Toulouse UPS, UMR 825, CHU de Toulouse, France; and Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Inserm, UMR 825, CHU de Toulouse, Toulouse, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bled</LastName>
<ForeName>Clara</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Psychology (T.B.), Universit Catholique de Louvain, Louvain-la-Neuve, Belgium; Universit de Toulouse UPS &amp; Centre de Recherche Cerveau et Cognition (CNRS) (T.B., E.J.B., C.B.), Cerco, UMR 5549, Toulouse, France; Service de Neurologie et Ple Neurosciences (B.P., C.B., E.M., N.R., J.-F.A., F.C., J.P.), CHU de Toulouse, France; Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Universit de Toulouse UPS, UMR 825, CHU de Toulouse, France; and Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Inserm, UMR 825, CHU de Toulouse, Toulouse, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Montaut</LastName>
<ForeName>Emilie</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Psychology (T.B.), Universit Catholique de Louvain, Louvain-la-Neuve, Belgium; Universit de Toulouse UPS &amp; Centre de Recherche Cerveau et Cognition (CNRS) (T.B., E.J.B., C.B.), Cerco, UMR 5549, Toulouse, France; Service de Neurologie et Ple Neurosciences (B.P., C.B., E.M., N.R., J.-F.A., F.C., J.P.), CHU de Toulouse, France; Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Universit de Toulouse UPS, UMR 825, CHU de Toulouse, France; and Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Inserm, UMR 825, CHU de Toulouse, Toulouse, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Raposo</LastName>
<ForeName>Nicolas</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Psychology (T.B.), Universit Catholique de Louvain, Louvain-la-Neuve, Belgium; Universit de Toulouse UPS &amp; Centre de Recherche Cerveau et Cognition (CNRS) (T.B., E.J.B., C.B.), Cerco, UMR 5549, Toulouse, France; Service de Neurologie et Ple Neurosciences (B.P., C.B., E.M., N.R., J.-F.A., F.C., J.P.), CHU de Toulouse, France; Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Universit de Toulouse UPS, UMR 825, CHU de Toulouse, France; and Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Inserm, UMR 825, CHU de Toulouse, Toulouse, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Albucher</LastName>
<ForeName>Jean-Franois</ForeName>
<Initials>JF</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Psychology (T.B.), Universit Catholique de Louvain, Louvain-la-Neuve, Belgium; Universit de Toulouse UPS &amp; Centre de Recherche Cerveau et Cognition (CNRS) (T.B., E.J.B., C.B.), Cerco, UMR 5549, Toulouse, France; Service de Neurologie et Ple Neurosciences (B.P., C.B., E.M., N.R., J.-F.A., F.C., J.P.), CHU de Toulouse, France; Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Universit de Toulouse UPS, UMR 825, CHU de Toulouse, France; and Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Inserm, UMR 825, CHU de Toulouse, Toulouse, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chollet</LastName>
<ForeName>Franois</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Psychology (T.B.), Universit Catholique de Louvain, Louvain-la-Neuve, Belgium; Universit de Toulouse UPS &amp; Centre de Recherche Cerveau et Cognition (CNRS) (T.B., E.J.B., C.B.), Cerco, UMR 5549, Toulouse, France; Service de Neurologie et Ple Neurosciences (B.P., C.B., E.M., N.R., J.-F.A., F.C., J.P.), CHU de Toulouse, France; Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Universit de Toulouse UPS, UMR 825, CHU de Toulouse, France; and Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Inserm, UMR 825, CHU de Toulouse, Toulouse, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pariente</LastName>
<ForeName>Jrmie</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From the Institute of Psychology (T.B.), Universit Catholique de Louvain, Louvain-la-Neuve, Belgium; Universit de Toulouse UPS &amp; Centre de Recherche Cerveau et Cognition (CNRS) (T.B., E.J.B., C.B.), Cerco, UMR 5549, Toulouse, France; Service de Neurologie et Ple Neurosciences (B.P., C.B., E.M., N.R., J.-F.A., F.C., J.P.), CHU de Toulouse, France; Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Universit de Toulouse UPS, UMR 825, CHU de Toulouse, France; and Imagerie crbrale et handicaps neurologiques (N.R., J.-F.A., F.C., J.P.), Inserm, UMR 825, CHU de Toulouse, Toulouse, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Neurology</MedlineTA>
<NlmUniqueID>0401060</NlmUniqueID>
<ISSNLinking>0028-3878</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003936">Diagnosis, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007839">Functional Laterality</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020762">Infarction, Posterior Cerebral Artery</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008377">Maps as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018782">Maze Learning</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008569">Memory Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010364">Pattern Recognition, Visual</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25098537</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1526-632X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>83</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>9</Day>
</PubDate>
</JournalIssue>
<Title>Neurology</Title>
<ISOAbbreviation>Neurology</ISOAbbreviation>
</Journal>
<ArticleTitle>Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS.</ArticleTitle>
<Pagination>
<MedlinePgn>974-80</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000000775</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the effects of corticosteroids on the lower extremity muscles in boys with Duchenne muscular dystrophy (DMD) using MRI and magnetic resonance spectroscopy (MRS).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Transverse relaxation time (T2) and fat fraction were measured by MRI/MRS in lower extremity muscles of 15 boys with DMD (age 5.0-6.9 years) taking corticosteroids and 15 corticosteroid-naive boys. Subsequently, fat fraction was measured in a subset of these boys at 1 year. Finally, MRI/MRS data were collected from 16 corticosteroid-naive boys with DMD (age 5-8.9 years) at baseline, 3 months, and 6 months. Five boys were treated with corticosteroids after baseline and the remaining 11 served as corticosteroid-naive controls.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Cross-sectional comparisons demonstrated lower muscle T2 and less intramuscular (IM) fat deposition in boys with DMD on corticosteroids, suggesting reduced inflammation/damage and fat infiltration with treatment. Boys on corticosteroids demonstrated less increase in IM fat infiltration at 1 year. Finally, T2 by MRI/MRS detected effects of corticosteroids on leg muscles as early as 3 months after drug initiation.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These results demonstrate the ability of MRI/MRS to detect therapeutic effects of corticosteroids in reducing inflammatory processes in skeletal muscles of boys with DMD. Our work highlights the potential of MRI/MRS as a biomarker in evaluating therapeutic interventions in DMD.</AbstractText>
<CopyrightInformation> 2014 American Academy of Neurology.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Arpan</LastName>
<ForeName>Ishu</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Willcocks</LastName>
<ForeName>Rebecca J</ForeName>
<Initials>RJ</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Forbes</LastName>
<ForeName>Sean C</ForeName>
<Initials>SC</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Finkel</LastName>
<ForeName>Richard S</ForeName>
<Initials>RS</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lott</LastName>
<ForeName>Donovan J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rooney</LastName>
<ForeName>William D</ForeName>
<Initials>WD</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Triplett</LastName>
<ForeName>William T</ForeName>
<Initials>WT</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Senesac</LastName>
<ForeName>Claudia R</ForeName>
<Initials>CR</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Daniels</LastName>
<ForeName>Michael J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Byrne</LastName>
<ForeName>Barry J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Finanger</LastName>
<ForeName>Erika L</ForeName>
<Initials>EL</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Russman</LastName>
<ForeName>Barry S</ForeName>
<Initials>BS</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Dah-Jyuu</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tennekoon</LastName>
<ForeName>Gihan I</ForeName>
<Initials>GI</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Walter</LastName>
<ForeName>Glenn A</ForeName>
<Initials>GA</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sweeney</LastName>
<ForeName>H L</ForeName>
<Initials>HL</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vandenborne</LastName>
<ForeName>Krista</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>From the Departments of Physical Therapy (I.A., R.J.W., S.C.F., D.J.L., W.T.T., C.R.S., K.V.), Physiology and Functional Genomics (G.A.W.), and Pediatrics (B.J.B.), and Molecular Genetics &amp; Microbiology, Powell Gene Therapy Center (B.J.B.), University of Florida, Gainesville; The Children's Hospital of Philadelphia (R.S.F., D.-J.W., G.I.T.), PA; Oregon Health &amp; Science University (W.D.R., E.L.F., B.S.R.), Portland; the Departments of Integrative Biology and Statistics and Data Sciences (M.J.D.), The University of Texas at Austin; Shriners Hospital for Children (B.S.R.), Philadelphia, PA; and the Department of Physiology (H.L.S.), University of Pennsylvania, Philadelphia. kvandenb@phhp.ufl.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01AR05697</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01AR065943</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Neurology</MedlineTA>
<NlmUniqueID>0401060</NlmUniqueID>
<ISSNLinking>0028-3878</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Neurology. 2014 Sep 9;83(11):956-7</RefSource>
<PMID Version="1">25098536</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000273">Adipose Tissue</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000305">Adrenal Cortex Hormones</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000893">Anti-Inflammatory Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003430">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007866">Leg</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000254">growth &amp; development</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008137">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009682">Magnetic Resonance Spectroscopy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053580">Muscle Strength</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018482">Muscle, Skeletal</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000254">growth &amp; development</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020388">Muscular Dystrophy, Duchenne</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4162304 [Available on 09/09/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25098541</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1526-632X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>83</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>9</Day>
</PubDate>
</JournalIssue>
<Title>Neurology</Title>
<ISOAbbreviation>Neurology</ISOAbbreviation>
</Journal>
<ArticleTitle>Cerebral small-vessel disease associated with COL4A1 and COL4A2 gene duplications.</ArticleTitle>
<Pagination>
<MedlinePgn>1029-31</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000000769</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Renard</LastName>
<ForeName>Dimitri</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>From CHU Nmes (D.R., P.L.), Hpital Caremeau; AP-HP, Service de Gntique Neuro-vasculaire (M.M., E.T.-L.), Hpital Lariboisire, Paris; UMR-S 1161 Universit Paris Diderot (M.M., E.T.-L.), Sorbonne Paris Cit, Gntique des Maladies Vasculaires, Paris; and AP-HP, Hpital Jean Verdier (E.P., A.D., B.B.), Cytogntique, Bondy, INSERM, Paris, Universit Paris Nord, Sorbonne Paris Cit, Bobigny, France. dimitrirenard@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Min</LastName>
<ForeName>Manuele</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>From CHU Nmes (D.R., P.L.), Hpital Caremeau; AP-HP, Service de Gntique Neuro-vasculaire (M.M., E.T.-L.), Hpital Lariboisire, Paris; UMR-S 1161 Universit Paris Diderot (M.M., E.T.-L.), Sorbonne Paris Cit, Gntique des Maladies Vasculaires, Paris; and AP-HP, Hpital Jean Verdier (E.P., A.D., B.B.), Cytogntique, Bondy, INSERM, Paris, Universit Paris Nord, Sorbonne Paris Cit, Bobigny, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pipiras</LastName>
<ForeName>Eva</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From CHU Nmes (D.R., P.L.), Hpital Caremeau; AP-HP, Service de Gntique Neuro-vasculaire (M.M., E.T.-L.), Hpital Lariboisire, Paris; UMR-S 1161 Universit Paris Diderot (M.M., E.T.-L.), Sorbonne Paris Cit, Gntique des Maladies Vasculaires, Paris; and AP-HP, Hpital Jean Verdier (E.P., A.D., B.B.), Cytogntique, Bondy, INSERM, Paris, Universit Paris Nord, Sorbonne Paris Cit, Bobigny, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Labauge</LastName>
<ForeName>Pierre</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>From CHU Nmes (D.R., P.L.), Hpital Caremeau; AP-HP, Service de Gntique Neuro-vasculaire (M.M., E.T.-L.), Hpital Lariboisire, Paris; UMR-S 1161 Universit Paris Diderot (M.M., E.T.-L.), Sorbonne Paris Cit, Gntique des Maladies Vasculaires, Paris; and AP-HP, Hpital Jean Verdier (E.P., A.D., B.B.), Cytogntique, Bondy, INSERM, Paris, Universit Paris Nord, Sorbonne Paris Cit, Bobigny, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Delahaye</LastName>
<ForeName>Andre</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>From CHU Nmes (D.R., P.L.), Hpital Caremeau; AP-HP, Service de Gntique Neuro-vasculaire (M.M., E.T.-L.), Hpital Lariboisire, Paris; UMR-S 1161 Universit Paris Diderot (M.M., E.T.-L.), Sorbonne Paris Cit, Gntique des Maladies Vasculaires, Paris; and AP-HP, Hpital Jean Verdier (E.P., A.D., B.B.), Cytogntique, Bondy, INSERM, Paris, Universit Paris Nord, Sorbonne Paris Cit, Bobigny, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Benzacken</LastName>
<ForeName>Brigitte</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>From CHU Nmes (D.R., P.L.), Hpital Caremeau; AP-HP, Service de Gntique Neuro-vasculaire (M.M., E.T.-L.), Hpital Lariboisire, Paris; UMR-S 1161 Universit Paris Diderot (M.M., E.T.-L.), Sorbonne Paris Cit, Gntique des Maladies Vasculaires, Paris; and AP-HP, Hpital Jean Verdier (E.P., A.D., B.B.), Cytogntique, Bondy, INSERM, Paris, Universit Paris Nord, Sorbonne Paris Cit, Bobigny, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tournier-Lasserve</LastName>
<ForeName>Elisabeth</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>From CHU Nmes (D.R., P.L.), Hpital Caremeau; AP-HP, Service de Gntique Neuro-vasculaire (M.M., E.T.-L.), Hpital Lariboisire, Paris; UMR-S 1161 Universit Paris Diderot (M.M., E.T.-L.), Sorbonne Paris Cit, Gntique des Maladies Vasculaires, Paris; and AP-HP, Hpital Jean Verdier (E.P., A.D., B.B.), Cytogntique, Bondy, INSERM, Paris, Universit Paris Nord, Sorbonne Paris Cit, Bobigny, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Neurology</MedlineTA>
<NlmUniqueID>0401060</NlmUniqueID>
<ISSNLinking>0028-3878</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C547475">COL4A1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C502625">COL4A2 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D024141">Collagen Type IV</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059345">Cerebral Small Vessel Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D024141">Collagen Type IV</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004252">DNA Mutational Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018450">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D020440">Gene Duplication</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25186857</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1526-632X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>83</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>9</Day>
</PubDate>
</JournalIssue>
<Title>Neurology</Title>
<ISOAbbreviation>Neurology</ISOAbbreviation>
</Journal>
<ArticleTitle>Poor sleep quality is associated with increased cortical atrophy in community-dwelling adults.</ArticleTitle>
<Pagination>
<MedlinePgn>967-73</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000000774</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine the relationship between sleep quality and cortical and hippocampal volume and atrophy within a community-based sample, explore the influence of age on results, and assess the possible confounding effects of physical activity levels, body mass index (BMI), and blood pressure.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">In 147 community-dwelling adults (92 female; age 53.9  15.5 years), sleep quality was measured using the Pittsburgh Sleep Quality Index and correlated with cross-sectional measures of volume and longitudinal measures of atrophy derived from MRI scans separated by an average of 3.5 years. Exploratory post hoc analysis compared correlations between different age groups and included physical activity, BMI, and blood pressure as additional covariates.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Poor sleep quality was associated with reduced volume within the right superior frontal cortex in cross-sectional analyses, and an increased rate of atrophy within widespread frontal, temporal, and parietal regions in longitudinal analyses. Results were largely driven by correlations within adults over the age of 60, and could not be explained by variation in physical activity, BMI, or blood pressure. Sleep quality was not associated with hippocampal volume or atrophy.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We found that longitudinal measures of cortical atrophy were widely correlated with sleep quality. Poor sleep quality may be a cause or a consequence of brain atrophy, and future studies examining the effect of interventions that improve sleep quality on rates of atrophy may hold key insights into the direction of this relationship.</AbstractText>
<CopyrightInformation> 2014 American Academy of Neurology.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sexton</LastName>
<ForeName>Claire E</ForeName>
<Initials>CE</Initials>
<AffiliationInfo>
<Affiliation>From the University of Oxford (C.E.S., H.J.-B.), UK; and the University of Oslo (A.B.S., K.B.W., A.M.F.), Norway. claire.sexton@ndcn.ox.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Storsve</LastName>
<ForeName>Andreas B</ForeName>
<Initials>AB</Initials>
<AffiliationInfo>
<Affiliation>From the University of Oxford (C.E.S., H.J.-B.), UK; and the University of Oslo (A.B.S., K.B.W., A.M.F.), Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Walhovd</LastName>
<ForeName>Kristine B</ForeName>
<Initials>KB</Initials>
<AffiliationInfo>
<Affiliation>From the University of Oxford (C.E.S., H.J.-B.), UK; and the University of Oslo (A.B.S., K.B.W., A.M.F.), Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Johansen-Berg</LastName>
<ForeName>Heidi</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>From the University of Oxford (C.E.S., H.J.-B.), UK; and the University of Oslo (A.B.S., K.B.W., A.M.F.), Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fjell</LastName>
<ForeName>Anders M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>From the University of Oxford (C.E.S., H.J.-B.), UK; and the University of Oslo (A.B.S., K.B.W., A.M.F.), Norway.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Neurology</MedlineTA>
<NlmUniqueID>0401060</NlmUniqueID>
<ISSNLinking>0028-3878</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000367">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001284">Atrophy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001794">Blood Pressure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001927">Brain Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002540">Cerebral Cortex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003430">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015444">Exercise</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006624">Hippocampus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008137">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009929">Organ Size</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012111">Residence Characteristics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007319">Sleep Initiation and Maintenance Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4162301 [Available on 03/09/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25200715</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1526-632X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>83</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>9</Day>
</PubDate>
</JournalIssue>
<Title>Neurology</Title>
<ISOAbbreviation>Neurology</ISOAbbreviation>
</Journal>
<ArticleTitle>An anomalous developmental venous anomaly.</ArticleTitle>
<Pagination>
<MedlinePgn>1033-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000000772</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Narendra</LastName>
<ForeName>Derek P</ForeName>
<Initials>DP</Initials>
<AffiliationInfo>
<Affiliation>From Brigham and Women's Hospital (D.P.N., N.W., M.G.E., J.J., T.C.L., E.E.Z., J.P.K.); Massachusetts General Hospital (D.P.N., N.W., M.G.E., E.E.Z.); and Harvard Medical School (D.P.N., N.W., M.G.E., J.J., T.C.L., E.E.Z., J.P.K.), Boston, MA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Nancy</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>From Brigham and Women's Hospital (D.P.N., N.W., M.G.E., J.J., T.C.L., E.E.Z., J.P.K.); Massachusetts General Hospital (D.P.N., N.W., M.G.E., E.E.Z.); and Harvard Medical School (D.P.N., N.W., M.G.E., J.J., T.C.L., E.E.Z., J.P.K.), Boston, MA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Erkkinen</LastName>
<ForeName>Michael G</ForeName>
<Initials>MG</Initials>
<AffiliationInfo>
<Affiliation>From Brigham and Women's Hospital (D.P.N., N.W., M.G.E., J.J., T.C.L., E.E.Z., J.P.K.); Massachusetts General Hospital (D.P.N., N.W., M.G.E., E.E.Z.); and Harvard Medical School (D.P.N., N.W., M.G.E., J.J., T.C.L., E.E.Z., J.P.K.), Boston, MA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jagadeesan</LastName>
<ForeName>Jayender</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>From Brigham and Women's Hospital (D.P.N., N.W., M.G.E., J.J., T.C.L., E.E.Z., J.P.K.); Massachusetts General Hospital (D.P.N., N.W., M.G.E., E.E.Z.); and Harvard Medical School (D.P.N., N.W., M.G.E., J.J., T.C.L., E.E.Z., J.P.K.), Boston, MA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Thomas C</ForeName>
<Initials>TC</Initials>
<AffiliationInfo>
<Affiliation>From Brigham and Women's Hospital (D.P.N., N.W., M.G.E., J.J., T.C.L., E.E.Z., J.P.K.); Massachusetts General Hospital (D.P.N., N.W., M.G.E., E.E.Z.); and Harvard Medical School (D.P.N., N.W., M.G.E., J.J., T.C.L., E.E.Z., J.P.K.), Boston, MA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zimmerman</LastName>
<ForeName>Eli E</ForeName>
<Initials>EE</Initials>
<AffiliationInfo>
<Affiliation>From Brigham and Women's Hospital (D.P.N., N.W., M.G.E., J.J., T.C.L., E.E.Z., J.P.K.); Massachusetts General Hospital (D.P.N., N.W., M.G.E., E.E.Z.); and Harvard Medical School (D.P.N., N.W., M.G.E., J.J., T.C.L., E.E.Z., J.P.K.), Boston, MA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Klein</LastName>
<ForeName>Joshua P</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>From Brigham and Women's Hospital (D.P.N., N.W., M.G.E., J.J., T.C.L., E.E.Z., J.P.K.); Massachusetts General Hospital (D.P.N., N.W., M.G.E., E.E.Z.); and Harvard Medical School (D.P.N., N.W., M.G.E., J.J., T.C.L., E.E.Z., J.P.K.), Boston, MA. jpklein@partners.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Neurology</MedlineTA>
<NlmUniqueID>0401060</NlmUniqueID>
<ISSNLinking>0028-3878</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002524">Cerebellar Ataxia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002550">Cerebral Veins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000002">abnormalities</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008959">Models, Neurological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014717">Vertigo</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4162298 [Available on 09/09/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25199420</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1558-1373</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>45</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The Orthopedic clinics of North America</Title>
<ISOAbbreviation>Orthop. Clin. North Am.</ISOAbbreviation>
</Journal>
<ArticleTitle>High-energy pediatric pelvic and acetabular fractures.</ArticleTitle>
<Pagination>
<MedlinePgn>483-500</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ocl.2014.06.009</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0030-5898(14)00092-3</ELocationID>
<Abstract>
<AbstractText>Pediatric pelvic and acetabular fractures are rare injuries. They are almost always the result of a high-energy injury mechanism. A full trauma protocol should be instituted, having a high index of suspicion for associated life-threatening injuries. In the past, it was recommended that almost all of these injuries be treated nonoperatively. However, pelvic and acetabular fractures do not all remodel well. Prospective studies are needed to establish optimal treatment guidelines. Until then, in the presence of instability or significant displacement, operative fixation by a pelvic and acetabular fracture specialist should be considered to allow the best possible outcome. </AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Amorosa</LastName>
<ForeName>Louis F</ForeName>
<Initials>LF</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, New York Medical College, Westchester Medical Center, Valhalla, NY, USA. Electronic address: amorosal@wcmc.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kloen</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, Academic Medical Center, Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Helfet</LastName>
<ForeName>David L</ForeName>
<Initials>DL</Initials>
<AffiliationInfo>
<Affiliation>Orthopaedic Trauma Service, Hospital for Special Surgery, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Orthop Clin North Am</MedlineTA>
<NlmUniqueID>0254463</NlmUniqueID>
<ISSNLinking>0030-5898</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000077">Acetabulum</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000293">injuries</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003951">Diagnostic Errors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003952">Diagnostic Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004195">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005593">Fracture Fixation, Internal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050723">Fractures, Bone</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010388">Pelvis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000293">injuries</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014949">Wounds, Nonpenetrating</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Acetabulum</Keyword>
<Keyword MajorTopicYN="N">High-energy fracture</Keyword>
<Keyword MajorTopicYN="N">Pediatric</Keyword>
<Keyword MajorTopicYN="N">Pelvis</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24814096</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1555-7162</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>127</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of medicine</Title>
<ISOAbbreviation>Am. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>In vein: blinding bilateral ophthalmic thrombosis.</ArticleTitle>
<Pagination>
<MedlinePgn>826-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjmed.2014.05.001</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0002-9343(14)00374-X</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Angelousi</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Diabetology, Hospital Htel Dieu, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lemoine</LastName>
<ForeName>Amal Y</ForeName>
<Initials>AY</Initials>
<AffiliationInfo>
<Affiliation>Department of Diabetology, Hospital Htel Dieu, France; Universit Paris Descartes, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Louvet</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Raymond Poincar University Hospital, Garches, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Larger</LastName>
<ForeName>Etienne</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Diabetology, Hospital Htel Dieu, France. Electronic address: etienne.larger@htd.aphp.fr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Med</MedlineTA>
<NlmUniqueID>0267200</NlmUniqueID>
<ISSNLinking>0002-9343</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001766">Blindness</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054517">Orbital Cellulitis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012170">Retinal Vein Occlusion</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020246">Venous Thrombosis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25204250</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1365-2044</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Anaesthesia</Title>
<ISOAbbreviation>Anaesthesia</ISOAbbreviation>
</Journal>
<ArticleTitle>Magnetic resonance imaging safety of Epilong Soft epidural catheters.</ArticleTitle>
<Pagination>
<MedlinePgn>1180</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/anae.12842</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>McCall</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Golden Jubilee National Hospital, Clydebank, Scotland. philipmccall@nhs.net.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Steven</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shelley</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Anaesthesia</MedlineTA>
<NlmUniqueID>0370524</NlmUniqueID>
<ISSNLinking>0003-2409</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000767">Anesthesia, Epidural</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002408">Catheters, Indwelling</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25203383</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1530-0358</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>57</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Diseases of the colon and rectum</Title>
<ISOAbbreviation>Dis. Colon Rectum</ISOAbbreviation>
</Journal>
<ArticleTitle>Imaging of pelvic floor disorders: are we underestimating gravity?</ArticleTitle>
<Pagination>
<MedlinePgn>1242-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000000201</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ribas</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>1Department of Surgery, Consorci Sanitari de Terrassa, UIB CST-UAB, Terrassa, Spain 2Academic Surgical Unit, Barts Health NHS Trust, Whitechapel, London, United Kingdom 3Unitat d' Exploracions Funcionals Digestives, Department of Surgery, Hospital de Matar, Matar, Spain 4Centro de Investigacin Biomdica en Red de Enfermedades Hepticas y Digestivas (CIBERehd), Instituto Carlos III, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hotouras</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chan</LastName>
<ForeName>C L</ForeName>
<Initials>CL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Clav</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Dis Colon Rectum</MedlineTA>
<NlmUniqueID>0372764</NlmUniqueID>
<ISSNLinking>0012-3706</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001259">Ataxia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D003672">Defecation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019841">Defecography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059952">Pelvic Floor Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020047">Rectocele</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014463">Ultrasonography</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24980644</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1528-1132</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>472</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Clinical orthopaedics and related research</Title>
<ISOAbbreviation>Clin. Orthop. Relat. Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>What are the factors that affect survival and relapse after local recurrence of osteosarcoma?</ArticleTitle>
<Pagination>
<MedlinePgn>3188-95</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11999-014-3759-7</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite improvements in treatment of primary osteosarcoma, treatment of patients who have local recurrence is not well defined.</AbstractText>
<AbstractText Label="QUESTIONS/PURPOSES" NlmCategory="OBJECTIVE">We asked: (1) What are the 5- and 10-year overall survival rates of patients with osteosarcoma who have a local recurrence? (2) What factors are associated with better survival after a local recurrence? (3) Does chemotherapy affect overall survival after local recurrence? (4) What are the rates of rerecurrence after amputation and with limb salvage?</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We reviewed 45 patients with nonmetastatic conventional high-grade osteosarcoma who had local recurrence between 1985 and 2007, during which time 461 patients were treated for the same disease. Seven patients with known local recurrence were lost to followup and not included in our study. The median age of the patients was 18 years, and minimum followup was 2 months (median, 39 months; range, 2-350 months). The primary tumor was located in the extremity in 36 patients and the pelvis in nine. The median time from initial surgery for resection or amputation of the primary tumor to local recurrence was 18 months (range, 2-149 months). Ten recurrences developed in bone and 35 in soft tissue. In 21 of the latter cases, the soft tissue recurrence was undetectable on conventional radiographs. Prognostic factors for overall patient survival after recurrence were evaluated by Kaplan-Meier survival and Cox multivariate analyses.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall postrecurrence patient survival was 30% at 5 years and 13% at 10 years. Cox multivariate analysis revealed that concurrent metastasis (relative risk = 4, p = 0.003) and recurrent tumor size 5 cm or larger (relative risk = 13, p &lt; 0.0001) were independent predictors of worse survival. With the numbers available, treatment with chemotherapy after local recurrence was not associated with better survival (p = 0.54). Nine patients had a second local recurrence, and the actuarial risk of rerecurrence was 34% at 5 years. There was no difference in the frequency of rerecurrence between patients treated by amputation and wide local excision (p = 0.23).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The long-term prognosis of patients who have local recurrence of osteosarcoma is poor. Followup beyond 5 years is essential, because the disease can have a protracted course. Most recurrences develop in soft tissue and are difficult to see on plain radiographs alone. The size of the recurrence and presence of metastasis were independent prognostic factors, suggesting that early detection may be important. Chemotherapy did not have a significant effect on survival, and surgical eradication of recurrence with wide margins may be critical to maximizing the chances for survival.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Takeuchi</LastName>
<ForeName>Akihiko</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopedic Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lewis</LastName>
<ForeName>Valerae O</ForeName>
<Initials>VO</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Satcher</LastName>
<ForeName>Robert L</ForeName>
<Initials>RL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Moon</LastName>
<ForeName>Bryan S</ForeName>
<Initials>BS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lin</LastName>
<ForeName>Patrick P</ForeName>
<Initials>PP</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Clin Orthop Relat Res</MedlineTA>
<NlmUniqueID>0075674</NlmUniqueID>
<ISSNLinking>0009-921X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000671">Amputation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001859">Bone Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053208">Kaplan-Meier Estimate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D023821">Limb Salvage</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015999">Multivariate Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D060787">Neoplasm Grading</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D009364">Neoplasm Recurrence, Local</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018365">Neoplasm, Residual</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019637">Orthopedic Procedures</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012516">Osteosarcoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000556">secondary</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016016">Proportional Hazards Models</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012086">Reoperation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047368">Tumor Burden</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4160478 [Available on 10/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25024031</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1528-1132</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>472</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Clinical orthopaedics and related research</Title>
<ISOAbbreviation>Clin. Orthop. Relat. Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Small improvements in mechanical axis alignment achieved with MRI versus CT-based patient-specific instruments in TKA: a randomized clinical trial.</ArticleTitle>
<Pagination>
<MedlinePgn>2913-22</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11999-014-3784-6</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patient-specific instrumentation in TKA has the proposed benefits of improving coronal and sagittal alignment and rotation of the components. In contrast, the literature is inconsistent if the use of patient-specific instrumentation improves alignment in comparison to conventional instrumentation. Depending on the manufacturer, patient-specific instrumentation is based on either MRI or CT scans. However, it is unknown whether one patient-specific instrumentation approach is more accurate than the other and if there is a potential benefit in terms of reduction of duration of surgery.</AbstractText>
<AbstractText Label="QUESTIONS/PURPOSES" NlmCategory="OBJECTIVE">We compared the accuracy of MRI- and CT-based patient-specific instrumentation with conventional instrumentation and with each other in TKAs. The three approaches also were compared with respect to validated outcomes scores and duration of surgery.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A randomized clinical trial was conducted in which 90 patients were enrolled and divided into three groups: CT-based, MRI-based patient-specific instrumentation, and conventional instrumentation. The groups were not different regarding age, male/female sex distribution, and BMI. In all groups, coronal and sagittal alignments were measured on postoperative standing long-leg and lateral radiographs. Component rotation was measured on CT scans. Clinical outcomes (Knee Society and WOMAC scores) were evaluated preoperatively and at a mean of 3 months postoperatively and the duration of surgery was analyzed for each patient. MRI- and CT-based patient-specific instrumentation groups were first compared with conventional instrumentation, the patient-specific instrumentation groups were compared with each other, and all three approaches were compared for clinical outcome measures and duration of surgery.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with conventional instrumentation MRI- and CT-based patient-specific instrumentation showed higher accuracy regarding the coronal limb axis (MRI versus conventional, 1.0 [range, 0-4] versus 4.5 [range, 0-8], p &lt; 0.001; CT versus conventional, 3.0 [range, 0-5] versus 4.5 [range, 0-8], p = 0.02), femoral rotation (MRI versus conventional, 1.0 [range, 0-2] versus 4.0 [range, 1-7], p &lt; 0.001; CT versus conventional, 1.0 [range, 0-2] versus 4.0 [range, 1-7], p &lt; 0.001), and tibial slope (MRI versus conventional, 1.0 [range, 0-2] versus 3.5 [range, 1-7], p &lt; 0.001; CT versus conventional, 1.0 [range, 0-2] versus 3.5 [range, 1-7], p &lt; 0.001), but the differences were small. Furthermore, MRI-based patient-specific instrumentation showed a smaller deviation in the postoperative coronal mechanical limb axis compared with CT-based patient-specific instrumentation (MRI versus CT, 1.0 [range, 0-4] versus 3.0 [range, 0-5], p = 0.03), while there was no difference in femoral rotation or tibial slope. Although there was a significant reduction of the duration of surgery in both patient-specific instrumentation groups in comparison to conventional instrumentation (MRI versus conventional, 58 minutes [range, 53-67 minutes] versus 76 minutes [range, 57-83 minutes], p &lt; 0.001; CT versus conventional, 63 minutes [range, 59-69 minutes] versus 76 minutes [range, 57-83 minutes], p &lt; .001), there were no differences in the postoperative Knee Society pain and function and WOMAC scores among the groups.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although this study supports that patient-specific instrumentation increased accuracy compared with conventional instrumentation and that MRI-based patient-specific instrumentation is more accurate compared with CT-based patient-specific instrumentation regarding coronal mechanical limb axis, differences are only subtle and of questionable clinical relevance. Because there are no differences in the long-term clinical outcome or survivorship yet available, the widespread use of this technique cannot be recommended.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pfitzner</LastName>
<ForeName>Tilman</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Center for Musculoskeletal Surgery-Orthopedic Department, Charit-Universittsmedizin Berlin, Berlin, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abdel</LastName>
<ForeName>Matthew P</ForeName>
<Initials>MP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>von Roth</LastName>
<ForeName>Philipp</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Perka</LastName>
<ForeName>Carsten</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hommel</LastName>
<ForeName>Hagen</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Clin Orthop Relat Res</MedlineTA>
<NlmUniqueID>0075674</NlmUniqueID>
<ISSNLinking>0009-921X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Clin Orthop Relat Res. 2014 Oct;472(10):2909-12</RefSource>
<PMID Version="1">25113265</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Clin Orthop Relat Res. 2014 Oct;472(10):2907-8</RefSource>
<PMID Version="1">25099265</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019645">Arthroplasty, Replacement, Knee</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001696">Biomechanical Phenomena</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017076">Computer-Aided Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004059">Diffusion of Innovation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D005858">Germany</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007719">Knee Joint</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007720">Knee Prosthesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D061646">Operative Time</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020370">Osteoarthritis, Knee</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018579">Patient Selection</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011237">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011474">Prosthesis Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011475">Prosthesis Failure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020127">Recovery of Function</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D025321">Surgery, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4160476 [Available on 10/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25099265</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1528-1132</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>472</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Clinical orthopaedics and related research</Title>
<ISOAbbreviation>Clin. Orthop. Relat. Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Editorial: Our love affair with technology and the choices we make.</ArticleTitle>
<Pagination>
<MedlinePgn>2907-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11999-014-3846-9</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Leopold</LastName>
<ForeName>Seth S</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Clinical Orthopaedics and Related Research, Philadelphia, PA, 19103, USA, sleopold@clinorthop.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Clin Orthop Relat Res</MedlineTA>
<NlmUniqueID>0075674</NlmUniqueID>
<ISSNLinking>0009-921X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Clin Orthop Relat Res. 2014 Oct;472(10):2913-22</RefSource>
<PMID Version="1">25024031</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019645">Arthroplasty, Replacement, Knee</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007719">Knee Joint</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007720">Knee Prosthesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020370">Osteoarthritis, Knee</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D025321">Surgery, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4160468 [Available on 10/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25113265</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1528-1132</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>472</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Clinical orthopaedics and related research</Title>
<ISOAbbreviation>Clin. Orthop. Relat. Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Editor's Spotlight/Take 5: Small improvements in mechanical axis alignment achieved with MRI versus CT-based patient-specific instruments in TKA: a randomized clinical trial.</ArticleTitle>
<Pagination>
<MedlinePgn>2909-12</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11999-014-3848-7</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Abdel</LastName>
<ForeName>Matthew P</ForeName>
<Initials>MP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Leopold</LastName>
<ForeName>Seth S</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Clinical Orthopaedics and Related Research, 1600 Spruce Street, Philadelphia, PA, 19013, USA, sleopold@clinorthop.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D017203">Interview</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Clin Orthop Relat Res</MedlineTA>
<NlmUniqueID>0075674</NlmUniqueID>
<ISSNLinking>0009-921X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Clin Orthop Relat Res. 2014 Oct;472(10):2913-22</RefSource>
<PMID Version="1">25024031</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019645">Arthroplasty, Replacement, Knee</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007719">Knee Joint</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007720">Knee Prosthesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020370">Osteoarthritis, Knee</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D025321">Surgery, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4160511 [Available on 10/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24842398</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1365-229X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Clinical radiology</Title>
<ISOAbbreviation>Clin Radiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Neural stimulators: a guide to imaging and postoperative appearances.</ArticleTitle>
<Pagination>
<MedlinePgn>993-1003</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.crad.2014.03.005</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0009-9260(14)00105-6</ELocationID>
<Abstract>
<AbstractText>Implantable neural stimulators have been developed to aid patients with debilitating neurological conditions that are not amenable to other therapies. The aim of this article is to improve understanding of correct anatomical placement as well as the relevant imaging methods used to assess these devices. Potential complications following their insertion and an overview of the current indications and potential mechanism of action of these devices is provided. </AbstractText>
<CopyrightInformation>Copyright  2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Adams</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Neuroradiology, Barts and the Royal London Hospital, West Smithfield, London, EC1A 7BE, UK. Electronic address: ashokadams@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shand-Smith</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Watkins</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McEvoy</LastName>
<ForeName>A W</ForeName>
<Initials>AW</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Elneil</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Urogynaecology, National Hospital for Neurology and Neurosurgery, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zrinzo</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Davagnanam</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Clin Radiol</MedlineTA>
<NlmUniqueID>1306016</NlmUniqueID>
<ISSNLinking>0009-9260</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003287">Contrast Media</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003952">Diagnostic Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004599">Electric Stimulation Therapy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011184">Postoperative Period</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24957855</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1365-229X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Clinical radiology</Title>
<ISOAbbreviation>Clin Radiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Feasibility of gadoxetate disodium-enhanced MR cholangiography in chronic cholestatic biliary disease.</ArticleTitle>
<Pagination>
<MedlinePgn>1027-33</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.crad.2014.05.009</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0009-9260(14)00192-5</ELocationID>
<Abstract>
<AbstractText Label="AIM" NlmCategory="OBJECTIVE">To investigate the feasibility of gadoxetate disodium-enhanced magnetic resonance (MR) cholangiography in chronic obstructive cholestatic biliary disease in the clinical setting.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Twenty-three patients with dilated bile duct trees and ten volunteers underwent gadoxetate disodium-enhanced liver MR cholangiography and were enrolled in the present retrospective study. Gadoxetate disodium was given in a standardized manner as a bolus injection at a dose of 0.25 mmol/kg of body weight (0.1 ml/kg). Region of interest-based measurement of mean enhancement of the dilated bile ducts was performed in series before gadoxetate disodium administration and during hepatobiliary phases.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Direct comparison of mean bile duct enhancement during hepatobiliary phases in the clinical imaging window between healthy volunteers [4.7  2.2 arbitrary units (au)] and patients with dilated bile ducts (0.1  0.3 au) revealed significantly lower or absent enhancement in dilated bile ducts (p = 0.001).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Standard clinical gadoxetate disodium-enhanced MR cholangiography is not a reliable technique for the evaluation of the biliary trees, because of altered biliary gadoxetate disodium elimination in patients with chronic obstructive biliary diseases.</AbstractText>
<CopyrightInformation>Copyright  2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Khn</LastName>
<ForeName>J-P</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology and Neuroradiology, Ernst Moritz Arndt University Greifswald, Ferdinand-Sauerbruch-Strae NK, Greifswald, D-17475, Germany. Electronic address: kuehn@uni-greifswald.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Spoerl</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology and Neuroradiology, Ernst Moritz Arndt University Greifswald, Ferdinand-Sauerbruch-Strae NK, Greifswald, D-17475, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nassif</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Pharmacology, Ernst Moritz Arndt University Greifswald, Felix Hausdorff-Strasse 3, Greifswald, D-17475, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mester</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology and Neuroradiology, Ernst Moritz Arndt University Greifswald, Ferdinand-Sauerbruch-Strae NK, Greifswald, D-17475, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Weitschies</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Biopharmacy and Pharmaceutical Technology, Ernst Moritz Arndt University Greifswald, Felix Hausdorff-Strasse 3, Greifswald, D-17475, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Siegmund</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Pharmacology, Ernst Moritz Arndt University Greifswald, Felix Hausdorff-Strasse 3, Greifswald, D-17475, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hosten</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology and Neuroradiology, Ernst Moritz Arndt University Greifswald, Ferdinand-Sauerbruch-Strae NK, Greifswald, D-17475, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mensel</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology and Neuroradiology, Ernst Moritz Arndt University Greifswald, Ferdinand-Sauerbruch-Strae NK, Greifswald, D-17475, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Clin Radiol</MedlineTA>
<NlmUniqueID>1306016</NlmUniqueID>
<ISSNLinking>0009-9260</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C073590">gadolinium ethoxybenzyl DTPA</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>K2I13DR72L</RegistryNumber>
<NameOfSubstance UI="D019786">Gadolinium DTPA</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001649">Bile Duct Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001652">Bile Ducts</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002758">Cholangiography</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002779">Cholestasis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002908">Chronic Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003287">Contrast Media</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005240">Feasibility Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019786">Gadolinium DTPA</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24990452</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1365-229X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Clinical radiology</Title>
<ISOAbbreviation>Clin Radiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Fibromatosis of the breast: a pictorial review of the imaging and histopathology findings.</ArticleTitle>
<Pagination>
<MedlinePgn>1077-83</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.crad.2014.05.105</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0009-9260(14)00288-8</ELocationID>
<Abstract>
<AbstractText>Fibromatosis of the breast is a rare condition that predominantly affects middle-aged women. It is locally aggressive, and exhibits a high incidence of local recurrence. The clinical presentation and radiological appearance are highly suspicious for carcinoma. Definitive diagnosis is made by diagnostic open biopsy. The aim of this review is to illustrate the main radiological and histopathological characteristics of this rare disease to increase awareness of this entity and discuss the role of magnetic resonance imaging (MRI) in its management. </AbstractText>
<CopyrightInformation>Copyright  2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ebrahim</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Diagnostic and Interventional Radiology, Royal Perth Hospital, Perth, Western Australia, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Parry</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Anatomical Pathology, Royal Perth Hospital, Perth, Western Australia, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taylor</LastName>
<ForeName>D B</ForeName>
<Initials>DB</Initials>
<AffiliationInfo>
<Affiliation>Department of Diagnostic and Interventional Radiology, Royal Perth Hospital, Perth, Western Australia, Australia; School of Surgery, University of Western Australia, Australia. Electronic address: donna.taylor@health.wa.gov.au.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Clin Radiol</MedlineTA>
<NlmUniqueID>1306016</NlmUniqueID>
<ISSNLinking>0009-9260</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001943">Breast Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005350">Fibroma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016217">Ultrasonography, Mammary</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25017450</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1365-229X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Clinical radiology</Title>
<ISOAbbreviation>Clin Radiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Lesions of the ovary with T1-hypersignal.</ArticleTitle>
<Pagination>
<MedlinePgn>e404-13</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.crad.2014.05.107</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0009-9260(14)00290-6</ELocationID>
<Abstract>
<AbstractText>Pelvic magnetic resonance imaging (MRI) has been used successfully to diagnose ovarian masses that cannot be adequately evaluated using pelvic ultrasound. T1 hyperintensity is a common finding in an ovarian mass and has important diagnostic implications. The aims of this review are to list the substances that may produce high signal intensity on T1-weighted MRI, to explain the physical basis for causes of the high T1 signal intensity, and to describe common and uncommon T1 hyperintense ovarian lesions. The morphological findings, the imaging features of the additional sequences, and clinical variables can help in the differential diagnosis, and in some cases, enable a specific diagnosis, leading to appropriate management of the patient. </AbstractText>
<CopyrightInformation>Copyright  2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chabrol</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Centre Hospitalier Lyon Sud, chemin du grand revoyet, 69310 Pierre Bnite, France. Electronic address: aurelie_chabrol@yahoo.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rousset</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Centre Hospitalier Lyon Sud, chemin du grand revoyet, 69310 Pierre Bnite, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Charlot</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Centre Hospitalier Lyon Sud, chemin du grand revoyet, 69310 Pierre Bnite, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chateau</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Centre Hospitalier Lyon Sud, chemin du grand revoyet, 69310 Pierre Bnite, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cotton</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Centre Hospitalier Lyon Sud, chemin du grand revoyet, 69310 Pierre Bnite, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Golfier</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Gynaecological and Oncological Surgery-Obstetrics, Centre Hospitalier Lyon Sud, chemin du grand revoyet, 69310 Pierre Bnite, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rety</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Centre Hospitalier Lyon Sud, chemin du grand revoyet, 69310 Pierre Bnite, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Clin Radiol</MedlineTA>
<NlmUniqueID>1306016</NlmUniqueID>
<ISSNLinking>0009-9260</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010049">Ovarian Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010051">Ovarian Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010053">Ovary</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25037149</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1365-229X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Clinical radiology</Title>
<ISOAbbreviation>Clin Radiol</ISOAbbreviation>
</Journal>
<ArticleTitle>National audit of appropriate imaging.</ArticleTitle>
<Pagination>
<MedlinePgn>1039-44</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.crad.2014.05.109</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0009-9260(14)00306-7</ELocationID>
<Abstract>
<AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To audit the availability of imaging referral guidelines; vetting by radiologists of GP-initiated CT and MRI requests; and the achievement of appropriate imaging using retrospective assessment as a surrogate.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A web-based questionnaire was distributed to imaging departments in the UK seeking awareness of guideline availability; the percentage of consecutive general practitioner (GP)-requested computed tomography (CT) and magnetic resonance imaging (MRI) investigations that showed evidence of vetting; and the percentage of procedures where retrospective assessment showed the investigation to be appropriate according to imaging referral guidelines.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Replies were received from 88 departments covering 1700 of 2700 (63%) consultant radiologists practising in the UK. Regarding the availability of guidelines, approximately a third of respondents were not aware of guidelines being available to all radiologists and radiographers. The 68% level of availability (58/88 departments) is well below the standard of 100%. In keeping with the target of 95%, vetting of CT requests was shown in 1815/1890 (96%) and MRI in 1181/1250 (95%). Appropriateness of CT examinations was shown in 1746/1870 (93%) and MRI in 1154/1215 (95%), well above the target of 90%. The most common reason for an inappropriate investigation for both MRI and CT was the inability to affect patient management.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although awareness of referral guidelines availability was limited at 68%, well below the 100% standard, the meticulous vetting of requests (shown in 95-96%) with the amendment or return of inappropriate requests (9-12%) enables a high level of appropriate imaging (93-95%) for GP-requested CT and MRI, thus making the best use of clinical radiology.</AbstractText>
<CopyrightInformation>Copyright  2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Remedios</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Radiology, Northwick Park Hospital, Harrow, HA1 3UJ, UK. Electronic address: denis.remedios@imperial.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Drinkwater</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>The Royal College of Radiologists, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Warwick</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Radiology, Buckinghamshire Healthcare NHS Trust, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>Clinical Radiology Audit Committee (CRAC), The Royal College of Radiologists, London</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Clin Radiol</MedlineTA>
<NlmUniqueID>1306016</NlmUniqueID>
<ISSNLinking>0009-9260</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D006113">Great Britain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019983">Guideline Adherence</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017408">Guidelines as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000656">utilization</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008485">Medical Audit</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011795">Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012017">Referral and Consultation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000656">utilization</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000656">utilization</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019564">Unnecessary Procedures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25060931</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1365-229X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Clinical radiology</Title>
<ISOAbbreviation>Clin Radiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Real-time phase-contrast flow MRI of haemodynamic changes in the ascending aorta and superior vena cava during Mueller manoeuvre.</ArticleTitle>
<Pagination>
<MedlinePgn>1066-71</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.crad.2014.06.004</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0009-9260(14)00313-4</ELocationID>
<Abstract>
<AbstractText Label="AIM" NlmCategory="OBJECTIVE">To evaluate the potential of real-time phase-contrast flow magnetic resonance imaging (MRI) at 40 ms resolution for the simultaneous determination of blood flow in the ascending aorta (AA) and superior vena cava (SVC) in response to reduced intrathoracic pressure (Mueller manoeuvre).</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Through-plane flow was assessed in 20 healthy young subjects using real-time phase-contrast MRI based on highly undersampled radial fast low-angle shot (FLASH) with image reconstruction by regularized non-linear inversion. Haemodynamic alterations (three repetitions per subject = 60 events) were evaluated during normal breathing (10 s), inhalation with nearly closed epiglottis (10 s), and recovery (20 s).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Relative to normal breathing and despite interindividual differences, reduced intrathoracic pressure by at least 30 mmHg significantly decreased the initial peak mean velocity (averaged across the lumen) in the AA by -24  9% and increased the velocity in the SVC by +28  25% (p &lt; 0.0001, n = 23 successful events). Respective changes in flow volume per heartbeat were -25  9% in the AA and +49  44% in the SVC (p &lt; 0.0001, n = 23). Flow parameters returned to baseline during sustained pressure reduction, while the heart rate was elevated by 10% (p &lt; 0.0001) after the start (n = 24) and end (n = 17) of the manoeuvre.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Real-time flow MRI during low intrathoracic pressure non-invasively revealed quantitative haemodynamic adjustments in both the AA and SVC.</AbstractText>
<CopyrightInformation>Copyright  2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fasshauer</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diagnostic and Interventional Radiology, Heart Centre, University Medical Centre, Georg-August-University Gttingen, Germany; DZHK, German Centre for Cardiovascular Research, Gttingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Joseph</LastName>
<ForeName>A A</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>Biomedizinische NMR Forschungs GmbH am Max-Planck-Institut fr biophysikalische Chemie, Gttingen, Germany; DZHK, German Centre for Cardiovascular Research, Gttingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kowallick</LastName>
<ForeName>J T</ForeName>
<Initials>JT</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diagnostic and Interventional Radiology, Heart Centre, University Medical Centre, Georg-August-University Gttingen, Germany; DZHK, German Centre for Cardiovascular Research, Gttingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Unterberg-Buchwald</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diagnostic and Interventional Radiology, Heart Centre, University Medical Centre, Georg-August-University Gttingen, Germany; Clinic for Cardiology and Pneumology, Heart Centre, University Medical Centre, Georg-August-University Gttingen, Germany; DZHK, German Centre for Cardiovascular Research, Gttingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Merboldt</LastName>
<ForeName>K D</ForeName>
<Initials>KD</Initials>
<AffiliationInfo>
<Affiliation>Biomedizinische NMR Forschungs GmbH am Max-Planck-Institut fr biophysikalische Chemie, Gttingen, Germany; DZHK, German Centre for Cardiovascular Research, Gttingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Voit</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Biomedizinische NMR Forschungs GmbH am Max-Planck-Institut fr biophysikalische Chemie, Gttingen, Germany; DZHK, German Centre for Cardiovascular Research, Gttingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Steinmetz</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>DZHK, German Centre for Cardiovascular Research, Gttingen, Germany; Clinic for Paediatric Cardiology and Intensive Care Medicine, Heart Centre, University Medical Centre, Georg-August-University Gttingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Staab</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diagnostic and Interventional Radiology, Heart Centre, University Medical Centre, Georg-August-University Gttingen, Germany; DZHK, German Centre for Cardiovascular Research, Gttingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schaetz</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Biomedizinische NMR Forschungs GmbH am Max-Planck-Institut fr biophysikalische Chemie, Gttingen, Germany; DZHK, German Centre for Cardiovascular Research, Gttingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Biomedizinische NMR Forschungs GmbH am Max-Planck-Institut fr biophysikalische Chemie, Gttingen, Germany; DZHK, German Centre for Cardiovascular Research, Gttingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Frahm</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Biomedizinische NMR Forschungs GmbH am Max-Planck-Institut fr biophysikalische Chemie, Gttingen, Germany; DZHK, German Centre for Cardiovascular Research, Gttingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lotz</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diagnostic and Interventional Radiology, Heart Centre, University Medical Centre, Georg-August-University Gttingen, Germany; DZHK, German Centre for Cardiovascular Research, Gttingen, Germany. Electronic address: Joachim.lotz@med.uni-goettingen.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sohns</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Institute for Diagnostic and Interventional Radiology, Heart Centre, University Medical Centre, Georg-August-University Gttingen, Germany; DZHK, German Centre for Cardiovascular Research, Gttingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Clin Radiol</MedlineTA>
<NlmUniqueID>1306016</NlmUniqueID>
<ISSNLinking>0009-9260</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000704">Analysis of Variance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001011">Aorta</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001783">Blood Flow Velocity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001794">Blood Pressure</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006339">Heart Rate</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006439">Hemodynamics</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001239">Inhalation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011652">Pulmonary Circulation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012016">Reference Values</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015656">Respiratory Mechanics</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013318">Stroke Volume</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014683">Vena Cava, Superior</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25060932</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1365-229X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Clinical radiology</Title>
<ISOAbbreviation>Clin Radiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Visualizing cerebral veins in fetal brain using susceptibility-weighted MRI.</ArticleTitle>
<Pagination>
<MedlinePgn>e392-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.crad.2014.06.010</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0009-9260(14)00320-1</ELocationID>
<Abstract>
<AbstractText Label="AIM" NlmCategory="OBJECTIVE">To explore the feasibility of two-dimensional (2D) susceptibility-weighted imaging (SWI) in the visualization of cerebral veins in the foetal brain.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Forty-two pregnant healthy women (gestational age: 19-37 weeks, mean: 28.5  7.1 weeks) underwent SWI examination using a 1.5 T MRI system. Two neurologists independently analysed all magnetic resonance imaging (MRI) studies. The relationship between the veins detected and the gestational age was investigated. The prominence of veins was assessed using a categorical score.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 167 veins were detected by SWI in 29 subjects with a symmetric hemisphere distribution (p &gt; 0.05). An additional vein was detected by SWI biweekly from 24 weeks of gestation. Most veins of Galen and internal cerebral veins on SWI images were prominent, whereas others were faint or moderate.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">SWI appears to be a feasible method of detecting cerebral veins in the foetal brain.</AbstractText>
<CopyrightInformation>Copyright  2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dai</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Philips Healthcare, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dong</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhu</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine, People's Republic of China. Electronic address: zhuming1946@sina.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Key Laboratory of Magnetic Resonance, Department of Physics, East China Normal University, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhong</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Clin Radiol</MedlineTA>
<NlmUniqueID>1306016</NlmUniqueID>
<ISSNLinking>0009-9260</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000196">embryology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002550">Cerebral Veins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000196">embryology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005240">Feasibility Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005865">Gestational Age</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015588">Observer Variation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25062923</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1365-229X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Clinical radiology</Title>
<ISOAbbreviation>Clin Radiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Assessment of change in prostate volume and shape following surgical resection through co-registration of in-vivo MRI and fresh specimen ex-vivo MRI.</ArticleTitle>
<Pagination>
<MedlinePgn>e398-403</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.crad.2014.06.012</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0009-9260(14)00322-5</ELocationID>
<Abstract>
<AbstractText Label="AIM" NlmCategory="OBJECTIVE">To compare the size and shape of the prostate between in-vivo and fresh ex-vivo magnetic resonance imaging (MRI), in order to quantify alterations in the prostate resulting from surgical resection.</AbstractText>
<AbstractText Label="MATERIAL AND METHOD" NlmCategory="METHODS">Ten patients who had undergone 3 T prostate MRI using a phased-array coil and who were scheduled for prostatectomy were included in this prospective study. The ex-vivo specimen underwent MRI prior to formalin fixation or any other histopathological processing. Prostate volume in vivo and ex vivo was assessed using planimetry. Prostate shape was assessed by calculating ratios between the diameters of the prostate in all three dimensions.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Mean prostate volume was significantly smaller ex vivo than in vivo (39.7  18.6 versus 50.8  26.8 cm(3); p = 0.008), with an average change in volume of -19.5%. The right-to-left (RL)/anteroposterior (AP) ratio of the prostate, representing the shape of the prostate within its axial plane, was significantly larger ex vivo than in vivo (1.33  0.14 versus 1.21  0.12; p = 0.015), with an average percent change in RL/AP ratio of the prostate of +12.2%. There was no significant difference between in-vivo and ex-vivo acquisitions in terms of craniocaudal (CC)/AP (p = 0.963, median change = -2.1%) or RL/CC (p = 0.265, median change = +1.3%) ratios.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The observed volume and shape change following resection has not previously been assessed by comparison of in-vivo and fresh ex-vivo MRI and likely represents loss of vascularity and of connective tissue attachments in the ex-vivo state. These findings have implications for co-registration platforms under development to facilitate improved understanding of the accuracy of MRI in spatial localization of prostate tumours.</AbstractText>
<CopyrightInformation>Copyright  2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Orczyk</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Division of Urologic Oncology, Department of Urology, New York University Langone Medical Center, New York, NY, USA; Department of Urology, Cte de Nacre University Hospital, Caen, France; CNRS, UMR 6301 ISTCT, CERVOxy. GIP CYCERON, F-14074 Caen, France; CEA, DSV/I2BM, UMR 6301 ISTCT, F-14074 Caen, France; UNICAEN, UMR 6301 ISTCT, F-14074 Caen, France; Normandie Univ, France. Electronic address: clementorczyk@yahoo.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taneja</LastName>
<ForeName>S S</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Division of Urologic Oncology, Department of Urology, New York University Langone Medical Center, New York, NY, USA; Department of Radiology, New York University Langone Medical Center, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rusinek</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Division of Urologic Oncology, Department of Urology, New York University Langone Medical Center, New York, NY, USA; Department of Radiology, New York University Langone Medical Center, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rosenkrantz</LastName>
<ForeName>A B</ForeName>
<Initials>AB</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, New York University Langone Medical Center, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>UL1 RR029893</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1 RR029893</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Clin Radiol</MedlineTA>
<NlmUniqueID>1306016</NlmUniqueID>
<ISSNLinking>0009-9260</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D066298">In Vitro Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009929">Organ Size</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011467">Prostate</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011468">Prostatectomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011471">Prostatic Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25062925</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1365-229X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Clinical radiology</Title>
<ISOAbbreviation>Clin Radiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Surface reconstructions of foetal brain abnormalities using ultrafast steady state 3D acquisitions.</ArticleTitle>
<Pagination>
<MedlinePgn>1084-91</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.crad.2014.06.014</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0009-9260(14)00324-9</ELocationID>
<Abstract>
<AbstractText>MRI of the foetal brain in utero is performed in routine clinical practice using sequences that produce two-dimensional (2D) images. Recent developments in image post-processing have allowed the construction of three-dimensional (3D) volume data sets from 2D images acquired in different anatomical planes, but these have limitations due to the unpredictable nature of foetal movement. These limitations have been overcome by development of several different advanced computer techniques, which require specialist knowledge, software, and processing methods, which are rarely available in routine clinical settings. Our aim was to develop a technique that can be used in routine clinical situations without the need for custom-developed or expensive software by utilizing MRI sequences that can produce a 3D data set in "ultrafast" timescales. The 3D dataset, combined with versatile image post-processing and visualization techniques, has resulted in the production of high-resolution images of foetal brain surfaces in utero. The aim of this paper is to demonstrate our methods and early results by way of a pictorial review illustrating a range of developmental brain disease in utero. </AbstractText>
<CopyrightInformation>Copyright  2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jarvis</LastName>
<ForeName>D A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>Academic Unit of Radiology, University of Sheffield, Sheffield, UK. Electronic address: Deborah.jarvis@sheffield.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Armitage</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Academic Unit of Radiology, University of Sheffield, Sheffield, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dean</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Histopathology Department, Cambridge University Hospitals NHS Foundation Trust, Box 235, Hills Road, Cambridge CB2 0QQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Griffiths</LastName>
<ForeName>P D</ForeName>
<Initials>PD</Initials>
<AffiliationInfo>
<Affiliation>Academic Unit of Radiology, University of Sheffield, Sheffield, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Clin Radiol</MedlineTA>
<NlmUniqueID>1306016</NlmUniqueID>
<ISSNLinking>0009-9260</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000196">embryology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012984">Software</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013499">Surface Properties</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25064764</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1365-229X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Clinical radiology</Title>
<ISOAbbreviation>Clin Radiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Soft-tissue masses in the abdominal wall.</ArticleTitle>
<Pagination>
<MedlinePgn>e422-31</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.crad.2014.06.006</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0009-9260(14)00315-8</ELocationID>
<Abstract>
<AbstractText>Masses involving the abdominal wall arise from a large number of aetiologies. This article will describe a diagnostic approach, imaging features of the most common causes of abdominal wall masses, and highly specific characteristics of less common diseases. A diagnostic algorithm for abdominal wall masses combines clinical history and imaging appearances to classify lesions. </AbstractText>
<CopyrightInformation>Copyright  2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bashir</LastName>
<ForeName>U</ForeName>
<Initials>U</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Radiology, The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London, UK. Electronic address: drusmanbashir@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moskovic</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Radiology, The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Strauss</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hayes</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgery, Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thway</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Histopathology, Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pope</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Radiology, The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Messiou</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Radiology, The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Clin Radiol</MedlineTA>
<NlmUniqueID>1306016</NlmUniqueID>
<ISSNLinking>0009-9260</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000008">Abdominal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D034861">Abdominal Wall</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003287">Contrast Media</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003952">Diagnostic Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000592">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008487">Medical History Taking</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017410">Practice Guidelines as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011860">Radiography, Abdominal</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012983">Soft Tissue Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25073976</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1365-229X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Clinical radiology</Title>
<ISOAbbreviation>Clin Radiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Optimizing MRI of small joints and extremities.</ArticleTitle>
<Pagination>
<MedlinePgn>e414-21</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.crad.2014.06.002</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0009-9260(14)00310-9</ELocationID>
<Abstract>
<AbstractText>Obtaining optimal images of small joints using magnetic resonance imaging (MRI) can be technically challenging. The aim of this review is to outline the practical aspects of MRI of small joints, with reference to the underlying physical principles. Although the most important contribution to successful imaging of small joints comes from the magnet field strength and design of the receiver coil, there are a number of factors to balance including the signal-to-noise ratio, image resolution, and acquisition times. We discuss strategies to minimize artefacts from movement, inhomogeneity, chemical shift, and fat suppression. As with all MRI, each strategy comes at a price, but the benefits and costs of each approach can be fine-tuned to each combination of joint, receiver coil, and MRI machine. </AbstractText>
<CopyrightInformation>Copyright  2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Thomas</LastName>
<ForeName>M S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Radiology Department, Norfolk &amp; Norwich University Hospitals NHS Foundation Trust, Norwich, UK. Electronic address: Marianna@doctors.org.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Greenwood</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Radiology Department, Norfolk &amp; Norwich University Hospitals NHS Foundation Trust, Norwich, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nolan</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Radiology Department, Norfolk &amp; Norwich University Hospitals NHS Foundation Trust, Norwich, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Malcolm</LastName>
<ForeName>P N</ForeName>
<Initials>PN</Initials>
<AffiliationInfo>
<Affiliation>Radiology Department, Norfolk &amp; Norwich University Hospitals NHS Foundation Trust, Norwich, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Toms</LastName>
<ForeName>A P</ForeName>
<Initials>AP</Initials>
<AffiliationInfo>
<Affiliation>Radiology Department, Norfolk &amp; Norwich University Hospitals NHS Foundation Trust, Norwich, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Clin Radiol</MedlineTA>
<NlmUniqueID>1306016</NlmUniqueID>
<ISSNLinking>0009-9260</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016477">Artifacts</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007596">Joints</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059629">Signal-To-Noise Ratio</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25110301</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1365-229X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Clinical radiology</Title>
<ISOAbbreviation>Clin Radiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Duodenal diverticula: potential complications and common imaging pitfalls.</ArticleTitle>
<Pagination>
<MedlinePgn>1072-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.crad.2014.05.103</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0009-9260(14)00286-4</ELocationID>
<Abstract>
<AbstractText>A duodenal diverticulum is a commonly encountered entity in gastrointestinal radiology with a wide variety of appearances. The purpose of this review is to describe the normal anatomy and embryology of the duodenum, discuss the differences between a true versus intraluminal duodenal diverticulum, and to highlight the normal appearance, potential complications, and imaging pitfalls of duodenal diverticula. </AbstractText>
<CopyrightInformation>Copyright  2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Schroeder</LastName>
<ForeName>T C</ForeName>
<Initials>TC</Initials>
<AffiliationInfo>
<Affiliation>Department of Diagnostic Radiology, Allegheny General Hospital, West Penn Allegheny Health System, Pittsburgh, PA, USA. Electronic address: theodore.schroeder@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hartman</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Diagnostic Radiology, Allegheny General Hospital, West Penn Allegheny Health System, Pittsburgh, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heller</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Diagnostic Radiology, Allegheny General Hospital, West Penn Allegheny Health System, Pittsburgh, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Klepchick</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Diagnostic Radiology, Allegheny General Hospital, West Penn Allegheny Health System, Pittsburgh, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ilkhanipour</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Diagnostic Radiology, Allegheny General Hospital, West Penn Allegheny Health System, Pittsburgh, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Clin Radiol</MedlineTA>
<NlmUniqueID>1306016</NlmUniqueID>
<ISSNLinking>0009-9260</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015746">Abdominal Pain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049448">Cholangiopancreatography, Magnetic Resonance</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003952">Diagnostic Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004238">Diverticulitis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004240">Diverticulum</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004378">Duodenal Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004386">Duodenum</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24554101</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1468-330X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>85</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurology, neurosurgery, and psychiatry</Title>
<ISOAbbreviation>J. Neurol. Neurosurg. Psychiatr.</ISOAbbreviation>
</Journal>
<ArticleTitle>Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study.</ArticleTitle>
<Pagination>
<MedlinePgn>1109-15</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/jnnp-2013-306906</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To identify MRI biomarkers associated with long-term disability progression in patients with multiple sclerosis (MS), and to define the rate of evolution of global, tissue-specific and regional atrophy in patients with MS over long-term.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">MRI of the brain and clinical neurological assessment was performed in 81 patients at time of first visit and after 5 and 10 years of follow-up. MRI was acquired on 1.5 T scanners. T1-lesion and T2-lesion volumes (LVs) were calculated. Global and tissue-specific atrophy changes were longitudinally assessed, using a direct measurement approach, by calculating percentage volume changes between different time points. Regional tissue volumes for the subcortical deep grey matter (SDGM) structures were also obtained. Disability progression was defined as an increase in Expanded Disability Status Scale of  1.0 compared to baseline at 5-year and 10-year follow-up.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Over 5 years, patients with disability progression showed significantly increased loss of whole brain (-3.8% vs -2.0%, p&lt;0.001), cortical (-3.4% vs -1.8%, p=0.009) and putamen volume changes (-10.6% vs -3.8%, p=0.003) compared to patients with no disability progression. No significant change in white matter (WM) volume was observed when comparing progressing and non-progressing patients. Over 10 years, there was a trend for greater decrease in whole brain volume (-5.5% vs -3.7%, p=0.015) in the progressing patients. No significant changes in LV measures were detected between the patients with and without disability progression.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This long-term study shows that whole brain, cortical and putamen atrophy occurs throughout the 10-year follow-up of this MS cohort and is more pronounced in the group that showed disability progression at 5, but not at 10 years of follow-up. Overall, GM atrophy showed better association with disease progression than WM atrophy over 5-year and 10-year follow-up.</AbstractText>
<CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jacobsen</LastName>
<ForeName>Cecilie</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Stavanger University Hospital, Stavanger, Norway Department of Neurology, School of Medicine and Biomedical Sciences, Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, Buffalo, New York, USA Department of Clinical Medicine, University of Bergen, Bergen, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hagemeier</LastName>
<ForeName>Jesper</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, School of Medicine and Biomedical Sciences, Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, Buffalo, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Myhr</LastName>
<ForeName>Kjell-Morten</ForeName>
<Initials>KM</Initials>
<AffiliationInfo>
<Affiliation>KG Jebsen Centre for MS-Research, Department of Clinical Medicine, University of Bergen, Bergen, Norway Department of Neurology, Norwegian Multiple Sclerosis Competence Centre, Haukeland University Hospital, Bergen, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nyland</LastName>
<ForeName>Harald</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>KG Jebsen Centre for MS-Research, Department of Clinical Medicine, University of Bergen, Bergen, Norway Department of Neurology, Norwegian Multiple Sclerosis Competence Centre, Haukeland University Hospital, Bergen, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lode</LastName>
<ForeName>Kirsten</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Stavanger University Hospital, Stavanger, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bergsland</LastName>
<ForeName>Niels</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, School of Medicine and Biomedical Sciences, Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, Buffalo, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ramasamy</LastName>
<ForeName>Deepa P</ForeName>
<Initials>DP</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, School of Medicine and Biomedical Sciences, Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, Buffalo, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dalaker</LastName>
<ForeName>Turi O</ForeName>
<Initials>TO</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Medicine, University of Bergen, Bergen, Norway Department of Radiology, Stavanger University Hospital, Stavanger, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Larsen</LastName>
<ForeName>Jan Petter</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Medicine, University of Bergen, Bergen, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Farbu</LastName>
<ForeName>Elisabeth</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Stavanger University Hospital, Stavanger, Norway Department of Clinical Medicine, University of Bergen, Bergen, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zivadinov</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, School of Medicine and Biomedical Sciences, Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, Buffalo, New York, USA MR Imaging Clinical Translational Research Center, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>02</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA>
<NlmUniqueID>2985191R</NlmUniqueID>
<ISSNLinking>0022-3050</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001284">Atrophy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004185">Disability Evaluation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D018450">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009103">Multiple Sclerosis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009413">Nerve Fibers, Myelinated</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D036421">Nerve Fibers, Unmyelinated</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059906">Neuroimaging</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">MULTIPLE SCLEROSIS</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24554104</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1468-330X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>85</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurology, neurosurgery, and psychiatry</Title>
<ISOAbbreviation>J. Neurol. Neurosurg. Psychiatr.</ISOAbbreviation>
</Journal>
<ArticleTitle>Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.</ArticleTitle>
<Pagination>
<MedlinePgn>1116-21</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/jnnp-2013-307207</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Autologous haematopoietic stem cell transplantation (HSCT) is a viable option for treatment of aggressive multiple sclerosis (MS). No randomised controlled trial has been performed, and thus, experiences from systematic and sustained follow-up of treated patients constitute important information about safety and efficacy. In this observational study, we describe the characteristics and outcome of the Swedish patients treated with HSCT for MS.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Neurologists from the major hospitals in Sweden filled out a follow-up form with prospectively collected data. Fifty-two patients were identified in total; 48 were included in the study and evaluated for safety and side effects; 41 patients had at least 1 year of follow-up and were further analysed for clinical and radiological outcome. In this cohort, 34 patients (83%) had relapsing-remitting MS, and mean follow-up time was 47 months.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">At 5 years, relapse-free survival was 87%; MRI event-free survival 85%; expanded disability status scale (EDSS) score progression-free survival 77%; and disease-free survival (no relapses, no new MRI lesions and no EDSS progression) 68%. Presence of gadolinium-enhancing lesions prior to HSCT was associated with a favourable outcome (disease-free survival 79% vs 46%, p=0.028). There was no mortality. The most common long-term side effects were herpes zoster reactivation (15%) and thyroid disease (8.4%).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">HSCT is a very effective treatment of inflammatory active MS and can be performed with a high degree of safety at experienced centres.</AbstractText>
<CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Burman</LastName>
<ForeName>Joachim</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Neuroscience, Uppsala University, Uppsala, Sweden Department of Neurology, Uppsala University Hospital, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Iacobaeus</LastName>
<ForeName>Ellen</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institute Solna, Center for Molecular Medicine, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Svenningsson</LastName>
<ForeName>Anders</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology and Clinical Neuroscience, Ume University and University Hospital of Northern Sweden, Ume, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lycke</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Institute of Neuroscience and Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gunnarsson</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, rebro University Hospital, rebro, Sweden School of Health and Medical Sciences, rebro University, rebro, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nilsson</LastName>
<ForeName>Petra</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Skne University Hospital Lund, Lund, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vrethem</LastName>
<ForeName>Magnus</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Neurology and Clinical Neurophysiology, Faculty of Health Sciences, Department of Clinical and Experimental Medicine, Linkping University, Linkping, Sweden Department of Neurology and Neurophysiology, County Council of stergtland, Linkping, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fredrikson</LastName>
<ForeName>Sten</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Neuroscience, Karolinska Institute Huddinge, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martin</LastName>
<ForeName>Claes</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Neurology Unit, Division of Internal Medicine, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sandstedt</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Hematology, Linkping University Hospital, Linkping, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Uggla</LastName>
<ForeName>Bertil</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>School of Health and Medical Sciences, rebro University, rebro, Sweden Division of Hematology, Department of Medicine, rebro University Hospital, rebro, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lenhoff</LastName>
<ForeName>Stig</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Hematology and Coagulation, Skne University Hospital, Lund, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Johansson</LastName>
<ForeName>Jan-Erik</ForeName>
<Initials>JE</Initials>
<AffiliationInfo>
<Affiliation>Department of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Isaksson</LastName>
<ForeName>Cecilia</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiosciences, Ume University, Ume, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hgglund</LastName>
<ForeName>Hans</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology, Department of Medical Science, Uppsala University Hospital, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Carlson</LastName>
<ForeName>Kristina</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology, Department of Medical Science, Uppsala University Hospital, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fagius</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Neuroscience, Uppsala University, Uppsala, Sweden Department of Neurology, Uppsala University Hospital, Uppsala, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D064888">Observational Study</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>02</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA>
<NlmUniqueID>2985191R</NlmUniqueID>
<ISSNLinking>0022-3050</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004185">Disability Evaluation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018572">Disease-Free Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018380">Hematopoietic Stem Cell Transplantation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000401">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009103">Multiple Sclerosis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059906">Neuroimaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012008">Recurrence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D013548">Sweden</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014182">Transplantation, Autologous</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000401">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Multiple Sclerosis</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24569686</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1468-330X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>85</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurology, neurosurgery, and psychiatry</Title>
<ISOAbbreviation>J. Neurol. Neurosurg. Psychiatr.</ISOAbbreviation>
</Journal>
<ArticleTitle>Tracking the progression of social cognition in neurodegenerative disorders.</ArticleTitle>
<Pagination>
<MedlinePgn>1076-83</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/jnnp-2013-307098</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">Behavioural-variant frontotemporal dementia (bvFTD) and Alzheimer's disease (AD) patients experience behavioural and emotion recognition alterations, yet understanding of how socioemotional processing is affected with disease progression is minimal. Additionally, evidence suggests that bvFTD patients with limited brain atrophy on neuroimaging at presentation (bvFTD-la) have a more benign course than those with marked atrophy (bvFTD-ma). Longitudinal investigation of these patients, however, is lacking.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We investigated general cognition, emotion recognition and sarcasm detection in 20 bvFTD (8 with limited brain atrophy) and 17 AD patients longitudinally and used mixed models analyses to determine the level and rates of decline across groups over time.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">At baseline, all patient groups performed worse than controls on general cognition and emotion recognition measures. The bvFTD-ma group showed significant impairment on the sarcasm detection task compared with controls. Longitudinally, an overall effect of time was present for general cognition (p&lt;0.001); however, the rate of decline did not differ across groups. Trends for interactions between time and diagnosis were observed for both emotion recognition tasks (p=0.055; p=0.062), with the bvFTD-ma group declining more rapidly than AD or bvFTD-la groups. On the sarcasm detection task, the bvFTD-ma and AD patients declined, whereas bvFTD-la patients remained stable over time (p=0.002).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Tasks of sarcasm detection represent a clinically useful tool to differentiate between bvFTD and AD at baseline. Furthermore, tasks of socioemotional functioning can track progression within bvFTD and identify bvFTD patients more likely to show a faster rate of decline.</AbstractText>
<CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kumfor</LastName>
<ForeName>Fiona</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Neuroscience Research Australia, Sydney, New South Wales, Australia School of Medical Sciences, The University of New South Wales, Sydney, New South Wales, Australia ARC Centre of Excellence in Cognition and its Disorders, Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Irish</LastName>
<ForeName>Muireann</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Neuroscience Research Australia, Sydney, New South Wales, Australia ARC Centre of Excellence in Cognition and its Disorders, Sydney, New South Wales, Australia School of Psychology, The University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leyton</LastName>
<ForeName>Cristian</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Neuroscience Research Australia, Sydney, New South Wales, Australia ARC Centre of Excellence in Cognition and its Disorders, Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Miller</LastName>
<ForeName>Laurie</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>ARC Centre of Excellence in Cognition and its Disorders, Sydney, New South Wales, Australia Neuropsychology Unit, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia School of Psychology, The University of Sydney, Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lah</LastName>
<ForeName>Suncica</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>ARC Centre of Excellence in Cognition and its Disorders, Sydney, New South Wales, Australia School of Psychology, The University of Sydney, Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Devenney</LastName>
<ForeName>Emma</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Neuroscience Research Australia, Sydney, New South Wales, Australia School of Medical Sciences, The University of New South Wales, Sydney, New South Wales, Australia ARC Centre of Excellence in Cognition and its Disorders, Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hodges</LastName>
<ForeName>John R</ForeName>
<Initials>JR</Initials>
<AffiliationInfo>
<Affiliation>Neuroscience Research Australia, Sydney, New South Wales, Australia School of Medical Sciences, The University of New South Wales, Sydney, New South Wales, Australia ARC Centre of Excellence in Cognition and its Disorders, Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Piguet</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Neuroscience Research Australia, Sydney, New South Wales, Australia School of Medical Sciences, The University of New South Wales, Sydney, New South Wales, Australia ARC Centre of Excellence in Cognition and its Disorders, Sydney, New South Wales, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>02</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA>
<NlmUniqueID>2985191R</NlmUniqueID>
<ISSNLinking>0022-3050</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000544">Alzheimer Disease</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001284">Atrophy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016022">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D003071">Cognition</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018450">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004644">Emotions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057180">Frontotemporal Dementia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008137">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059906">Neuroimaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D021641">Recognition (Psychology)</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012919">Social Behavior</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24700881</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1468-330X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>85</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurology, neurosurgery, and psychiatry</Title>
<ISOAbbreviation>J. Neurol. Neurosurg. Psychiatr.</ISOAbbreviation>
</Journal>
<ArticleTitle>Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients.</ArticleTitle>
<Pagination>
<MedlinePgn>1177-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/jnnp-2014-307582</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hoepner</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, St. Josef Hospital Bochum, Ruhr University, Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ahlbrecht</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Faissner</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, St. Josef Hospital Bochum, Ruhr University, Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schneider</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, St. Josef Hospital Bochum, Ruhr University, Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dahlhaus</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, St. Josef Hospital Bochum, Ruhr University, Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Adams</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Department of Virology, Heinrich Heine University Duesseldorf, Duesseldorf, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Raab</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Institute of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lukas</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Institute of Diagnostic and Interventional Neuroradiology, St. Josef Hospital Bochum, Ruhr University, Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chan</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, St. Josef Hospital Bochum, Ruhr University, Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stangel</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gold</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, St. Josef Hospital Bochum, Ruhr University, Bochum, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>04</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA>
<NlmUniqueID>2985191R</NlmUniqueID>
<ISSNLinking>0022-3050</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D061067">Antibodies, Monoclonal, Humanized</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C469407">natalizumab</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D061067">Antibodies, Monoclonal, Humanized</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002531">Cerebellum</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018450">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007968">Leukoencephalopathy, Progressive Multifocal</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020529">Multiple Sclerosis, Relapsing-Remitting</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011149">Pons</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D063189">Symptom Assessment</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Clinical Neurology</Keyword>
<Keyword MajorTopicYN="N">Multiple Sclerosis</Keyword>
<Keyword MajorTopicYN="N">Neurovirology</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24805859</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>06</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1532-0979</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>38</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of surgical pathology</Title>
<ISOAbbreviation>Am. J. Surg. Pathol.</ISOAbbreviation>
</Journal>
<ArticleTitle>BCOR-CCNB3 (Ewing-like) sarcoma: a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma.</ArticleTitle>
<Pagination>
<MedlinePgn>1307-18</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/PAS.0000000000000223</ELocationID>
<Abstract>
<AbstractText>BCOR-CCNB3 fusion transcripts resulting from an X-chromosomal paracentric inversion were recently identified in a series of unclassifiable soft tissue and bone sarcomas with Ewing sarcoma-like morphology. The morphologic and clinical features of these sarcomas are, as yet, not well characterized. Here we describe the clinicopathologic features of 10 cases of BCOR-CCNB3 sarcoma and compare their clinical course with typical Ewing sarcoma. Nine of 10 patients were male, and all were 11 to 18 years of age. Seven tumors were located in the bone and 3 in the deep soft tissues. The histomorphologic spectrum was quite wide, with 7 tumors predominately showing small primitive cell morphology with angulated nuclei simulating so-called atypical Ewing sarcoma and 3 predominately showing spindle cell morphology. Recurrent and metastatic lesions showed increased cellularity and marked pleomorphism. Immunohistochemistry showed expression of CCNB3 (100%), bcl2 (90%), CD99 (60%), and CD117 (60%). Reverse transcription polymerase chain reaction for BCOR-CCNB3 fusion transcripts was positive in all 9 cases, which yielded sufficient extracted RNA. Five- and 10-year survival rates were 75% and 56%, respectively. BCOR-CCNB3 sarcomas located in axial skeleton and soft tissues showed a significantly shorter survival. The Ewing sarcoma overall survival was not statistically different, although there was a trend for longer survival of patients with BCOR-CCNB3 sarcomas in the extremities. In conclusion, this study provides a detailed description of the histologic spectrum, immunohistochemical features, and clinical characteristic of BCOR-CCNB3 sarcoma justifying distinction from Ewing sarcoma with its typical EWS/FUS-ETS translocations. Ideally immunohistochemistry is used in combination with reverse transcription polymerase chain reaction for definitive diagnosis. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Puls</LastName>
<ForeName>Florian</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Departments of *Musculoskeletal Pathology Oncology Musculoskeletal Radiology, Royal Orthopaedic Hospital NHS Foundation Trust, Birmingham Department of Histopathology, Robert Jones &amp; Ages Hunt Orthopaedic Hospital, Oswestry, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Niblett</LastName>
<ForeName>Angela</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Marland</LastName>
<ForeName>Gillian</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gaston</LastName>
<ForeName>Czar Louie L</ForeName>
<Initials>CL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Douis</LastName>
<ForeName>Hassan</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mangham</LastName>
<ForeName>D Chas</ForeName>
<Initials>DC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sumathi</LastName>
<ForeName>Vaiyapuri P</ForeName>
<Initials>VP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kindblom</LastName>
<ForeName>Lars-Gunnar</ForeName>
<Initials>LG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Surg Pathol</MedlineTA>
<NlmUniqueID>7707904</NlmUniqueID>
<ISSNLinking>0147-5185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C411984">BCOR protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C503694">CCNB3 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019926">Cyclin B</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012097">Repressor Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014408">Tumor Markers, Biological</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001706">Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001859">Bone Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019926">Cyclin B</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000032">analysis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050939">Gene Fusion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007150">Immunohistochemistry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053208">Kaplan-Meier Estimate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011237">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016016">Proportional Hazards Models</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011518">Proto-Oncogene Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000032">analysis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012097">Repressor Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000032">analysis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020133">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012512">Sarcoma, Ewing</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000556">secondary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014178">Translocation, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014408">Tumor Markers, Biological</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000032">analysis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25025447</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1532-0979</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>38</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of surgical pathology</Title>
<ISOAbbreviation>Am. J. Surg. Pathol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Granulomatosis with polyangiitis presenting as a renal tumor.</ArticleTitle>
<Pagination>
<MedlinePgn>1444-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/PAS.0000000000000294</ELocationID>
<Abstract>
<AbstractText>Inflammatory tumors of the kidney are uncommon and include primary inflammatory processes and systemic diseases such as sarcoidosis, IgG4 disease, and granulomatosis with polyangiitis (GPA). There are approximately 15 cases of the latter in the literature. Tumors in GPA are well described and have been reported in several organs including breast, orbit, mediastinum, central nervous system, and especially the lung. We report the case of a 48-year-old woman who presented with diffuse frontal headaches. Imaging showed both a cranial/sinus and renal mass. The pathology of the dura and nasal sinus biopsies were unrevealing. A nephrectomy was performed that demonstrated a discrete lesion with extensive necrosis, granulomatous inflammation, and crescentic pauci-immune glomerulonephritis, findings consistent with GPA. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ward</LastName>
<ForeName>Ashley</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Departments of *Pathology Rheumatology, Harvard Medical School, Beth Israel Deaconess Medical Center Department of Pathology, Harvard Medical School Massachusetts General Hospital, Boston, MA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Konya</LastName>
<ForeName>Christine</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mark</LastName>
<ForeName>Eugene J</ForeName>
<Initials>EJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rosen</LastName>
<ForeName>Seymour</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Surg Pathol</MedlineTA>
<NlmUniqueID>7707904</NlmUniqueID>
<ISSNLinking>0147-5185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biological Markers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015415">Biological Markers</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001706">Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005921">Glomerulonephritis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006104">Granuloma, Plasma Cell</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014890">Granulomatosis with Polyangiitis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007166">Immunosuppressive Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007668">Kidney</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007674">Kidney Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009336">Necrosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24885745</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1362-3095</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>90</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>International journal of radiation biology</Title>
<ISOAbbreviation>Int. J. Radiat. Biol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Total-body irradiation produces late degenerative joint damage in rats.</ArticleTitle>
<Pagination>
<MedlinePgn>821-30</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3109/09553002.2014.927935</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Premature musculoskeletal joint failure is a major source of morbidity among childhood cancer survivors. Radiation effects on synovial joint tissues of the skeleton are poorly understood. Our goal was to assess long-term changes in the knee joint from skeletally mature rats that received total-body irradiation while skeletal growth was ongoing.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">14 week-old rats were irradiated with 1, 3 or 7 Gy total-body doses of 18 MV X-rays. At 53 weeks of age, structural and compositional changes in knee joint tissues (articular cartilage, subchondral bone, and trabecular bone) were characterized using 7T MRI, nanocomputed tomography (nanoCT), microcomputed tomography (microCT), and histology.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">T2 relaxation times of the articular cartilage were lower after exposure to all doses. Likewise, calcifications were observed in the articular cartilage. Trabecular bone microarchitecture was compromised in the tibial metaphysis at 7 Gy. Mild to moderate cartilage erosion was scored in the 3 and 7 Gy rats.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Late degenerative changes in articular cartilage and bone were observed after total-body irradiation in adult rats exposed prior to skeletal maturity. 7T MRI, microCT, nanoCT, and histology identified potential prognostic indicators of late radiation-induced joint damage.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hutchinson</LastName>
<ForeName>Ian D</ForeName>
<Initials>ID</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Olson</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lindburg</LastName>
<ForeName>Carl A</ForeName>
<Initials>CA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Payne</LastName>
<ForeName>Valerie</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Collins</LastName>
<ForeName>Boyce</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Thomas L</ForeName>
<Initials>TL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Munley</LastName>
<ForeName>Michael T</ForeName>
<Initials>MT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wheeler</LastName>
<ForeName>Kenneth T</ForeName>
<Initials>KT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Willey</LastName>
<ForeName>Jeffrey S</ForeName>
<Initials>JS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 CA112593</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA136910</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01-CA112593-S1</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01-CA136910-S1</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 CA113267</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 CA113267</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Int J Radiat Biol</MedlineTA>
<NlmUniqueID>8809243</NlmUniqueID>
<ISSNLinking>0955-3002</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CitationSubset>S</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Blood Marrow Transplant. 2012 Mar;18(3):473-80</RefSource>
<PMID Version="1">22079789</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bone Miner Res. 2012 Apr;27(4):760-9</RefSource>
<PMID Version="1">22189761</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bone Miner Res. 2012 Apr;27(4):749-59</RefSource>
<PMID Version="1">22190044</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arthritis Rheum. 2012 Jun;64(6):1697-707</RefSource>
<PMID Version="1">22392533</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Osteoarthritis Cartilage. 2012 Jul;20(7):755-63</RefSource>
<PMID Version="1">22469853</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Osteoarthritis Cartilage. 2012 Jul;20(7):796-800</RefSource>
<PMID Version="1">22531460</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pediatr Hematol Oncol. 2012 Jul;34(5):378-82</RefSource>
<PMID Version="1">22246151</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Osteoarthritis Cartilage. 2013 Jan;21(1):94-101</RefSource>
<PMID Version="1">23025926</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Osteoarthritis Cartilage. 2013 Jan;21(1):69-76</RefSource>
<PMID Version="1">23059757</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Cell Mater. 2013;25:179-89</RefSource>
<PMID Version="1">23389752</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Radiol. 2013 Apr;82(4):647-50</RefSource>
<PMID Version="1">23333531</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Biol. 2013 Apr;89(4):268-77</RefSource>
<PMID Version="1">23134087</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Osteoarthritis Cartilage. 2013 May;21(5):700-9</RefSource>
<PMID Version="1">23384547</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cochrane Database Syst Rev. 2013;4:CD008796</RefSource>
<PMID Version="1">23633361</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiat Res. 2013 Jul;180(1):89-99</RefSource>
<PMID Version="1">23772924</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pediatr Blood Cancer. 2013 Nov;60(11):1766-71</RefSource>
<PMID Version="1">23818448</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mech Behav Biomed Mater. 2014 Jun;34:264-72</RefSource>
<PMID Version="1">24631625</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arthritis Res Ther. 2012;14(4):221</RefSource>
<PMID Version="1">22971952</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biomed Sci Instrum. 2012;48:470-7</RefSource>
<PMID Version="1">22846321</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiat Res. 2012 Oct;178(4):321-7</RefSource>
<PMID Version="1">22950352</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bone. 2013 Feb;52(2):712-7</RefSource>
<PMID Version="1">22885239</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2000 Dec;44(6):840-51</RefSource>
<PMID Version="1">11108620</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bone Miner Res. 2002 Apr;17(4):652-60</RefSource>
<PMID Version="1">11918222</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Cancer. 2002 Feb;2(2):124-32</RefSource>
<PMID Version="1">12635175</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 2003 Sep 24;290(12):1583-92</RefSource>
<PMID Version="1">14506117</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bone. 2013 Nov;57(1):252-8</RefSource>
<PMID Version="1">23978492</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Orthop Res. 2013 Nov;31(11):1780-5</RefSource>
<PMID Version="1">23913833</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cancer Surviv. 2013 Dec;7(4):511-22</RefSource>
<PMID Version="1">23784593</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Orthop Sports Phys Ther. 2013 Dec;43(12):881-90</RefSource>
<PMID Version="1">24175607</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Radiol. 2014 Jan;49(1):57-62</RefSource>
<PMID Version="1">24056113</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroradiology. 2014 Feb;56(2):91-6</RefSource>
<PMID Version="1">24281386</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Osteoarthritis Cartilage. 2014 Feb;22(2):264-74</RefSource>
<PMID Version="1">24315792</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pediatr Orthop. 2014 Apr-May;34(3):331-5</RefSource>
<PMID Version="1">23965908</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Histochem Cytochem. 2004 Feb;52(2):157-67</RefSource>
<PMID Version="1">14729867</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bone Marrow Transplant. 2004 Feb;33(4):435-41</RefSource>
<PMID Version="1">14716354</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Orthop Relat Res. 2004 May;(422):233-42</RefSource>
<PMID Version="1">15187862</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiology. 2004 Aug;232(2):592-8</RefSource>
<PMID Version="1">15215540</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Imaging. 2004 Sep;22(7):943-51</RefSource>
<PMID Version="1">15288135</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bone Joint Surg Am. 1967 Sep;49(6):1157-66</RefSource>
<PMID Version="1">6038861</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Calcif Tissue Res. 1972;10(3):238-51</RefSource>
<PMID Version="1">4639288</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Haematol. 1987 Dec;67(4):419-26</RefSource>
<PMID Version="1">3322361</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Bone Miner Res. 1987 Dec;2(6):595-610</RefSource>
<PMID Version="1">3455637</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Radiol. 1988 Jul;39(4):450-1</RefSource>
<PMID Version="1">3180660</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Rheum Dis. 1990 Jun;49(6):412-20</RefSource>
<PMID Version="1">2200357</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Scanning Microsc. 1990 Sep;4(3):769-73; discussion 773-4</RefSource>
<PMID Version="1">1706891</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiology. 1994 Apr;191(1):231-5</RefSource>
<PMID Version="1">8134578</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Scanning Microsc. 1993 Dec;7(4):1263-7; discussion 1267-8</RefSource>
<PMID Version="1">8023093</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1994 Nov;32(5):592-601</RefSource>
<PMID Version="1">7808260</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Scanning Microsc. 1996;10(3):833-40</RefSource>
<PMID Version="1">9813643</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nutrition. 2005 Jun;21(6):775-7</RefSource>
<PMID Version="1">15925305</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AJR Am J Roentgenol. 2005 Oct;185(4):899-914</RefSource>
<PMID Version="1">16177408</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1568-75</RefSource>
<PMID Version="1">15990246</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Orthop Res. 2006 Mar;24(3):366-74</RefSource>
<PMID Version="1">16479569</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Calcif Tissue Int. 2006 May;78(5):302-13</RefSource>
<PMID Version="1">16691495</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Knee. 2006 Oct;13(5):382-8</RefSource>
<PMID Version="1">16790353</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2006 Oct 12;355(15):1572-82</RefSource>
<PMID Version="1">17035650</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Biomech (Bristol, Avon). 2006 Dec;21(10):999-1012</RefSource>
<PMID Version="1">16979270</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2007 Jun;57(6):1000-11</RefSource>
<PMID Version="1">17534923</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bone Marrow Transplant. 2007 Jul;40(1):29-35</RefSource>
<PMID Version="1">17468769</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiat Res. 2008 Aug;170(2):201-7</RefSource>
<PMID Version="1">18666808</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiat Res. 2008 Sep;170(3):284-91</RefSource>
<PMID Version="1">18763859</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pediatr Radiol. 2009 Jan;39(1):23-9</RefSource>
<PMID Version="1">18953533</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiat Res. 2009 Mar;171(3):283-9</RefSource>
<PMID Version="1">19267555</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2009 Apr;61(4):803-9</RefSource>
<PMID Version="1">19189393</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):949-56</RefSource>
<PMID Version="1">19480974</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arthritis Rheum. 2009 Sep;60(9):2694-703</RefSource>
<PMID Version="1">19714647</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2009 Oct 31;374(9700):1484-5</RefSource>
<PMID Version="1">19880005</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2010 Jan;63(1):181-93</RefSource>
<PMID Version="1">19859960</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bone. 2010 Jan;46(1):101-11</RefSource>
<PMID Version="1">19747571</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bone. 2010 Aug;47(2):248-55</RefSource>
<PMID Version="1">20466089</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cells Tissues Organs. 2010;192(4):240-9</RefSource>
<PMID Version="1">20616531</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AJR Am J Roentgenol. 2010 Oct;195(4):1021-5</RefSource>
<PMID Version="1">20858834</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Osteoarthritis Cartilage. 2010 Oct;18 Suppl 3:S24-34</RefSource>
<PMID Version="1">20864021</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biomech. 2010 Oct 19;43(14):2738-46</RefSource>
<PMID Version="1">20655052</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2011 Aug 4;118(5):1413-20</RefSource>
<PMID Version="1">21652685</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Osteoarthritis Cartilage. 2012 Feb;20(2):162-71</RefSource>
<PMID Version="1">22209871</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Best Pract Res Clin Rheumatol. 2011 Dec;25(6):751-66</RefSource>
<PMID Version="1">22265258</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e493-500</RefSource>
<PMID Version="1">22000750</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001842">Bone and Bones</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002358">Cartilage, Articular</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004307">Dose-Response Relationship, Radiation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007596">Joints</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007719">Knee Joint</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D036103">Nanotechnology</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010003">Osteoarthritis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011916">Rats, Inbred F344</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014916">Whole-Body Irradiation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055114">X-Ray Microtomography</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS606221</OtherID>
<OtherID Source="NLM">PMC4163063</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">7T MRI</Keyword>
<Keyword MajorTopicYN="N">Radiation</Keyword>
<Keyword MajorTopicYN="N">arthritis</Keyword>
<Keyword MajorTopicYN="N">articular cartilage</Keyword>
<Keyword MajorTopicYN="N">knee joints</Keyword>
<Keyword MajorTopicYN="N">nanocomputed tomography</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24991879</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1362-3095</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>90</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>International journal of radiation biology</Title>
<ISOAbbreviation>Int. J. Radiat. Biol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Radiation-induced cognitive impairment and altered diffusion tensor imaging in a juvenile rat model of cranial radiotherapy.</ArticleTitle>
<Pagination>
<MedlinePgn>799-806</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3109/09553002.2014.938278</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To assess the long-term effects of fractionated whole brain irradiation (fWBI) using diffusion tensor imaging (DTI) and behavior in a pediatric rodent model for the clinical presentation of adult pediatric cancer survivors.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Five-week-old, male F344xBN rats were randomized to receive 0, 5, or 6.5 Gy fractions biweekly for 3 weeks, resulting in Sham, Irradiated-30 (IR-30) and IR-39 Gy total dose groups. Magnetic Resonance Imaging occurred at 1, 3, 6 and 9 months with behavioral assessment at 10-11 months post-fWBI.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Irradiation reduced brain size (p &lt; 0.001) and body weight (p &lt; 0.001) proportionate to dose. At 1 month post-fWBI and throughout follow-up, diffusion was reduced in IR-30 and IR-39 relative to shams (p &lt; 0.001). IR-30 but not IR-39 rats were impaired relative to Shams on the reversal trial of the Morris Water Maze (p &lt; 0.05), and IR-30 rats preferred a striatum- mediated strategy (p &lt; 0.06).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Hippocampal performance was impaired in IR-30 but not IR-39 animals. While gross size differences exist, white matter integrity is preserved in rats after fWBI at 5 weeks. This significant departure from childhood cancer survivors and single fraction rodent studies where white matter degradation is a prominent feature are discussed.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Peiffer</LastName>
<ForeName>Ann M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Wake Forest School of Medicine , Winston-Salem, NC.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Creer</LastName>
<ForeName>Rebecca M</ForeName>
<Initials>RM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Linville</LastName>
<ForeName>Constance</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Olson</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kulkarni</LastName>
<ForeName>Praveen</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brown</LastName>
<ForeName>Jacquelyn Ann</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Riddle</LastName>
<ForeName>David R</ForeName>
<Initials>DR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Robbins</LastName>
<ForeName>Mike E</ForeName>
<Initials>ME</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brunso-Bechtold</LastName>
<ForeName>Judy E</ForeName>
<Initials>JE</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>CA112593</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA119990</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA112593</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA119990</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 CA113267</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Int J Radiat Biol</MedlineTA>
<NlmUniqueID>8809243</NlmUniqueID>
<ISSNLinking>0955-3002</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CitationSubset>S</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001522">Behavior, Animal</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000532">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003071">Cognition</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D056324">Diffusion Tensor Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019583">Dose Fractionation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006624">Hippocampus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018782">Maze Learning</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D023421">Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011878">Radiotherapy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011897">Random Allocation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051381">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011916">Rats, Inbred F344</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">MRI</Keyword>
<Keyword MajorTopicYN="N">Rat</Keyword>
<Keyword MajorTopicYN="N">brain</Keyword>
<Keyword MajorTopicYN="N">fractionated whole-brain irradiation</Keyword>
<Keyword MajorTopicYN="N">pediatric</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24951640</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1460-2156</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>137</Volume>
<Issue>Pt 10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Brain : a journal of neurology</Title>
<ISOAbbreviation>Brain</ISOAbbreviation>
</Journal>
<ArticleTitle>Cortical thickness in individuals with non-clinical and clinical psychotic symptoms.</ArticleTitle>
<Pagination>
<MedlinePgn>2664-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awu167</ELocationID>
<Abstract>
<AbstractText>Symptoms that are linked to psychosis are also experienced by individuals who are not in need of care. In the present study, cortical thickness was investigated in these individuals. Fifty individuals with non-clinical auditory verbal hallucinations (most of them also experienced other non-clinical psychotic symptoms), 50 patients with a psychotic disorder and auditory verbal hallucinations, and 50 healthy control subjects underwent structural magnetic resonance imaging. Data were analysed using FreeSurfer. Cortical thickness in the pars orbitalis, paracentral lobule, fusiform gyrus and inferior temporal gyrus was lowest in patients, intermediate in the non-clinical hallucinating group, and highest in control subjects. The patients also showed thinning in widespread additional areas compared to the two other groups, whereas both hallucinating groups showed similar levels of thinning in the insula. Ranking the levels of cortical thickness per brain region across groups revealed that for 88% of brain regions, cortical thickness was lowest in patients, intermediate in the non-clinical hallucinating group, and highest in controls. These findings show that individuals with non-clinical psychotic symptoms show a similar but less pronounced pattern of cortical thinning as patients with a psychotic disorder, which is suggestive of a similar, but milder underlying pathophysiology in this group compared to the psychosis group.</AbstractText>
<CopyrightInformation> The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>van Lutterveld</LastName>
<ForeName>Remko</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Psychiatry, University Medical Centre, 3584 CX Utrecht, The Netherlands 2 Rudolf Magnus Institute of Neuroscience, 3584 CG Utrecht, The Netherlands 3 Centre for Mindfulness, University of Massachusetts School of Medicine, Shrewsbury, 01545, Massachusetts, USA Remko.vanLutterveld@umassmed.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van den Heuvel</LastName>
<ForeName>Martijn P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Psychiatry, University Medical Centre, 3584 CX Utrecht, The Netherlands 2 Rudolf Magnus Institute of Neuroscience, 3584 CG Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Diederen</LastName>
<ForeName>Kelly M J</ForeName>
<Initials>KM</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Psychiatry, University Medical Centre, 3584 CX Utrecht, The Netherlands 2 Rudolf Magnus Institute of Neuroscience, 3584 CG Utrecht, The Netherlands 4 Department of Physiology, Development and Neuroscience, Downing Street, University of Cambridge, Cambridge, CB2 3EG, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Weijer</LastName>
<ForeName>Antoin D</ForeName>
<Initials>AD</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Psychiatry, University Medical Centre, 3584 CX Utrecht, The Netherlands 2 Rudolf Magnus Institute of Neuroscience, 3584 CG Utrecht, The Netherlands 5 Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Begemann</LastName>
<ForeName>Marieke J H</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Psychiatry, University Medical Centre, 3584 CX Utrecht, The Netherlands 2 Rudolf Magnus Institute of Neuroscience, 3584 CG Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brouwer</LastName>
<ForeName>Rachel M</ForeName>
<Initials>RM</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Psychiatry, University Medical Centre, 3584 CX Utrecht, The Netherlands 2 Rudolf Magnus Institute of Neuroscience, 3584 CG Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Daalman</LastName>
<ForeName>Kirstin</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Psychiatry, University Medical Centre, 3584 CX Utrecht, The Netherlands 2 Rudolf Magnus Institute of Neuroscience, 3584 CG Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Blom</LastName>
<ForeName>Jan Dirk</ForeName>
<Initials>JD</Initials>
<AffiliationInfo>
<Affiliation>6 Parnassia Groep, 2553 RJ The Hague, The Netherlands 7 Department of Psychiatry, University of Groningen, 9713 GZ Groningen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kahn</LastName>
<ForeName>Ren S</ForeName>
<Initials>RS</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Psychiatry, University Medical Centre, 3584 CX Utrecht, The Netherlands 2 Rudolf Magnus Institute of Neuroscience, 3584 CG Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sommer</LastName>
<ForeName>Iris E</ForeName>
<Initials>IE</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Psychiatry, University Medical Centre, 3584 CX Utrecht, The Netherlands 2 Rudolf Magnus Institute of Neuroscience, 3584 CG Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Brain</MedlineTA>
<NlmUniqueID>0372537</NlmUniqueID>
<ISSNLinking>0006-8950</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001931">Brain Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002540">Cerebral Cortex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006212">Hallucinations</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011569">Psychiatric Status Rating Scales</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011618">Psychotic Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011795">Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012559">Schizophrenia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012565">Schizophrenic Psychology</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012569">Schizotypal Personality Disorder</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">auditory hallucination</Keyword>
<Keyword MajorTopicYN="N">continuum</Keyword>
<Keyword MajorTopicYN="N">psychosis</Keyword>
<Keyword MajorTopicYN="N">schizophrenia</Keyword>
<Keyword MajorTopicYN="N">structural MRI</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25012220</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1460-2156</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>137</Volume>
<Issue>Pt 10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Brain : a journal of neurology</Title>
<ISOAbbreviation>Brain</ISOAbbreviation>
</Journal>
<ArticleTitle>Early-onset Behr syndrome due to compound heterozygous mutations in OPA1.</ArticleTitle>
<Pagination>
<MedlinePgn>e301</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awu184</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bonneau</LastName>
<ForeName>Dominique</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>1 Unit Mixte de Recherche CNRS 6214 - INSERM 1083, Dpartement de Biochimie et Gntique, Centre Hospitalier Universitaire, Angers, France dobonneau@chu-angers.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Colin</LastName>
<ForeName>Estelle</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>1 Unit Mixte de Recherche CNRS 6214 - INSERM 1083, Dpartement de Biochimie et Gntique, Centre Hospitalier Universitaire, Angers, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Oca</LastName>
<ForeName>Florine</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>1 Unit Mixte de Recherche CNRS 6214 - INSERM 1083, Dpartement de Biochimie et Gntique, Centre Hospitalier Universitaire, Angers, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ferr</LastName>
<ForeName>Marc</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>1 Unit Mixte de Recherche CNRS 6214 - INSERM 1083, Dpartement de Biochimie et Gntique, Centre Hospitalier Universitaire, Angers, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chevrollier</LastName>
<ForeName>Arnaud</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>1 Unit Mixte de Recherche CNRS 6214 - INSERM 1083, Dpartement de Biochimie et Gntique, Centre Hospitalier Universitaire, Angers, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guguen</LastName>
<ForeName>Nag</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>1 Unit Mixte de Recherche CNRS 6214 - INSERM 1083, Dpartement de Biochimie et Gntique, Centre Hospitalier Universitaire, Angers, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Desquiret-Dumas</LastName>
<ForeName>Valrie</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>1 Unit Mixte de Recherche CNRS 6214 - INSERM 1083, Dpartement de Biochimie et Gntique, Centre Hospitalier Universitaire, Angers, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>N'Guyen</LastName>
<ForeName>Sylvie</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>2 Dpartement de Neuropdiatrie, Centre Hospitalier Universitaire, Angers, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barth</LastName>
<ForeName>Magalie</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>1 Unit Mixte de Recherche CNRS 6214 - INSERM 1083, Dpartement de Biochimie et Gntique, Centre Hospitalier Universitaire, Angers, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zanlonghi</LastName>
<ForeName>Xavier</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>3 Clinique Sourdille, Nantes, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rio</LastName>
<ForeName>Marlne</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>4 AP-HP, Service de Gntique Mdicale, Hpital Necker, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Desguerre</LastName>
<ForeName>Isabelle</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>5 AP-HP, Service de Neuropdiatrie, Hpital Necker, Universit Paris Descartes, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barnerias</LastName>
<ForeName>Christine</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>5 AP-HP, Service de Neuropdiatrie, Hpital Necker, Universit Paris Descartes, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Momtchilova</LastName>
<ForeName>Marta</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>6 AP-HP, Service d'Ophtalmologie, Hpital Armand Trousseau, HUEP, Paris France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rodriguez</LastName>
<ForeName>Diana</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>7 AP-HP, Service de Neuropdiatrie et Centre de Rfrence de Neurogntique, Hpital Armand Trousseau, HUEP; UMPC Universit Paris 6; Inserm U1141; Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Slama</LastName>
<ForeName>Abdelhamid</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>8 Laboratoire de Biochimie, AP-HP Hpital Kremlin-Bictre, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lenaers</LastName>
<ForeName>Guy</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>9 Institut des Neurosciences de Montpellier, INSERM U1051. Hpital Saint Eloi, Montpellier, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Procaccio</LastName>
<ForeName>Vincent</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>1 Unit Mixte de Recherche CNRS 6214 - INSERM 1083, Dpartement de Biochimie et Gntique, Centre Hospitalier Universitaire, Angers, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Amati-Bonneau</LastName>
<ForeName>Patrizia</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>1 Unit Mixte de Recherche CNRS 6214 - INSERM 1083, Dpartement de Biochimie et Gntique, Centre Hospitalier Universitaire, Angers, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reynier</LastName>
<ForeName>Pascal</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>1 Unit Mixte de Recherche CNRS 6214 - INSERM 1083, Dpartement de Biochimie et Gntique, Centre Hospitalier Universitaire, Angers, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Brain</MedlineTA>
<NlmUniqueID>0372537</NlmUniqueID>
<ISSNLinking>0006-8950</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>9007-49-2</RegistryNumber>
<NameOfSubstance UI="D004247">DNA</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.6.1.-</RegistryNumber>
<NameOfSubstance UI="D020558">GTP Phosphohydrolases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.6.1.-</RegistryNumber>
<NameOfSubstance UI="C415198">OPA1 protein, human</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C537669">Behr syndrome</SupplMeshName>
</SupplMeshList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017668">Age of Onset</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001259">Ataxia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001766">Blindness</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003248">Constipation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004247">DNA</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003680">Deglutition Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020558">GTP Phosphohydrolases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D034381">Hearing Loss</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006579">Heterozygote</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008607">Intellectual Disability</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009154">Mutation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009896">Optic Atrophy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000151">congenital</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D029241">Optic Atrophy, Autosomal Dominant</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010523">Peripheral Nervous System Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013035">Spasm</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25070514</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1460-2156</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>137</Volume>
<Issue>Pt 10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Brain : a journal of neurology</Title>
<ISOAbbreviation>Brain</ISOAbbreviation>
</Journal>
<ArticleTitle>Autonomic dysfunction is a major feature of cerebellar ataxia, neuropathy, vestibular areflexia 'CANVAS' syndrome.</ArticleTitle>
<Pagination>
<MedlinePgn>2649-56</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awu196</ELocationID>
<Abstract>
<AbstractText>Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) is a recently recognized neurodegenerative ganglionopathy. Prompted by the presence of symptomatic postural hypotension in two patients with CANVAS, we hypothesized that autonomic dysfunction may be an associated feature of the syndrome. We assessed symptoms of autonomic dysfunction and performed autonomic nervous system testing among 26 patients from New Zealand. After excluding three patients with diabetes mellitus, 83% had evidence of autonomic dysfunction; all patients had at least one autonomic symptom and 91% had more than two symptoms. We also found a higher rate of downbeat nystagmus (65%) than previously described in CANVAS. We confirmed that sensory findings on nerve conduction tests were consistent with a sensory ganglionopathy and describe two patients with loss of trigeminal sensation consistent with previous pathological descriptions of trigeminal sensory ganglionopathy. Our results suggest that autonomic dysfunction is a major feature of CANVAS. This has implications for the management of patients with CANVAS as the autonomic symptoms may be amenable to treatment. The findings also provide an important differential diagnosis from multiple system atrophy for patients who present with ataxia and autonomic failure.</AbstractText>
<CopyrightInformation> The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Teddy Y</ForeName>
<Initials>TY</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taylor</LastName>
<ForeName>Jennifer M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>2 Department of Neurology, Wellington Hospital, Riddiford Street, Wellington 6021, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kilfoyle</LastName>
<ForeName>Dean H</ForeName>
<Initials>DH</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand 1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Andrew D</ForeName>
<Initials>AD</Initials>
<AffiliationInfo>
<Affiliation>4 Department of Radiology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McGuinness</LastName>
<ForeName>Ben J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo>
<Affiliation>4 Department of Radiology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Simpson</LastName>
<ForeName>Mark P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand 1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Walker</LastName>
<ForeName>Elizabeth B</ForeName>
<Initials>EB</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand 1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bergin</LastName>
<ForeName>Peter S</ForeName>
<Initials>PS</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand 1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cleland</LastName>
<ForeName>James C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand 1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hutchinson</LastName>
<ForeName>David O</ForeName>
<Initials>DO</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand 1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Anderson</LastName>
<ForeName>Neil E</ForeName>
<Initials>NE</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand 1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Snow</LastName>
<ForeName>Barry J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand 1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Anderson</LastName>
<ForeName>Tim J</ForeName>
<Initials>TJ</Initials>
<AffiliationInfo>
<Affiliation>5 Department of Medicine, University of Otago, Christchurch, 2 Riccarton Avenue, Christchurch 8140, New Zealand 6 New Zealand Brain Research Institute, 66 Stewart Street, Christchurch 8011, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Paermentier</LastName>
<ForeName>Laura A F</ForeName>
<Initials>LA</Initials>
<AffiliationInfo>
<Affiliation>6 New Zealand Brain Research Institute, 66 Stewart Street, Christchurch 8011, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cutfield</LastName>
<ForeName>Nick J</ForeName>
<Initials>NJ</Initials>
<AffiliationInfo>
<Affiliation>7 Department of Medicine and Brain Health Research Centre, University of Otago, Dunedin, PO Box 56, Dunedin 9054, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chancellor</LastName>
<ForeName>Andrew M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>8 Department of Neurology, Tauranga Hospital, 829 Cameron Road, Tauranga 3112, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mossman</LastName>
<ForeName>Stuart S</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>2 Department of Neurology, Wellington Hospital, Riddiford Street, Wellington 6021, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Roxburgh</LastName>
<ForeName>Richard H</ForeName>
<Initials>RH</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Neurology, Auckland City Hospital, 2 Park Road, Auckland 1023, New Zealand 3 Centre for Brain Research, University of Auckland, 85 Park Road, Auckland 1142, New Zealand richardr@adhb.govt.nz.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Brain</MedlineTA>
<NlmUniqueID>0372537</NlmUniqueID>
<ISSNLinking>0006-8950</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>1406-18-4</RegistryNumber>
<NameOfSubstance UI="D014810">Vitamin E</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Brain. 2014 Oct;137(Pt 10):2625-6</RefSource>
<PMID Version="1">25217788</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017668">Age of Onset</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001342">Autonomic Nervous System Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002524">Cerebellar Ataxia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004244">Dizziness</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018737">Hand Strength</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006339">Heart Rate</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009460">Neurologic Examination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D009520">New Zealand</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009759">Nystagmus, Pathologic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010523">Peripheral Nervous System Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012027">Reflex, Vestibulo-Ocular</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013577">Syndrome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014636">Valsalva Maneuver</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015837">Vestibular Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014724">Vestibular Function Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014810">Vitamin E</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">CANVAS syndrome</Keyword>
<Keyword MajorTopicYN="N">autonomic failure</Keyword>
<Keyword MajorTopicYN="N">cerebellar ataxia</Keyword>
<Keyword MajorTopicYN="N">neuronopathy</Keyword>
<Keyword MajorTopicYN="N">vestibular failure</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25080285</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1460-2156</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>137</Volume>
<Issue>Pt 10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Brain : a journal of neurology</Title>
<ISOAbbreviation>Brain</ISOAbbreviation>
</Journal>
<ArticleTitle>Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.</ArticleTitle>
<Pagination>
<MedlinePgn>2743-58</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awu201</ELocationID>
<Abstract>
<AbstractText>Parkinson's disease is associated with multiple cognitive impairments and increased risk of dementia, but the extent of these deficits varies widely among patients. The ICICLE-PD study was established to define the characteristics and prevalence of cognitive change soon after diagnosis, in a representative cohort of patients, using a multimodal approach. Specifically, we tested the 'Dual Syndrome' hypothesis for cognitive impairment in Parkinson's disease, which distinguishes an executive syndrome (affecting the frontostriatal regions due to dopaminergic deficits) from a posterior cortical syndrome (affecting visuospatial, mnemonic and semantic functions related to Lewy body pathology and secondary cholinergic loss). An incident Parkinson's disease cohort (n = 168, median 8 months from diagnosis to participation) and matched control group (n = 85) were recruited to a neuroimaging study at two sites in the UK. All participants underwent clinical, neuropsychological and functional magnetic resonance imaging assessments. The three neuroimaging tasks (Tower of London, Spatial Rotations and Memory Encoding Tasks) were designed to probe executive, visuospatial and memory encoding domains, respectively. Patients were also genotyped for three polymorphisms associated with cognitive change in Parkinson's disease and related disorders: (i) rs4680 for COMT Val158Met polymorphism; (ii) rs9468 for MAPT H1 versus H2 haplotype; and (iii) rs429358 for APOE-2, 3, 4. We identified performance deficits in all three cognitive domains, which were associated with regionally specific changes in cortical activation. Task-specific regional activations in Parkinson's disease were linked with genetic variation: the rs4680 polymorphism modulated the effect of levodopa therapy on planning-related activations in the frontoparietal network; the MAPT haplotype modulated parietal activations associated with spatial rotations; and APOE allelic variation influenced the magnitude of activation associated with memory encoding. This study demonstrates that neurocognitive deficits are common even in recently diagnosed patients with Parkinson's disease, and that the associated regional brain activations are influenced by genotype. These data further support the dual syndrome hypothesis of cognitive change in Parkinson's disease. Longitudinal data will confirm the extent to which these early neurocognitive changes, and their genetic factors, influence the long-term risk of dementia in Parkinson's disease. The combination of genetics and functional neuroimaging provides a potentially useful method for stratification and identification of candidate markers, in future clinical trials against cognitive decline in Parkinson's disease.</AbstractText>
<CopyrightInformation> The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nombela</LastName>
<ForeName>Cristina</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>1 John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK dra.cristinanombela@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rowe</LastName>
<ForeName>James B</ForeName>
<Initials>JB</Initials>
<AffiliationInfo>
<Affiliation>2 Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK 3 Medical Research Council, Cognition and Brain Sciences Unit, Cambridge, UK 4 Behavioural and Clinical Neuroscience Institute, University of Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Winder-Rhodes</LastName>
<ForeName>Sophie E</ForeName>
<Initials>SE</Initials>
<AffiliationInfo>
<Affiliation>1 John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hampshire</LastName>
<ForeName>Adam</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>5 Computational, Cognitive and Clinical Neuroscience Laboratory, Imperial College London, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Owen</LastName>
<ForeName>Adrian M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>6 Brain and Mind Institute, University of Western Ontario, London, Canada 7 Department of Psychology, University of Western Ontario, London, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Breen</LastName>
<ForeName>David P</ForeName>
<Initials>DP</Initials>
<AffiliationInfo>
<Affiliation>1 John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Duncan</LastName>
<ForeName>Gordon W</ForeName>
<Initials>GW</Initials>
<AffiliationInfo>
<Affiliation>8 Institute for Ageing and Health, Newcastle University, Newcastle, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khoo</LastName>
<ForeName>Tien K</ForeName>
<Initials>TK</Initials>
<AffiliationInfo>
<Affiliation>9 Griffith Health Institute and School of Medicine, Griffith University, Gold Coast, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yarnall</LastName>
<ForeName>Alison J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>8 Institute for Ageing and Health, Newcastle University, Newcastle, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Firbank</LastName>
<ForeName>Michael J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>8 Institute for Ageing and Health, Newcastle University, Newcastle, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chinnery</LastName>
<ForeName>Patrick F</ForeName>
<Initials>PF</Initials>
<AffiliationInfo>
<Affiliation>10 Institute of Genetic Medicine, Newcastle University, Newcastle, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Robbins</LastName>
<ForeName>Trevor W</ForeName>
<Initials>TW</Initials>
<AffiliationInfo>
<Affiliation>4 Behavioural and Clinical Neuroscience Institute, University of Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>O'Brien</LastName>
<ForeName>John T</ForeName>
<Initials>JT</Initials>
<AffiliationInfo>
<Affiliation>11 Department of Psychiatry, University of Cambridge, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brooks</LastName>
<ForeName>David J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>12 Imperial College London, London, UK 13 Department of Clinical Medicine, Positron Emission Tomography Centre, Aarhus University, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Burn</LastName>
<ForeName>David J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>8 Institute for Ageing and Health, Newcastle University, Newcastle, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>ICICLE-PD study group</CollectiveName>
</Author>
<Author ValidYN="Y">
<LastName>Barker</LastName>
<ForeName>Roger A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>1 John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>JBR 088324</GrantID>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Brain</MedlineTA>
<NlmUniqueID>0372537</NlmUniqueID>
<ISSNLinking>0006-8950</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.1.1.6</RegistryNumber>
<NameOfSubstance UI="D002394">Catechol O-Methyltransferase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.24</RegistryNumber>
<NameOfSubstance UI="D020928">Mitogen-Activated Protein Kinases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosci Lett. 2008 Dec 19;448(1):20-3</RefSource>
<PMID Version="1">18930114</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2008 Dec 15;23(16):2398-403</RefSource>
<PMID Version="1">19025759</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Clin Psychol. 2009;5:343-62</RefSource>
<PMID Version="1">19327032</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol. 2009 Mar;256(3):493-8</RefSource>
<PMID Version="1">19308307</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2009 Nov;132(Pt 11):2958-69</RefSource>
<PMID Version="1">19812213</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurol. 2009 Dec;16(12):1278-84</RefSource>
<PMID Version="1">19538208</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2010 Jan;16(1):46-50</RefSource>
<PMID Version="1">19665420</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Soc Cogn Affect Neurosci. 2007 Mar;2(1):67-70</RefSource>
<PMID Version="1">18985121</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Aging. 2010 Jun;31(6):1064-8</RefSource>
<PMID Version="1">18755526</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Pathol. 2010 May;20(3):633-9</RefSource>
<PMID Version="1">20522088</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2010 Nov 15;25(15):2550-4</RefSource>
<PMID Version="1">20878993</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2010 Nov 15;25(15):2649-53</RefSource>
<PMID Version="1">21069833</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Neurol. 2010 Dec;9(12):1200-13</RefSource>
<PMID Version="1">20880750</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Int Neuropsychol Soc. 2011 Jan;17(1):91-100</RefSource>
<PMID Version="1">21092386</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychology. 2011 Jan;25(1):114-24</RefSource>
<PMID Version="1">20954781</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychopharmacology. 2011 Mar;36(4):763-71</RefSource>
<PMID Version="1">21150912</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Psychiatry. 2011 Jun 15;69(12):e113-25</RefSource>
<PMID Version="1">21531388</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Neurol Neurosci Rep. 2011 Aug;11(4):371-8</RefSource>
<PMID Version="1">21487730</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychologia. 2001;39(3):315-27</RefSource>
<PMID Version="1">11163609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2002 Mar;125(Pt 3):584-94</RefSource>
<PMID Version="1">11872615</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2002 Apr;125(Pt 4):861-70</RefSource>
<PMID Version="1">11912118</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2003 Mar;60(3):387-92</RefSource>
<PMID Version="1">12633150</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2003 Jul 16;23(15):6351-6</RefSource>
<PMID Version="1">12867520</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Int Neuropsychol Soc. 2003 Nov;9(7):1078-87</RefSource>
<PMID Version="1">14738288</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2004 Mar;127(Pt 3):550-60</RefSource>
<PMID Version="1">14691062</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychology. 1997 Jan;11(1):44-52</RefSource>
<PMID Version="1">9055268</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Lang. 1997 Mar;57(1):100-21</RefSource>
<PMID Version="1">9126409</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychologia. 1998 Jan;36(1):109-14</RefSource>
<PMID Version="1">9533393</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neuropathol. 1998 May;95(5):450-4</RefSource>
<PMID Version="1">9600590</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7721-6</RefSource>
<PMID Version="1">9636217</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Brain Mapp. 1999;8(2-3):102-8</RefSource>
<PMID Version="1">10524600</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2012 Jul;27(8):965-73</RefSource>
<PMID Version="1">22693110</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Neurol. 2012 Aug;11(8):679-87</RefSource>
<PMID Version="1">22742929</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2012 Aug;135(Pt 8):2449-57</RefSource>
<PMID Version="1">22843413</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2012 Aug;18(7):881-6</RefSource>
<PMID Version="1">22658654</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2012 Oct;72(4):587-98</RefSource>
<PMID Version="1">23037886</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurodegener Dis. 2013;11(2):79-92</RefSource>
<PMID Version="1">23038420</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):23-8</RefSource>
<PMID Version="1">23154124</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2012 Dec 20;76(6):1225-37</RefSource>
<PMID Version="1">23259956</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2013 Jan 1;80(1):85-91</RefSource>
<PMID Version="1">23243071</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cereb Cortex. 2013 Feb;23(2):361-9</RefSource>
<PMID Version="1">22351648</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2013 Feb;136(Pt 2):392-9</RefSource>
<PMID Version="1">23413260</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurochem Int. 2013 Apr;62(5):803-19</RefSource>
<PMID Version="1">23291248</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Aging. 2013 Aug;34(8):2078.e1-2</RefSource>
<PMID Version="1">23522842</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA Neurol. 2013 May;70(5):580-6</RefSource>
<PMID Version="1">23529397</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hippocampus. 2013 Aug;23(8):720-8</RefSource>
<PMID Version="1">23553678</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2004 Jun 8;62(11):2005-9</RefSource>
<PMID Version="1">15184605</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2004 Aug;19(8):885-91</RefSource>
<PMID Version="1">15300652</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Hum Genet. 2004 Nov;75(5):807-21</RefSource>
<PMID Version="1">15457404</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cortex. 1972 Jun;8(2):191-212</RefSource>
<PMID Version="1">5043793</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Psychiatr Res. 1975 Nov;12(3):189-98</RefSource>
<PMID Version="1">1202204</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cortex. 1978 Jun;14(2):234-44</RefSource>
<PMID Version="1">679704</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Philos Trans R Soc Lond B Biol Sci. 1982 Jun 25;298(1089):199-209</RefSource>
<PMID Version="1">6125971</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 1988 Jun;111 ( Pt 3):695-718</RefSource>
<PMID Version="1">3382917</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1988 Nov;8(11):4049-68</RefSource>
<PMID Version="1">2846794</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 1992 Dec;115 ( Pt 6):1727-51</RefSource>
<PMID Version="1">1486458</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1993 Aug 13;261(5123):921-3</RefSource>
<PMID Version="1">8346443</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychologia. 1995 Jan;33(1):1-24</RefSource>
<PMID Version="1">7731533</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 1996 Feb;119 ( Pt 1):89-100</RefSource>
<PMID Version="1">8624697</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 1996 Feb;8(2):353-64</RefSource>
<PMID Version="1">8714706</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychologia. 1996 Jun;34(6):515-26</RefSource>
<PMID Version="1">8736565</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Cogn Sci. 2004 Jul;8(7):325-35</RefSource>
<PMID Version="1">15242692</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cogn Behav Neurol. 2004 Dec;17(4):195-200</RefSource>
<PMID Version="1">15622014</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Geriatr Soc. 2005 Apr;53(4):695-9</RefSource>
<PMID Version="1">15817019</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Neurosci. 2011 Oct;18(10):1333-5</RefSource>
<PMID Version="1">21782446</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2011 Dec;68(12):1562-8</RefSource>
<PMID Version="1">22159053</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2011 Dec;26(14):2483-95</RefSource>
<PMID Version="1">22170275</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Neurol. 2012 Jan;233(1):513-22</RefSource>
<PMID Version="1">22155743</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2012 Jan 31;78(5):352-60</RefSource>
<PMID Version="1">22262753</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2012 Apr;27(4):512-8</RefSource>
<PMID Version="1">22344634</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Dis. 2012 May;46(2):389-92</RefSource>
<PMID Version="1">22349451</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neuropsychol. 2013 Sep;7(2):179-92</RefSource>
<PMID Version="1">23560529</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1258-64</RefSource>
<PMID Version="1">23781007</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Aging. 2014 Jan;35(1):223-31</RefSource>
<PMID Version="1">23932879</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sci Rep. 2013;3:2972</RefSource>
<PMID Version="1">24135857</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2014 Jan 28;82(4):308-16</RefSource>
<PMID Version="1">24363137</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neurol Belg. 2014 Mar;114(1):25-31</RefSource>
<PMID Version="1">23794363</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2000 Jan;123 ( Pt 1):65-73</RefSource>
<PMID Version="1">10611121</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2000 Jun 2;288(5471):1656-60</RefSource>
<PMID Version="1">10834847</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cogn Neurosci. 2005 Jul;17(7):1018-25</RefSource>
<PMID Version="1">16102234</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2005 Oct 25;65(8):1239-45</RefSource>
<PMID Version="1">16247051</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychologia. 2006;44(2):229-37</RefSource>
<PMID Version="1">15979109</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychologia. 2006;44(3):339-49</RefSource>
<PMID Version="1">16061263</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2006 Feb;63(2):189-93</RefSource>
<PMID Version="1">16476806</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2006 Jul 15;31(4):1790-801</RefSource>
<PMID Version="1">16624583</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2006 Sep;21(9):1343-9</RefSource>
<PMID Version="1">16721732</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2007 May 2;27(18):4832-8</RefSource>
<PMID Version="1">17475791</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosci Lett. 2007 Jun 21;421(1):57-61</RefSource>
<PMID Version="1">17548151</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2007 Jul;130(Pt 7):1787-98</RefSource>
<PMID Version="1">17535834</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2007 Aug;62(2):145-53</RefSource>
<PMID Version="1">17683088</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2008 Feb;131(Pt 2):397-408</RefSource>
<PMID Version="1">18178571</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cogn Neurosci. 2008 Jan;20(1):1-19</RefSource>
<PMID Version="1">17919082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2008 Apr 30;23(6):837-44</RefSource>
<PMID Version="1">18307261</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2008 Aug;131(Pt 8):2094-105</RefSource>
<PMID Version="1">18577547</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Brain. 2014 Oct;137(Pt 10):2630-1</RefSource>
<PMID Version="1">25217791</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001057">Apolipoproteins E</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002394">Catechol O-Methyltransferase</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003071">Cognition</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003072">Cognition Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015331">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007092">Imagination</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008137">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008568">Memory</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020928">Mitogen-Activated Protein Kinases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059906">Neuroimaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011597">Psychomotor Performance</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012399">Rotation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013028">Space Perception</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016875">tau Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4163033</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Parkinsons disease</Keyword>
<Keyword MajorTopicYN="N">cognition</Keyword>
<Keyword MajorTopicYN="N">functional MRI</Keyword>
<Keyword MajorTopicYN="N">genetics</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25100039</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1460-2156</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>137</Volume>
<Issue>Pt 10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Brain : a journal of neurology</Title>
<ISOAbbreviation>Brain</ISOAbbreviation>
</Journal>
<ArticleTitle>Domain-specific impairment in metacognitive accuracy following anterior prefrontal lesions.</ArticleTitle>
<Pagination>
<MedlinePgn>2811-22</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awu221</ELocationID>
<Abstract>
<AbstractText>Humans have the capacity to evaluate the success of cognitive processes, known as metacognition. Convergent evidence supports a role for anterior prefrontal cortex in metacognitive judgements of perceptual processes. However, it is unknown whether metacognition is a global phenomenon, with anterior prefrontal cortex supporting metacognition across domains, or whether it relies on domain-specific neural substrates. To address this question, we measured metacognitive accuracy in patients with lesions to anterior prefrontal cortex (n = 7) in two distinct domains, perception and memory, by assessing the correspondence between objective performance and subjective ratings of performance. Despite performing equivalently to a comparison group with temporal lobe lesions (n = 11) and healthy controls (n = 19), patients with lesions to the anterior prefrontal cortex showed a selective deficit in perceptual metacognitive accuracy (meta-d'/d', 95% confidence interval 0.28-0.64). Crucially, however, the anterior prefrontal cortex lesion group's metacognitive accuracy on an equivalent memory task remained unimpaired (meta-d'/d', 95% confidence interval 0.78-1.29). Metacognitive accuracy in the temporal lobe group was intact in both domains. Our results support a causal role for anterior prefrontal cortex in perceptual metacognition, and indicate that the neural architecture of metacognition, while often considered global and domain-general, comprises domain-specific components that may be differentially affected by neurological insult.</AbstractText>
<CopyrightInformation> The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fleming</LastName>
<ForeName>Stephen M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>1 Centre for Neural Science, New York University, USA 2 Department of Experimental Psychology, University of Oxford, UK sf102@nyu.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ryu</LastName>
<ForeName>Jihye</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>1 Centre for Neural Science, New York University, USA 3 Department of Psychology, City University of New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Golfinos</LastName>
<ForeName>John G</ForeName>
<Initials>JG</Initials>
<AffiliationInfo>
<Affiliation>4 Department of Neurosurgery, New York University School of Medicine, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Blackmon</LastName>
<ForeName>Karen E</ForeName>
<Initials>KE</Initials>
<AffiliationInfo>
<Affiliation>5 Department of Neurology, New York University School of Medicine, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>WT096185</GrantID>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Brain</MedlineTA>
<NlmUniqueID>0372537</NlmUniqueID>
<ISSNLinking>0006-8950</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Cogn Neurosci. 2009 Sep;21(9):1751-65</RefSource>
<PMID Version="1">18823230</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pers Soc Psychol Rev. 2009 Aug;13(3):219-35</RefSource>
<PMID Version="1">19638628</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2009 Sep;132(Pt 9):2531-40</RefSource>
<PMID Version="1">19433438</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Cogn Sci. 2009 Sep;13(9):372-80</RefSource>
<PMID Version="1">19716751</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cereb Cortex. 2010 Feb;20(2):479-85</RefSource>
<PMID Version="1">19542474</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Cogn Sci. 2010 Jan;14(1):16-21</RefSource>
<PMID Version="1">19969501</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychologia. 2010 Mar;48(4):921-32</RefSource>
<PMID Version="1">19932707</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurophysiol. 2010 Jul;104(1):539-47</RefSource>
<PMID Version="1">20393062</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychol Rehabil. 2010 Aug;20(4):481-508</RefSource>
<PMID Version="1">20182952</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2010 Sep 17;329(5998):1541-3</RefSource>
<PMID Version="1">20847276</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cognition. 2010 Nov;117(2):182-90</RefSource>
<PMID Version="1">20825936</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosci Res. 2010 Nov;68(3):199-206</RefSource>
<PMID Version="1">20688112</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Gerontol Geriatr. 2011 May-Jun;52(3):e192-7</RefSource>
<PMID Version="1">21126778</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cereb Cortex. 2011 Jul;21(7):1485-97</RefSource>
<PMID Version="1">21098620</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Biol. 2011 Jun;9(6):e1001093</RefSource>
<PMID Version="1">21738446</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Cogn Sci. 2011 Aug;15(8):365-73</RefSource>
<PMID Version="1">21737339</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Conscious Cogn. 2011 Dec;20(4):1787-92</RefSource>
<PMID Version="1">21256051</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychologia. 2011 Nov;49(13):3525-31</RefSource>
<PMID Version="1">21930138</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2012 Feb 9;73(3):595-607</RefSource>
<PMID Version="1">22325209</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Conscious Cogn. 2012 Mar;21(1):422-30</RefSource>
<PMID Version="1">22071269</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Philos Trans R Soc Lond B Biol Sci. 2012 May 19;367(1594):1338-49</RefSource>
<PMID Version="1">22492751</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Philos Trans R Soc Lond B Biol Sci. 2012 May 19;367(1594):1379-90</RefSource>
<PMID Version="1">22492754</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2012 May 2;32(18):6117-25</RefSource>
<PMID Version="1">22553018</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2012 Jun 20;32(25):8434-42</RefSource>
<PMID Version="1">22723683</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Brain Mapp. 2012 Aug;33(8):1952-63</RefSource>
<PMID Version="1">21834102</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2013 Jan;16(1):105-10</RefSource>
<PMID Version="1">23222911</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2013 Jan 30;33(5):1897-906</RefSource>
<PMID Version="1">23365229</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Conscious Cogn. 2013 Mar;22(1):264-71</RefSource>
<PMID Version="1">23376348</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2013 Jun;73:80-94</RefSource>
<PMID Version="1">23380166</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Int Neuropsychol Soc. 2013 Apr;19(4):453-62</RefSource>
<PMID Version="1">23406983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Atten Percept Psychophys. 2013 Oct;75(7):1406-26</RefSource>
<PMID Version="1">23868563</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2013 Oct 16;33(42):16657-65</RefSource>
<PMID Version="1">24133268</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychol Methods. 2013 Dec;18(4):535-52</RefSource>
<PMID Version="1">24079931</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mem Cognit. 2000 Jan;28(1):92-107</RefSource>
<PMID Version="1">10714142</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Conscious Cogn. 2000 Jun;9(2 Pt 1):313-23; discussion 324-6</RefSource>
<PMID Version="1">10924251</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Behav Brain Sci. 1999 Jun;22(3):341-65; discussion 366-423</RefSource>
<PMID Version="1">11301517</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2001 May;124(Pt 5):849-81</RefSource>
<PMID Version="1">11335690</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cereb Cortex. 2001 Nov;11(11):1040-6</RefSource>
<PMID Version="1">11590113</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Neurosci. 2004 Mar;5(3):184-94</RefSource>
<PMID Version="1">14976518</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychologia. 2004;42(7):957-66</RefSource>
<PMID Version="1">14998710</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychon Bull Rev. 2003 Dec;10(4):843-76</RefSource>
<PMID Version="1">15000533</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Clin Neuropsychol. 2004 Mar;19(2):203-14</RefSource>
<PMID Version="1">15010086</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Psychol Gen. 1984 Sep;113(3):443-63</RefSource>
<PMID Version="1">6237172</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cortex. 1991 Mar;27(1):81-92</RefSource>
<PMID Version="1">2055045</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Psychol Rev. 1993 Oct;100(4):609-39</RefSource>
<PMID Version="1">8255951</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stat Med. 1995 Apr 30;14(8):811-9</RefSource>
<PMID Version="1">7644861</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Spat Vis. 1997;10(4):433-6</RefSource>
<PMID Version="1">9176952</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychology. 1998 Apr;12(2):268-77</RefSource>
<PMID Version="1">9556773</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Psychol Hum Percept Perform. 1998 Jun;24(3):929-45</RefSource>
<PMID Version="1">9627426</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14529-34</RefSource>
<PMID Version="1">9826734</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Philos Trans R Soc Lond B Biol Sci. 1998 Nov 29;353(1377):1911-4</RefSource>
<PMID Version="1">9854263</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychology. 1999 Apr;13(2):298-305</RefSource>
<PMID Version="1">10353379</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cereb Cortex. 2005 Mar;15(3):239-49</RefSource>
<PMID Version="1">15238433</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Cogn Sci. 2005 Sep;9(9):445-53</RefSource>
<PMID Version="1">16054861</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Int Neuropsychol Soc. 2005 Oct;11(6):668-76</RefSource>
<PMID Version="1">16248902</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Image Anal. 2001 Jun;5(2):143-56</RefSource>
<PMID Version="1">11516708</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2006 Jun 1;50(5):781-9</RefSource>
<PMID Version="1">16731515</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2006 Jun 15;441(7095):876-9</RefSource>
<PMID Version="1">16778890</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cereb Cortex. 2006 Nov;16(11):1623-30</RefSource>
<PMID Version="1">16400154</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cereb Cortex. 2006 Dec;16(12):1783-9</RefSource>
<PMID Version="1">16421331</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2006 Dec;33(4):1188-93</RefSource>
<PMID Version="1">17029986</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Cogn Sci. 2007 Jul;11(7):290-8</RefSource>
<PMID Version="1">17548231</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2007 Oct 26;318(5850):594-8</RefSource>
<PMID Version="1">17962551</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2007 Nov 7;27(45):12190-7</RefSource>
<PMID Version="1">17989285</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prog Brain Res. 2008;168:35-48</RefSource>
<PMID Version="1">18166384</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cogn Neurosci. 2007 Dec;19(12):2082-99</RefSource>
<PMID Version="1">17892391</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuropsychologia. 2008 Oct;46(12):2958-65</RefSource>
<PMID Version="1">18606176</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2008;3(9):e3227</RefSource>
<PMID Version="1">18795100</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Psychol Learn Mem Cogn. 2009 Mar;35(2):509-27</RefSource>
<PMID Version="1">19271863</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001288">Attention</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003071">Cognition</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004827">Epilepsy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007361">Intelligence Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008568">Memory</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010465">Perception</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010775">Photic Stimulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017397">Prefrontal Cortex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000293">injuries</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011597">Psychomotor Performance</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017603">Signal Detection, Psychological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013702">Temporal Lobe</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000293">injuries</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4163038</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">cognitive control</Keyword>
<Keyword MajorTopicYN="N">consciousness</Keyword>
<Keyword MajorTopicYN="N">neuropsychology</Keyword>
<Keyword MajorTopicYN="N">prefrontal cortex</Keyword>
<Keyword MajorTopicYN="N">temporal lobe</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25104094</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1460-2156</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>137</Volume>
<Issue>Pt 10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Brain : a journal of neurology</Title>
<ISOAbbreviation>Brain</ISOAbbreviation>
</Journal>
<ArticleTitle>Resilience of developing brain networks to interictal epileptiform discharges is associated with cognitive outcome.</ArticleTitle>
<Pagination>
<MedlinePgn>2690-702</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awu214</ELocationID>
<Abstract>
<AbstractText>The effects of interictal epileptiform discharges on neurocognitive development in children with medically-intractable epilepsy are poorly understood. Such discharges may have a deleterious effect on the brain's intrinsic connectivity networks, which reflect the organization of functional networks at rest, and in turn on neurocognitive development. Using a combined functional magnetic resonance imaging-magnetoencephalography approach, we examine the effects of interictal epileptiform discharges on intrinsic connectivity networks and neurocognitive outcome. Functional magnetic resonance imaging was used to determine the location of regions comprising various intrinsic connectivity networks in 26 children (7-17 years), and magnetoencephalography data were reconstructed from these locations. Inter-regional phase synchronization was then calculated across interictal epileptiform discharges and graph theoretical analysis was applied to measure event-related changes in network topology in the peri-discharge period. The magnitude of change in network topology (network resilience/vulnerability) to interictal epileptiform discharges was associated with neurocognitive outcomes and functional magnetic resonance imaging networks using dual regression. Three main findings are reported: (i) large-scale network changes precede and follow interictal epileptiform discharges; (ii) the resilience of network topologies to interictal discharges is associated with stronger resting-state network connectivity; and (iii) vulnerability to interictal discharges is associated with worse neurocognitive outcomes. By combining the spatial resolution of functional magnetic resonance imaging with the temporal resolution of magnetoencephalography, we describe the effects of interictal epileptiform discharges on neurophysiological synchrony in intrinsic connectivity networks and establish the impact of interictal disruption of functional networks on cognitive outcome in children with epilepsy. The association between interictal discharges, network changes and neurocognitive outcomes suggests that it is of clinical importance to suppress discharges to foster more typical brain network development in children with focal epilepsy.</AbstractText>
<CopyrightInformation> The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ibrahim</LastName>
<ForeName>George M</ForeName>
<Initials>GM</Initials>
<AffiliationInfo>
<Affiliation>1 Division of Neurosurgery, Hospital for Sick Children, Department of Surgery, University of Toronto, Toronto, Ontario, Canada 2 Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada georgem.ibrahim@utoronto.ca.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cassel</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>3 Neuroscience and Mental Health Program, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Morgan</LastName>
<ForeName>Benjamin R</ForeName>
<Initials>BR</Initials>
<AffiliationInfo>
<Affiliation>4 Department of Diagnostic Imaging, Hospital for Sick Children, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Mary Lou</ForeName>
<Initials>ML</Initials>
<AffiliationInfo>
<Affiliation>5 Department of Psychology, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Otsubo</LastName>
<ForeName>Hiroshi</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>6 Division of Neurology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ochi</LastName>
<ForeName>Ayako</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>6 Division of Neurology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taylor</LastName>
<ForeName>Margot</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>3 Neuroscience and Mental Health Program, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada 4 Department of Diagnostic Imaging, Hospital for Sick Children, Toronto, Ontario, Canada 5 Department of Psychology, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rutka</LastName>
<ForeName>James T</ForeName>
<Initials>JT</Initials>
<AffiliationInfo>
<Affiliation>1 Division of Neurosurgery, Hospital for Sick Children, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Snead</LastName>
<ForeName>O Carter</ForeName>
<Initials>OC</Initials>
<Suffix>3rd</Suffix>
<AffiliationInfo>
<Affiliation>2 Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada 3 Neuroscience and Mental Health Program, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada 6 Division of Neurology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Doesburg</LastName>
<ForeName>Sam</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>2 Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada 3 Neuroscience and Mental Health Program, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada 4 Department of Diagnostic Imaging, Hospital for Sick Children, Toronto, Ontario, Canada 5 Department of Psychology, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Brain</MedlineTA>
<NlmUniqueID>0372537</NlmUniqueID>
<ISSNLinking>0006-8950</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>S88TT14065</RegistryNumber>
<NameOfSubstance UI="D010100">Oxygen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001931">Brain Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003071">Cognition</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004351">Drug Resistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004827">Epilepsy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015225">Magnetoencephalography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009415">Nerve Net</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000254">growth &amp; development</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009434">Neural Pathways</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010100">Oxygen</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012146">Rest</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4163036 [Available on 10/01/15]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">IED</Keyword>
<Keyword MajorTopicYN="N">functional connectivity</Keyword>
<Keyword MajorTopicYN="N">graph theoretical analysis</Keyword>
<Keyword MajorTopicYN="N">resting-state functional MRI</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25113789</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1460-2156</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>137</Volume>
<Issue>Pt 10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Brain : a journal of neurology</Title>
<ISOAbbreviation>Brain</ISOAbbreviation>
</Journal>
<ArticleTitle>The evolution of primary progressive apraxia of speech.</ArticleTitle>
<Pagination>
<MedlinePgn>2783-95</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awu223</ELocationID>
<Abstract>
<AbstractText>Primary progressive apraxia of speech is a recently described neurodegenerative disorder in which patients present with an isolated apraxia of speech and show focal degeneration of superior premotor cortex. Little is known about how these individuals progress over time, making it difficult to provide prognostic estimates. Thirteen subjects with primary progressive apraxia of speech underwent two serial comprehensive clinical and neuroimaging evaluations 2.4 years apart [median age of onset = 67 years (range: 49-76), seven females]. All underwent detailed speech and language, neurological and neuropsychological assessments, and magnetic resonance imaging, diffusion tensor imaging and (18)F-fluorodeoxyglucose positron emission tomography at both baseline and follow-up. Rates of change of whole brain, ventricle, and midbrain volumes were calculated using the boundary-shift integral and atlas-based parcellation, and rates of regional grey matter atrophy were assessed using tensor-based morphometry. White matter tract degeneration was assessed on diffusion-tensor imaging at each time-point. Patterns of hypometabolism were assessed at the single subject-level. Neuroimaging findings were compared with a cohort of 20 age, gender, and scan-interval matched healthy controls. All subjects developed extrapyramidal signs. In eight subjects the apraxia of speech remained the predominant feature. In the other five there was a striking progression of symptoms that had evolved into a progressive supranuclear palsy-like syndrome; they showed a combination of severe parkinsonism, near mutism, dysphagia with choking, vertical supranuclear gaze palsy or slowing, balance difficulties with falls and urinary incontinence, and one was wheelchair bound. Rates of whole brain atrophy (1.5% per year; controls = 0.4% per year), ventricular expansion (8.0% per year; controls = 3.3% per year) and midbrain atrophy (1.5% per year; controls = 0.1% per year) were elevated (P  0.001) in all 13, compared to controls. Increased rates of brain atrophy over time were observed throughout the premotor cortex, as well as prefrontal cortex, motor cortex, basal ganglia and midbrain, while white matter tract degeneration spread into the splenium of the corpus callosum and motor cortex white matter. Hypometabolism progressed over time in almost all subjects. These findings demonstrate that some subjects with primary progressive apraxia of speech will rapidly evolve and develop a devastating progressive supranuclear palsy-like syndrome  5 years after onset, perhaps related to progressive involvement of neocortex, basal ganglia and midbrain. These findings help improve our understanding of primary progressive apraxia of speech and provide some important prognostic guidelines.</AbstractText>
<CopyrightInformation> The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Josephs</LastName>
<ForeName>Keith A</ForeName>
<Initials>KA</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Neurology (Behavioural Neurology), Mayo Clinic, Rochester, MN 55905, USA 2 Department of Neurology (Movement Disorders), Mayo Clinic, Rochester, MN 55905, USA Josephs.keith@mayo.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Duffy</LastName>
<ForeName>Joseph R</ForeName>
<Initials>JR</Initials>
<AffiliationInfo>
<Affiliation>3 Department of Neurology (Speech Pathology), Mayo Clinic, Rochester, MN 55905, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Strand</LastName>
<ForeName>Edythe A</ForeName>
<Initials>EA</Initials>
<AffiliationInfo>
<Affiliation>3 Department of Neurology (Speech Pathology), Mayo Clinic, Rochester, MN 55905, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Machulda</LastName>
<ForeName>Mary M</ForeName>
<Initials>MM</Initials>
<AffiliationInfo>
<Affiliation>4 Department of Psychiatry and Psychology (Neuropsychology), Mayo Clinic, Rochester, MN 55905, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Senjem</LastName>
<ForeName>Matthew L</ForeName>
<Initials>ML</Initials>
<AffiliationInfo>
<Affiliation>5 Department of Information Technology, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gunter</LastName>
<ForeName>Jeffrey L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo>
<Affiliation>5 Department of Information Technology, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schwarz</LastName>
<ForeName>Christopher G</ForeName>
<Initials>CG</Initials>
<AffiliationInfo>
<Affiliation>6 Department of Radiology (Neuroradiology), Mayo Clinic, Rochester, MN 55905, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reid</LastName>
<ForeName>Robert I</ForeName>
<Initials>RI</Initials>
<AffiliationInfo>
<Affiliation>6 Department of Radiology (Neuroradiology), Mayo Clinic, Rochester, MN 55905, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Spychalla</LastName>
<ForeName>Anthony J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>6 Department of Radiology (Neuroradiology), Mayo Clinic, Rochester, MN 55905, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lowe</LastName>
<ForeName>Val J</ForeName>
<Initials>VJ</Initials>
<AffiliationInfo>
<Affiliation>7 Department of Radiology (Nuclear Medicine), Mayo Clinic, Rochester, MN 55905, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jack</LastName>
<ForeName>Clifford R</ForeName>
<Initials>CR</Initials>
<Suffix>Jr</Suffix>
<AffiliationInfo>
<Affiliation>6 Department of Radiology (Neuroradiology), Mayo Clinic, Rochester, MN 55905, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Whitwell</LastName>
<ForeName>Jennifer L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo>
<Affiliation>6 Department of Radiology (Neuroradiology), Mayo Clinic, Rochester, MN 55905, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 DC010367</GrantID>
<Acronym>DC</Acronym>
<Agency>NIDCD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DC012519</GrantID>
<Acronym>DC</Acronym>
<Agency>NIDCD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Brain</MedlineTA>
<NlmUniqueID>0372537</NlmUniqueID>
<ISSNLinking>0006-8950</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0Z5B2CJX4D</RegistryNumber>
<NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017668">Age of Onset</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003071">Cognition</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056324">Diffusion Tensor Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018450">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004522">Educational Status</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019788">Fluorodeoxyglucose F18</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059906">Neuroimaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009460">Neurologic Examination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019275">Radiopharmaceuticals</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013060">Speech</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013064">Speech Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013494">Supranuclear Palsy, Progressive</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000531">radionuclide imaging</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4229741 [Available on 10/01/15]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">disease progression</Keyword>
<Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword>
<Keyword MajorTopicYN="N">non-fluent speech</Keyword>
<Keyword MajorTopicYN="N">parkinsonism</Keyword>
<Keyword MajorTopicYN="N">progressive supranuclear palsy</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25036879</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>15</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>06</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1879-1891</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>158</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>American journal of ophthalmology</Title>
<ISOAbbreviation>Am. J. Ophthalmol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Granulomatous dacryoadenitis in regional enteritis (crohn disease).</ArticleTitle>
<Pagination>
<MedlinePgn>838-844.e1</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajo.2014.07.011</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0002-9394(14)00402-4</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate the clinical and immunopathologic features of 2 patients with bilateral dacryoadenitis associated with regional enteritis.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective, clinicopathologic study.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Clinical records, photographs, and imaging studies were reviewed and microscopic sections of lacrimal gland biopsy samples were critically re-evaluated. The microscopic slides were stained with hematoxylin and eosin, special stains for organisms, and a range of immunohistochemical biomarkers, including CD3, CD4, CD5, CD8, CD20, CD68, CD138, CD1a, and immunoglobulins Ig G, IgG4, and IgA.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Both patients were young women with a well-established diagnosis of regional enteritis. Histopathologic examination of biopsy samples disclosed moderate intraparenchymal fibrosis and lymphoplasmacytic infiltrates without lymphoid follicles. Small to medium intraparenchymal, noncaseating granulomas lacking multinucleated giant cells and, in 1 patient, CD68-positive and CD1a-negative palisading granulomas in widened interlobular fibrous septa were detected. Vasculitis and IgG4 plasma cells were not observed. Additional immunohistochemical studies revealed that CD8T lymphocytes (suppressor or cytotoxic subset) predominated over CD4-positive T lymphocytes (helper cells) surrounding the necrobiotic foci and were intermixed with the CD68-positive histiocytes in the absence of CD20 B lymphocytes. Special stains for organisms demonstrated negative results.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Dacryoadenitis is the rarest form of ocular adnexal involvement in regional enteritis, which affects the orbit far more frequently than ulcerative colitis. It is a granulomatous process with the possibility of palisading necrobiotic foci. In contrast, ulcerative colitis causes an interstitial lymphocytic and nongranulomatous myositis. Sarcoidosis, Wegener granulomatosis, and pseudorheumatoid nodules must be ruled out. Treatment options entail a wide variety of agents with selection based on empirical considerations and tailored to the patient's symptoms.</AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jakobiec</LastName>
<ForeName>Frederick A</ForeName>
<Initials>FA</Initials>
<AffiliationInfo>
<Affiliation>David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts. Electronic address: Fred_Jakobiec@meei.harvard.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rashid</LastName>
<ForeName>Alia</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lane</LastName>
<ForeName>Katherine A</ForeName>
<Initials>KA</Initials>
<AffiliationInfo>
<Affiliation>Ophthalmic Consultants of Vermont, South Burlington, Vermont.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kazim</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Edward S. Harkness Eye Institute of the New York Hospital Presbyterian Medical Center, and Columbia University, New York, New York.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Ophthalmol</MedlineTA>
<NlmUniqueID>0370500</NlmUniqueID>
<ISSNLinking>0002-9394</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biological Markers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>3XC8GUZ6CB</RegistryNumber>
<NameOfSubstance UI="D012460">Sulfasalazine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015703">Antigens, CD</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015415">Biological Markers</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018414">CD8-Positive T-Lymphocytes</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003424">Crohn Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003607">Dacryocystitis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006105">Granulomatous Disease, Chronic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007124">Immunoenzyme Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012460">Sulfasalazine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013602">T-Lymphocytes, Cytotoxic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006377">T-Lymphocytes, Helper-Inducer</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24890995</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>15</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1532-8406</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>29</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of arthroplasty</Title>
<ISOAbbreviation>J Arthroplasty</ISOAbbreviation>
</Journal>
<ArticleTitle>Patient-specific instrumentation in total knee arthroplasty provides no improvement in component alignment.</ArticleTitle>
<Pagination>
<MedlinePgn>1705-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.arth.2014.04.025</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0883-5403(14)00283-6</ELocationID>
<Abstract>
<AbstractText>Improved component alignment in TKA remains a commonly cited benefit of MRI based patient-specific instrumentation (PSI). We hypothesized that PSI would lead to improved alignment versus traditional instrumentation (TI) during primary TKA. Fifty-eight knees (54 patients) that underwent TKA with PSI were compared to 62 knees that had previously undergone TKA with TI. Radiographs were evaluated for mechanical axis and alignment of the femoral and tibial components. Alignment was similar between the groups. However, the PSI group showed fewer knees in the target range for posterior tibial slope (PSI 38% vs. TI 61%, P=0.01) in addition to a trend for fewer knees in target range for femoral flexion (PSI 40% vs. TI 56%, P=0.07). This study demonstrated no improvement in overall alignment and perhaps a worsening of the tibial slope. </AbstractText>
<CopyrightInformation>Copyright  2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Stronach</LastName>
<ForeName>Benjamin M</ForeName>
<Initials>BM</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, University of Mississippi Medical Center, Jackson, Mississippi.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pelt</LastName>
<ForeName>Christopher E</ForeName>
<Initials>CE</Initials>
<AffiliationInfo>
<Affiliation>University of Utah, University Orthopaedic Center, Salt Lake City, Utah.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Erickson</LastName>
<ForeName>Jill A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>University of Utah, University Orthopaedic Center, Salt Lake City, Utah.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peters</LastName>
<ForeName>Christopher L</ForeName>
<Initials>CL</Initials>
<AffiliationInfo>
<Affiliation>University of Utah, University Orthopaedic Center, Salt Lake City, Utah.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>04</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Arthroplasty</MedlineTA>
<NlmUniqueID>8703515</NlmUniqueID>
<ISSNLinking>0883-5403</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019645">Arthroplasty, Replacement, Knee</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000592">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005269">Femur</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007719">Knee Joint</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007720">Knee Prosthesis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000592">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058996">Quality Improvement</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016059">Range of Motion, Articular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013977">Tibia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">MRI</Keyword>
<Keyword MajorTopicYN="N">femoral component alignment</Keyword>
<Keyword MajorTopicYN="N">patient-specific instrumentation</Keyword>
<Keyword MajorTopicYN="N">tibial component alignment</Keyword>
<Keyword MajorTopicYN="N">total knee arthroplasty</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24947083</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>15</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1878-0539</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>67</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS</Title>
<ISOAbbreviation>J Plast Reconstr Aesthet Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Characteristic features and natural evolution of Kienbck's disease: five years' results of a prospective case series and retrospective case series of 106 patients.</ArticleTitle>
<Pagination>
<MedlinePgn>1415-26</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjps.2014.05.037</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1748-6815(14)00279-4</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Scientific databases index numerous references related to the treatment of Kienbck's disease; yet little is known about the nature of the disease and its pathognomonic features. This study provides a cross-sectional analysis of the pattern and extent of osteonecrosis in a large cohort and a longitudinal analysis to determine the spontaneous disease progression in single patients who have not had surgical management until fragmentation of the lunate.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">In a prospective case series, the pattern and extent of osteonecrosis were correlated with the duration of symptoms in all patients with Kienbck's disease confirmed using high-resolution 3-T magnetic resonance imaging (MRI) and ultra-thin section computed tomographic (CT) scan since 2009. Furthermore, a retrospective consecutive case series study was conducted to determine the rate of spontaneous evolution in all consecutive patients treated conservatively in our university hospital since 1990.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 35 consecutive patients with Kienbck's disease diagnosed in high-resolution 3-T MRI and ultra-thin section CT, 46% (16/35) presented degeneration of lunate cartilage on CT scan in the first 12 months following the onset of symptoms. Median wrist pain duration of patients presenting a fracture of the lunate was 14 months. Thirty-one percent (11/35) of the patients had arthritis of the lunate, yet no fractures at the time of examination. Of 106 consecutive patients with Kienbck's disease and complete records, who did not have surgical intervention until fragmentation of the lunate, three cases were identified with well-documented spontaneous courses from apparently intact lunate morphology until fragmentation within 6 months.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Kienbck's disease progresses substantially faster than previously described and, contrary to current classifications, the articular cartilage of the lunate degenerates in early stages.</AbstractText>
<AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Diagnostic accuracy, Level IV.</AbstractText>
<CopyrightInformation>Copyright  2014 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Stahl</LastName>
<ForeName>Stphane</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Plastic, Hand and Reconstructive Surgery, Burn Center, BG-Trauma Center, Eberhard-Karl University of Tbingen, Schnarrenbergstr. 95, 72076 Tbingen, Germany. Electronic address: sstahl@bgu-tuebingen.de.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hentschel</LastName>
<ForeName>Pascal J H</ForeName>
<Initials>PJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Plastic, Hand and Reconstructive Surgery, Burn Center, BG-Trauma Center, Eberhard-Karl University of Tbingen, Schnarrenbergstr. 95, 72076 Tbingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Held</LastName>
<ForeName>Manuel</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Plastic, Hand and Reconstructive Surgery, Burn Center, BG-Trauma Center, Eberhard-Karl University of Tbingen, Schnarrenbergstr. 95, 72076 Tbingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Manoli</LastName>
<ForeName>Theodora</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Plastic, Hand and Reconstructive Surgery, Burn Center, BG-Trauma Center, Eberhard-Karl University of Tbingen, Schnarrenbergstr. 95, 72076 Tbingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Meisner</LastName>
<ForeName>Christoph</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Institute for Clinical Epidemiology and Applied Biometry, Eberhard-Karls-University Tbingen, Silcherstr. 5, 72076 Tbingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schaller</LastName>
<ForeName>Hans-Eberhard</ForeName>
<Initials>HE</Initials>
<AffiliationInfo>
<Affiliation>Department of Plastic, Hand and Reconstructive Surgery, Burn Center, BG-Trauma Center, Eberhard-Karl University of Tbingen, Schnarrenbergstr. 95, 72076 Tbingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Santos Stahl</LastName>
<ForeName>Adelana</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department for Plastic Surgery, Marienhospital Stuttgart, Bheimstr. 37, 70199 Stuttgart, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>J Plast Reconstr Aesthet Surg</MedlineTA>
<NlmUniqueID>101264239</NlmUniqueID>
<ISSNLinking>1748-6815</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003430">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010020">Osteonecrosis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Etiopathogenesis</Keyword>
<Keyword MajorTopicYN="N">Kienbcks disease</Keyword>
<Keyword MajorTopicYN="N">Lunate necrosis</Keyword>
<Keyword MajorTopicYN="N">Natural evolution</Keyword>
<Keyword MajorTopicYN="N">Spontaneous evolution</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25223111</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>09</Month>
<Day>23</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0301-0066</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>43</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Perception</Title>
<ISOAbbreviation>Perception</ISOAbbreviation>
</Journal>
<ArticleTitle>Contrast response functions with wide-view stimuli in the human visual cortex.</ArticleTitle>
<Pagination>
<MedlinePgn>677-93</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In this manuscript, using a novel wide-view visual presentation system that we developed for vision research and functional magnetic resonance imaging (fMRI), we studied contrast response functions in regions of the brain that are central and peripheral to the entire set of visual areas (V1, V2, V3, V3A, MT+), regions that have not been all investigated in previous vision research. Under the stimulus conditions which were 0-20 deg, 20-40 deg, and 40-60 deg eccentricity black-and-white checkerboard patterns, we measured the blood oxygenation level-dependent fMRI contrast response at five contrast levels (6, 12, 24, 48, and 96%) in the visual areas. On the basis of these data, the central and pericentral visual areas had low-contrast gain, whereas the peripheral visual areas had high-contrast gain. In addition, our results showed that the signals fundamentally shift during visual processing through posterior visual cortical areas (V1, V2, and V3) to superior visual cortical areas (V3A and MT+).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yan</LastName>
<ForeName>Tianyi</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Bin</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Geng</LastName>
<ForeName>Yansong</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yan</LastName>
<ForeName>Yaqi</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mu</LastName>
<ForeName>Nan</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Jinglong</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Guo</LastName>
<ForeName>Qiyong</ForeName>
<Initials>Q</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tang</LastName>
<ForeName>Xiaoying</ForeName>
<Initials>X</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zeng</LastName>
<ForeName>Yanjun</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Peng</LastName>
<ForeName>Yuhua</ForeName>
<Initials>Y</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Perception</MedlineTA>
<NlmUniqueID>0372307</NlmUniqueID>
<ISSNLinking>0301-0066</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001931">Brain Mapping</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000295">instrumentation</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015350">Contrast Sensitivity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009039">Motion Perception</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010364">Pattern Recognition, Visual</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015349">Vision, Monocular</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014793">Visual Cortex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014794">Visual Fields</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014796">Visual Perception</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25040567</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1365-2141</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>167</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>British journal of haematology</Title>
<ISOAbbreviation>Br. J. Haematol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Bilateral renal infiltration as the initial presentation of multiple myeloma.</ArticleTitle>
<Pagination>
<MedlinePgn>2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/bjh.13022</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kubota</LastName>
<ForeName>Yasushi</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Division of Haematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan; Department of Transfusion Medicine, Saga University Hospital, Saga, Japan. kubotay@cc.saga-u.ac.jp.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Matsuzaki</LastName>
<ForeName>Miwako</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kimura</LastName>
<ForeName>Shinya</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Br J Haematol</MedlineTA>
<NlmUniqueID>0372544</NlmUniqueID>
<ISSNLinking>0007-1048</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0Z5B2CJX4D</RegistryNumber>
<NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001706">Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001853">Bone Marrow</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019788">Fluorodeoxyglucose F18</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007668">Kidney</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009101">Multiple Myeloma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25223773</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1524-4539</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>130</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>16</Day>
</PubDate>
</JournalIssue>
<Title>Circulation</Title>
<ISOAbbreviation>Circulation</ISOAbbreviation>
</Journal>
<ArticleTitle>Multimodality imaging of hypertrophic cardiomyopathy in a transplanted heart.</ArticleTitle>
<Pagination>
<MedlinePgn>1010-3</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCULATIONAHA.114.010802</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Abbasi</LastName>
<ForeName>Siddique A</ForeName>
<Initials>SA</Initials>
<AffiliationInfo>
<Affiliation>From the Noninvasive Cardiovascular Imaging Section, Cardiovascular Division, Departments of Medicine and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.A.A., M.K.C., N.G., M.F.D.C.); and Division of Cardiovascular Medicine, Center for Advanced Heart Disease, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (G.C.S.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cheezum</LastName>
<ForeName>Michael K</ForeName>
<Initials>MK</Initials>
<AffiliationInfo>
<Affiliation>From the Noninvasive Cardiovascular Imaging Section, Cardiovascular Division, Departments of Medicine and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.A.A., M.K.C., N.G., M.F.D.C.); and Division of Cardiovascular Medicine, Center for Advanced Heart Disease, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (G.C.S.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ghosh</LastName>
<ForeName>Nina</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>From the Noninvasive Cardiovascular Imaging Section, Cardiovascular Division, Departments of Medicine and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.A.A., M.K.C., N.G., M.F.D.C.); and Division of Cardiovascular Medicine, Center for Advanced Heart Disease, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (G.C.S.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stewart</LastName>
<ForeName>Garrick C</ForeName>
<Initials>GC</Initials>
<AffiliationInfo>
<Affiliation>From the Noninvasive Cardiovascular Imaging Section, Cardiovascular Division, Departments of Medicine and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.A.A., M.K.C., N.G., M.F.D.C.); and Division of Cardiovascular Medicine, Center for Advanced Heart Disease, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (G.C.S.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Di Carli</LastName>
<ForeName>Marcelo F</ForeName>
<Initials>MF</Initials>
<AffiliationInfo>
<Affiliation>From the Noninvasive Cardiovascular Imaging Section, Cardiovascular Division, Departments of Medicine and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.A.A., M.K.C., N.G., M.F.D.C.); and Division of Cardiovascular Medicine, Center for Advanced Heart Disease, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (G.C.S.). mdicarli@partners.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Circulation</MedlineTA>
<NlmUniqueID>0147763</NlmUniqueID>
<ISSNLinking>0009-7322</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002312">Cardiomyopathy, Hypertrophic</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004562">Electrocardiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016027">Heart Transplantation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D064847">Multimodal Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24965103</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1528-1167</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>55</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Epilepsia</Title>
<ISOAbbreviation>Epilepsia</ISOAbbreviation>
</Journal>
<ArticleTitle>Automated versus manual hippocampal segmentation in preoperative and postoperative patients with epilepsy.</ArticleTitle>
<Pagination>
<MedlinePgn>1374-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/epi.12694</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare manual and automated preoperative and postoperative hippocampal volume measurements in patients with intractable epilepsy.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We studied 34 patients referred to the Clinical Epilepsy Section, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH) for evaluation of intractable epilepsy and 21 normal volunteers who received 1.5 or 3 T GE Signa magnetic resonance imaging (MRI) scans. Hippocampal volumes were traced manually on each slice and assembled into three-dimensional volumes by investigators who were blinded to other data. Automated volumetric measurements were obtained using FreeSurfer. Statistical analysis was performed with GraphPad Prism.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Automated hippocampal volumes were larger than manual volumes in both patients and normal volunteers (p &lt; 0.05). Right to left hemisphere hippocampal ratio and percent of hippocampus resected did not differ significantly by segmentation method. It was not possible to obtain accurate total resection volumes with the automated method.</AbstractText>
<AbstractText Label="SIGNIFICANCE" NlmCategory="CONCLUSIONS">Values such as side-to-side ratio and percent resected may be more directly translatable between manual and automated methods than absolute measures of volume. Accurate determination of resection volumes is important for studies of the effects of surgery on both seizure control and postoperative neuropsychological deficits. Our preliminary data suggest that FreeSurfer may provide an accurate and simple method for quantitating hippocampal resections. However, it may be less valuable for large or extratemporal resections, or when distortions of normal anatomy are present. A PowerPoint slide summarizing this article is available for download in the Supporting Information section here.</AbstractText>
<CopyrightInformation>Published 2014. This article is a U.S. Government work and is in the public domain in the USA.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Germeyan</LastName>
<ForeName>Sierra C</ForeName>
<Initials>SC</Initials>
<AffiliationInfo>
<Affiliation>Clinical Epilepsy Section, NINDS, NIH, Bethesda, Maryland, U.S.A.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kalikhman</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jones</LastName>
<ForeName>Lucy</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Theodore</LastName>
<ForeName>William H</ForeName>
<Initials>WH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>ZIA NS002236-38</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Epilepsia</MedlineTA>
<NlmUniqueID>2983306R</NlmUniqueID>
<ISSNLinking>0013-9580</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000704">Analysis of Variance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004827">Epilepsy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007839">Functional Laterality</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006624">Hippocampus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011184">Postoperative Period</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS598969 [Available on 09/01/15]</OtherID>
<OtherID Source="NLM">PMC4167188 [Available on 09/01/15]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Epilepsy</Keyword>
<Keyword MajorTopicYN="N">Hippocampus</Keyword>
<Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword>
<Keyword MajorTopicYN="N">Segmentation</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25052858</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1528-1167</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>55</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Epilepsia</Title>
<ISOAbbreviation>Epilepsia</ISOAbbreviation>
</Journal>
<ArticleTitle>The variable phenotypes of KCNQ-related epilepsy.</ArticleTitle>
<Pagination>
<MedlinePgn>e99-105</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/epi.12715</ELocationID>
<Abstract>
<AbstractText>Mutations in KCNQ2 and KCNQ3 were originally described in infants with benign familial neonatal seizures (BFNS). Recently, KCNQ2 mutations have also been shown to cause epileptic encephalopathy. This report describes three infants carrying abnormalities of KCNQ2 and one infant with a KCNQ3 mutation. The different KCNQ2 abnormalities led to different phenotypes and included a novel intragenic duplication, c.419_430dup, in an infant with BFNS, a 0.761Mb 20q13.3 contiguous gene deletion in an infant with seizures at 3 months, and a recurrent de novo missense mutation c.881C&gt;T in a neonate with "KCNQ2-encephalopathy." The mutation in KCNQ3, c.989G&gt;A, was novel and occurred in an infant with BFNS. KCNQ-related seizures often present with tonic/clonic manifestations, cyanosis, or apnea. Certain genotype-phenotype correlations help predict outcome. Similarly affected family members suggests benign familial "KCNQ-related" epilepsy, whereas neonatal seizures with unexplained multifocal epileptiform discharges or burst suppression on electroencephalography, and acute abnormalities of the basal ganglia/thalami are suggestive of KCNQ2-encephalopathy, which is often sporadic. 20q13.33 contiguous gene deletion encompassing KCNQ2 may harbor atypical features depending on deletion size. Although the phenotype often guides direct targeted gene testing in these conditions, array CGH should also be considered in suspected sporadic or atypical familial cases to diagnose 20q13.33 deletion.</AbstractText>
<CopyrightInformation>Wiley Periodicals, Inc.  2014 International League Against Epilepsy.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Allen</LastName>
<ForeName>Nicholas M</ForeName>
<Initials>NM</Initials>
<AffiliationInfo>
<Affiliation>Department of Paediatric Neurology &amp; Clinical Neurophysiology, Children's University Hospital, Dublin, Ireland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mannion</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Conroy</LastName>
<ForeName>Judith</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lynch</LastName>
<ForeName>Sally A</ForeName>
<Initials>SA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shahwan</LastName>
<ForeName>Amre</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lynch</LastName>
<ForeName>Bryan</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>King</LastName>
<ForeName>Mary D</ForeName>
<Initials>MD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Epilepsia</MedlineTA>
<NlmUniqueID>2983306R</NlmUniqueID>
<ISSNLinking>0013-9580</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051656">KCNQ Potassium Channels</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C536797">Chromosome 22, microdeletion 22 q11</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001479">Basal Ganglia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002872">Chromosome Deletion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002892">Chromosomes, Human, Pair 22</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004827">Epilepsy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056726">Genetic Association Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007231">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051656">KCNQ Potassium Channels</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009154">Mutation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010641">Phenotype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013788">Thalamus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Array CGH</Keyword>
<Keyword MajorTopicYN="N">CHRNA4</Keyword>
<Keyword MajorTopicYN="N">Encephalopathy</Keyword>
<Keyword MajorTopicYN="N">Epilepsy</Keyword>
<Keyword MajorTopicYN="N">KCNQ2</Keyword>
<Keyword MajorTopicYN="N">KCNQ3</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25060924</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1528-1167</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>55</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Epilepsia</Title>
<ISOAbbreviation>Epilepsia</ISOAbbreviation>
</Journal>
<ArticleTitle>Improved mapping of interictal epileptiform discharges with EEG-fMRI and voxel-wise functional connectivity analysis.</ArticleTitle>
<Pagination>
<MedlinePgn>1380-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/epi.12733</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We describe a novel method to spatially map interictal epileptiform discharges (IEDs) through voxel-wise functional connectivity analysis of the functional magnetic resonance imaging (fMRI) portion of simultaneous electroencephalography (EEG)-fMRI data. This method measures the local synchronicity of fMRI signals associated with IED and, in contrast to conventional methods, does not require modeling of neural activities or hemodynamic response.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Simultaneous EEG-fMRI was performed on six patients with focal epilepsy. IED events were detected from the EEG data. The fMRI data was subdivided into time segments of 20 s in length, and then reorganized into one set of concatenated time series containing the IED events and many sets without IEDs. Local degree centrality (LDC), a metric of functional connectivity, was computed for each brain voxel to summarize its signal correlations to brain voxels within 14 mm of physical distance. This computation was repeated for each set of concatenated time series, yielding one whole-brain LDC map for time with the IED events and many maps for time without IED. A statistical score was computed for each voxel to detect the voxels with significant LDC value differences associated with IEDs. The fMRI data were also processed separately by conventional methods for comparison.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In all six patients, regions with significant LDC increase during IEDs were concordant in location to both simultaneous EEG and the epileptogenic focus determined from separate clinical studies. In contrast, results from the conventional methods were concordant in only three patients.</AbstractText>
<AbstractText Label="SIGNIFICANCE" NlmCategory="CONCLUSIONS">We show that for focal epilepsy, voxel-wise functional connectivity analysis of EEG-fMRI data may improve IED localization and EEG concordance compared to the conventional analysis. This new analytic method may improve the robustness of interictal EEG-fMRI as a technique for mapping the epileptogenic focus, and helps study the local synchronization aspect of the epileptic network.</AbstractText>
<CopyrightInformation>Wiley Periodicals, Inc.  2014 International League Against Epilepsy.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Junjie V</ForeName>
<Initials>JV</Initials>
<AffiliationInfo>
<Affiliation>M.D. Class of 2015, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, U.S.A.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kobylarz</LastName>
<ForeName>Erik J</ForeName>
<Initials>EJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Darcey</LastName>
<ForeName>Terrance M</ForeName>
<Initials>TM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lu</LastName>
<ForeName>Zhengang</ForeName>
<Initials>Z</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Yu-Chien</ForeName>
<Initials>YC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Meng</LastName>
<ForeName>Ming</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jobst</LastName>
<ForeName>Barbara C</ForeName>
<Initials>BC</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Epilepsia</MedlineTA>
<NlmUniqueID>2983306R</NlmUniqueID>
<ISSNLinking>0013-9580</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>S88TT14065</RegistryNumber>
<NameOfSubstance UI="D010100">Oxygen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000098">blood supply</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001931">Brain Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058256">Brain Waves</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004827">Epilepsy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016014">Linear Models</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010100">Oxygen</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Dynamic connectivity changes</Keyword>
<Keyword MajorTopicYN="N">Local synchronicity</Keyword>
<Keyword MajorTopicYN="N">Network centrality</Keyword>
<Keyword MajorTopicYN="N">Resting-state functional MRI</Keyword>
<Keyword MajorTopicYN="N">Whole-brain mapping</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25092547</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1528-1167</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>55</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Epilepsia</Title>
<ISOAbbreviation>Epilepsia</ISOAbbreviation>
</Journal>
<ArticleTitle>Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after.</ArticleTitle>
<Pagination>
<MedlinePgn>1452-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/epi.12739</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Neurocysticercosis (NCC) is a major cause of seizures and epilepsy in endemic countries. Antiparasitic treatment of brain cysts leads to seizures due to the host's inflammatory reaction, requiring concomitant steroids. We hypothesized that increased steroid dosing will reduce treatment-associated seizures.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Open-label randomized trial comparing 6 mg/day dexamethasone for 10 days (conventional) with 8 mg/day for 28 days followed by a 2-week taper (enhanced) in patients with NCC receiving albendazole. Follow-up included active seizure surveillance and brain imaging. Study outcomes were seizure days and patients with seizures, both measured in days 11-42. Additional analyses compared days 1-10, 11-21, 22-32, 33-42, 43-60, and 61-180.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-two individuals were randomized into each study arm; two did not complete follow-up. From days 11 to 42, 59 partial and 6 generalized seizure days occurred in 20 individuals, nonsignificantly fewer in the enhanced arm (12 vs. 49, p = 0.114). The numbers of patients with seizures in this period showed similar nonsignificant differences. In the enhanced steroid arm there were significantly fewer days and individuals with seizures during antiparasitic treatment (days 1-10: 4 vs. 17, p = 0.004, and 1 vs. 10, p = 0.003, number needed to treat [NNT] 4.6, relative risk [RR] 0.1013, 95% confidence interval [CI] 0.01-0.74) and early after dexamethasone cessation (days 11-21: 6 vs. 27, p = 0.014, and 4 vs. 12, p = 0.021, NNT 4.0, RR 0.33, 95% CI 0.12-0.92) but not after day 21. There were no significant differences in antiparasitic efficacy or relevant adverse events.</AbstractText>
<AbstractText Label="SIGNIFICANCE" NlmCategory="CONCLUSIONS">Increased dexamethasone dosing results in fewer seizures for the first 21 days during and early after antiparasitic treatment for viable parenchymal NCC but not during the first 11-42 days, which was the primary predetermined time of analysis.</AbstractText>
<CopyrightInformation>Wiley Periodicals, Inc.  2014 International League Against Epilepsy.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Garcia</LastName>
<ForeName>Hector H</ForeName>
<Initials>HH</Initials>
<AffiliationInfo>
<Affiliation>Cysticercosis Unit, National Institute of Neurological Sciences, Lima, Peru; Department of Microbiology, School of Sciences, Cayetano Heredia Peruvian University, Lima, Peru; Center for Global Health - Tumbes, Cayetano Heredia Peruvian University, Lima, Peru; School of Public Health, Cayetano Heredia Peruvian University, Lima, Peru.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gonzales</LastName>
<ForeName>Isidro</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lescano</LastName>
<ForeName>Andres G</ForeName>
<Initials>AG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bustos</LastName>
<ForeName>Javier A</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pretell</LastName>
<ForeName>E Javier</ForeName>
<Initials>EJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Saavedra</LastName>
<ForeName>Herbert</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nash</LastName>
<ForeName>Theodore E</ForeName>
<Initials>TE</Initials>
</Author>
<Author ValidYN="Y">
<CollectiveName>Cysticercosis Working Group in Peru</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>D43 TW001140</GrantID>
<Acronym>TW</Acronym>
<Agency>FIC NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>D43 TW001140</GrantID>
<Acronym>TW</Acronym>
<Agency>FIC NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>D43 TW007393</GrantID>
<Acronym>TW</Acronym>
<Agency>FIC NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>D43 TW007393</GrantID>
<Acronym>TW</Acronym>
<Agency>FIC NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 NS054805</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Epilepsia</MedlineTA>
<NlmUniqueID>2983306R</NlmUniqueID>
<ISSNLinking>0013-9580</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000977">Antiparasitic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7S5I7G3JQL</RegistryNumber>
<NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000977">Antiparasitic Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003551">Cysticercosis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003907">Dexamethasone</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012640">Seizures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS609539 [Available on 09/01/15]</OtherID>
<OtherID Source="NLM">PMC4167469 [Available on 09/01/15]</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cestodes</Keyword>
<Keyword MajorTopicYN="N">Cysticercosis</Keyword>
<Keyword MajorTopicYN="N">Epilepsy</Keyword>
<Keyword MajorTopicYN="N">Neurocysticercosis</Keyword>
<Keyword MajorTopicYN="N">Peru</Keyword>
<Keyword MajorTopicYN="N">Seizures</Keyword>
<Keyword MajorTopicYN="N">Taenia solium</Keyword>
</KeywordList>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Martinez</LastName>
<ForeName>Manuel</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Alvarado</LastName>
<ForeName>Manuel</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Porras</LastName>
<ForeName>Miguel</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cjuno</LastName>
<ForeName>Alfredo</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vargas</LastName>
<ForeName>Victor</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Escalante</LastName>
<ForeName>Diego</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vera</LastName>
<ForeName>Monica</ForeName>
<Initials>M</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24678957</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>24</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1093-5266</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society</Title>
<ISOAbbreviation>Pediatr. Dev. Pathol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Meningioangiomatosis in a second trimester fetus.</ArticleTitle>
<Pagination>
<MedlinePgn>292-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2350/13-08-1366-CR.1</ELocationID>
<Abstract>
<AbstractText>We describe to our knowledge the first case of meningioangiomatosis identified in a second trimester fetus. A 30-year-old pregnant woman was attended at our hospital for a second-trimester ultrasound screening scan. With a diagnosis of partial agenesis of the corpus callosum, the parents requested termination of the pregnancy. At autopsy, frontal serial sections of the fetal brain disclosed a short corpus callosum that lacked the posterior splenium, confirming the sonographic diagnosis. At close inspection, a slight bilateral hardening of both medial aspects of the frontal lobes and anterior genu of the corpus callosum was found associated with meningeal adhesion between both frontal lobes. Microscopically, cerebral cortex and corpus callosum were permeated by intersecting bundles of spindle cells with eosinophilic cytoplasm and bland, round nuclei, with a fibroblast or meningothelial-like appearance surrounding abundant blood vessels, consistent with the diagnosis of meningioangiomatosis. According to this finding, meningioangiomatosis must be included in the differential diagnosis of meningocortical fetal lesions.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hakim</LastName>
<ForeName>Sofia</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>1 Anatomia Patolgica, Hospital Clnic, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sanz-Cortes</LastName>
<ForeName>Magda</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Puerto</LastName>
<ForeName>Bienvenido</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ribalta</LastName>
<ForeName>Teresa</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nadal</LastName>
<ForeName>Alfons</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>03</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Pediatr Dev Pathol</MedlineTA>
<NlmUniqueID>9809673</NlmUniqueID>
<ISSNLinking>1093-5266</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000028">Abortion, Induced</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D061085">Agenesis of Corpus Callosum</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000736">ultrasonography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000798">Angiomatosis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001344">Autopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008577">Meningeal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008579">Meningioma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011252">Pregnancy Complications, Neoplastic</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011262">Pregnancy Trimester, Second</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016216">Ultrasonography, Prenatal</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">autopsy</Keyword>
<Keyword MajorTopicYN="N">fetus</Keyword>
<Keyword MajorTopicYN="N">immunohistochemistry</Keyword>
<Keyword MajorTopicYN="N">meningeal neoplasms</Keyword>
<Keyword MajorTopicYN="N">prenatal ultrasonography</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24735155</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>24</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1093-5266</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society</Title>
<ISOAbbreviation>Pediatr. Dev. Pathol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Clear cell sarcoma of the kidney in a child with Fanconi anemia.</ArticleTitle>
<Pagination>
<MedlinePgn>297-301</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2350/14-03-1450-CR.1</ELocationID>
<Abstract>
<AbstractText>Patients with Fanconi anemia subgroup D1, attributable to biallelic mutations in BRCA2, have an increased risk of solid tumors. Tumors in the kidneys of these patients are almost exclusively Wilms tumor. We report the first recorded case, to our knowledge, of a Clear Cell Sarcoma of the Kidney in a patient with this cancer predisposition syndrome. We review different aspects of the need for careful clinical observation in patients of this complementation group, given their risk for malignancy.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Trejo Bittar</LastName>
<ForeName>Humberto E</ForeName>
<Initials>HE</Initials>
<AffiliationInfo>
<Affiliation>1 Division of Pediatric Pathology, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Radder</LastName>
<ForeName>Josiah E</ForeName>
<Initials>JE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ranganathan</LastName>
<ForeName>Sarangarajan</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Srinivasan</LastName>
<ForeName>Abhay</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Madan-Khetarpal</LastName>
<ForeName>Suneeta</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reyes-Mgica</LastName>
<ForeName>Miguel</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>04</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Pediatr Dev Pathol</MedlineTA>
<NlmUniqueID>9809673</NlmUniqueID>
<ISSNLinking>1093-5266</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001706">Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017024">Chemotherapy, Adjuvant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005199">Fanconi Anemia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017809">Fatal Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007680">Kidney Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009364">Neoplasm Recurrence, Local</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009392">Nephrectomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018227">Sarcoma, Clear Cell</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017211">Treatment Failure</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">CCSK</Keyword>
<Keyword MajorTopicYN="N">Clear Cell Sarcoma of Kidney</Keyword>
<Keyword MajorTopicYN="N">Fanconi anemia</Keyword>
<Keyword MajorTopicYN="N">cancer predisposition</Keyword>
<Keyword MajorTopicYN="N">pediatric renal cancer</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24834886</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1532-3145</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>38</Volume>
<Issue>5</Issue>
<PubDate>
<MedlineDate>2014 Sep-Oct</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of computer assisted tomography</Title>
<ISOAbbreviation>J Comput Assist Tomogr</ISOAbbreviation>
</Journal>
<ArticleTitle>Quantitative magnetic resonance imaging analysis of the lacrimal gland in sickle cell disease.</ArticleTitle>
<Pagination>
<MedlinePgn>674-80</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/RCT.0000000000000104</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Clinical manifestations of sickle cell disease (SCD) can affect the orbit with prior reports describing changes in the lacrimal gland potentially related to chronic vaso-occlusion. The purpose of this study was to evaluate lacrimal gland volumes and quantifiable shifts in MR-relaxation times in patients with SCD.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Thirteen patients with SCD and 12 age-matched control subjects underwent magnetic resonance imaging (MRI) of the orbits with 1.5-T MRI. Lacrimal glands were segmented manually; and gland volumes, peak, and mean T1- and T2-relaxation times were obtained from histogram analysis.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In patients with SCD, significant peak and mean T2 shortening (P &lt; 0.001 and P &lt; 0.001) and increased gland volume (P = 0.008) were observed. Significant correlations were seen between gland volumes in the patients SCD and peak T1 and T2 values (r = 0.6, P = 0.017; r = 0.56; P = 0.031) as well as between gland volumes and mean T1 and T2 values (r = 0.54, P = 0.039; r = 0.57, P = 0.026).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Significant differences in MR relaxometry and lacrimal gland enlargement provide evidence of subclinical lacrimal gland pathology and chronic lacrimal gland changes patients with SCD.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Buch</LastName>
<ForeName>Karen</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>From the *Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, Boston University School of Medicine, Boston, MA, Department of Medicine, and Department of Otolaryngology - Head and Neck Surgery, Boston Medical Center, Boston University School of Medicine, Boston, MA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Watanabe</LastName>
<ForeName>Memi</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Elias</LastName>
<ForeName>Elliott J</ForeName>
<Initials>EJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Liao</LastName>
<ForeName>Joseph H</ForeName>
<Initials>JH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jara</LastName>
<ForeName>Hernan</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nadgir</LastName>
<ForeName>Rohini N</ForeName>
<Initials>RN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Saito</LastName>
<ForeName>Naoko</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Steinberg</LastName>
<ForeName>Martin H</ForeName>
<Initials>MH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sakai</LastName>
<ForeName>Osamu</ForeName>
<Initials>O</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D018848">Controlled Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Comput Assist Tomogr</MedlineTA>
<NlmUniqueID>7703942</NlmUniqueID>
<ISSNLinking>0363-8715</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000755">Anemia, Sickle Cell</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007765">Lacrimal Apparatus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007766">Lacrimal Apparatus Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24834891</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1532-3145</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>38</Volume>
<Issue>5</Issue>
<PubDate>
<MedlineDate>2014 Sep-Oct</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of computer assisted tomography</Title>
<ISOAbbreviation>J Comput Assist Tomogr</ISOAbbreviation>
</Journal>
<ArticleTitle>Imaging features and metastatic pattern of non-IVC retroperitoneal leiomyosarcomas: are they different from IVC leiomyosarcomas?</ArticleTitle>
<Pagination>
<MedlinePgn>687-92</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/RCT.0000000000000097</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The purposes of this study were to describe the imaging features and metastatic pattern of non-inferior vena cava (IVC) retroperitoneal leiomyosarcomas (non-IVC LMS) and to compare them with those of IVC leiomyosarcomas (IVC LMS) to assess any differences between the 2 groups.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">In this institutional review board-approved, Health Insurance Portability and Accountability Act-compliant retrospective study, all 56 patients with pathologically confirmed primary retroperitoneal leiomyosarcoma (34 non-IVC LMS and 22 IVC LMS) seen at our tertiary cancer center during a 10-year period were included. All available imaging of primary tumor (18 non-IVC LMS and 19 IVC LMS) and follow-up imaging studies (on all 56 patients) were reviewed in consensus by 2 fellowship-trained oncoradiologists. Imaging features and metastatic spread of non-IVC LMS were described and compared with those of IVC LMS. Continuous variables were compared using the Student t test, binary variables with the Fisher exact test, and survival using the log-rank test.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Non-inferior vena cava retroperitoneal leiomyosarcomas had a mean size of 11.3 cm (range, 3.7-27 cm) and most commonly occurred in the perirenal space (16/18). Primary tumors were hyperattenuating to muscle (11/18) and showed heterogeneous enhancement (17/18). Lungs (22/34), peritoneum (18/34), and liver (18/34) were the most common metastatic sites. There was no significant difference between the imaging features and metastatic pattern of non-IVC and IVC LMS. Although non-IVC LMS presented at a more advanced stage (P &lt; 0.002), there was statistically non-significant trend toward better median survival of non-IVC LMS (P = 0.07).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Non-inferior vena cava retroperitoneal leiomyosarcomas are large heterogeneous tumors arising in the perirenal space and frequently metastasize to lungs, peritoneum, and liver. From a radiologist's perspective, non-IVC LMS behave similar to IVC-LMS.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cooley</LastName>
<ForeName>Christine L</ForeName>
<Initials>CL</Initials>
<AffiliationInfo>
<Affiliation>From the *Department of Imaging, Dana-Farber Cancer Institute, and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jagannathan</LastName>
<ForeName>Jyothi P</ForeName>
<Initials>JP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kurra</LastName>
<ForeName>Vikram</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tirumani</LastName>
<ForeName>Sree Harsha</ForeName>
<Initials>SH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Saboo</LastName>
<ForeName>Sachin S</ForeName>
<Initials>SS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ramaiya</LastName>
<ForeName>Nikhil H</ForeName>
<Initials>NH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shinagare</LastName>
<ForeName>Atul B</ForeName>
<Initials>AB</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Comput Assist Tomogr</MedlineTA>
<NlmUniqueID>7703942</NlmUniqueID>
<ISSNLinking>0363-8715</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007890">Leiomyosarcoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000556">secondary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012186">Retroperitoneal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019043">Vascular Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014682">Vena Cava, Inferior</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000530">radiography</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24943251</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1532-3145</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>38</Volume>
<Issue>5</Issue>
<PubDate>
<MedlineDate>2014 Sep-Oct</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Journal of computer assisted tomography</Title>
<ISOAbbreviation>J Comput Assist Tomogr</ISOAbbreviation>
</Journal>
<ArticleTitle>Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of pancreatic ductal adenocarcinoma from other pancreatic solid lesions.</ArticleTitle>
<Pagination>
<MedlinePgn>681-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/RCT.0000000000000120</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The purpose of this study was to investigate the diagnostic value of quantitative dynamic contrast-enhanced magnetic resonance imaging (QDCE-MRI) of pancreatic ductal adenocarcinoma (PDA) on a 3.0-T magnetic resonance.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The study was approved by the local institutional review board, and all subjects provided written informed consent. Seventy-five patients with suspected pancreatic tumors underwent QDCE-MRI, in which 33 patients with cases of pancreatic solid lesions (23 patients with PDA, 3 patients with solid pseudopapillary tumor, 3 patients with neuroendocrine tumor, 2 patients with mass-forming pancreatitis, 2 patients with ampullary adenocarcinoma) proven through histopathologic diagnosis were included in this study. The parameters of QDCE-MRI were recorded and compared.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The parameters of QDCE-MRI of PDA tissue and non-cancer tissue did not show significant difference between 2-compartment model (2C) and 3-compartment model (3C). The contrast enhancement ratio of non-cancer tissue with dilatation of pancreatic duct was significantly higher than that of non-cancer tissue without dilatation of pancreatic duct, whereas the rate constant (Kep) of 2C was significantly lower. The maximun slope of signal intensity ascent (MxSIp), the volume transfer constant (Ktrans), and the Kep of PDA tissue were significantly lower than those of the non-cancer tissue, but the time of peaking of contrast agent (PeakT) was significantly longer. Receiver operating characteristic curves showed that the areas under the curve of differentiating PDA tissue from the non-cancer tissue were 0.82, 0.79, 0.91, 0.94, 0.88, and 0.89 for PeakT, MxSIp, Ktrans-2C, Kep-2C, Ktrans-3C, and Kep-3C, respectively. The PDA tissue showed lower MxSIp and Kep as well as longer PeakT than those of the non-PDA lesions. The receiver operating characteristic curves showed that the areas under the curve of differentiating the PDA from the non-PDA tumor were 0.73, 0.72, 0.79, and 0.72 for PeakT, MxSIp, Kep-2C, and Kep-3C, respectively</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The parameters of QDCE-MRI are useful for the diagnosis of PDA.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Kefu</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>From the *Department of Radiology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai; and Department of Radiology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Xie</LastName>
<ForeName>Ping</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Peng</LastName>
<ForeName>Weijun</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Zhengrong</ForeName>
<Initials>Z</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Comput Assist Tomogr</MedlineTA>
<NlmUniqueID>7703942</NlmUniqueID>
<ISSNLinking>0363-8715</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>K2I13DR72L</RegistryNumber>
<NameOfSubstance UI="D019786">Gadolinium DTPA</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000230">Adenocarcinoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021441">Carcinoma, Pancreatic Ductal</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003287">Contrast Media</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019786">Gadolinium DTPA</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010190">Pancreatic Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25228571</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1661-8157</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>103</Volume>
<Issue>19</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>17</Day>
</PubDate>
</JournalIssue>
<Title>Praxis</Title>
<ISOAbbreviation>Praxis (Bern 1994)</ISOAbbreviation>
</Journal>
<ArticleTitle>[Acute spondylodiscitis].</ArticleTitle>
<Pagination>
<MedlinePgn>1103-13</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1024/1661-8157/a001767</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Flckiger</LastName>
<ForeName>Miriam</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Klinik und Poliklinik fr Innere Medizin, Universittsspital Zrich.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Andreisek</LastName>
<ForeName>Gustav</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Institut fr Diagnostische und Interventionelle Radiologie, Universittsspital Zrich.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hasse</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Klinik fr Infektionskrankheiten und Spitalhygiene, Universittsspital Zrich.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Akute Spondylodiszitis.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Praxis (Bern 1994)</MedlineTA>
<NlmUniqueID>101468093</NlmUniqueID>
<ISSNLinking>1661-8157</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-41-4</RegistryNumber>
<NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000900">Anti-Bacterial Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001424">Bacterial Infections</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002097">C-Reactive Protein</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003287">Contrast Media</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003299">Cooperative Behavior</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015299">Discitis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018450">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D061705">Image-Guided Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D033183">Interdisciplinary Communication</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008159">Lumbar Vertebrae</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008826">Microbial Sensitivity Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009460">Neurologic Examination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013203">Staphylococcal Infections</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25232074</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>18</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1535-1386</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>96</Volume>
<Issue>18</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>17</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of bone and joint surgery. American volume</Title>
<ISOAbbreviation>J Bone Joint Surg Am</ISOAbbreviation>
</Journal>
<ArticleTitle>Tendon repair compared with physiotherapy in the treatment of rotator cuff tears: a randomized controlled study in 103 cases with a five-year follow-up.</ArticleTitle>
<Pagination>
<MedlinePgn>1504-14</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2106/JBJS.M.01393</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is limited Level-I evidence that compares operative and nonoperative treatment of rotator cuff tears. We compared outcomes of patients treated with primary tendon repair with outcomes of those treated with physiotherapy and optional secondary tendon repair if needed.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A single-center, pragmatic, randomized controlled study with follow-ups after six months and one, two, and five years was conducted in a secondary-care institution. One hundred and three patients with a rotator cuff tear not exceeding 3 cm were randomized to primary tendon repair (n = 52) or physiotherapy (n = 51). The primary outcome measure was the Constant score. Secondary outcome measures included the self-report section of the American Shoulder and Elbow Surgeons score; the physical component summary measure of the Short Form 36 Health Survey; the measurement of pain, strength, and shoulder motion; patient satisfaction; and findings from magnetic resonance imaging and sonography. Analysis was by intention to treat.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The five-year follow-up rate was 98%. Twelve of the fifty-one patients in the physiotherapy group were treated with secondary tendon repair. The results from primary tendon repair were superior to those from physiotherapy plus secondary repair, with between-group mean differences of 5.3 points on the Constant score (p = 0.05), 9.0 points on the American Shoulder and Elbow Surgeons score (p &lt; 0.001), 1.1 cm on a 10-cm visual analog scale for pain (p &lt; 0.001), and 1.0 cm on a 10-cm visual analog scale for patient satisfaction (p = 0.03). In 37% of tears treated with physiotherapy only, there were increasing tear sizes on ultrasound of &gt;5 mm, over five years, associated with an inferior outcome.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although primary repair of small and medium-sized rotator cuff tears was associated with better outcome than physiotherapy treatment, the differences were small and may be below clinical importance. In the physiotherapy treatment group, there were increasing tear sizes and inferior outcomes in one-third of patients who did not undergo repair.</AbstractText>
<CopyrightInformation>Copyright  2014 by The Journal of Bone and Joint Surgery, Incorporated.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Moosmayer</LastName>
<ForeName>Stefan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Departments of Orthopaedic Surgery (S.M.), Physiotherapy (G.L., U.S.S., B.H., and I.C.S.), and Occupational Therapy (T.H.), Martina Hansens Hospital, Donskiveien 8, P.O.B. 823, 1306 Sandvika, Norway. E-mail address for S. Moosmayer: st.moos@online.no.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lund</LastName>
<ForeName>Gerty</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Departments of Orthopaedic Surgery (S.M.), Physiotherapy (G.L., U.S.S., B.H., and I.C.S.), and Occupational Therapy (T.H.), Martina Hansens Hospital, Donskiveien 8, P.O.B. 823, 1306 Sandvika, Norway. E-mail address for S. Moosmayer: st.moos@online.no.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Seljom</LastName>
<ForeName>Unni S</ForeName>
<Initials>US</Initials>
<AffiliationInfo>
<Affiliation>Departments of Orthopaedic Surgery (S.M.), Physiotherapy (G.L., U.S.S., B.H., and I.C.S.), and Occupational Therapy (T.H.), Martina Hansens Hospital, Donskiveien 8, P.O.B. 823, 1306 Sandvika, Norway. E-mail address for S. Moosmayer: st.moos@online.no.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Haldorsen</LastName>
<ForeName>Benjamin</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Departments of Orthopaedic Surgery (S.M.), Physiotherapy (G.L., U.S.S., B.H., and I.C.S.), and Occupational Therapy (T.H.), Martina Hansens Hospital, Donskiveien 8, P.O.B. 823, 1306 Sandvika, Norway. E-mail address for S. Moosmayer: st.moos@online.no.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Svege</LastName>
<ForeName>Ida C</ForeName>
<Initials>IC</Initials>
<AffiliationInfo>
<Affiliation>Departments of Orthopaedic Surgery (S.M.), Physiotherapy (G.L., U.S.S., B.H., and I.C.S.), and Occupational Therapy (T.H.), Martina Hansens Hospital, Donskiveien 8, P.O.B. 823, 1306 Sandvika, Norway. E-mail address for S. Moosmayer: st.moos@online.no.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hennig</LastName>
<ForeName>Toril</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Departments of Orthopaedic Surgery (S.M.), Physiotherapy (G.L., U.S.S., B.H., and I.C.S.), and Occupational Therapy (T.H.), Martina Hansens Hospital, Donskiveien 8, P.O.B. 823, 1306 Sandvika, Norway. E-mail address for S. Moosmayer: st.moos@online.no.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pripp</LastName>
<ForeName>Are H</ForeName>
<Initials>AH</Initials>
<AffiliationInfo>
<Affiliation>Department of Biostatistics, Epidemiology and Health Economics, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, P.O.B. 4950 Nydalen, 0424 Oslo, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Hans-Jrgen</ForeName>
<Initials>HJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology and Nuclear Medicine, Oslo University Hospital, Sognsvannsveien 20, P.O.B. 1078 Blindern, 0424 Oslo, Norway.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D065007">Pragmatic Clinical Trial</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Bone Joint Surg Am</MedlineTA>
<NlmUniqueID>0014030</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Bone Joint Surg Am. 2014 Sep 17;96(18):e162</RefSource>
<PMID Version="1">25232092</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053580">Muscle Strength</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059352">Musculoskeletal Pain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017060">Patient Satisfaction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D026741">Physical Therapy Modalities</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016059">Range of Motion, Articular</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020127">Recovery of Function</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017006">Rotator Cuff</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000293">injuries</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013708">Tendon Injuries</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25064508</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>19</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>12</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1434-3916</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>134</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Archives of orthopaedic and trauma surgery</Title>
<ISOAbbreviation>Arch Orthop Trauma Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Can physical examination predict the intraarticular tear pattern of the anterior cruciate ligament?</ArticleTitle>
<Pagination>
<MedlinePgn>1451-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s00402-014-2048-y</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">We evaluated the correlation between physical examinations and the tear patterns of the anterior cruciate ligament (ACL).</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">From January 2003 to May 2007, we reviewed 201 cases of ACL rupture, diagnosed by MRI. Two orthopaedic surgeons (a fellow and a senior surgeon) evaluated the instability of the knee under anaesthesia: physical examinations were the anterior draw test (AD), Lachman test (LT), and pivot shift test (PT). By describing the rupture pattern and the site of the anteromedial (AMB) and posterolateral bundle (PLB) during arthroscopic examination, we analysed the correlation between the physical examination under anaesthesia and arthroscopic findings.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In terms of the arthroscopic findings, rupture of the PLB was seen in 83 cases (41.3 %), of the AMB in 24 cases (11.9 %), and of both bundles in 94 cases (46.8 %). The kappa values for the physical examinations between the examiners were 0.963 (AD), 0.92 (LT), and 0.865 (PT). AD and LT above grade 2 did not differ significantly according to the pattern of rupture, but a PT above grade 2 was significantly different in ruptured PLB versus complete rupture.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A PT of more than grade 2 is a reliable physical examination for prediction of ruptured PLB or complete rupture.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yoon</LastName>
<ForeName>Kyoung Ho</ForeName>
<Initials>KH</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedic Surgery, School of Medicine, Kyung Hee University, 1 Hoegi-Dong, Dongdaemoon-Gu, 130-702, Seoul, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Sang Hak</ForeName>
<Initials>SH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Park</LastName>
<ForeName>Soo Yeon</ForeName>
<Initials>SY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kang</LastName>
<ForeName>Dong Geun</ForeName>
<Initials>DG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chung</LastName>
<ForeName>Kee Yun</ForeName>
<Initials>KY</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Arch Orthop Trauma Surg</MedlineTA>
<NlmUniqueID>9011043</NlmUniqueID>
<ISSNLinking>0936-8051</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="ErratumIn">
<RefSource>Arch Orthop Trauma Surg. 2014 Oct;134(10):1459</RefSource>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016118">Anterior Cruciate Ligament</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000293">injuries</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059549">Anterior Cruciate Ligament Reconstruction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001182">Arthroscopy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007718">Knee Injuries</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D010808">Physical Examination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012421">Rupture</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24825844</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>19</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1468-2079</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>98</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The British journal of ophthalmology</Title>
<ISOAbbreviation>Br J Ophthalmol</ISOAbbreviation>
</Journal>
<ArticleTitle>Clinical and demographic associations with optic nerve hypoplasia in New Zealand.</ArticleTitle>
<Pagination>
<MedlinePgn>1364-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/bjophthalmol-2013-304605</ELocationID>
<Abstract>
<AbstractText Label="AIM" NlmCategory="OBJECTIVE">To identify the clinical features of optic nerve hypoplasia (ONH) and prevalence within a population of New Zealand children with severe visual impairment.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective review of medical records of children with severe visual impairment registered with Blind and Low Vision Educational Network New Zealand.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 1500 children with severe visual impairment, 94 (6.3%) exhibited ONH, and 91 (97%) cases were bilateral. Of these 94 cases, 52 (55%) were males and ethnicities were European Caucasian (52%), Maori (40%), Pasifika (6%) and other (2%). Most children with ONH had poor vision, with 60% having  6/60 Snellen visual acuity equivalent. The median maternal age was 20.0 years old with 52%  20 years. There was a statistically significant over-representation of Maori ethnicity (40%) and young maternal age with age less than 20 years old (44%) in our cohort compared to the general population (14.6% and 7.4%, respectively; p&lt;0.0001). Half had hypopituitarism, while neuroimaging abnormalities were detected in 60% cases. Cerebral neuroradiographic abnormalities were found to be associated with higher rate of developmental delay (OR 9.764 95% CI 3.246 to 29.373).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This is the first major study of visual impairment in New Zealand children, and it demonstrates that ONH is an important cause of severe visual disability; with an over-representation of Maori children and younger maternal age.</AbstractText>
<CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Goh</LastName>
<ForeName>Yi Wei</ForeName>
<Initials>YW</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, Faculty of Medical and Health Sciences, New Zealand National Eye Centre, University of Auckland, Auckland, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Andrew</LastName>
<ForeName>Dale</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, Faculty of Medical and Health Sciences, New Zealand National Eye Centre, University of Auckland, Auckland, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McGhee</LastName>
<ForeName>Charles</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, Faculty of Medical and Health Sciences, New Zealand National Eye Centre, University of Auckland, Auckland, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dai</LastName>
<ForeName>Shuan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, Faculty of Medical and Health Sciences, New Zealand National Eye Centre, University of Auckland, Auckland, New Zealand.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Br J Ophthalmol</MedlineTA>
<NlmUniqueID>0421041</NlmUniqueID>
<ISSNLinking>0007-1161</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C563492">Optic Nerve Hypoplasia, Bilateral</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000002">abnormalities</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002658">Developmental Disabilities</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005006">Ethnic Groups</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007018">Hypopituitarism</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008423">Maternal Age</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D009520">New Zealand</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009901">Optic Nerve Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000151">congenital</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015995">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012042">Registries</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014786">Vision Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014792">Visual Acuity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Imaging</Keyword>
<Keyword MajorTopicYN="N">Optic Nerve</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25144204</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>19</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2168-619X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>140</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>JAMA otolaryngology-- head &amp; neck surgery</Title>
<ISOAbbreviation>JAMA Otolaryngol Head Neck Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>A bulky mass in the neck.</ArticleTitle>
<Pagination>
<MedlinePgn>879-80</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1001/jamaoto.2014.1760</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Greco</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Institute of Otorhinolaryngology, Audiology and Phoniatrics "Giorgio Ferreri," Department of Sensory Organs, Faculty of Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Iannella</LastName>
<ForeName>Giannicola</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Institute of Otorhinolaryngology, Audiology and Phoniatrics "Giorgio Ferreri," Department of Sensory Organs, Faculty of Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tombolini</LastName>
<ForeName>Mario</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute of Otorhinolaryngology, Audiology and Phoniatrics "Giorgio Ferreri," Department of Sensory Organs, Faculty of Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gallo</LastName>
<ForeName>Andrea</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Institute of Otorhinolaryngology, Audiology and Phoniatrics "Giorgio Ferreri," Department of Sensory Organs, Faculty of Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fusconi</LastName>
<ForeName>Massimo</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute of Otorhinolaryngology, Audiology and Phoniatrics "Giorgio Ferreri," Department of Sensory Organs, Faculty of Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Vincentiis</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute of Otorhinolaryngology, Audiology and Phoniatrics "Giorgio Ferreri," Department of Sensory Organs, Faculty of Medicine, Sapienza University of Rome, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>JAMA Otolaryngol Head Neck Surg</MedlineTA>
<NlmUniqueID>101589542</NlmUniqueID>
<ISSNLinking>2168-6181</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002291">Carcinoma, Papillary</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003287">Contrast Media</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008198">Lymph Nodes</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008207">Lymphatic Metastasis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013964">Thyroid Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25240071</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1938-3207</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>100</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of clinical nutrition</Title>
<ISOAbbreviation>Am. J. Clin. Nutr.</ISOAbbreviation>
</Journal>
<ArticleTitle>Derivation and validation of simple equations to predict total muscle mass from simple anthropometric and demographic data.</ArticleTitle>
<Pagination>
<MedlinePgn>1041-51</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3945/ajcn.113.070466</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Muscle mass reflects and influences health status. Its reliable estimation would be of value for epidemiology.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of the study was to derive and validate anthropometric prediction equations to quantify whole-body skeletal muscle mass (SM) in adults.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">The derivation sample included 423 subjects (227 women) aged 18-81 y with a body mass index (BMI; in kg/m(2)) of 15.9-40.8. The validation sample included 197 subjects (105 women) aged 19-83 y with a BMI of 15.7-36.4. Both samples were of mixed ethnic/racial groups. All underwent whole-body magnetic resonance imaging to quantify SM (dependent variable for multiple regressions) and anthropometric variables (independent variables).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Two prediction equations with high practicality and optimal derivation correlations with SM were further investigated to assess agreement and bias by using Bland-Altman plots and validated in separate data sets. Including race as a variable increased R(2) by only 0.1% in men and by 8% in women. For men: SM (kg) = 39.5 + 0.665 body weight (BW; kg) - 0.185 waist circumference (cm) - 0.418 hip circumference (cm) - 0.08 age (y) (derivation: R(2) = 0.76, SEE = 2.7 kg; validation: R(2) = 0.79, SEE = 2.7 kg). Bland-Altman plots showed moderate agreement in both derivation and validation analyses. For women: SM (kg) = 2.89 + 0.255 BW (kg) - 0.175 hip circumference (cm) - 0.038 age (y) + 0.118 height (cm) (derivation: R(2) = 0.58, SEE = 2.2 kg; validation: R(2) = 0.59, SEE = 2.1 kg). Bland-Altman plots had a negative slope, indicating a tendency to overestimate SM among women with smaller muscle mass and to underestimate SM among those with larger muscle mass.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Anthropometry predicts SM better in men than in women. Equations that include hip circumference showed agreement between methods, with predictive power similar to that of BMI to predict fat mass, with the potential for applications in groups, as well as epidemiology and survey settings.</AbstractText>
<CopyrightInformation> 2014 American Society for Nutrition.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Al-Gindan</LastName>
<ForeName>Yasmin Y</ForeName>
<Initials>YY</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Human Nutrition (YYA-G, CH, and MEJL) and the Institute of Health and Well Being (LG), College of Medical, Veterinary, and Life Sciences, School of Medicine, University of Glasgow, Glasgow, United Kingdom; the Institute of Human Nutrition, Columbia University, New York, NY (DG); and Pennington Biomedical Research Center, Baton Rouge, LA (SBH).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hankey</LastName>
<ForeName>Catherine</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Human Nutrition (YYA-G, CH, and MEJL) and the Institute of Health and Well Being (LG), College of Medical, Veterinary, and Life Sciences, School of Medicine, University of Glasgow, Glasgow, United Kingdom; the Institute of Human Nutrition, Columbia University, New York, NY (DG); and Pennington Biomedical Research Center, Baton Rouge, LA (SBH).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Govan</LastName>
<ForeName>Lindsay</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Human Nutrition (YYA-G, CH, and MEJL) and the Institute of Health and Well Being (LG), College of Medical, Veterinary, and Life Sciences, School of Medicine, University of Glasgow, Glasgow, United Kingdom; the Institute of Human Nutrition, Columbia University, New York, NY (DG); and Pennington Biomedical Research Center, Baton Rouge, LA (SBH).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gallagher</LastName>
<ForeName>Dympna</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Human Nutrition (YYA-G, CH, and MEJL) and the Institute of Health and Well Being (LG), College of Medical, Veterinary, and Life Sciences, School of Medicine, University of Glasgow, Glasgow, United Kingdom; the Institute of Human Nutrition, Columbia University, New York, NY (DG); and Pennington Biomedical Research Center, Baton Rouge, LA (SBH).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heymsfield</LastName>
<ForeName>Steven B</ForeName>
<Initials>SB</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Human Nutrition (YYA-G, CH, and MEJL) and the Institute of Health and Well Being (LG), College of Medical, Veterinary, and Life Sciences, School of Medicine, University of Glasgow, Glasgow, United Kingdom; the Institute of Human Nutrition, Columbia University, New York, NY (DG); and Pennington Biomedical Research Center, Baton Rouge, LA (SBH).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lean</LastName>
<ForeName>Michael E J</ForeName>
<Initials>ME</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Human Nutrition (YYA-G, CH, and MEJL) and the Institute of Health and Well Being (LG), College of Medical, Veterinary, and Life Sciences, School of Medicine, University of Glasgow, Glasgow, United Kingdom; the Institute of Human Nutrition, Columbia University, New York, NY (DG); and Pennington Biomedical Research Center, Baton Rouge, LA (SBH).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D023361">Validation Studies</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Clin Nutr</MedlineTA>
<NlmUniqueID>0376027</NlmUniqueID>
<ISSNLinking>0002-9165</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000886">Anthropometry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003430">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016014">Linear Models</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018482">Muscle, Skeletal</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25237746</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>08</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1543-3641</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>27</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology</Title>
<ISOAbbreviation>Cogn Behav Neurol</ISOAbbreviation>
</Journal>
<ArticleTitle>Progressive neurodegenerative syndrome in a patient with X-linked agammaglobulinemia receiving intravenous immunoglobulin therapy.</ArticleTitle>
<Pagination>
<MedlinePgn>155-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/WNN.0000000000000037</ELocationID>
<Abstract>
<AbstractText>A progressive encephalopathy of unknown etiology has been described in patients with primary immunodeficiency disorders. In this report, we characterize the clinical features of this progressive neurodegenerative dementing disorder in a young man with Bruton agammaglobulinemia, through neuropsychological tests and a video sequence. The clinical course of the encephalopathy seems rather uniform: Cognition, especially frontal lobe function, is affected in the early stages, and some patients develop movement disorders. The syndrome causes severe cognitive and physical disability, and can eventually be fatal. The autoimmunity results from dysregulated immune responses, but the underlying mechanism has not yet been fully explained. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sag</LastName>
<ForeName>Aslihan Taskiran</ForeName>
<Initials>AT</Initials>
<AffiliationInfo>
<Affiliation>*Institute of Neurological Sciences and Psychiatry Department of Neurology, Hacettepe University, Ankara, Turkey Department of Pediatrics, Immunology-Allergy, Akdeniz University, Faculty of Medicine, Antalya, Turkey Department of Immunology, Hacettepe University, Ihsan Dogramaci Children's Hospital, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saka</LastName>
<ForeName>Esen</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ozgur</LastName>
<ForeName>Tuba Turul</ForeName>
<Initials>TT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sanal</LastName>
<ForeName>Ozden</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ayvaz</LastName>
<ForeName>Deniz Cagdas</ForeName>
<Initials>DC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Elibol</LastName>
<ForeName>Bulent</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kurne</LastName>
<ForeName>Asli Tuncer</ForeName>
<Initials>AT</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Cogn Behav Neurol</MedlineTA>
<NlmUniqueID>101167278</NlmUniqueID>
<ISSNLinking>1543-3633</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C537409">Bruton type agammaglobulinemia</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000361">Agammaglobulinemia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001284">Atrophy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003072">Cognition Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018450">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005625">Frontal Lobe</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D040181">Genetic Diseases, X-Linked</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016756">Immunoglobulins, Intravenous</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009069">Movement Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019636">Neurodegenerative Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25237748</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>08</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1543-3641</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>27</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology</Title>
<ISOAbbreviation>Cogn Behav Neurol</ISOAbbreviation>
</Journal>
<ArticleTitle>Cerebellar allocentric and action-intentional spatial neglect.</ArticleTitle>
<Pagination>
<MedlinePgn>166-72</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/WNN.0000000000000033</ELocationID>
<Abstract>
<AbstractText>Contralesional hemispatial neglect most often results from lesions in the right posterior temporoparietal cortex. Less commonly, contralesional and ipsilesional neglect are caused by lesions in the frontal lobe. Although unilateral left cerebellar lesions have been reported to cause body-centered (egocentric) ipsilesional neglect, they have not been reported to cause left-side object-centered (allocentric) neglect together with a leftward action-intentional bias. We describe a patient who had these signs of neglect 7 months after a left cerebellar hemorrhage. This 61-year-old right-handed woman reported emotional lability and difficulty walking, frequently bumping into things on her left side. Neurologic examination revealed ocular dysmetria and left-side limb ataxia. Neuropsychological tests showed evidence of neglect. On a clock-drawing test, the patient accurately drew a circle but her number placement deviated to the left side. She showed the same leftward deviation when she tried to draw a circle composed of small triangles. Although her line bisection was normal, on an allocentric task of open-triangle cancellation she was most likely to neglect triangles with a left-side opening. Her performance on this task indicated left allocentric neglect. Her leftward deviation on the clock and figure drawing tasks seems to be a form of an action-intentional grasp, which may have been induced by right frontal dysfunction superimposed on a deficit of global attention. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Milano</LastName>
<ForeName>Nicholas J</ForeName>
<Initials>NJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, University of Florida College of Medicine, Center for Neuropsychological Studies, and the Malcom Randall Veterans Affairs Medical Center, Gainesville, Florida.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heilman</LastName>
<ForeName>Kenneth M</ForeName>
<Initials>KM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Cogn Behav Neurol</MedlineTA>
<NlmUniqueID>101167278</NlmUniqueID>
<ISSNLinking>1543-3633</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002524">Cerebellar Ataxia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002543">Cerebral Hemorrhage</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004678">Encephalomalacia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004827">Epilepsy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007839">Functional Laterality</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009048">Motor Skills</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D010364">Pattern Recognition, Visual</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010468">Perceptual Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D011597">Psychomotor Performance</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25237939</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-3886</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>62</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Neurology India</Title>
<ISOAbbreviation>Neurol India</ISOAbbreviation>
</Journal>
<ArticleTitle>Characterizing brain mineral deposition in patients with Wilson disease using susceptibility-weighted imaging.</ArticleTitle>
<Pagination>
<MedlinePgn>362-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0028-3886.141221</ELocationID>
<Abstract>
<AbstractText Label="AIMS" NlmCategory="OBJECTIVE">The aim of this study was to evaluate the feasibility of characterizing the brain-mineral deposition in patients with Wilson disease (WD) using susceptibility-weighted imaging (SWI).</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The study enrolled 30 WD patients and 20 age-matched healthy controls. Neurological symptoms were scored using the modified Young Scale. The hepatic function indices, serum and urinary copper content, and serum iron content were determined. All study objects received the magnetic resonance imaging (MRI) and SWI test of the brain. The values of corrected phase (CP) were calculated on SWI. The relationship between CP values and the clinical status were evaluated.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The serum iron content of WD patients was higher than the normal. The CP values of substantia nigra, caudate nucleus, and globus pallidus of WD were lower than the normal values, while the CP value of substantia nigra was the lowest. No correlations were determined between the CP values and the iron and copper parameters. There was negative correlation between the scores of dysarthria and the CP values of the globus pallidus. There was negative correlation between the scores of tremor and the CP values of caudate nucleus. Some regions, which had high signals on T2-weighted image, had low signals on SWI.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There might be abnormal iron metabolism in patients with WD. The decreased CP values might reflect a deposition of both copper and iron. SWI may be more sensitive than the ordinary MRI. The mineral deposition may contribute to the neural symptoms.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Xiang-Xue</ForeName>
<Initials>XX</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, The East Area of the First Affiliated Hospital, Guangzhou, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Qin</LastName>
<ForeName>Hao-Lin</ForeName>
<Initials>HL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Xun-Hua</ForeName>
<Initials>XH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Hai-Wei</ForeName>
<Initials>HW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Liang</LastName>
<ForeName>Ying-Ying</ForeName>
<Initials>YY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Liang</LastName>
<ForeName>Xiu-Ling</ForeName>
<Initials>XL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pu</LastName>
<ForeName>Xiao-Yong</ForeName>
<Initials>XY</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Neurol India</MedlineTA>
<NlmUniqueID>0042005</NlmUniqueID>
<ISSNLinking>0028-3886</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>789U1901C5</RegistryNumber>
<NameOfSubstance UI="D003300">Copper</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>E1UOL152H7</RegistryNumber>
<NameOfSubstance UI="D007501">Iron</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003300">Copper</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006527">Hepatolenticular Degeneration</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007501">Iron</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25237940</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-3886</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>62</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Neurology India</Title>
<ISOAbbreviation>Neurol India</ISOAbbreviation>
</Journal>
<ArticleTitle>Spinal angiolipoma: experience of twelve patients and literature.</ArticleTitle>
<Pagination>
<MedlinePgn>367-70</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0028-3886.141232</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To summarize our experience in treating patients with spinal angiolipomas.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We conducted a retrospective review of the case records of patients with spinal angiolipoma who underwent surgery between March 1992 and March 2013.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 12 patients seen during the study period, 10 patients had total removal of the lesion and 2 patients had sub-total removal. The postoperative course was uneventful, and the outcomes were good in patients who underwent total excision of the lesion. No patient received adjuvant radiation even in the patients with sub-total excision.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In patients with spinal angiolipoma, total excision should be achieved and is associated with good outcomes.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Bo</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Zhijun</ForeName>
<Initials>Z</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Jun</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Guihuai</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Xu</LastName>
<ForeName>Yulun</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Pinan</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery,Beijing Tiantan Hospital, Capital Medical University; Department of Neurosurgery,China National Clinical Research Center for Neurological Diseases, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Neurol India</MedlineTA>
<NlmUniqueID>0042005</NlmUniqueID>
<ISSNLinking>0028-3886</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018206">Angiolipoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013125">Spinal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25237950</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-3886</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>62</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Neurology India</Title>
<ISOAbbreviation>Neurol India</ISOAbbreviation>
</Journal>
<ArticleTitle>Olfactory schwannoma: a report of two cases and literature review.</ArticleTitle>
<Pagination>
<MedlinePgn>429-31</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0028-3886.141289</ELocationID>
<Abstract>
<AbstractText>Intracranial schwannoma is a kind of benign intracranial tumors, derived from neuron myelin sheath, growing slowly and curable. Olfactory schwannoma is an exceedingly rare kind of schwannoma, whose origin is still uncovered. Although several theories have been put up for pathogenesis of olfactory schwannoma, till now, none of these hypotheses has been widely accepted and acknowledged officially. Up to date, only 46 cases of olfactory schwannoma were reported across numerous institutes worldwide. Here we gathered two cases from Department of Neurosurgery in Beijing Tiantan Hospital across two years collection. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Zheng</ForeName>
<Initials>Z</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Wei</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>You</LastName>
<ForeName>Gan</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Jiangfei</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Guilin</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gao</LastName>
<ForeName>Zhixian</ForeName>
<Initials>Z</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Xie</LastName>
<ForeName>Jian</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Beijing Tiantan Hospital, Beijing; Beijing Institute for Brain Disorders Brain Tumor Center, Beijing 100050, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Neurol India</MedlineTA>
<NlmUniqueID>0042005</NlmUniqueID>
<ISSNLinking>0028-3886</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003390">Cranial Nerve Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009442">Neurilemmoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019635">Neurosurgical Procedures</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020431">Olfactory Nerve Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25237959</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-3886</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>62</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Neurology India</Title>
<ISOAbbreviation>Neurol India</ISOAbbreviation>
</Journal>
<ArticleTitle>Bilateral thalamic gliomas: report of two cases with review of literature.</ArticleTitle>
<Pagination>
<MedlinePgn>444-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0028-3886.141247</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Bi-Wu</ForeName>
<Initials>BW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Yi</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Wen-Gang</ForeName>
<Initials>WG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Zhi-Qi</ForeName>
<Initials>ZQ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Neurol India</MedlineTA>
<NlmUniqueID>0042005</NlmUniqueID>
<ISSNLinking>0028-3886</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005910">Glioma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013788">Thalamus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25237960</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-3886</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>62</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Neurology India</Title>
<ISOAbbreviation>Neurol India</ISOAbbreviation>
</Journal>
<ArticleTitle>Central nervous system Erdheim Chester disease presenting with raised intracranial pressure and cerebellar signs mimicking neurosarcoidosis with secondary cerebral venous thrombosis.</ArticleTitle>
<Pagination>
<MedlinePgn>446-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0028-3886.141250</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Viswanathan</LastName>
<ForeName>Shanthi</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kadir</LastName>
<ForeName>Nurulanissa Abdul</ForeName>
<Initials>NA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lip</LastName>
<ForeName>Ang Chong</ForeName>
<Initials>AC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rafia</LastName>
<ForeName>Mohammad Hanip</ForeName>
<Initials>MH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Neurol India</MedlineTA>
<NlmUniqueID>0042005</NlmUniqueID>
<ISSNLinking>0028-3886</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C535814">Neurosarcoidosis</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002493">Central Nervous System Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D031249">Erdheim-Chester Disease</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019586">Intracranial Hypertension</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012507">Sarcoidosis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020246">Venous Thrombosis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25237979</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-3886</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>62</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Neurology India</Title>
<ISOAbbreviation>Neurol India</ISOAbbreviation>
</Journal>
<ArticleTitle>Bithalamic T2 hypointensity: a diagnostic clue for Sandhoff's disease.</ArticleTitle>
<Pagination>
<MedlinePgn>481-2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0028-3886.141311</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Devendra</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ramanathan</LastName>
<ForeName>Subramaniyan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Hamad Medical Corporation, Doha, Qatar.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Khanna</LastName>
<ForeName>Maneesh</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Palaniappan</LastName>
<ForeName>Yegu</ForeName>
<Initials>Y</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Neurol India</MedlineTA>
<NlmUniqueID>0042005</NlmUniqueID>
<ISSNLinking>0028-3886</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012497">Sandhoff Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013788">Thalamus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24830599</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1097-0142</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>120</Volume>
<Issue>19</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>Cancer</Title>
<ISOAbbreviation>Cancer</ISOAbbreviation>
</Journal>
<ArticleTitle>Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.</ArticleTitle>
<Pagination>
<MedlinePgn>2955-64</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/cncr.28771</ELocationID>
<Abstract>
<AbstractText>Breast cancer screening holds a prominent place in public health, health care delivery, policy, and women's health care decisions. Several factors are driving shifts in how population-based breast cancer screening is approached, including advanced imaging technologies, health system performance measures, health care reform, concern for "overdiagnosis," and improved understanding of risk. Maximizing benefits while minimizing the harms of screening requires moving from a "1-size-fits-all" guideline paradigm to more personalized strategies. A refined conceptual model for breast cancer screening is needed to align women's risks and preferences with screening regimens. A conceptual model of personalized breast cancer screening is presented herein that emphasizes key domains and transitions throughout the screening process, as well as multilevel perspectives. The key domains of screening awareness, detection, diagnosis, and treatment and survivorship are conceptualized to function at the level of the patient, provider, facility, health care system, and population/policy arena. Personalized breast cancer screening can be assessed across these domains with both process and outcome measures. Identifying, evaluating, and monitoring process measures in screening is a focus of a National Cancer Institute initiative entitled PROSPR (Population-based Research Optimizing Screening through Personalized Regimens), which will provide generalizable evidence for a risk-based model of breast cancer screening, The model presented builds on prior breast cancer screening models and may serve to identify new measures to optimize benefits-to-harms tradeoffs in population-based screening, which is a timely goal in the era of health care reform.</AbstractText>
<CopyrightInformation> 2014 American Cancer Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Onega</LastName>
<ForeName>Tracy</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Community &amp; Family Medicine and The Dartmouth Institute for Health Policy &amp; Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; Norris Cotton Cancer Center, Lebanon, New Hampshire.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Beaber</LastName>
<ForeName>Elisabeth F</ForeName>
<Initials>EF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sprague</LastName>
<ForeName>Brian L</ForeName>
<Initials>BL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Barlow</LastName>
<ForeName>William E</ForeName>
<Initials>WE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Haas</LastName>
<ForeName>Jennifer S</ForeName>
<Initials>JS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tosteson</LastName>
<ForeName>Anna N A</ForeName>
<Initials>AN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>D Schnall</LastName>
<ForeName>Mitchell</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Armstrong</LastName>
<ForeName>Katrina</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schapira</LastName>
<ForeName>Marilyn M</ForeName>
<Initials>MM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Geller</LastName>
<ForeName>Berta</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Weaver</LastName>
<ForeName>Donald L</ForeName>
<Initials>DL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Conant</LastName>
<ForeName>Emily F</ForeName>
<Initials>EF</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>U54 CA163303</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54 CA163307</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54 CA163313</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54CA163313</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Cancer</MedlineTA>
<NlmUniqueID>0374236</NlmUniqueID>
<ISSNLinking>0008-543X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001943">Breast Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003657">Decision Making</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D055088">Early Detection of Cancer</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019317">Evidence-Based Medicine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005189">False Positive Reactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D057285">Individualized Medicine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008327">Mammography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008403">Mass Screening</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000592">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054547">National Cancer Institute (U.S.)</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017410">Practice Guidelines as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">breast cancer</Keyword>
<Keyword MajorTopicYN="N">guidelines</Keyword>
<Keyword MajorTopicYN="N">mammography</Keyword>
<Keyword MajorTopicYN="N">process of care</Keyword>
<Keyword MajorTopicYN="N">screening</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25158914</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1879-1190</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>219</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of the American College of Surgeons</Title>
<ISOAbbreviation>J. Am. Coll. Surg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure.</ArticleTitle>
<Pagination>
<MedlinePgn>620-30</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jamcollsurg.2014.04.022</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1072-7515(14)00485-2</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">After portal vein embolization (PVE), the future liver remnant (FLR) hypertrophies for several weeks. An early marker that predicts a low risk of post-hepatectomy liver failure can reduce the delay to surgery.</AbstractText>
<AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Liver volumes of 153 patients who underwent a major hepatectomy (&gt;3 segments) after PVE for primary or secondary liver malignancy between September 1999 and November 2012 were retrospectively evaluated with computerized volumetry. Pre- and post-PVE FLR volume and functional liver volume were measured. Degree of hypertrophy (DH = post-FLR/post-functional liver volume - pre-FLR/pre-functional liver volume) and growth rate (GR = DH/weeks since PVE) were calculated. Postoperative complications and liver failure were correlated with DH, measured GR, and estimated GR derived from a formula based on body surface area.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Eligible patients underwent 93 right hepatectomies, 51 extended right hepatectomies, 4 left hepatectomies, and 5 extended left hepatectomies. Major complications occurred in 44 patients (28.7%) and liver failure in 6 patients (3.9%). Nonparametric regression showed that post-embolization FLR percent correlated poorly with liver failure. Receiver operating characteristic curves showed that DH and GR were good predictors of liver failure (area under the curve [AUC] = 0.80; p = 0.011 and AUC = 0.79; p = 0.015) and modest predictors of major complications (AUC = 0.66; p = 0.002 and AUC = 0.61; p = 0.032). No patient with GR &gt;2.66% per week had liver failure develop. The predictive value of measured GR was superior to estimated GR for liver failure (AUC = 0.79 vs 0.58; p = 0.046).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Both DH and GR after PVE are strong predictors of post-hepatectomy liver failure. Growth rate might be a better guide for the optimum timing of liver resection than static volumetric measurements. Measured volumetrics correlated with outcomes better than estimated volumetrics.</AbstractText>
<CopyrightInformation>Copyright  2014 American College of Surgeons. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Leung</LastName>
<ForeName>Universe</ForeName>
<Initials>U</Initials>
<AffiliationInfo>
<Affiliation>Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Simpson</LastName>
<ForeName>Amber L</ForeName>
<Initials>AL</Initials>
<AffiliationInfo>
<Affiliation>Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Biomedical Engineering, Vanderbilt University, Nashville, TN.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Araujo</LastName>
<ForeName>Raphael L C</ForeName>
<Initials>RL</Initials>
<AffiliationInfo>
<Affiliation>Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gnen</LastName>
<ForeName>Mithat</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McAuliffe</LastName>
<ForeName>Conor</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Miga</LastName>
<ForeName>Michael I</ForeName>
<Initials>MI</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Engineering, Vanderbilt University, Nashville, TN.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Parada</LastName>
<ForeName>E Patricia</ForeName>
<Initials>EP</Initials>
<AffiliationInfo>
<Affiliation>Pathfinder Therapeutics Inc., Nashville, TN.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Allen</LastName>
<ForeName>Peter J</ForeName>
<Initials>PJ</Initials>
<AffiliationInfo>
<Affiliation>Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>D'Angelica</LastName>
<ForeName>Michael I</ForeName>
<Initials>MI</Initials>
<AffiliationInfo>
<Affiliation>Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kingham</LastName>
<ForeName>T Peter</ForeName>
<Initials>TP</Initials>
<AffiliationInfo>
<Affiliation>Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>DeMatteo</LastName>
<ForeName>Ronald P</ForeName>
<Initials>RP</Initials>
<AffiliationInfo>
<Affiliation>Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fong</LastName>
<ForeName>Yuman</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jarnagin</LastName>
<ForeName>William R</ForeName>
<Initials>WR</Initials>
<AffiliationInfo>
<Affiliation>Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: jarnagiw@mskcc.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 CA008748</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 CA008748</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA162477</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 CA162477</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Am Coll Surg</MedlineTA>
<NlmUniqueID>9431305</NlmUniqueID>
<ISSNLinking>1072-7515</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004621">Embolization, Therapeutic</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006498">Hepatectomy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006984">Hypertrophy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008099">Liver</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017093">Liver Failure</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008113">Liver Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011169">Portal Vein</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D011183">Postoperative Complications</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012372">ROC Curve</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS608913 [Available on 10/01/15]</OtherID>
<OtherID Source="NLM">PMC4171195 [Available on 10/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25242814</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>14</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0023-7213</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>100</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Lknablai</Title>
<ISOAbbreviation>Laeknabladid</ISOAbbreviation>
</Journal>
<ArticleTitle>[Mediastinal parathyroid cyst - a case report].</ArticleTitle>
<Pagination>
<MedlinePgn>453-5</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The most common causes of mediastinal masses are thymomas, lymphomas and neuromas. Mediastinal cysts, such as bronchogenic cysts, which are usually benign, are less common. We report the case of a 59-year-old woman with a history of progressive dysphagia. A computed tomography scan revealed a cystic lesion in the anterior mediastinum. The cyst was surgically resected and turned out to be a benign parathyroid cyst. The patient's symptoms disappeared after surgical removal. Both the serum calcium and parathyroid hormone levels were normal before, and after surgery. Parathyroid cysts are rare lesions of the mediastinum and only around 100 cases have been reported in literature. Here we report the first case of a mediastinal parathyroid cyst in Iceland.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hoskuldsdottir</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kristvinsson</LastName>
<ForeName>Hoskuldur</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gudjonsson</LastName>
<ForeName>Hallgrmur</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Geirsson</LastName>
<ForeName>Arnar</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gudbjartsson</LastName>
<ForeName>Tomas</ForeName>
<Initials>T</Initials>
</Author>
</AuthorList>
<Language>ice</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Kalkkirtlabladra  midmxti - sjkratilfelli.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Iceland</Country>
<MedlineTA>Laeknabladid</MedlineTA>
<NlmUniqueID>7901326</NlmUniqueID>
<ISSNLinking>0023-7213</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001706">Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003680">Deglutition Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008476">Mediastinal Cyst</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D010279">Parathyroid Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011237">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25241760</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-3886</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>62</Volume>
<Issue>4</Issue>
<PubDate>
<MedlineDate>2014 Jul-Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Neurology India</Title>
<ISOAbbreviation>Neurol India</ISOAbbreviation>
</Journal>
<ArticleTitle>Surgical management of intramedullary cavernous angiomas and analysis pain relief.</ArticleTitle>
<Pagination>
<MedlinePgn>423-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/0028-3886.141477</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of this study was to conduct a retrospective analysis of the clinical characteristics of 20 individuals with intramedullary cavernous angiomas (ICA) presented with serious pain complaints. This study was to investigate the efficacy of short- and long-term pain relief following surgical resection.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Between 2006 and 2012, 55 patients with ICA were surgically managed in our institution. Of these 20 (36.4%) patients presented with serious pain as a unique clinical feature. Numerical pain scores (NPS: 0-10) were used to assess the patients' pain levels preoperatively, as well as at 1 month and 1 year postoperatively. All the patients had magnetic resonance imaging (MRI) preoperatively and during follow-up. IBM SPSS Statistics 19.0 was used to analysis the outcomes.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 20 patients with ICA, 9 (45%) required cervical and 11 (55%) thoracic surgery. Seven (35%) patients presented with radicular pain and 13 (65%) presented with central pain. Pain improved from a total mean preoperative score of 8.60 to total mean score of 2.95 (P &lt; 0.01) at one month and 3.35 (P &lt; 0.01) at one year post-surgery. However, the pain symptoms completely disappeared in the long-term follow-up only in three (15%) patients. Five (25%) patients reported new pain symptoms with no lesion reoccurrence postoperatively.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Pain is the common complaint in patients with ICA. Surgery is effective in providing short- and long-term pain relief. However, long-term follow-up measures on postoperative pain levels show that the pain does recur in the months following surgery.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Qing</LastName>
<ForeName>Huang Si</ForeName>
<Initials>HS</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Sichuan University, West China Hospital, Sichuan, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shuhui</LastName>
<ForeName>Gong</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jiagang</LastName>
<ForeName>Liu</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>Neurol India</MedlineTA>
<NlmUniqueID>0042005</NlmUniqueID>
<ISSNLinking>0028-3886</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Neurol India. 2014 Jul-Aug;62(4):345-6</RefSource>
<PMID Version="1">25237936</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006392">Hemangioma, Cavernous</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010146">Pain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013120">Spinal Cord Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25242599</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0369-4305</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>70</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Nihon Hoshasen Gijutsu Gakkai zasshi</Title>
<ISOAbbreviation>Nihon Hoshasen Gijutsu Gakkai Zasshi</ISOAbbreviation>
</Journal>
<ArticleTitle>[What kind of information we would like to acquire on hepatic MR examination?].</ArticleTitle>
<Pagination>
<MedlinePgn>1089-94</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kobayashi</LastName>
<ForeName>Satoshi</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>jpn</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>Nihon Hoshasen Gijutsu Gakkai Zasshi</MedlineTA>
<NlmUniqueID>7505722</NlmUniqueID>
<ISSNLinking>0369-4305</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008099">Liver</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008107">Liver Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009682">Magnetic Resonance Spectroscopy</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25245907</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>28</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0095-6562</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>85</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Aviation, space, and environmental medicine</Title>
<ISOAbbreviation>Aviat Space Environ Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Radiotherapeutic treatment of a fighter pilot with nasopharyngeal carcinoma.</ArticleTitle>
<Pagination>
<MedlinePgn>1056-60</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3357/ASEM.3901.2014</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Radiotherapy is the standard and most effective treatment for nasopharyngeal carcinoma (NPC) in its early stages. However, its application in fighter pilots returning to flying duties with NPC has not been previously reported, presumably due to post-radiotherapeutic complications.</AbstractText>
<AbstractText Label="CASE REPORT" NlmCategory="METHODS">A 36-yr-old male fighter pilot had a painless mass in the left neck for 5 mo. Pathological diagnosis demonstrated nonkeratinizing squamous cell carcinoma in the left nasopharynx which had metastasized to lymph nodes in the left side of the neck. He was diagnosed and staged with NPC (T1N2M0) before treatment with radiotherapy and adjuvant chemotherapy. The patient suffered from catarrhal otitis media and xerostomia after 3 mo of radiotherapy, but these symptoms resolved. After a total of 8 mo of radiotherapy, he was in remission with no evidence of tumor recurrence or metastasis. He had normal Eustachian tube, hearing, and vestibular function before and after hypobaric chamber testing and passed all flight-related physical examinations. Consequently, he was granted a medical waiver and returned to flying status in two-seat fighter aircraft, flying for 53 h in a 12-mo period. After passing all flight-related tests again, he was then allowed to fly in single-seat aircraft. At the time of submission of this article, he has flown for 147 h and remained on flying status for 26 mo. He will be monitored annually for long-term effects of radiotherapy and/or disease recurrence.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Fighter pilots with NPC may be safely considered for medical waiver with appropriate monitoring after successful treatment.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Xu</LastName>
<ForeName>Xian-Rong</ForeName>
<Initials>XR</Initials>
<AffiliationInfo>
<Affiliation>Center of Clinical Aviation Medicine, General Hospital of PLA Air Force, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Bin-Ru</ForeName>
<Initials>BR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Yang</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jin</LastName>
<ForeName>Zhan-Guo</ForeName>
<Initials>ZG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Aviat Space Environ Med</MedlineTA>
<NlmUniqueID>7501714</NlmUniqueID>
<ISSNLinking>0095-6562</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C538339">Nasopharyngeal carcinoma</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<CitationSubset>S</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000337">Aerospace Medicine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008889">Military Personnel</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009303">Nasopharyngeal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000532">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009305">Nasopharynx</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009960">Oropharynx</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000528">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010033">Otitis Media</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050397">Radiotherapy, Intensity-Modulated</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015837">Vestibular Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014987">Xerostomia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25246817</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">2005-8330</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>15</Volume>
<Issue>5</Issue>
<PubDate>
<MedlineDate>2014 Sep-Oct</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Korean journal of radiology : official journal of the Korean Radiological Society</Title>
<ISOAbbreviation>Korean J Radiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Perfusion magnetic resonance imaging: a comprehensive update on principles and techniques.</ArticleTitle>
<Pagination>
<MedlinePgn>554-77</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3348/kjr.2014.15.5.554</ELocationID>
<Abstract>
<AbstractText>Perfusion is a fundamental biological function that refers to the delivery of oxygen and nutrients to tissue by means of blood flow. Perfusion MRI is sensitive to microvasculature and has been applied in a wide variety of clinical applications, including the classification of tumors, identification of stroke regions, and characterization of other diseases. Perfusion MRI techniques are classified with or without using an exogenous contrast agent. Bolus methods, with injections of a contrast agent, provide better sensitivity with higher spatial resolution, and are therefore more widely used in clinical applications. However, arterial spin-labeling methods provide a unique opportunity to measure cerebral blood flow without requiring an exogenous contrast agent and have better accuracy for quantification. Importantly, MRI-based perfusion measurements are minimally invasive overall, and do not use any radiation and radioisotopes. In this review, we describe the principles and techniques of perfusion MRI. This review summarizes comprehensive updated knowledge on the physical principles and techniques of perfusion MRI. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jahng</LastName>
<ForeName>Geon-Ho</ForeName>
<Initials>GH</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul 134-727, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Ka-Loh</ForeName>
<Initials>KL</Initials>
<AffiliationInfo>
<Affiliation>Wolfson Molecular Imaging Center, The University of Manchester, Manchester M20 3LJ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ostergaard</LastName>
<ForeName>Leif</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Center for Functionally Integrative Neuroscience, Department of Neuroradiology, Aarhus University Hospital, Aarhus C 8000, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Calamante</LastName>
<ForeName>Fernando</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria 3084, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>09</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Korea (South)</Country>
<MedlineTA>Korean J Radiol</MedlineTA>
<NlmUniqueID>100956096</NlmUniqueID>
<ISSNLinking>1229-6929</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013113">Spin Labels</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Radiology. 2005 Mar;234(3):851-9</RefSource>
<PMID Version="1">15734937</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Phys. 2005 Jun;32(6):1524-8</RefSource>
<PMID Version="1">16013709</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2005 Aug;54(2):366-72</RefSource>
<PMID Version="1">16032674</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2005 Aug;54(2):491-8</RefSource>
<PMID Version="1">16032686</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2005 Oct;54(4):841-9</RefSource>
<PMID Version="1">16155888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2005 Nov;54(5):1241-7</RefSource>
<PMID Version="1">16193469</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 2005 Dec;22(6):693-6</RefSource>
<PMID Version="1">16261568</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 2005 Dec;22(6):718-22</RefSource>
<PMID Version="1">16261569</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 2006 Jan;37(1):263-6</RefSource>
<PMID Version="1">16339467</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2006 Feb;55(2):219-32</RefSource>
<PMID Version="1">16416430</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Radiol. 2006 Mar;41(3):213-21</RefSource>
<PMID Version="1">16481903</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2006 Apr;55(4):805-15</RefSource>
<PMID Version="1">16526016</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2006 Apr 15;30(3):768-79</RefSource>
<PMID Version="1">16412666</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroradiology. 2013 Jan;55(1):25-34</RefSource>
<PMID Version="1">22828738</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>NMR Biomed. 2013 Aug;26(8):913-31</RefSource>
<PMID Version="1">22782914</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>NMR Biomed. 2013 Aug;26(8):901-12</RefSource>
<PMID Version="1">22807022</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>NMR Biomed. 2013 Aug;26(8):887-91</RefSource>
<PMID Version="1">23733501</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Korean J Radiol. 2013 Jul-Aug;14(4):662-72</RefSource>
<PMID Version="1">23901325</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2013 Oct 10;250:364-71</RefSource>
<PMID Version="1">23876323</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prog Nucl Magn Reson Spectrosc. 2013 Oct;74:1-32</RefSource>
<PMID Version="1">24083460</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2013 Dec;70(6):1653-61</RefSource>
<PMID Version="1">23878098</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2013 Dec;70(6):1500-6</RefSource>
<PMID Version="1">24130105</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2014 Feb 15;87:265-75</RefSource>
<PMID Version="1">24246488</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2014;9(3):e90300</RefSource>
<PMID Version="1">24594707</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 2014 Jul;40(1):1-10</RefSource>
<PMID Version="1">24424918</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Radiol. 2013 May;54(4):448-54</RefSource>
<PMID Version="1">23592805</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2004 Nov;52(5):1190-9</RefSource>
<PMID Version="1">15508169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Appl Physiol. 1954 Jun;6(12):731-44</RefSource>
<PMID Version="1">13174454</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 1964 Jun;14:502-15</RefSource>
<PMID Version="1">14169969</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2005 Mar;53(3):511-8</RefSource>
<PMID Version="1">15723393</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiology. 2005 Mar;234(3):661-73</RefSource>
<PMID Version="1">15734925</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1995 Sep;34(3):293-301</RefSource>
<PMID Version="1">7500865</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1995 Dec;34(6):878-87</RefSource>
<PMID Version="1">8598815</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1996 Oct;36(4):562-6</RefSource>
<PMID Version="1">8892208</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cereb Blood Flow Metab. 1996 Nov;16(6):1236-49</RefSource>
<PMID Version="1">8898697</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1996 Nov;36(5):715-25</RefSource>
<PMID Version="1">8916022</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 1997 Jan-Feb;7(1):91-101</RefSource>
<PMID Version="1">9039598</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Imaging. 1997;15(3):307-17</RefSource>
<PMID Version="1">9201678</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1997 Aug;38(2):232-7</RefSource>
<PMID Version="1">9256102</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>NMR Biomed. 1997 Jun-Aug;10(4-5):237-49</RefSource>
<PMID Version="1">9430354</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 1998 Mar;50(3):633-41</RefSource>
<PMID Version="1">9521248</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1998 May;39(5):702-8</RefSource>
<PMID Version="1">9581600</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiology. 1998 Aug;208(2):410-6</RefSource>
<PMID Version="1">9680569</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2006 May;55(5):1180-5</RefSource>
<PMID Version="1">16598717</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2006 Jun;55(6):1334-41</RefSource>
<PMID Version="1">16700025</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2006 Jul;56(1):146-56</RefSource>
<PMID Version="1">16767744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2006 Sep;56(3):671-5</RefSource>
<PMID Version="1">16902980</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2006 Nov 1;33(2):570-9</RefSource>
<PMID Version="1">16971140</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2006 Oct 10;67(7):1215-20</RefSource>
<PMID Version="1">17030755</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2006 Nov;56(5):1140-4</RefSource>
<PMID Version="1">16986112</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 2006 Nov;24(5):1133-9</RefSource>
<PMID Version="1">16969793</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cereb Blood Flow Metab. 2007 Mar;27(3):632-45</RefSource>
<PMID Version="1">16850030</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2007 Jul;58(1):41-54</RefSource>
<PMID Version="1">17659615</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2007 Sep;58(3):544-53</RefSource>
<PMID Version="1">17763347</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 2007 Oct;26(4):871-80</RefSource>
<PMID Version="1">17896358</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2007 Dec;58(6):1232-41</RefSource>
<PMID Version="1">17969025</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2007 Dec;58(6):1086-91</RefSource>
<PMID Version="1">17969084</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Phys. 2007 Nov;34(11):4519-25</RefSource>
<PMID Version="1">18072518</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2008 Feb;59(2):316-25</RefSource>
<PMID Version="1">18183614</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 2008 Apr;27(4):754-62</RefSource>
<PMID Version="1">18383268</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 2008 May;27(5):970-7</RefSource>
<PMID Version="1">18425844</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2008 Nov;60(5):1011-9</RefSource>
<PMID Version="1">18956419</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2008 Dec;60(6):1362-71</RefSource>
<PMID Version="1">18828149</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2008 Dec;60(6):1488-97</RefSource>
<PMID Version="1">19025913</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>NMR Biomed. 2008 Nov;21(10):1126-37</RefSource>
<PMID Version="1">18727165</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2009 Feb;61(2):486-92</RefSource>
<PMID Version="1">19161169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 2009 Mar;29(3):641-8</RefSource>
<PMID Version="1">19243046</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cereb Blood Flow Metab. 2009 Apr;29(4):840-52</RefSource>
<PMID Version="1">19142193</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>IEEE Trans Biomed Eng. 2009 May;56(5):1287-97</RefSource>
<PMID Version="1">19188118</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2009 Jul;62(1):205-17</RefSource>
<PMID Version="1">19449435</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Clin Oncol. 2009 Aug;6(8):445-54</RefSource>
<PMID Version="1">19546864</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2009 Nov;62(5):1270-81</RefSource>
<PMID Version="1">19780145</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Comput Methods Programs Biomed. 2010 May;98(2):204-13</RefSource>
<PMID Version="1">20060614</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cereb Blood Flow Metab. 2010 May;30(5):1066-78</RefSource>
<PMID Version="1">20087370</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 2010 Jun;41(6):1169-74</RefSource>
<PMID Version="1">20413735</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2010 Jun;63(6):1548-56</RefSource>
<PMID Version="1">20512858</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>MAGMA. 2010 Jun;23(3):187-95</RefSource>
<PMID Version="1">20512521</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2010 Aug;64(2):358-68</RefSource>
<PMID Version="1">20665779</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2010 Sep;64(3):777-86</RefSource>
<PMID Version="1">20597127</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiology. 2010 Nov;257(2):507-15</RefSource>
<PMID Version="1">20959548</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2010 Nov;64(5):1529-39</RefSource>
<PMID Version="1">20677231</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 2010 Nov;32(5):1024-37</RefSource>
<PMID Version="1">21031505</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2011 Feb;65(2):448-56</RefSource>
<PMID Version="1">21264935</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2011 Apr;65(4):1173-83</RefSource>
<PMID Version="1">21337417</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2011 Jul;66(1):57-66</RefSource>
<PMID Version="1">21287594</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2011 Sep;82(9):1011-6</RefSource>
<PMID Version="1">21386110</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cereb Blood Flow Metab. 2011 Oct;31(10):2041-53</RefSource>
<PMID Version="1">21505483</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cereb Blood Flow Metab. 2011 Nov;31(11):2189-98</RefSource>
<PMID Version="1">21629260</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>MAGMA. 2012 Apr;25(2):135-44</RefSource>
<PMID Version="1">21863374</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>MAGMA. 2012 Apr;25(2):75-7</RefSource>
<PMID Version="1">22427138</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2012 Aug;68(2):452-62</RefSource>
<PMID Version="1">22791559</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>NMR Biomed. 2011 May;24(4):404-12</RefSource>
<PMID Version="1">22945292</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(12):e52656</RefSource>
<PMID Version="1">23285132</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2013 Feb;69(2):531-7</RefSource>
<PMID Version="1">22528959</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2014 Dec;72(6):1762-74</RefSource>
<PMID Version="1">24453108</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2000 Apr;47(4):462-9</RefSource>
<PMID Version="1">10762157</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2000 May;43(5):691-700</RefSource>
<PMID Version="1">10800034</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2000 May;43(5):739-46</RefSource>
<PMID Version="1">10800040</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 2000 Jun;11(6):575-85</RefSource>
<PMID Version="1">10862055</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2000 Jul;44(1):92-100</RefSource>
<PMID Version="1">10893526</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Radiol. 2000 Jul;35(7):401-11</RefSource>
<PMID Version="1">10901101</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2000 Sep;44(3):466-73</RefSource>
<PMID Version="1">10975900</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 2000 Sep;12(3):381-7</RefSource>
<PMID Version="1">10992304</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2000 Oct;44(4):563-74</RefSource>
<PMID Version="1">11025512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2000 Nov;44(5):665-7</RefSource>
<PMID Version="1">11064398</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2000 Nov;44(5):680-5</RefSource>
<PMID Version="1">11064401</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 2001 Feb;13(2):313-7</RefSource>
<PMID Version="1">11169840</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Radiol. 2001 Jul;36(7):378-85</RefSource>
<PMID Version="1">11496093</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2001 Nov;46(5):974-84</RefSource>
<PMID Version="1">11675650</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2001 Dec;46(6):1113-22</RefSource>
<PMID Version="1">11746577</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2002 Jan;47(1):135-42</RefSource>
<PMID Version="1">11754452</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AJR Am J Roentgenol. 2002 Mar;178(3):711-6</RefSource>
<PMID Version="1">11856703</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2002 Mar;47(3):601-6</RefSource>
<PMID Version="1">11870848</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 2002 Apr;33(4):1146-51</RefSource>
<PMID Version="1">11935075</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2003 Feb;49(2):307-14</RefSource>
<PMID Version="1">12541251</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2003 May;49(5):885-94</RefSource>
<PMID Version="1">12704771</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 2003 May;17(5):509-20</RefSource>
<PMID Version="1">12720260</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2003 Jun;49(6):1067-76</RefSource>
<PMID Version="1">12768585</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2003 Jun;49(6):1133-42</RefSource>
<PMID Version="1">12768592</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2003 Jul;50(1):164-74</RefSource>
<PMID Version="1">12815691</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2003 Jun;19(2 Pt 1):341-53</RefSource>
<PMID Version="1">12814584</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2003 Dec;50(6):1237-47</RefSource>
<PMID Version="1">14648572</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stroke. 2004 Apr;35(4):882-7</RefSource>
<PMID Version="1">14988567</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Imaging. 2004 Apr;22(3):307-14</RefSource>
<PMID Version="1">15062926</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AJNR Am J Neuroradiol. 2004 May;25(5):746-55</RefSource>
<PMID Version="1">15140713</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 2004 Jun;19(6):758-70</RefSource>
<PMID Version="1">15170782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2004 Jul;52(1):131-40</RefSource>
<PMID Version="1">15236376</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2004 Aug;52(2):420-9</RefSource>
<PMID Version="1">15282828</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2004 Oct;52(4):789-97</RefSource>
<PMID Version="1">15389944</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncologist. 2004;9(5):528-37</RefSource>
<PMID Version="1">15477637</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Appl Physiol. 1970 Feb;28(2):219-20</RefSource>
<PMID Version="1">4905082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neurol Scand Suppl. 1977;64:492-3</RefSource>
<PMID Version="1">268887</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1986 Jun;3(3):454-62</RefSource>
<PMID Version="1">3724425</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiology. 1989 Jun;171(3):767-73</RefSource>
<PMID Version="1">2717749</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1990 May;14(2):249-65</RefSource>
<PMID Version="1">2345506</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1990 Oct;16(1):117-31</RefSource>
<PMID Version="1">2255233</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1991 Apr;18(2):257-68</RefSource>
<PMID Version="1">2046511</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1991 Feb;17(2):357-67</RefSource>
<PMID Version="1">2062210</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1991 Jun;19(2):285-92</RefSource>
<PMID Version="1">1881317</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):212-6</RefSource>
<PMID Version="1">1729691</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1992 Jan;23(1):37-45</RefSource>
<PMID Version="1">1734182</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1993 Apr;29(4):553-8</RefSource>
<PMID Version="1">8464373</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiology. 1994 Aug;192(2):513-20</RefSource>
<PMID Version="1">8029425</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1994 Jun;31(6):601-10</RefSource>
<PMID Version="1">8057812</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1998 Sep;40(3):383-96</RefSource>
<PMID Version="1">9727941</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cereb Blood Flow Metab. 1998 Dec;18(12):1378-85</RefSource>
<PMID Version="1">9850150</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiology. 1999 Jan;210(1):269-76</RefSource>
<PMID Version="1">9885619</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 1999 Feb;9(2):342-7</RefSource>
<PMID Version="1">10077035</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1999 Jun;41(6):1093-8</RefSource>
<PMID Version="1">10371440</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1999 Jun;41(6):1246-54</RefSource>
<PMID Version="1">10371458</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cereb Blood Flow Metab. 1999 Jul;19(7):701-35</RefSource>
<PMID Version="1">10413026</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 1999 Aug;10(2):109-17</RefSource>
<PMID Version="1">10441012</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 1999 Sep;10(3):223-32</RefSource>
<PMID Version="1">10508281</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1995 Oct;34(4):555-66</RefSource>
<PMID Version="1">8524024</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Imaging. 2000 Feb;18(2):157-67</RefSource>
<PMID Version="1">10722976</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001158">Arteries</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003287">Contrast Media</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000592">standards</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000639">trends</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013113">Spin Labels</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020521">Stroke</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4170157</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Arterial spin-labeling</Keyword>
<Keyword MajorTopicYN="N">Dynamic contrast-enhanced</Keyword>
<Keyword MajorTopicYN="N">Dynamic susceptibility contrast</Keyword>
<Keyword MajorTopicYN="N">Perfusion</Keyword>
<Keyword MajorTopicYN="N">Perfusion MRI</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25246821</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">2005-8330</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>15</Volume>
<Issue>5</Issue>
<PubDate>
<MedlineDate>2014 Sep-Oct</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Korean journal of radiology : official journal of the Korean Radiological Society</Title>
<ISOAbbreviation>Korean J Radiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Hepatic arterial phase on gadoxetic acid-enhanced liver MR imaging: a randomized comparison of 0.5 mL/s and 1 mL/s injection rates.</ArticleTitle>
<Pagination>
<MedlinePgn>605-12</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3348/kjr.2014.15.5.605</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare gadoxetic acid injection rates of 0.5 mL/s and 1 mL/s for hepatic arterial-phase magnetic resonance (MR) imaging.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">In this prospective study, 101 consecutive patients with suspected focal liver lesions were included and randomly divided into two groups. Each group underwent dynamic liver MR imaging using a 3.0-T scanner after an intravenous injection of gadoxetic acid at rates of either 0.5 mL/s (n = 50) or 1 mL/s (n = 51). Arterial phase images were analyzed after blinding the injection rates. The signal-to-noise ratios (SNRs) of the liver, aorta, portal vein, hepatic vein, spleen, and pancreas were measured. The contrast-to-noise ratios (CNRs) of the hepatocellular carcinomas (HCC) were calculated. Finally, two experienced radiologists were independently asked to identify, if any, HCCs in the liver on the images and score the image quality in terms of the presence of artifacts and the proper enhancement of the liver, aorta, portal vein, hepatic vein, hepatic artery, spleen, pancreas, and kidney.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The SNRs were not significantly different between the groups (p = 0.233-0.965). The CNRs of the HCCs were not significantly different (p = 0.597). The sensitivity for HCC detection and the image quality scores were not significantly different between the two injection rates (p = 0.082-1.000).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Image quality and sensitivity for hepatic HCCs of arterial-phase gadoxetic acid-enhanced MR were not significantly improved by reducing the contrast injection rate to 0.5 mL/s compared with 1 mL/s.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Sung Mo</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Chonnam National University Hwasun Hospital, Hwasun 519-763, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Heo</LastName>
<ForeName>Suk Hee</ForeName>
<Initials>SH</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Chonnam National University Hwasun Hospital, Hwasun 519-763, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Jin Woong</ForeName>
<Initials>JW</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Chonnam National University Hwasun Hospital, Hwasun 519-763, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lim</LastName>
<ForeName>Hyo Soon</ForeName>
<Initials>HS</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Chonnam National University Hwasun Hospital, Hwasun 519-763, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shin</LastName>
<ForeName>Sang Soo</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Chonnam National University Hospital, Gwangju 501-757, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jeong</LastName>
<ForeName>Yong Yeon</ForeName>
<Initials>YY</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Chonnam National University Hwasun Hospital, Hwasun 519-763, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kang</LastName>
<ForeName>Heoung Keun</ForeName>
<Initials>HK</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Chonnam National University Hwasun Hospital, Hwasun 519-763, Korea.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>09</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Korea (South)</Country>
<MedlineTA>Korean J Radiol</MedlineTA>
<NlmUniqueID>100956096</NlmUniqueID>
<ISSNLinking>1229-6929</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C073590">gadolinium ethoxybenzyl DTPA</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>K2I13DR72L</RegistryNumber>
<NameOfSubstance UI="D019786">Gadolinium DTPA</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2001 Apr;34(4):570-5</RefSource>
<PMID Version="1">11394657</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiology. 2005 Feb;234(2):468-78</RefSource>
<PMID Version="1">15591431</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiology. 2004 Jan;230(1):266-75</RefSource>
<PMID Version="1">14695400</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AJR Am J Roentgenol. 1984 Mar;142(3):619-24</RefSource>
<PMID Version="1">6607655</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AJR Am J Roentgenol. 1984 Mar;142(3):625-30</RefSource>
<PMID Version="1">6607656</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 1993 Jan-Feb;3(1):137-48</RefSource>
<PMID Version="1">8428081</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroradiology. 1994;36(1):27-30</RefSource>
<PMID Version="1">8107991</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiology. 1995 Jun;195(3):785-92</RefSource>
<PMID Version="1">7754011</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiology. 1996 Apr;199(1):177-83</RefSource>
<PMID Version="1">8633143</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiology. 1996 Jul;200(1):59-67</RefSource>
<PMID Version="1">8657946</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Radiol. 1997;7(2):275-80</RefSource>
<PMID Version="1">9038130</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiology. 2005 Oct;237(1):89-98</RefSource>
<PMID Version="1">16126918</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Radiol. 2005 Nov;40(11):715-24</RefSource>
<PMID Version="1">16230904</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comput Assist Tomogr. 2006 May-Jun;30(3):345-54</RefSource>
<PMID Version="1">16778605</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Radiol. 2008 Mar;18(3):457-67</RefSource>
<PMID Version="1">18058107</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Radiol. 2009 Feb;19(2):342-57</RefSource>
<PMID Version="1">18810454</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Invest Radiol. 2009 Jun;44(6):305-10</RefSource>
<PMID Version="1">19462484</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Roentgenol. 2009 Oct;44(4):266-82</RefSource>
<PMID Version="1">19715792</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Korean J Hepatol. 2009 Sep;15(3):391-423</RefSource>
<PMID Version="1">19783891</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Magn Reson Imaging. 2010 Feb;31(2):365-72</RefSource>
<PMID Version="1">20099350</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comput Assist Tomogr. 2010 Mar-Apr;34(2):163-72</RefSource>
<PMID Version="1">20351497</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2011 Mar;53(3):1020-2</RefSource>
<PMID Version="1">21374666</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Radiol. 2012 Nov 1;53(9):961-5</RefSource>
<PMID Version="1">23024179</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Radiol. 2001;11(8):1374-88</RefSource>
<PMID Version="1">11519546</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016477">Artifacts</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006528">Carcinoma, Hepatocellular</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003287">Contrast Media</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004305">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019786">Gadolinium DTPA</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006499">Hepatic Artery</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008113">Liver Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059629">Signal-To-Noise Ratio</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4170161</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Gadoxetic acid</Keyword>
<Keyword MajorTopicYN="N">Hepatocellular carcinoma</Keyword>
<Keyword MajorTopicYN="N">Injection rate</Keyword>
<Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24497089</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1438-9010</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>186</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>RFo : Fortschritte auf dem Gebiete der Rntgenstrahlen und der Nuklearmedizin</Title>
<ISOAbbreviation>Rofo</ISOAbbreviation>
</Journal>
<ArticleTitle>[Extensive pneumatization of the occipital bone with atlanto-occipital pneumarthrosis].</ArticleTitle>
<Pagination>
<MedlinePgn>962-3</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0033-1356419</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kalmar</LastName>
<ForeName>P I</ForeName>
<Initials>PI</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vollmann</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Ausgedehnte Pneumatisation des Os occipitale mit einem atlantookzipitalen Pneumarthros.</VernacularTitle>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>02</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Rofo</MedlineTA>
<NlmUniqueID>7507497</NlmUniqueID>
<ISSNLinking>1438-9010</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000388">Air</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001168">Arthritis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001269">Atlanto-Occipital Joint</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006562">Herpes Zoster</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009437">Neuralgia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009777">Occipital Bone</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011007">Pneumocephalus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24648233</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1438-9010</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>186</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>RFo : Fortschritte auf dem Gebiete der Rntgenstrahlen und der Nuklearmedizin</Title>
<ISOAbbreviation>Rofo</ISOAbbreviation>
</Journal>
<ArticleTitle>Cardiac remodeling following percutaneous mitral valve repair - initial results assessed by cardiovascular magnetic resonance imaging.</ArticleTitle>
<Pagination>
<MedlinePgn>951-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0034-1366216</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Percutaneous mitral valve repair with the MitraClip device (Abbott Vascular, Redwood City, California, USA) is a novel therapeutic option in patients with mitral regurgitation. This study evaluated the feasibility of cardiac volume measurements by cardiovascular magnetic resonance imaging (CMR) to assess reverse myocardial remodeling in patients after MitraClip implantation.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">12 patients underwent CMR at baseline (BL) before and at 6 months follow-up (FU) after MitraClip implantation. Cine-CMR was performed in short- and long-axes for the assessment of left ventricular (LV), right ventricular (RV) and left atrial (LA) volumes.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Assessment of endocardial contours was not compromised by the device-related artifact. No significant differences in observer variances were observed for LV, RV and LA volume measurements between BL and FU. LV end-diastolic (median 127 [IQR 96-150] vs. 112 [86-150] ml/m(2); p=0.03) and LV end-systolic (82 [54-91] vs. 69 [48-99] ml/m(2); p=0.03) volume indices decreased significantly from BL to FU. No significant differences were found for RV end-diastolic (94 [75-103] vs. 99 [77-123] ml/m(2); p=0.91), RV end-systolic (48 [42-80] vs. 51 [40-81] ml/m(2); p=0.48), and LA (87 [55-124] vs. 92 [48-137] ml/m(2); p=0.20) volume indices between BL and FU.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">CMR enables the assessment of cardiac volumes in patients after MitraClip implantation. Our CMR findings indicate that percutaneous mitral valve repair results in reverse LV but not in RV or LA remodeling.</AbstractText>
<AbstractText Label="KEY POINTS" NlmCategory="CONCLUSIONS">Volume measurements by cardiovascular magnetic resonance imaging are feasible following percutaneous mitral valve repair despite device-related artifacts.A significant reduction of left ventricular volume was found in terms of beneficial, reverse left ventricular remodeling after 6-month follow-up.No significant reduction was found in right ventricular or left atrial volumes after percutaneous mitral valve repair after 6-month follow-up.</AbstractText>
<CopyrightInformation>Georg Thieme Verlag KG Stuttgart  New York.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Radunski</LastName>
<ForeName>U K</ForeName>
<Initials>UK</Initials>
<AffiliationInfo>
<Affiliation>Cardiology, University Heart Center, Hamburg.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Franzen</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Cardiology, Rigshospitalet, Copenhagen.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barmeyer</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Cardiology, Klinikum Dortmund.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lange</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Cardiology, University Heart Center, Hamburg.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lund</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Radiology, University Medical Center Hamburg-Eppendorf, Hamburg.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rudolph</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Cardiology, University Heart Center, Hamburg.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schlter</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Cardiology, University Heart Center, Hamburg.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Adam</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Radiology, University Medical Center Hamburg-Eppendorf, Hamburg.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reichenspurner</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Cardiovascular Surgery, University Heart Center, Hamburg.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Blankenberg</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Cardiology, University Heart Center, Hamburg.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baldus</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Cardiology, University Heart Center, Hamburg.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Muellerleile</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Cardiology, University Heart Center, Hamburg.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>03</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Rofo</MedlineTA>
<NlmUniqueID>7507497</NlmUniqueID>
<ISSNLinking>1438-9010</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016477">Artifacts</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006328">Cardiac Catheterization</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002306">Cardiac Volume</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004452">Echocardiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004867">Equipment Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005240">Feasibility Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006325">Heart Atria</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006352">Heart Ventricles</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019028">Magnetic Resonance Imaging, Cine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019060">Minimally Invasive Surgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008943">Mitral Valve</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008944">Mitral Valve Insufficiency</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013525">Surgical Instruments</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020257">Ventricular Remodeling</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24729409</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1438-9010</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>186</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>RFo : Fortschritte auf dem Gebiete der Rntgenstrahlen und der Nuklearmedizin</Title>
<ISOAbbreviation>Rofo</ISOAbbreviation>
</Journal>
<ArticleTitle>Chemosaturation with percutaneous hepatic perfusions of melphalan for hepatic metastases: experience from two European centers.</ArticleTitle>
<Pagination>
<MedlinePgn>937-44</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0034-1366081</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Chemosaturation with percutaneous hepatic perfusion (PHP; Hepatic CHEMOSAT() Delivery System; Delcath Systems Inc, USA) is a minimally invasive, repeatable regional therapy for unresectable hepatic metastases. It uses a system of catheters and filters to isolate hepatic venous blood from the systemic circulation, allowing delivery of high-dose chemotherapy to the hepatic artery. Effluent hepatic venous blood is filtered before being returned to the systemic circulation, thereby reducing exposure to chemotherapy. We describe our experiences with chemosaturation-PHP at 2 European centers.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">14 patients presented unresectable hepatic metastases from solid tumors; 13 received 1-3 sessions of chemosaturation-PHP. Melphalan 2.0 (n=1) or 3.0 (n=12) mg/kg was given as a 30-minute infusion into the hepatic artery. 12 patients were evaluable for tumor response.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">One complete (cholangiocarcinoma, n=1) and 6 partial responses (ocular, n=3 or cutaneous melanoma, n=3) were observed, 5 patients had stable disease (ocular melanoma, n=3; breast cancer, n=1; gastric cancer, n=1). Mild to moderate filter-related toxicity (i.e. thrombocytopenia, anemia) was observed immediately post-procedure. Grade 3/4 melphalan-related pancytopenia developed after 1-2 weeks. All hematological events were managed effectively with transfusions and/or other supportive measures. The new high-efficiency filter showed milder toxicity and faster recovery. In one case, chemosaturation-PHP was abandoned prematurely due to heparin-induced vaginal bleeding, and one patient died due to retroperitoneal hemorrhage from heparin anti-coagulation.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Chemosaturation-PHP for non-resectable liver metastases is a feasible treatment option when performed by an experienced multi-disciplinary team. It may be a promising regional therapy for patients with no effective treatment options.</AbstractText>
<CopyrightInformation>Georg Thieme Verlag KG Stuttgart  New York.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vogl</LastName>
<ForeName>T J</ForeName>
<Initials>TJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Diagnostic and Interventional Radiology, University Hospital of Frankfurt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zangos</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Diagnostic and Interventional Radiology, University Hospital of Frankfurt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Scholtz</LastName>
<ForeName>J E</ForeName>
<Initials>JE</Initials>
<AffiliationInfo>
<Affiliation>Department of Diagnostic and Interventional Radiology, University Hospital of Frankfurt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schmitt</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Diagnostic and Interventional Radiology, University Hospital of Frankfurt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Paetzold</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Dermatology, Venerology and Allergology, University Hospital of Frankfurt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Trojan</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine I, University Hospital of Frankfurt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Orsi</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Unit of Interventional Radiology, European Institute of Oncology, Milan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lotz</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital of Frankfurt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ferrucci</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Translational Research on Melanoma, European Institute of Oncology, Milan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>04</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Rofo</MedlineTA>
<NlmUniqueID>7507497</NlmUniqueID>
<ISSNLinking>1438-9010</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>Q41OR9510P</RegistryNumber>
<NameOfSubstance UI="D008558">Melphalan</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010478">Chemotherapy, Cancer, Regional Perfusion</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004305">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004867">Equipment Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D005060">Europe</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005374">Filtration</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008113">Liver Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000556">secondary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008558">Melphalan</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25122173</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1438-9010</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>186</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>RFo : Fortschritte auf dem Gebiete der Rntgenstrahlen und der Nuklearmedizin</Title>
<ISOAbbreviation>Rofo</ISOAbbreviation>
</Journal>
<ArticleTitle>Radiological evaluation of the therapeutic response of malignant diseases: status quo, innovative developments and requirements for radiology.</ArticleTitle>
<Pagination>
<MedlinePgn>927-36</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0034-1366741</ELocationID>
<Abstract>
<AbstractText Label="UNLABELLED">In consequence of the rapid development of newer targeted and personalized tumor therapies, radiology as an essential component of the treatment concept of numerous malignant diseases needs to improve in order to adequately capture and evaluate the effects, but also the side effects of these novel therapeutic agents. The early recognition of therapy response or failure is crucial for the optimal planning of the further treatment and can therefore have direct impact on the chances of recovery and the survival time of oncological patients. In previous years, the goal of medical imaging was to just qualitatively assess the increase or reduction in the size of tumors and their metastases, which was often achieved by a simple subjective estimation of the tumor findings by the diagnosing radiologist. Nowadays, radiology is faced with the challenge of evaluating changes during therapy quantitatively and of visualizing therapeutic effects that are more discrete (e.g. necrosis, altered tumor perfusion). The importance of an adequate assessment of therapy response is further underlined by the fact that in these days, a good portion of oncological patients are enrolled in clinical trials, in which the quantitative radiological evaluation of malignant disorders is an important surrogate parameter. On the basis of this development, the demands for radiology to provide more sophisticated assessments of therapy response and documentation of imaging findings have been constantly growing. The following article provides an overview of the established and still widely spread but in particular also the latest imaging modalities and evaluation criteria with regard to oncological diseases as well as of the increasing demands on radiology that result from these developments. Beyond that, future advancements in tumor imaging are taken into account and the new challenges these developments will bring are discussed.</AbstractText>
<AbstractText Label="KEY POINTS" NlmCategory="CONCLUSIONS">In the era of personalized medicine, evaluation criteria that are individually adapted to the respective patient are required.Radiology needs to substantially contribute to oncological treatment concepts and the evaluation of therapeutic response.</AbstractText>
<CopyrightInformation>Georg Thieme Verlag KG Stuttgart  New York.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hink</LastName>
<ForeName>A J</ForeName>
<Initials>AJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Heindel</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Buerke</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Rofo</MedlineTA>
<NlmUniqueID>7507497</NlmUniqueID>
<ISSNLinking>1438-9010</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006528">Carcinoma, Hepatocellular</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003287">Contrast Media</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003952">Diagnostic Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D038524">Diffusion Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D046152">Gastrointestinal Stromal Tumors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008113">Liver Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008223">Lymphoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009682">Magnetic Resonance Spectroscopy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D047368">Tumor Burden</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014463">Ultrasonography</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25243448</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1438-9010</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>186</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>RFo : Fortschritte auf dem Gebiete der Rntgenstrahlen und der Nuklearmedizin</Title>
<ISOAbbreviation>Rofo</ISOAbbreviation>
</Journal>
<ArticleTitle>[Lung volume reduction by coils and valves and the role of CT-imaging].</ArticleTitle>
<Pagination>
<MedlinePgn>909-13</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0034-1369265</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Horger</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Grosse</LastName>
<ForeName>U</ForeName>
<Initials>U</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hetzel</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ioanoviciu</LastName>
<ForeName>S D</ForeName>
<Initials>SD</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Lungenvolumenreduktion (LVR) mittels Coils und Ventilen: Die Rolle der CT-Bildgebung.</VernacularTitle>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>09</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Rofo</MedlineTA>
<NlmUniqueID>7507497</NlmUniqueID>
<ISSNLinking>1438-9010</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001999">Bronchoscopy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004621">Embolization, Therapeutic</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004867">Equipment Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004868">Equipment Failure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008168">Lung</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000098">blood supply</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011013">Pneumonectomy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019736">Prostheses and Implants</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011656">Pulmonary Emphysema</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015642">Radiology, Interventional</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011877">Radionuclide Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014692">Ventilation-Perfusion Ratio</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25055154</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1546-3141</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>203</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>AJR. American journal of roentgenology</Title>
<ISOAbbreviation>AJR Am J Roentgenol</ISOAbbreviation>
</Journal>
<ArticleTitle>Dose-toxicity relationship of gadoxetate disodium and transient severe respiratory motion artifact.</ArticleTitle>
<Pagination>
<MedlinePgn>796-802</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2214/AJR.13.11587</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The purpose of this article is to determine whether there is a dose-toxicity relationship between gadoxetate disodium and transient severe respiratory motion artifact.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Gadoxetate disodium-enhanced MRI studies (559 studies of 559 patients) using a fixed 20-mL (2 mL/s; n = 112) or 10-mL (1-2 mL/s; n = 447) volume at two health systems were included (dose range, 0.05-0.42 mL/kg; mean, 0.15 mL/kg; above-label dosing, 479 [86%]). Each dynamic phase was assigned a respiratory motion score from 1 (none) to 5 (nondiagnostic). Examinations with an unenhanced score of 1-2, arterial score of 4-5, and venous or late-dynamic scores of 1-3 were labeled as transient severe respiratory motion artifact. Stepwise multivariate logistic regression was performed.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The overall incidence of transient severe respiratory motion artifact was 12% (67/559; site 1, 15% [35/232]; site 2, 9.8% [32/327]). The administered volume of contrast material had a statistically significant effect (20 mL, 20% [22/112] vs 10 mL, 10%, [45/447]; multivariate p = 0.01; odds ratio, 2.1 [20 vs 10 mL]; 95% CI, 1.2-3.7). There was no dose-toxicity relationship for dose-by-weight (p = 0.61 [multivariate]) or above-label dosing (p = 0.88 [univariate]; 13% [10/80] rate for at- or below-label dosing vs 12% [57/479] rate for above-label dosing). Chronic obstructive pulmonary disease was the only non-dose-related predictor in the multivariate model (p &lt; 0.0001; OR, 5.1 [95% CI, 2.5-11.5]; 39% [12/31] vs 10% [55/528]).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Gadoxetate disodium-associated transient severe respiratory motion artifact is significantly more common after 20-mL administration (2 mL/s) and occurs significantly more often in patients with chronic obstructive pulmonary disease. The volume-related effect suggests a nonallergiclike mechanism.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Davenport</LastName>
<ForeName>Matthew S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Radiology, University of Michigan Health System, 1500 E Medical Center Dr, B2 A209P, Ann Arbor, MI 48109.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bashir</LastName>
<ForeName>Mustafa R</ForeName>
<Initials>MR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pietryga</LastName>
<ForeName>Jason A</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Weber</LastName>
<ForeName>Joseph T</ForeName>
<Initials>JT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Khalatbari</LastName>
<ForeName>Shokoufeh</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hussain</LastName>
<ForeName>Hero K</ForeName>
<Initials>HK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>UL1TR000433</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>AJR Am J Roentgenol</MedlineTA>
<NlmUniqueID>7708173</NlmUniqueID>
<ISSNLinking>0361-803X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C073590">gadolinium ethoxybenzyl DTPA</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>K2I13DR72L</RegistryNumber>
<NameOfSubstance UI="D019786">Gadolinium DTPA</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016477">Artifacts</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003287">Contrast Media</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004305">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019786">Gadolinium DTPA</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009068">Movement</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015656">Respiratory Mechanics</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">artifact</Keyword>
<Keyword MajorTopicYN="N">complication</Keyword>
<Keyword MajorTopicYN="N">gadoxetate disodium</Keyword>
<Keyword MajorTopicYN="N">respiratory motion</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25055198</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1546-3141</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>203</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>AJR. American journal of roentgenology</Title>
<ISOAbbreviation>AJR Am J Roentgenol</ISOAbbreviation>
</Journal>
<ArticleTitle>Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.</ArticleTitle>
<Pagination>
<MedlinePgn>W408-14</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2214/AJR.13.12251</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Inflammatory hepatocellular adenoma (HCA) is a recently categorized entity of hepatocellular neoplasms. We investigated whether gadoxetic acid-enhanced MRI can distinguish inflammatory HCA from focal nodular hyperplasia (FNH).</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">From January 1, 2009, through January 1, 2013, gadoxetic acid-enhanced MRI examinations from two institutions were reviewed for HCA, with specific histologic features of inflammatory HCA. Biopsy and resection slides were reviewed, and immunohistochemistry for glutamine synthetase was performed in a subset to confirm the initial diagnosis.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 10 possible cases of inflammatory HCA were identified in the pathology database. On the basis of glutamine synthetase staining performed for this study, three cases were rediagnosed as FNH and thus were excluded from the study. Therefore, a total of seven patients with inflammatory HCA were identified. On gadoxetic acid-enhanced MRI, four of these patients had classic features of FNH (group A, FNH mimics), and three had imaging features suggestive of HCA (group B, typical inflammatory HCA). Imaging features that were considered diagnostic of FNH included isointense or minimal T2 hyperintensity, arterial enhancement, and diffuse hyperintensity on hepatobiliary phase. Three of the four patients with FNH mimics had slides available for pathologic rereview, and the diagnosis of inflammatory HCA was supported by glutamine synthetase immunohistochemistry findings. The pathology reports of the remaining four cases were rereviewed and were also found to have features consistent with inflammatory HCA.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Inflammatory HCA can mimic FNH on MRI, including hepatobiliary phase hyperintensity. Moreover, conventional pathology using histopathology alone may lead to misclassification of inflammatory HCA.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Agarwal</LastName>
<ForeName>Sheela</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>1 Division of Abdominal Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St, Boston, MA 02114.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fuentes-Orrego</LastName>
<ForeName>Jorge M</ForeName>
<Initials>JM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Arnason</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Misdraji</LastName>
<ForeName>Joseph</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jhaveri</LastName>
<ForeName>Kartik S</ForeName>
<Initials>KS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Harisinghani</LastName>
<ForeName>Mukesh</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hahn</LastName>
<ForeName>Peter F</ForeName>
<Initials>PF</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>07</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>AJR Am J Roentgenol</MedlineTA>
<NlmUniqueID>7708173</NlmUniqueID>
<ISSNLinking>0361-803X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C073590">gadolinium ethoxybenzyl DTPA</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>K2I13DR72L</RegistryNumber>
<NameOfSubstance UI="D019786">Gadolinium DTPA</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018248">Adenoma, Liver Cell</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003287">Contrast Media</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005189">False Positive Reactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020518">Focal Nodular Hyperplasia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019786">Gadolinium DTPA</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006505">Hepatitis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008113">Liver Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015588">Observer Variation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">contrast-enhanced MRI</Keyword>
<Keyword MajorTopicYN="N">gadoxetate disodium</Keyword>
<Keyword MajorTopicYN="N">inflammatory hepatocellular adenoma</Keyword>
<Keyword MajorTopicYN="N">liver imaging</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25247931</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1546-3141</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>203</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>AJR. American journal of roentgenology</Title>
<ISOAbbreviation>AJR Am J Roentgenol</ISOAbbreviation>
</Journal>
<ArticleTitle>Reply to "Enlarged CSF spaces in pseudotumor cerebri".</ArticleTitle>
<Pagination>
<MedlinePgn>W459</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2214/AJR.14.12916</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Saindane</LastName>
<ForeName>Amit M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>1 Emory University School of Medicine, Atlanta, GA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bruce</LastName>
<ForeName>Beau B</ForeName>
<Initials>BB</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K23-EY019341</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>AJR Am J Roentgenol</MedlineTA>
<NlmUniqueID>7708173</NlmUniqueID>
<ISSNLinking>0361-803X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>AJR Am J Roentgenol. 2014 Mar;202(3):608-13</RefSource>
<PMID Version="1">24555598</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>AJR Am J Roentgenol. 2014 Oct;203(4):W457-8</RefSource>
<PMID Version="1">25247982</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004677">Encephalocele</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008588">Meningocele</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011559">Pseudotumor Cerebri</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25247946</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1546-3141</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>203</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>AJR. American journal of roentgenology</Title>
<ISOAbbreviation>AJR Am J Roentgenol</ISOAbbreviation>
</Journal>
<ArticleTitle>MRI findings after prostatic artery embolization for treatment of benign hyperplasia.</ArticleTitle>
<Pagination>
<MedlinePgn>813-21</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2214/AJR.13.11692</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The purpose of this article is to assess and describe the MRI findings after prostatic artery embolization for treatment of benign prostatic hyperplasia.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We retrospectively evaluated 17 patients who underwent prostatic artery embolization as part of different prospective studies to evaluate this alternative treatment of benign prostatic hyperplasia. Clinical results were evaluated by assessment of urinary catheterization and International Prostate Symptom Score (IPSS). Serial MRI examinations were performed, and the prostatic central gland and peripheral zone were evaluated for signal intensity changes and the presence and characteristics of infarcted areas. Statistical analysis was performed with ANOVA for repeated measures and Student t test.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">All patients had clinical success, as defined by the removal of indwelling urinary catheter or decreased IPSS after embolization. Infarcts were seen in 70.6% of the subjects, exclusively in the central gland, were almost always characterized by hyperintensity on T1-weighted images and predominant hypointensity on T2-weighted images, and became smaller (mean reduction, p &lt; 0.001) and isointense to the remaining of the central gland over time. Volume reduction of the prostate after embolization was significant (averaging 32.0% after 12-18 months; p &lt; 0.001) only in patients with infarcts. No statistically significant association was seen between the development of infarcts and IPSS.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">MRI can be used for assessing the development of infarcts and volume reduction in the prostate after embolization. Further studies are needed to correlate these findings to clinical outcome.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Frenk</LastName>
<ForeName>Nathan E</ForeName>
<Initials>NE</Initials>
<AffiliationInfo>
<Affiliation>1 Instituto de Radiologia, Hospital das Clnicas, Faculdade de Medicina da Universidade de So Paulo, Av Dr. Enas Carvalho de Aguiar, s/n Rua 1, Cerqueira Csa, So Paulo, SP 05403-900, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baroni</LastName>
<ForeName>Ronaldo H</ForeName>
<Initials>RH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Carnevale</LastName>
<ForeName>Francisco C</ForeName>
<Initials>FC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gonalves</LastName>
<ForeName>Octavio M G</ForeName>
<Initials>OM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Antunes</LastName>
<ForeName>Alberto A</ForeName>
<Initials>AA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Srougi</LastName>
<ForeName>Miguel</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cerri</LastName>
<ForeName>Giovanni G</ForeName>
<Initials>GG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>AJR Am J Roentgenol</MedlineTA>
<NlmUniqueID>7708173</NlmUniqueID>
<ISSNLinking>0361-803X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000180">Acrylic Resins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006490">Hemostatics</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C496735">trisacryl gelatin microspheres</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9000-70-8</RegistryNumber>
<NameOfSubstance UI="D005780">Gelatin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000180">Acrylic Resins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005780">Gelatin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006490">Hemostatics</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011467">Prostate</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000098">blood supply</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011470">Prostatic Hyperplasia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">benign prostatic hyperplasia</Keyword>
<Keyword MajorTopicYN="N">prostate MRI</Keyword>
<Keyword MajorTopicYN="N">prostatic artery embolization</Keyword>
<Keyword MajorTopicYN="N">prostatic infarct</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25247952</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1546-3141</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>203</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>AJR. American journal of roentgenology</Title>
<ISOAbbreviation>AJR Am J Roentgenol</ISOAbbreviation>
</Journal>
<ArticleTitle>Tumor load in patients with multiple myeloma: 2-microglobulin levels versus whole-body MRI.</ArticleTitle>
<Pagination>
<MedlinePgn>854-62</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2214/AJR.13.10724</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Beta-2-microglobulin is a serum maker of tumor burden in hematologic malignancies. We aimed to correlate serum 2-microglobulin levels in patients with multiple myeloma (MM) to tumor mass determined by whole-body MRI.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We retrospectively included patients with newly diagnosed, untreated MM who underwent whole-body MRI at our institution between 2003 and 2011. Patients with a glomerular filtration rate of less than 60 mL/min were excluded from analysis because 2-microglobulin levels are increased in renal failure. Thirty patients could be included. Whole-body MRI examinations (T1-weighted turbo spin-echo and STIR sequences) were assessed by two musculoskeletal radiologists in consensus for focal lesions and the presence of diffuse myeloma infiltration. The presence of diffuse infiltration was confirmed by histology as the reference standard. MM was staged according to the Durie and Salmon PLUS staging system.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">According to whole-body MRI findings, MM was classified as Durie and Salmon PLUS stage I (low grade) in 13 patients, stage II (intermediate grade) in six patients, and stage III (high grade) in 11 patients. As we expected, most patients with stage I disease (12/13) had normal 2-microglobulin levels ( 3 mg/L). Higher 2-microglobulin values were associated with a higher stage of disease (p &lt; 0.05). However, five of six patients with stage II MM and five of 11 patients with stage III MM showed normal 2-microglobulin levels. Thus, 10 of 17 patients (58.8%) with substantial infiltration in the bone marrow showed false-negative 2-microglobulin levels.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Serum 2-microglobulin levels correlate with tumor stage in MM. However, it may be misleading as a marker of tumor load in a subset of patients with substantial myeloma infiltration in the bone marrow. Whole-body MRI may display the full tumor load and correctly show the extension of myeloma infiltrates.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>D'Anastasi</LastName>
<ForeName>Melvin</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>1 Institute for Clinical Radiology, University Hospitals Munich, Campus Grosshadern, Ludwig-Maximilians-Universitt, Marchioninistrasse 15, 81377 Munich, Bayern, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Notohamiprodjo</LastName>
<ForeName>Mike</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schmidt</LastName>
<ForeName>Gerwin P</ForeName>
<Initials>GP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Drr</LastName>
<ForeName>Hans-Roland</ForeName>
<Initials>HR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reiser</LastName>
<ForeName>Maximilian Ferdinand</ForeName>
<Initials>MF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Baur-Melnyk</LastName>
<ForeName>Andrea</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>AJR Am J Roentgenol</MedlineTA>
<NlmUniqueID>7708173</NlmUniqueID>
<ISSNLinking>0361-803X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014408">Tumor Markers, Biological</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001613">beta 2-Microglobulin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009101">Multiple Myeloma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D047368">Tumor Burden</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014408">Tumor Markers, Biological</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051598">Whole Body Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001613">beta 2-Microglobulin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">MRI</Keyword>
<Keyword MajorTopicYN="N">multiple myeloma</Keyword>
<Keyword MajorTopicYN="N">tumor burden</Keyword>
<Keyword MajorTopicYN="N">whole-body imaging</Keyword>
<Keyword MajorTopicYN="N">2-microglobulin</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25247969</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1546-3141</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>203</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>AJR. American journal of roentgenology</Title>
<ISOAbbreviation>AJR Am J Roentgenol</ISOAbbreviation>
</Journal>
<ArticleTitle>Lymphoid nodular hyperplasia of the terminal ileum can mimic active crohn disease on MR enterography.</ArticleTitle>
<Pagination>
<MedlinePgn>W400-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2214/AJR.13.12055</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The purpose of this article is to describe the MRI findings associated with lymphoid nodular hyperplasia at MR enterography and test the ability of radiologists to differentiate healthy control subjects from patients with Crohn disease (CD).</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Ethical approval was granted for this retrospective study. Thirty-five subjects (nine with lymphoid nodular hyperplasia, 13 with CD, and 13 control subjects) who had undergone MR enterography and ileocolonoscopy were identified from the hospital database. Two abdominal radiologists, working in consensus and blinded to diagnosis, scored enteric MR images for T2 signal, contrast enhancement, mural thickness, and diffusion-weighted imaging (DWI) signal and measured the apparent diffusion coefficient (ADC) in all three groups. Scores were compared using the Kruskal-Wallis test.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">T2 signal and contrast enhancement were judged subjectively to be greater in patients with lymphoid nodular hyperplasia and CD than control subjects (p &lt; 0.001). Mural thickness was greater for patients with lymphoid nodular hyperplasia (median, 6.0 mm) and CD (median, 7.3 mm) than control subjects (median, 2.3 mm) (p &lt; 0.001). Lymphoid nodular hyperplasia and CD increased subjective DWI signal and reduced ADC in comparison with normal control subjects; median ADC was 1.34  10(-3) mm(2)/s for lymphoid nodular hyperplasia, 1.36  10(-3) mm(2)/s for CD, and 1.86  10(-3) mm(2)/s for control subjects (p &lt; 0.001). None of T2 signal, contrast enhancement, wall thickness, DWI signal, or ADC value significantly differed between lymphoid nodular hyperplasia and CD. Lymphoid nodular hyperplasia was erroneously diagnosed as CD in blinded assessment in four of nine cases (44%), whereas all cases of CD and healthy control subjects were correctly classified.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Lymphoid nodular hyperplasia alters both subjective and quantitative MRI parameters, including T2 signal, contrast enhancement, mural thickness, and ADC. In a subset of patients, lymphoid nodular hyperplasia may be indistinguishable from CD on MR enterography.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Plumb</LastName>
<ForeName>Andrew A</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>1 Centre for Medical Imaging, University College London, Podium Level 2, University College Hospital, 235 Euston Rd, London, NW1 2BU, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pends</LastName>
<ForeName>Douglas A</ForeName>
<Initials>DA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>McCartney</LastName>
<ForeName>Sara</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Punwani</LastName>
<ForeName>Shonit</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Halligan</LastName>
<ForeName>Steve</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Taylor</LastName>
<ForeName>Stuart A</ForeName>
<Initials>SA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>AJR Am J Roentgenol</MedlineTA>
<NlmUniqueID>7708173</NlmUniqueID>
<ISSNLinking>0361-803X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003424">Crohn Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007078">Ileal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007082">Ileum</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019310">Pseudolymphoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016037">Single-Blind Method</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Crohn disease</Keyword>
<Keyword MajorTopicYN="N">MR enterography</Keyword>
<Keyword MajorTopicYN="N">diffusion-weighted imaging</Keyword>
<Keyword MajorTopicYN="N">lymphoid nodular hyperplasia</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25247971</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1546-3141</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>203</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>AJR. American journal of roentgenology</Title>
<ISOAbbreviation>AJR Am J Roentgenol</ISOAbbreviation>
</Journal>
<ArticleTitle>In-phase signal intensity loss in solid renal masses on dual-echo gradient-echo MRI: association with malignancy and pathologic classification.</ArticleTitle>
<Pagination>
<MedlinePgn>W421-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2214/AJR.13.11113</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The purposes of this study were to determine the prevalence of in-phase signal intensity loss on dual-echo gradient-echo MRI in solid renal masses using visual and quantitative techniques and to test for any association between in-phase signal intensity loss and pathologic classification.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The renal MRI studies of 177 patients (192 solid masses consisting of 166 renal cell carcinomas [RCCs], four malignant non-RCCs, and 22 benign tumors) were qualitatively reviewed by two blinded readers for visual evidence of relative in-phase signal intensity loss. For lesions without visual evidence, whole-lesion ROIs were used to attempt quantification of subtle signal intensity loss between opposed- and in-phase images (signal intensity loss index).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Visual in-phase signal intensity loss was noted in 18% of clear cell RCC, 42% of papillary RCC, and no benign lesions. There was significant correlation between malignancy and visual signal intensity loss (Fisher exact test, p = 0.0092). Visual signal intensity loss was predictive of papillary RCC over clear cell RCC (odds ratio, 5.79; p = 0.0002) in logistic regression analysis of all RCCs, controlling for size. Quantitative assessment of remaining lesions provided no additional diagnostic benefit.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Visible in-phase signal intensity loss is relatively common within solid renal masses and was associated with RCC and particularly papillary RCC (among all RCCs) in our population. Quantitative analysis in lesions without visible signal intensity loss was not predictive of RCC. Further work should be performed to validate the usefulness of this additional imaging parameter to help characterize renal masses and to determine the impact of this finding on imaging techniques potentially sensitive to susceptibility effects.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Childs</LastName>
<ForeName>David D</ForeName>
<Initials>DD</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Radiology, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Clingan</LastName>
<ForeName>M Jennings</ForeName>
<Initials>MJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zagoria</LastName>
<ForeName>Ronald J</ForeName>
<Initials>RJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sirintrapun</LastName>
<ForeName>Joseph</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tangtiang</LastName>
<ForeName>Kaan</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Anderson</LastName>
<ForeName>Andrea</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Leyendecker</LastName>
<ForeName>John R</ForeName>
<Initials>JR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>AJR Am J Roentgenol</MedlineTA>
<NlmUniqueID>7708173</NlmUniqueID>
<ISSNLinking>0361-803X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016477">Artifacts</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002292">Carcinoma, Renal Cell</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007680">Kidney Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059629">Signal-To-Noise Ratio</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016037">Single-Blind Method</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">dual-echo gradient-echo MRI</Keyword>
<Keyword MajorTopicYN="N">hemosiderin</Keyword>
<Keyword MajorTopicYN="N">renal MRI</Keyword>
<Keyword MajorTopicYN="N">renal mass</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25247976</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1546-3141</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>203</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>AJR. American journal of roentgenology</Title>
<ISOAbbreviation>AJR Am J Roentgenol</ISOAbbreviation>
</Journal>
<ArticleTitle>A fifth mesh appearance: the gas density mesh.</ArticleTitle>
<Pagination>
<MedlinePgn>W449</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2214/AJR.13.12429</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Scheinfeld</LastName>
<ForeName>Meir H</ForeName>
<Initials>MH</Initials>
<AffiliationInfo>
<Affiliation>1 Montefiore Medical Center, Bronx, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Avery</LastName>
<ForeName>Laura L</ForeName>
<Initials>LL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>AJR Am J Roentgenol</MedlineTA>
<NlmUniqueID>7708173</NlmUniqueID>
<ISSNLinking>0361-803X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>AJR Am J Roentgenol. 2013 Dec;201(6):1180-3</RefSource>
<PMID Version="1">24261353</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059685">Herniorrhaphy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013526">Surgical Mesh</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000145">classification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25247980</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1546-3141</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>203</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>AJR. American journal of roentgenology</Title>
<ISOAbbreviation>AJR Am J Roentgenol</ISOAbbreviation>
</Journal>
<ArticleTitle>Central-variant posterior reversible encephalopathy syndrome: more than meets the eye.</ArticleTitle>
<Pagination>
<MedlinePgn>W454</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2214/AJR.14.12671</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gao</LastName>
<ForeName>Bo</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>1 Yantai Yuhuangding Hospital, Qingdao University Shandong, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lv</LastName>
<ForeName>Cui</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>AJR Am J Roentgenol</MedlineTA>
<NlmUniqueID>7708173</NlmUniqueID>
<ISSNLinking>0361-803X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>AJR Am J Roentgenol. 2014 Oct;203(4):W455</RefSource>
<PMID Version="1">25247981</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>AJR Am J Roentgenol. 2013 Sep;201(3):631-8</RefSource>
<PMID Version="1">23971457</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001479">Basal Ganglia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001933">Brain Stem</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054038">Posterior Leukoencephalopathy Syndrome</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25247981</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1546-3141</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>203</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>AJR. American journal of roentgenology</Title>
<ISOAbbreviation>AJR Am J Roentgenol</ISOAbbreviation>
</Journal>
<ArticleTitle>Reply to "Central-variant posterior reversible encephalopathy syndrome: more than meets the eye".</ArticleTitle>
<Pagination>
<MedlinePgn>W455</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2214/AJR.14.12824</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>McKinney</LastName>
<ForeName>Alexander M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>1 Hennepin County Medical Center University of Minnesota Medical Center, Minneapolis, MN.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>AJR Am J Roentgenol</MedlineTA>
<NlmUniqueID>7708173</NlmUniqueID>
<ISSNLinking>0361-803X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>AJR Am J Roentgenol. 2013 Sep;201(3):631-8</RefSource>
<PMID Version="1">23971457</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>AJR Am J Roentgenol. 2014 Oct;203(4):W454</RefSource>
<PMID Version="1">25247980</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001479">Basal Ganglia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001933">Brain Stem</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054038">Posterior Leukoencephalopathy Syndrome</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25247982</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1546-3141</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>203</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>AJR. American journal of roentgenology</Title>
<ISOAbbreviation>AJR Am J Roentgenol</ISOAbbreviation>
</Journal>
<ArticleTitle>Enlarged CSF spaces in pseudotumor cerebri.</ArticleTitle>
<Pagination>
<MedlinePgn>W457-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2214/AJR.14.12787</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>San Milln</LastName>
<ForeName>Diego</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>1 Hpital de Sion, Valais, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kohler</LastName>
<ForeName>Romain</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>AJR Am J Roentgenol</MedlineTA>
<NlmUniqueID>7708173</NlmUniqueID>
<ISSNLinking>0361-803X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>AJR Am J Roentgenol. 2014 Oct;203(4):W459</RefSource>
<PMID Version="1">25247931</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentOn">
<RefSource>AJR Am J Roentgenol. 2014 Mar;202(3):608-13</RefSource>
<PMID Version="1">24555598</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004677">Encephalocele</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008588">Meningocele</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011559">Pseudotumor Cerebri</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24760137</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1939-327X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>63</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Diabetes</Title>
<ISOAbbreviation>Diabetes</ISOAbbreviation>
</Journal>
<ArticleTitle>Cerebral microvascular lesions on high-resolution 7-Tesla MRI in patients with type 2 diabetes.</ArticleTitle>
<Pagination>
<MedlinePgn>3523-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2337/db14-0122</ELocationID>
<Abstract>
<AbstractText>Cerebral small vessel disease, including microvascular lesions, is considered to play an important role in the development of type 2 diabetes mellitus (T2DM)-associated cognitive deficits. With ultra-high field MRI, microvascular lesions (e.g., microinfarcts and microbleeds) can now be visualized in vivo. For the current study, 48 nondemented older individuals with T2DM (mean age 70.3  4.1 years) and 49 age-, sex-, and education-matched control subjects underwent a 7-Tesla brain MRI scan and a detailed cognitive assessment. The occurrence of cortical microinfarcts and cerebral microbleeds was assessed on fluid-attenuated inversion recovery and T1-weighted and T2*-weighted images, respectively, compared between the groups, and related to cognitive performance. Microinfarcts were found in 38% of control subjects and 48% of patients with T2DM. Microbleeds were present in 41% of control subjects and 33% of patients (all P &gt; 0.05). The presence and number of microinfarcts or microbleeds were unrelated to cognitive performance. This study showed that microvascular brain lesions on ultra-high field MRI are not significantly more common in well-controlled patients with T2DM than in control subjects. </AbstractText>
<CopyrightInformation> 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Brundel</LastName>
<ForeName>Manon</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands m.brundel-2@umcutrecht.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reijmer</LastName>
<ForeName>Yael D</ForeName>
<Initials>YD</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van Veluw</LastName>
<ForeName>Susanne J</ForeName>
<Initials>SJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kuijf</LastName>
<ForeName>Hugo J</ForeName>
<Initials>HJ</Initials>
<AffiliationInfo>
<Affiliation>Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Luijten</LastName>
<ForeName>Peter R</ForeName>
<Initials>PR</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kappelle</LastName>
<ForeName>L Jaap</ForeName>
<Initials>LJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Biessels</LastName>
<ForeName>Geert Jan</ForeName>
<Initials>GJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>Utrecht Vascular Cognitive Impairment Study Group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>04</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Diabetes</MedlineTA>
<NlmUniqueID>0372763</NlmUniqueID>
<ISSNLinking>0012-1797</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000098">blood supply</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059345">Cerebral Small Vessel Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003072">Cognition Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003924">Diabetes Mellitus, Type 2</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055806">Microvessels</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Biessels</LastName>
<ForeName>G J</ForeName>
<Initials>GJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bouvy</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Brundel</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Heringa</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kappelle</LastName>
<ForeName>L J</ForeName>
<Initials>LJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van den Berg</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>de Bresser</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kuijf</LastName>
<ForeName>H J</ForeName>
<Initials>HJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Leemans</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Luijten</LastName>
<ForeName>P R</ForeName>
<Initials>PR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mali</LastName>
<ForeName>W P Th</ForeName>
<Initials>WP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Viergever</LastName>
<ForeName>M A</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vincken</LastName>
<ForeName>K L</ForeName>
<Initials>KL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zwanenburg</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Algra</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rutten</LastName>
<ForeName>G E H M</ForeName>
<Initials>GE</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24072250</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1536-3678</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>36</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of pediatric hematology/oncology</Title>
<ISOAbbreviation>J. Pediatr. Hematol. Oncol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Basal ganglia germinoma: MRI classification correlates well with neurological and cognitive outcome.</ArticleTitle>
<Pagination>
<MedlinePgn>e443-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/MPH.0000000000000014</ELocationID>
<Abstract>
<AbstractText>Basal ganglia germinomas (BGG) are often associated with delayed diagnosis because of their nonspecific clinical presentation and subtle abnormalities on initial neuroimaging. Despite excellent survival, the prognostic indicators still remained unclear. From our case series, we demonstrated that the MRI classification scheme devised by Phi and colleagues is useful in predicting neurological and cognitive outcomes for patients with unilateral BGG. Subtle lesions with faint or no contrast enhancement are associated with early cerebral atrophy with progressive neurological deficits and poor cognitive outcomes. BGG along with bilateral involvement, regardless of the types of lesion, are also associated with poor neurological and cognitive outcomes. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tso</LastName>
<ForeName>Winnie Wan-Yee</ForeName>
<Initials>WW</Initials>
<AffiliationInfo>
<Affiliation>Departments of *Paediatrics and Adolescent Medicine Diagnostic Radiology, Hong Kong University, Queen Mary Hospital, Hong Kong, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yung</LastName>
<ForeName>Ada Wing-Yan</ForeName>
<Initials>AW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lau</LastName>
<ForeName>Hin-Yue</ForeName>
<Initials>HY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chan</LastName>
<ForeName>Godfrey Chi-Fung</ForeName>
<Initials>GC</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Pediatr Hematol Oncol</MedlineTA>
<NlmUniqueID>9505928</NlmUniqueID>
<ISSNLinking>1077-4114</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001479">Basal Ganglia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000145">classification</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059248">Chemoradiotherapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003071">Cognition</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018237">Germinoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000145">classification</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24390451</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1536-3678</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>36</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of pediatric hematology/oncology</Title>
<ISOAbbreviation>J. Pediatr. Hematol. Oncol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Inferior vena cava aneurysm in an infant presenting with a renal mass.</ArticleTitle>
<Pagination>
<MedlinePgn>583-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/MPH.0000000000000096</ELocationID>
<Abstract>
<AbstractText>Aneurysm of the inferior vena cava is a rare finding in the pediatric population. We report the case of a 5-month-old infant presenting with anemia, hypertension, and dehydration in the emergency room. A renal mass was found with ultrasound and MRI and a renal tumor was first considered. Histopathologic review of the surgical specimen led to the diagnosis of aneurysmal dilatation of the vena cava. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Unzueta-Roch</LastName>
<ForeName>Jos L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo>
<Affiliation>*Pediatric Intensive Care Unit Departments of Pediatric Oncology &amp; Hematology Radiology Surgery Pathology, Hospital Infantil Universitario Nio Jess, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Garca-Abs</LastName>
<ForeName>Miriam</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sirvent-Cerd</LastName>
<ForeName>Sara</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>de Prada</LastName>
<ForeName>Inmaculada</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Martnez de Azagra</LastName>
<ForeName>Amelia</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ollero</LastName>
<ForeName>Jose M</ForeName>
<Initials>JM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Madero-Lpez</LastName>
<ForeName>Luis</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Pediatr Hematol Oncol</MedlineTA>
<NlmUniqueID>9505928</NlmUniqueID>
<ISSNLinking>1077-4114</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000783">Aneurysm</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007680">Kidney Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007813">Laparotomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014682">Vena Cava, Inferior</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000736">ultrasonography</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24942031</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1536-3678</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>36</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of pediatric hematology/oncology</Title>
<ISOAbbreviation>J. Pediatr. Hematol. Oncol.</ISOAbbreviation>
</Journal>
<ArticleTitle>An orbital mass. Ewing sarcoma.</ArticleTitle>
<Pagination>
<MedlinePgn>579-80</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/MPH.0000000000000201</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Balc</LastName>
<ForeName>Mehmet</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Departments of *Ophthalmology Pediatric Onkology and Heamatology Pathology, Ministry of Health Ankara Dr Abdurrahman Yurtaslan Oncology Education and Research Hospital Department of Ophthalmology, Ministry of Health Ankara Education and Research Hospital, ankaya, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kkazman</LastName>
<ForeName>Selma </ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Duman</LastName>
<ForeName>Rahmi</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sar</LastName>
<ForeName>Neriman</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dilek</LastName>
<ForeName>Glay</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Pediatr Hematol Oncol</MedlineTA>
<NlmUniqueID>9505928</NlmUniqueID>
<ISSNLinking>1077-4114</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009918">Orbital Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010808">Physical Examination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012512">Sarcoma, Ewing</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25252468</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0792-9935</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2014</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Refu&amp;#x02be;at ha-peh eha-shinayim (1993)</Title>
<ISOAbbreviation>Refuat Hapeh Vehashinayim</ISOAbbreviation>
</Journal>
<ArticleTitle>[MRI of the temporomandibular joint--the gold standard].</ArticleTitle>
<Pagination>
<MedlinePgn>19-27, 86</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>MRI has been established as the imaging modality of choice for the evaluation of temporomandibular joint disorders (TMD), as it allows for a noninvasive detailed evaluation of the joint that is not otherwise available. During the last decade, the introduction of dynamic (cine-mode) MR imaging has made functional evaluation feasible in addition to the morphologic study of the joint. The major advantage of MRI is its ability to study the articular disc and its congruity as well as its location relative to the condyle in both closed- and open-mouth positions. Due to its high contrast resolution, MRI is unique in demonstrating joint effusion, bone edema and sclerosis, rupture of the retrodiscal layers and impairment of the lateral pterigoid muscle. In Mor-Mar Imaging Center we performed during the last two years MRI studies of the TMJ in 234 subjects, 172 (74%) female and 62 (26%) male patients. The average age of the patients was 29 years. In this article we present our experience in the evaluation of TMD and review the main indications and findings. In addition, our experience in optimizing the MRI sequence protocols in both static and dynamic modes are discussed. MRI examinations provide the clinician with anatomic and physiologic information that can guide treatment decisions. It has a special role in monitoring and evaluating treatment results, both conservative and surgical.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Barmeir</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Teich</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gutmcher</LastName>
<ForeName>Z</ForeName>
<Initials>Z</Initials>
</Author>
</AuthorList>
<Language>heb</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Israel</Country>
<MedlineTA>Refuat Hapeh Vehashinayim</MedlineTA>
<NlmUniqueID>9816240</NlmUniqueID>
<ISSNLinking>0792-9935</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013704">Temporomandibular Joint</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013705">Temporomandibular Joint Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25252525</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0030-9982</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>64</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>JPMA. The Journal of the Pakistan Medical Association</Title>
<ISOAbbreviation>J Pak Med Assoc</ISOAbbreviation>
</Journal>
<ArticleTitle>Piriformis syndrome--a rare cause of extraspinal sciatica.</ArticleTitle>
<Pagination>
<MedlinePgn>949-51</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Piriformis syndrome is a rare entity resulting in severe unilateral isolated buttock pain shooting in nature, non discogenic in origin. MR imaging of pelvis plays an important role in such patients to see the normal anatomy of piriformis muscle and its relationship with sciatic nerve. A 35-year-old woman presented with one year history of radiating leg pain with normal MR lumbosacral spine. MRI pelvis showed an abnormal orientation of left sciatic nerve through cleaved fibers of the piriformis muscle. The patient's symptoms were relieved by surgical decompression. The purpose of this case report is to show the role and importance of MR imaging for tracing sciatic nerve and its relationship to the Piriformis muscle. MR imaging of pelvis for sciatic nerve plays an important role in symptomatic patients with isolated buttock pain having normal MRI lumbosacral spine.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Arooj</LastName>
<ForeName>Shumaila</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Azeemuddin</LastName>
<ForeName>Muhammad</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Pakistan</Country>
<MedlineTA>J Pak Med Assoc</MedlineTA>
<NlmUniqueID>7501162</NlmUniqueID>
<ISSNLinking>0030-9982</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002081">Buttocks</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055958">Piriformis Muscle Syndrome</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012585">Sciatica</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25252541</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0023-2130</ISSN>
<JournalIssue CitedMedium="Print">
<Issue>6</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Klinichna khirurhiia / Ministerstvo okhorony zdorov'ia Ukrany, Naukove tovarystvo khirurhiv Ukrany</Title>
<ISOAbbreviation>Klin Khir</ISOAbbreviation>
</Journal>
<ArticleTitle>[The choice of pancreaticojejunal anastomosis based on the performance experience of 200 operations of pancreaticoduodenal resection].</ArticleTitle>
<Pagination>
<MedlinePgn>5-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Analysis of the surgical treatment results in 200 patients, operated for obstructive diseases of the biliopancreatoduodenal zone, in whom pancreaticoduodenal resection (PDR) was performed in 1991 - 2013 yrs period, were presented. The choice of the pancreaticojejunoanastomosis (PJA) variant in PDR have depended on dimension of diameter of the pancreatic gland stump and the jejunum diameter, as well as from state of pancreatic parenchyma and duct. Application of differentiated approach to choice of the PJA variant have permitted to reduce the complications rate, including the sutures insufficiency.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Veligodski</LastName>
<ForeName>N N</ForeName>
<Initials>NN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Veligodski</LastName>
<ForeName>A N</ForeName>
<Initials>AN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Arutiunov</LastName>
<ForeName>S </ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Klimenko</LastName>
<ForeName>M V</ForeName>
<Initials>MV</Initials>
</Author>
</AuthorList>
<Language>rus</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Ukraine</Country>
<MedlineTA>Klin Khir</MedlineTA>
<NlmUniqueID>9516872</NlmUniqueID>
<ISSNLinking>0023-2130</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001661">Biliary Tract Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002760">Cholangiopancreatography, Endoscopic Retrograde</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004379">Duodenal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007583">Jejunum</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010190">Pancreatic Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016577">Pancreaticoduodenectomy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010193">Pancreaticojejunostomy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D036542">Tomography, Spiral Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25252548</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0023-2130</ISSN>
<JournalIssue CitedMedium="Print">
<Issue>6</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Klinichna khirurhiia / Ministerstvo okhorony zdorov'ia Ukrany, Naukove tovarystvo khirurhiv Ukrany</Title>
<ISOAbbreviation>Klin Khir</ISOAbbreviation>
</Journal>
<ArticleTitle>[Treatment of nonparasitic hepatic cysts].</ArticleTitle>
<Pagination>
<MedlinePgn>27-30</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The results of treatment of 160 patients, suffering nonparasitic hepatic cysts (NHC), in 2004 - 2013 yrs period are presented. Algorithm of NHC diagnostic and treatment was elaborated. There was noted, that NHC may persist durably, not enhancing, what was confirmed by results of ultrasonographic investigation in dynamics. Threat of fatal complications occurrence in presence of hepatic cysts is exaggerated. The author recommends to restrict indications for operative treatment of cysts, restraintly concerns to their laparoscopic excision, consider the puncture-aspiration method the main in treatment of the disease. The method technology and results of its application are adduced.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bababeli</LastName>
<ForeName> Iu</ForeName>
<Initials>Iu</Initials>
</Author>
</AuthorList>
<Language>rus</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Ukraine</Country>
<MedlineTA>Klin Khir</MedlineTA>
<NlmUniqueID>9516872</NlmUniqueID>
<ISSNLinking>0023-2130</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003560">Cysts</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000531">radionuclide imaging</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000736">ultrasonography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006498">Hepatectomy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D010535">Laparoscopy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008107">Liver Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000531">radionuclide imaging</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000736">ultrasonography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D011677">Punctures</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013396">Suction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D036542">Tomography, Spiral Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24962098</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1554-527X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>32</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2014</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Journal of orthopaedic research : official publication of the Orthopaedic Research Society</Title>
<ISOAbbreviation>J. Orthop. Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>A decreased volume of the medial tibial spine is associated with an increased risk of suffering an anterior cruciate ligament injury for males but not females.</ArticleTitle>
<Pagination>
<MedlinePgn>1451-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/jor.22670</ELocationID>
<Abstract>
<AbstractText>Measurements of tibial plateau subchondral bone and articular cartilage slope have been associated with the risk of suffering anterior cruciate ligament (ACL) injury. Such single-plane measures of the tibial plateau may not sufficiently characterize its complex, three-dimensional geometry and how it relates to knee injury. Further, the tibial spines have not been studied in association with the risk of suffering a non-contact ACL injury. We questioned whether the geometries of the tibial spines are associated with non-contact ACL injury risk, and if this relationship is different for males and females. Bilateral MRI scans were acquired on 88 ACL-injured subjects and 88 control subjects matched for sex, age and sports team. Medial and lateral tibial spine geometries were characterized with measurements of length, width, height, volume and anteroposterior location. Analyses of females revealed no associations between tibial spine geometry and risk of ACL injury. Analyses of males revealed that an increased medial tibial spine volume was associated with a decreased risk of ACL injury (OR=0.667 per 100mm(3) increase). Smaller medial spines could provide less resistance to internal rotation and medial translation of the tibia relative to the femur, subsequently increasing ACL strains and risk of ACL injury.</AbstractText>
<CopyrightInformation> 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sturnick</LastName>
<ForeName>Daniel R</ForeName>
<Initials>DR</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedics and Rehabilitation, University of Vermont, Burlington, Vermont.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Argentieri</LastName>
<ForeName>Erin C</ForeName>
<Initials>EC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vacek</LastName>
<ForeName>Pamela M</ForeName>
<Initials>PM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>DeSarno</LastName>
<ForeName>Michael J</ForeName>
<Initials>MJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gardner-Morse</LastName>
<ForeName>Mack G</ForeName>
<Initials>MG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tourville</LastName>
<ForeName>Timothy W</ForeName>
<Initials>TW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Slauterbeck</LastName>
<ForeName>James R</ForeName>
<Initials>JR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Johnson</LastName>
<ForeName>Robert J</ForeName>
<Initials>RJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shultz</LastName>
<ForeName>Sandra J</ForeName>
<Initials>SJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Beynnon</LastName>
<ForeName>Bruce D</ForeName>
<Initials>BD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01-AR050421</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Orthop Res</MedlineTA>
<NlmUniqueID>8404726</NlmUniqueID>
<ISSNLinking>0736-0266</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016118">Anterior Cruciate Ligament</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000293">injuries</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002358">Cartilage, Articular</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016022">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005269">Femur</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015588">Observer Variation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012044">Regression Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012399">Rotation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012737">Sex Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013977">Tibia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000293">injuries</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ACL injury</Keyword>
<Keyword MajorTopicYN="N">risk factors</Keyword>
<Keyword MajorTopicYN="N">tibial anatomy</Keyword>
<Keyword MajorTopicYN="N">tibial plateau geometry</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25087777</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1554-527X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>32</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2014</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Journal of orthopaedic research : official publication of the Orthopaedic Research Society</Title>
<ISOAbbreviation>J. Orthop. Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Hip contact force in presence of aberrant bone geometry during normal and pathological gait.</ArticleTitle>
<Pagination>
<MedlinePgn>1406-15</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/jor.22698</ELocationID>
<Abstract>
<AbstractText>Children with cerebral palsy (CP) often present aberrant hip geometry, specifically increased femoral anteversion and neck-shaft angle. Furthermore, altered gait patterns are present within this population. We analyzed the effect of aberrant femoral geometry, as present in CP subjects, on hip contact force (HCF) during pathological and normal gait. We ran dynamic simulations of CP-specific and normal gait using two musculoskeletal models (MSMs), one reflecting normal femoral geometry and one reflecting proximal femoral deformities. The combination of aberrant bone geometry and CP-specific gait characteristics reduced HCF compared to normal gait on a CP subject-specific MSM, but drastically changed the orientation of the HCF vector. The HCF was orientated more vertically and anteriorly than compared to HCF orientation during normal gait. Furthermore, subjects with more pronounced bony deformities encountered larger differences in resultant HCF and HCF orientation. When bone deformities were not accounted for in MSMs of pathologic gait, the HCF orientation was more similar to normal children. Thus, our results support a relation between aberrant femoral geometry and joint loading during pathological/normal gait and confirm a compensatory effect of altered gait kinematics on joint loading.</AbstractText>
<CopyrightInformation> 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bosmans</LastName>
<ForeName>Lode</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>KU Leuven, Human Movement Biomechanics Research Group, Department of Kinesiology, Leuven, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wesseling</LastName>
<ForeName>Mariska</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Desloovere</LastName>
<ForeName>Kaat</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Molenaers</LastName>
<ForeName>Guy</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Scheys</LastName>
<ForeName>Lennart</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jonkers</LastName>
<ForeName>Ilse</ForeName>
<Initials>I</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Orthop Res</MedlineTA>
<NlmUniqueID>8404726</NlmUniqueID>
<ISSNLinking>0736-0266</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000886">Anthropometry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001696">Biomechanical Phenomena</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002547">Cerebral Palsy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003198">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005269">Femur</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D005684">Gait</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006615">Hip</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006621">Hip Joint</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013314">Stress, Mechanical</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">aberrant hip geometry</Keyword>
<Keyword MajorTopicYN="N">cerebral palsy</Keyword>
<Keyword MajorTopicYN="N">gait</Keyword>
<Keyword MajorTopicYN="N">hip joint contact force</Keyword>
<Keyword MajorTopicYN="N">subject-specific musculoskeletal modeling</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25099246</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1554-527X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>32</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2014</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Journal of orthopaedic research : official publication of the Orthopaedic Research Society</Title>
<ISOAbbreviation>J. Orthop. Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Tibial articular cartilage and meniscus geometries combine to influence female risk of anterior cruciate ligament injury.</ArticleTitle>
<Pagination>
<MedlinePgn>1487-94</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/jor.22702</ELocationID>
<Abstract>
<AbstractText>Tibial plateau subchondral bone geometry has been associated with the risk of sustaining a non-contact ACL injury; however, little is known regarding the influence of the meniscus and articular cartilage interface geometry on risk. We hypothesized that geometries of the tibial plateau articular cartilage surface and meniscus were individually associated with the risk of non-contact ACL injury. In addition, we hypothesized that the associations were independent of the underlying subchondral bone geometry. MRI scans were acquired on 88 subjects that suffered non-contact ACL injuries (27 males, 61 females) and 88 matched control subjects that were selected from the injured subject's teammates and were thus matched on sex, sport, level of play, and exposure to risk of injury. Multivariate analysis of the female data revealed that increased posterior-inferior directed slope of the middle articular cartilage region and decreased height of the posterior horn of the meniscus in the lateral compartment were associated with increased risk of sustaining a first time, non-contact ACL injury, independent of each other and of the slope of the tibial plateau subchondral bone. No measures were independently related to risk of non-contact ACL injury among males.</AbstractText>
<CopyrightInformation> 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sturnick</LastName>
<ForeName>Daniel R</ForeName>
<Initials>DR</Initials>
<AffiliationInfo>
<Affiliation>Department of Orthopaedics and Rehabilitation, University of Vermont, Burlington, Vermont.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Van Gorder</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vacek</LastName>
<ForeName>Pamela M</ForeName>
<Initials>PM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>DeSarno</LastName>
<ForeName>Michael J</ForeName>
<Initials>MJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gardner-Morse</LastName>
<ForeName>Mack G</ForeName>
<Initials>MG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tourville</LastName>
<ForeName>Timothy W</ForeName>
<Initials>TW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Slauterbeck</LastName>
<ForeName>James R</ForeName>
<Initials>JR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Johnson</LastName>
<ForeName>Robert J</ForeName>
<Initials>RJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shultz</LastName>
<ForeName>Sandra J</ForeName>
<Initials>SJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Beynnon</LastName>
<ForeName>Bruce D</ForeName>
<Initials>BD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01-AR050421</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Orthop Res</MedlineTA>
<NlmUniqueID>8404726</NlmUniqueID>
<ISSNLinking>0736-0266</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016118">Anterior Cruciate Ligament</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000293">injuries</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001696">Biomechanical Phenomena</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002358">Cartilage, Articular</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016022">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007717">Knee</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007718">Knee Injuries</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015999">Multivariate Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016017">Odds Ratio</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012737">Sex Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013977">Tibia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000293">injuries</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25113840</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1759-4782</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>11</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Nature reviews. Clinical oncology</Title>
<ISOAbbreviation>Nat Rev Clin Oncol</ISOAbbreviation>
</Journal>
<ArticleTitle>Vessel caliber--a potential MRI biomarker of tumour response in clinical trials.</ArticleTitle>
<Pagination>
<MedlinePgn>566-84</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/nrclinonc.2014.126</ELocationID>
<Abstract>
<AbstractText>Our understanding of the importance of blood vessels and angiogenesis in cancer has increased considerably over the past decades, and the assessment of tumour vessel calibre and structure has become increasingly important for in vivo monitoring of therapeutic response. The preferred method for in vivo imaging of most solid cancers is MRI, and the concept of vessel-calibre MRI has evolved since its initial inception in the early 1990s. Almost a quarter of a century later, unlike traditional contrast-enhanced MRI techniques, vessel-calibre MRI remains widely inaccessible to the general clinical community. The narrow availability of the technique is, in part, attributable to limited awareness and a lack of imaging standardization. Thus, the role of vessel-calibre MRI in early phase clinical trials remains to be determined. By contrast, regulatory approvals of antiangiogenic agents that are not directly cytotoxic have created an urgent need for clinical trials incorporating advanced imaging analyses, going beyond traditional assessments of tumour volume. To this end, we review the field of vessel-calibre MRI and summarize the emerging evidence supporting the use of this technique to monitor response to anticancer therapy. We also discuss the potential use of this biomarker assessment in clinical imaging trials and highlight relevant avenues for future research. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Emblem</LastName>
<ForeName>Kyrre E</ForeName>
<Initials>KE</Initials>
<AffiliationInfo>
<Affiliation>The Intervention Centre, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Farrar</LastName>
<ForeName>Christian T</ForeName>
<Initials>CT</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology and Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gerstner</LastName>
<ForeName>Elizabeth R</ForeName>
<Initials>ER</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, 100 Blossom Street, Boston, MA 02114, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Batchelor</LastName>
<ForeName>Tracy T</ForeName>
<Initials>TT</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, 100 Blossom Street, Boston, MA 02114, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Borra</LastName>
<ForeName>Ronald J H</ForeName>
<Initials>RJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology and Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rosen</LastName>
<ForeName>Bruce R</ForeName>
<Initials>BR</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology and Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sorensen</LastName>
<ForeName>A Gregory</ForeName>
<Initials>AG</Initials>
<AffiliationInfo>
<Affiliation>Siemens Healthcare Health Services, 51 Valley Stream Parkway, Malvern, PA 19355, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jain</LastName>
<ForeName>Rakesh K</ForeName>
<Initials>RK</Initials>
<AffiliationInfo>
<Affiliation>Edwin L. Steele Laboratory of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, 100 Blossom Street, Boston, MA 02114, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT00254943</AccessionNumber>
<AccessionNumber>NCT00662506</AccessionNumber>
<AccessionNumber>NCT00756106</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P01CA80124</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>S10 RR02111001A1</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32-CA009502</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Nat Rev Clin Oncol</MedlineTA>
<NlmUniqueID>101500077</NlmUniqueID>
<ISSNLinking>1759-4774</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D043925">Angiogenesis Inducing Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020533">Angiogenesis Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014408">Tumor Markers, Biological</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D043925">Angiogenesis Inducing Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020533">Angiogenesis Inhibitors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001808">Blood Vessels</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000648">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002986">Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009389">Neovascularization, Pathologic</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014408">Tumor Markers, Biological</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25042574</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1294-9361</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Epileptic disorders : international epilepsy journal with videotape</Title>
<ISOAbbreviation>Epileptic Disord</ISOAbbreviation>
</Journal>
<ArticleTitle>PET-positive extralimbic presentation of anti-glutamic acid decarboxylase antibody-associated encephalitis.</ArticleTitle>
<Pagination>
<MedlinePgn>358-61</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1684/epd.2014.0666</ELocationID>
<Abstract>
<AbstractText>Anti-glutamic acid decarboxylase (GAD) antibody-associated autoimmune encephalitis has been reported mostly as limbic encephalitis. Only few cases with extralimbic involvement are reported with limited investigation. Here, we report an extensive investigation with MRI, PET, and pathological examination. A 66-year-old Japanese female with a history of hypothyroidism, colon cancer, pheochromocytoma, and thymoma-associated myasthenia gravis presented with generalised tonic-clonic seizures. MRI showed multiple hyperintense lesions and PET showed hypermetabolic lesions in the brain. Biopsy showed non-specific gliosis, microglial proliferation, and perivascular lymphohistiocytic infiltrates. Various neuronal antibodies were negative, except for anti-GAD antibody. Anti-GAD antibody-associated encephalitis is an increasingly recognised CNS disease. Pathophysiology of this encephalitis is unclear. While PET showed hypermetabolic lesions, the biopsy showed non-specific changes. The treatments may include immunosuppressants, IVIg, and plasma exchange. One should consider to measure this antibody, in addition to others, when autoimmune encephalitis is suspected [Published with video sequences] . </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kojima</LastName>
<ForeName>Gotaro</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>The John A. Hartford Foundation Center of Excellence in Geriatrics, Department of Geriatric Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, Japan Green Medical Centre, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Inaba</LastName>
<ForeName>Michiko</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>The John A. Hartford Foundation Center of Excellence in Geriatrics, Department of Geriatric Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bruno</LastName>
<ForeName>Michiko K</ForeName>
<Initials>MK</Initials>
<AffiliationInfo>
<Affiliation>Neuroscience Institute, Queen's Medical Center, Honolulu, Hawaii, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D059040">Video-Audio Media</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>France</Country>
<MedlineTA>Epileptic Disord</MedlineTA>
<NlmUniqueID>100891853</NlmUniqueID>
<ISSNLinking>1294-9361</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 4.1.1.15</RegistryNumber>
<NameOfSubstance UI="D005968">Glutamate Decarboxylase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001323">Autoantibodies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000531">radionuclide imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004660">Encephalitis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000531">radionuclide imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005968">Glutamate Decarboxylase</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059906">Neuroimaging</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">anti-GAD antibody</Keyword>
<Keyword MajorTopicYN="N">autoimmune encephalitis</Keyword>
<Keyword MajorTopicYN="N">generalized seizure</Keyword>
<Keyword MajorTopicYN="N">glutamic acid decarboxylase</Keyword>
<Keyword MajorTopicYN="N">limbic encephalitis</Keyword>
<Keyword MajorTopicYN="N">palatal myoclonus</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25042667</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1294-9361</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Epileptic disorders : international epilepsy journal with videotape</Title>
<ISOAbbreviation>Epileptic Disord</ISOAbbreviation>
</Journal>
<ArticleTitle>Unusual presentation of hypothalamic hamartoma with hypersomnia in an adult patient.</ArticleTitle>
<Pagination>
<MedlinePgn>366-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1684/epd.2014.0669</ELocationID>
<Abstract>
<AbstractText>We report a patient with polysomnography findings related to hypersomnia, as a primary presenting symptom, who was shown to have stereotypical gelastic seizures. Her cranial magnetic resonance imaging revealed a hypothalamic hamartoma in the posterior region of the hypothalamus. The patient had no previous history of gelastic seizures. We suggest that patients who present with hypersomnia should be investigated for gelastic seizures in order to avoid misdiagnosis and receive appropriate treatment. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tezer</LastName>
<ForeName>F Irsel</ForeName>
<Initials>FI</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pektezel</LastName>
<ForeName>Mehmet Yasir</ForeName>
<Initials>MY</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gocmen</LastName>
<ForeName>Rahsan</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saygi</LastName>
<ForeName>Serap</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>France</Country>
<MedlineTA>Epileptic Disord</MedlineTA>
<NlmUniqueID>100891853</NlmUniqueID>
<ISSNLinking>1294-9361</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C537158">Hypothalamic hamartomas</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006970">Disorders of Excessive Somnolence</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004828">Epilepsies, Partial</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006222">Hamartoma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007027">Hypothalamic Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017286">Polysomnography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012890">Sleep</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">gelastic seizure</Keyword>
<Keyword MajorTopicYN="N">hypersomnia</Keyword>
<Keyword MajorTopicYN="N">hypothalamic hamartoma</Keyword>
<Keyword MajorTopicYN="N">polysomnography (PSG)</Keyword>
<Keyword MajorTopicYN="N">seizure</Keyword>
<Keyword MajorTopicYN="N">sleep</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25166001</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1294-9361</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Epileptic disorders : international epilepsy journal with videotape</Title>
<ISOAbbreviation>Epileptic Disord</ISOAbbreviation>
</Journal>
<ArticleTitle>Focal epilepsy recruiting a generalised network of juvenile myoclonic epilepsy: a case report.</ArticleTitle>
<Pagination>
<MedlinePgn>370-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1684/epd.2014.0672</ELocationID>
<Abstract>
<AbstractText>We report a patient with juvenile myoclonic epilepsy who subsequently developed temporal lobe epilepsy, which gradually became clinically dominant. Video telemetry revealed both myoclonic seizures and temporal lobe seizures. The temporal lobe seizures were accompanied by a focal recruiting rhythm with rapid generalisation on EEG, in which the ictal EEG pattern during the secondary generalised phase was morphologically similar to the ictal pattern during myoclonic seizures. The secondary generalised seizures of the focal epilepsy responded to sodium valproate, similar to the myoclonic epilepsy. In this rare case of coexistent Juvenile Myoclonic Epilepsy and Temporal lobe epilepsy, the possibility of focal epilepsy recruiting a generalised epileptic network was proposed and discussed. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Khaing</LastName>
<ForeName>Myo</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Malaysia, Department of Medicine, University of Medicine, Mandalay, Myanmar.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lim</LastName>
<ForeName>Kheng-Seang</ForeName>
<Initials>KS</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tan</LastName>
<ForeName>Chong-Tin</ForeName>
<Initials>CT</Initials>
<AffiliationInfo>
<Affiliation>Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Malaysia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>France</Country>
<MedlineTA>Epileptic Disord</MedlineTA>
<NlmUniqueID>100891853</NlmUniqueID>
<ISSNLinking>1294-9361</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004833">Epilepsy, Temporal Lobe</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020190">Myoclonic Epilepsy, Juvenile</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">electroencephalography</Keyword>
<Keyword MajorTopicYN="N">epileptic network</Keyword>
<Keyword MajorTopicYN="N">focal epilepsy</Keyword>
<Keyword MajorTopicYN="N">juvenile myoclonic epilepsy</Keyword>
</KeywordList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25255018</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1536-5964</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>93</Volume>
<Issue>14</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Medicine</Title>
<ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation>
</Journal>
<ArticleTitle>Fascicular ratio: a new parameter to evaluate peripheral nerve pathology on magnetic resonance imaging: a feasibility study on a 3T MRI system.</ArticleTitle>
<Pagination>
<MedlinePgn>e68</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000000068</ELocationID>
<Abstract>
<AbstractText>The objective of the study was to define and quantitatively evaluate the fascicular ratio (FR) on magnetic resonance imaging (MRI) in patients with peripheral neuropathies compared with healthy controls. Forty control subjects (20 women, 20 men; age, 44.613.4 years) and 40 patients with peripheral neuropathy (22 women, 18 men; age, 50.310.2 years) were examined with a standard 3T MRI protocol. With customized software (with semiautomatic and automatic interface), the hypointense and hyperintense areas of the peripheral nerves corresponding to fascicular and nonfascicular tissue were examined on T1-weighted sequences. The ratio of fascicular pixels to total pixels was called FR. Correlation with FR calculated on high-resolution ultrasound was performed. The statistical analysis included the Mann-Whitney U test of controls versus patients, the receiver operating characteristic (ROC) analysis, and the subgroup analysis of patients according to etiologies of neuropathy. Intraobserver and interobserver agreement was calculated based on the evaluation made by 3 readers. Finally, a complete automatic evaluation was performed. On MRI, FRs were significantly increased in patients compared with controls (FR, 76.715.1 vs 5612.3; P&lt;0.0001 for the semiautomatic interface; and FR 66.317.5 vs 47.818.4; P&lt;0.0001 for the automatic interface). The increase in FR was caused mainly by an increase in the hypointense part of the nerve. This observation was valid for all causes of neuropathies. ROC analysis found an area under the curve of 0.75 (95% confidence interval, 0.44-0.81) for FR to discriminate neuropathy from control. The correlation coefficient between MRI and ultrasound was significant (r=0.49; 95% confidence interval for r, 0.21-0.70; P=0.012). With the semiautomated evaluation, the mean intraobserver agreement was good (K=0.86). The interobserver agreements were also good (reader 1 vs reader 2, k=0.71; reader 2 vs reader 3, k=0.78; reader 3 vs reader 1, k=0.71). There were no statistically significant differences between the results obtained using the 2 methods. FR calculation on MRI is feasible, and it may be used in adjunct to standard MRI evaluation in peripheral nerve disorders.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tagliafico</LastName>
<ForeName>Alberto S</ForeName>
<Initials>AS</Initials>
<AffiliationInfo>
<Affiliation>Institute of Anatomy, Department of Experimental Medicine (DIMES), University of Genoa (AST); and CNR-IMATI, Consiglio Nazionale delle Ricerche, Istituto di Matematica Applicata e Tecnologie Informatiche, Genova, Italy (GT).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tagliafico</LastName>
<ForeName>Giulio</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Medicine (Baltimore)</MedlineTA>
<NlmUniqueID>2985248R</NlmUniqueID>
<ISSNLinking>0025-7974</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005240">Feasibility Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009412">Nerve Fibers</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010523">Peripheral Nervous System Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012372">ROC Curve</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25272551</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>14</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0030-9982</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>64</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2014</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>JPMA. The Journal of the Pakistan Medical Association</Title>
<ISOAbbreviation>J Pak Med Assoc</ISOAbbreviation>
</Journal>
<ArticleTitle>Condensing osteitis of the clavicle in a man: any relationship with tooth decay?</ArticleTitle>
<Pagination>
<MedlinePgn>583-5</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Condensing osteitis of the clavicle is a rarely seen pathology since its first description in 1974. Although mechanical stress is claimed for aetiology, but remains a dilemma for physicians. The intermittent or steady pain is variable in intensity and generally localised at the medial end of the involved clavicle, supraclavicular fossa, ipsilateral anterior thorax and shoulder. In this report, we present a 28-year-old man with the regression of the condensing osteitis of the clavicle after the extraction of a decayed tooth.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Altiok</LastName>
<ForeName>Inci Baltepe</ForeName>
<Initials>IB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tokmak</LastName>
<ForeName>Mehmet</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Akman</LastName>
<ForeName>Tarik</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Alkan</LastName>
<ForeName>Bahadir</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cosar</LastName>
<ForeName>Murat</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Pakistan</Country>
<MedlineTA>J Pak Med Assoc</MedlineTA>
<NlmUniqueID>7501162</NlmUniqueID>
<ISSNLinking>0030-9982</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D002968">Clavicle</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015897">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003731">Dental Caries</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010000">Osteitis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013314">Stress, Mechanical</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25272566</PMID>
<DateCreated>
<Year>2014</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>14</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0030-6096</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>60</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Osaka city medical journal</Title>
<ISOAbbreviation>Osaka City Med J</ISOAbbreviation>
</Journal>
<ArticleTitle>Cholangiocarcinoma in a middle-aged patient working at a printing plant.</ArticleTitle>
<Pagination>
<MedlinePgn>39-44</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>A 39-year-old male with elevated serum transferases consulted our hospital in September 2010. Since 1999, he had worked at a printing company using organic solvents. Cholangiography revealed stenosis of the left hepatic duct with peripheral dilation, stricture of the right hepatic duct, and irregularity of the extrahepatic bile duct. As a preoperative diagnosis of sclerosing cholangitis and cholangiocarcinoma was made, extended left hepatectomy with resection of the extrahepatic bile duct and anastomosis of the anterior and posterior branches of the bile duct and the jejunum (Roux-en Y reconstruction) were performed. A histological examination showed papillary carcinoma of the medial hepatic bile duct with intraductal growth, and biliary intraepithelial neoplasia-2/3 lesions from the medial hepatic bile duct to the right hepatic and the common bile ducts. Chronic cholangitis was shown around the tumors. Postoperatively, the patient was treated with adjuvant chemo-radiation, and he is doing well 30 months after the operation, without recurrence. Unknown causes, including exposure to organic solvents, might have induced chronic bile duct injury and contributed to the development of cholangiocarcinoma.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tanaka</LastName>
<ForeName>Shogo</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fukumoto</LastName>
<ForeName>Nobusuke</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ohno</LastName>
<ForeName>Kohichi</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tanaka</LastName>
<ForeName>Sayaka</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ohsawa</LastName>
<ForeName>Masahiko</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yamamoto</LastName>
<ForeName>Takatsugu</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nakanuma</LastName>
<ForeName>Yasuni</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kuboo</LastName>
<ForeName>Shoji</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Japan</Country>
<MedlineTA>Osaka City Med J</MedlineTA>
<NlmUniqueID>0376413</NlmUniqueID>
<ISSNLinking>0030-6096</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012997">Solvents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000713">Anastomosis, Roux-en-Y</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001650">Bile Duct Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001653">Bile Ducts, Intrahepatic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000531">radionuclide imaging</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059186">Chemoradiotherapy, Adjuvant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018281">Cholangiocarcinoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006498">Hepatectomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009784">Occupational Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016273">Occupational Exposure</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011237">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D011327">Printing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012997">Solvents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D017132">Workplace</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24871967</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1522-1490</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>307</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>American journal of physiology. Regulatory, integrative and comparative physiology</Title>
<ISOAbbreviation>Am. J. Physiol. Regul. Integr. Comp. Physiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Cold-activated brown adipose tissue in human adults: methodological issues.</ArticleTitle>
<Pagination>
<MedlinePgn>R103-13</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The relevance of functional brown adipose tissue (BAT) depots in human adults was undisputedly proven approximately seven years ago. Here we give an overview of all dedicated studies that were published on cold-induced BAT activity in adult humans that appeared since then. Different cooling protocols and imaging techniques to determine BAT activity are reviewed. BAT activation can be achieved by means of air- or water-cooling protocols. The most promising approach is individualized cooling, during which subjects are studied at the lowest temperature for nonshivering condition, probably revealing maximal nonshivering thermogenesis. The highest BAT prevalence (i.e., close to 100%) is observed using the individualized cooling protocol. Currently, the most widely used technique to study the metabolic activity of BAT is deoxy-2-[18F]fluoro-d-glucose ([18F]FDG)-positron emission tomography/computed tomography (PET/CT) imaging. Dynamic imaging provides quantitative information about glucose uptake rates, whereas static imaging reflects overall BAT glucose uptake, localization, and distribution. In general, standardized uptake values (SUV) are used to quantify BAT activity. An accurate determination of total BAT volume is hampered by the limited spatial resolution of the PET image, leading to spillover. Different research groups use different SUV threshold values, which make it difficult to directly compare BAT activity levels between studies. Another issue is the comparison of [18F]FDG uptake in BAT with respect to other tissues or upon with baseline values. This comparison can be performed by using the fixed volume methodology. Finally, the potential use of other relatively noninvasive methods to quantify BAT, like magnetic resonance imaging or thermography, is discussed.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>van der Lans</LastName>
<ForeName>Anouk A J J</ForeName>
<Initials>AA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wierts</LastName>
<ForeName>Roel</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vosselman</LastName>
<ForeName>Maarten J</ForeName>
<Initials>MJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schrauwen</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brans</LastName>
<ForeName>Boudewijn</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>van Marken Lichtenbelt</LastName>
<ForeName>Wouter D</ForeName>
<Initials>WD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Physiol Regul Integr Comp Physiol</MedlineTA>
<NlmUniqueID>100901230</NlmUniqueID>
<ISSNLinking>0363-6119</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002001">Adipose Tissue, Brown</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001692">Biological Transport</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003080">Cold Temperature</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D022722">Thermogenesis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25272766</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0131-1646</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>40</Volume>
<Issue>1</Issue>
<PubDate>
<MedlineDate>2014 Jan-Feb</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Fiziologiia cheloveka</Title>
<ISOAbbreviation>Fiziol Cheloveka</ISOAbbreviation>
</Journal>
<ArticleTitle>[Comparative MRI morphometric study of the corpus callosum at term and preterm infants].</ArticleTitle>
<Pagination>
<MedlinePgn>36-42</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>A comparative morphometric analysis of MRI brain tomograms of term ant preterm born children was conducted. Common morphometric indexes and a novel quantitative parameter, a coefficient of corpus callosum (kCC), developed with regard to prenatal cortex ontogenesis pattern were applied to the study in order to get objective structural characteristics of the brain. All these quantitative indexes display anatomical features of the preterm brain. Reduced values of corpus callosum coefficient at preterm born children are known to associate with altered proportion between its rostral and caudal segments. A threshold coefficient value was established to differentiate preterm brain from the term one and it has proven its statistical significance.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tkachenko</LastName>
<ForeName>L A</ForeName>
<Initials>LA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Toronova</LastName>
<ForeName>N O</ForeName>
<Initials>NO</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Krasnoshchekova</LastName>
<ForeName>E I</ForeName>
<Initials>EI</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Aleksandrov</LastName>
<ForeName>T A</ForeName>
<Initials>TA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zykin</LastName>
<ForeName>P A</ForeName>
<Initials>PA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ialfimov</LastName>
<ForeName>A N</ForeName>
<Initials>AN</Initials>
</Author>
</AuthorList>
<Language>rus</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Russia (Federation)</Country>
<MedlineTA>Fiziol Cheloveka</MedlineTA>
<NlmUniqueID>7603567</NlmUniqueID>
<ISSNLinking>0131-1646</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001931">Brain Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002540">Cerebral Cortex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003337">Corpus Callosum</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005865">Gestational Age</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007231">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007234">Infant, Premature</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25271430</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0893-9675</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>19</Volume>
<Issue>3-4</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Critical reviews in oncogenesis</Title>
<ISOAbbreviation>Crit Rev Oncog</ISOAbbreviation>
</Journal>
<ArticleTitle>Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy.</ArticleTitle>
<Pagination>
<MedlinePgn>143-76</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Nanotechnology plays an increasingly important role not only in our everyday life (with all its benefits and dangers) but also in medicine. Nanoparticles are to date the most intriguing option to deliver high concentrations of agents specifically and directly to cancer cells; therefore, a wide variety of these nanomaterials has been developed and explored. These span the range from simple nanoagents to sophisticated smart devices for drug delivery or imaging. Nanomaterials usually provide a large surface area, allowing for decoration with a large amount of moieties on the surface for either additional functionalities or targeting. Besides using particles solely for imaging purposes, they can also carry as a payload a therapeutic agent. If both are combined within the same particle, a theranostic agent is created. The sophistication of highly developed nanotechnology targeting approaches provides a promising means for many clinical implementations and can provide improved applications for otherwise suboptimal formulations. In this review we will explore nanotechnology both for imaging and therapy to provide a general overview of the field and its impact on cancer imaging and therapy. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kaittanis</LastName>
<ForeName>Charalambos</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shaffer</LastName>
<ForeName>Travis M</ForeName>
<Initials>TM</Initials>
<AffiliationInfo>
<Affiliation>Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thorek</LastName>
<ForeName>Daniel L J</ForeName>
<Initials>DL</Initials>
<AffiliationInfo>
<Affiliation>Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Grimm</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>1R01 EB014944</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>5R25CA096945-07</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 CA008748</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 CA008748-44 S5</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 EB014944</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R24 CA083084</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R25 CA096945</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Crit Rev Oncog</MedlineTA>
<NlmUniqueID>8914610</NlmUniqueID>
<ISSNLinking>0893-9675</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D062346">Molecular Medicine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053758">Nanoparticles</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D036103">Nanotechnology</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009369">Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015899">Tomography, Emission-Computed, Single-Photon</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS626574 [Available on 01/01/15]</OtherID>
<OtherID Source="NLM">PMC4183929 [Available on 01/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25277001</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>23</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1660-9379</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>10</Volume>
<Issue>440</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>Revue mdicale suisse</Title>
<ISOAbbreviation>Rev Med Suisse</ISOAbbreviation>
</Journal>
<ArticleTitle>["I am a little out of breath". When a commonplace symptom hides a rare disease: cardiac amyloidosis].</ArticleTitle>
<Pagination>
<MedlinePgn>1619-23</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Based on a case report, this article reviews the different forms of cardiac involvement in amyloidosis. This affection refers to the extracellular tissue deposition of protein fibrils (the amyloid substance), which gradually invades a variety of organs, disrupting their function. The clinical presentation depends on the type of the amyloidogenic protein and on its main distribution. The most severe cardiac impairment and with the worse prognosis is seen in its primary form (or AL), while it is less frequent, with a slower course and a better prognosis in its other forms: secondary (AA), familial (ATTR) or senile (SSA).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Excoffier</LastName>
<ForeName>Sophie</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Celik</LastName>
<ForeName>Hakan</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Durieux-Paillard</LastName>
<ForeName>Sophie</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>fre</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>"Je suis un peu essouffl". Ouand un symptme banal cache une maladie rare: l'amylidose cardiaque.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Rev Med Suisse</MedlineTA>
<NlmUniqueID>101219148</NlmUniqueID>
<ISSNLinking>1660-9379</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C109794">pro-brain natriuretic peptide (1-76)</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>114471-18-0</RegistryNumber>
<NameOfSubstance UI="D020097">Natriuretic Peptide, Brain</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000686">Amyloidosis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000145">classification</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001706">Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017147">Defibrillators, Implantable</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004417">Dyspnea</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004452">Echocardiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004562">Electrocardiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006331">Heart Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016027">Heart Transplantation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020097">Natriuretic Peptide, Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010446">Peptide Fragments</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25282843</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0025-8075</ISSN>
<JournalIssue CitedMedium="Print">
<Issue>3</Issue>
<PubDate>
<MedlineDate>2014 May-Jun</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Meditsinskaia tekhnika</Title>
<ISOAbbreviation>Med Tekh</ISOAbbreviation>
</Journal>
<ArticleTitle>[Problems of certification and quality monitoring of magnetic resonance imaging rooms].</ArticleTitle>
<Pagination>
<MedlinePgn>34-7</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Blinov</LastName>
<ForeName>N N</ForeName>
<Initials>NN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Snopova</LastName>
<ForeName>K A</ForeName>
<Initials>KA</Initials>
</Author>
</AuthorList>
<Language>rus</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Russia (Federation)</Country>
<MedlineTA>Med Tekh</MedlineTA>
<NlmUniqueID>1305457</NlmUniqueID>
<ISSNLinking>0025-8075</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002568">Certification</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000331">legislation &amp; jurisprudence</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000592">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000592">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011786">Quality Control</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25282940</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1438-3276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>156</Volume>
<Issue>15</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
<Day>11</Day>
</PubDate>
</JournalIssue>
<Title>MMW Fortschritte der Medizin</Title>
<ISOAbbreviation>MMW Fortschr Med</ISOAbbreviation>
</Journal>
<ArticleTitle>[Usual back pain?].</ArticleTitle>
<Pagination>
<MedlinePgn>64-5</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Stiebler</LastName>
<ForeName>Andreas</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Patient mit Lumbago, Fieber und Nachtschweiss. Nur "banale" Rckenschmerzen oder steckt da mehr dahinter?</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>MMW Fortschr Med</MedlineTA>
<NlmUniqueID>100893959</NlmUniqueID>
<ISSNLinking>1438-3276</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001022">Aortic Valve Insufficiency</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D064131">Back Muscles</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002481">Cellulitis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004452">Echocardiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017548">Echocardiography, Transesophageal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004697">Endocarditis, Bacterial</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005335">Fever of Unknown Origin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017116">Low Back Pain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008159">Lumbar Vertebrae</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25286667</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>07</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1505-1773</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Polish journal of veterinary sciences</Title>
<ISOAbbreviation>Pol J Vet Sci</ISOAbbreviation>
</Journal>
<ArticleTitle>The use of magnetic resonance imaging in diagnosing equine deep digital flexor tendinopathies--own experience.</ArticleTitle>
<Pagination>
<MedlinePgn>531-3</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Deep digital flexor tendinopathy is a common problem in horses of different athletic disciplines. Nowadays, the use of magnetic resonance imaging is considered to be a noninvasive and superior choice for recognizing bone and soft tissue pathologies especially related to difficult to access structures within the hoof capsule.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jasklska</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Adamiak</LastName>
<ForeName>Z</ForeName>
<Initials>Z</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zhalniarovich</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Przyborowska</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Peczyski</LastName>
<ForeName>Z</ForeName>
<Initials>Z</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Pol J Vet Sci</MedlineTA>
<NlmUniqueID>101125473</NlmUniqueID>
<ISSNLinking>1505-1773</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005552">Forelimb</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006734">Horse Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006736">Horses</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007794">Lameness, Animal</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000662">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D052256">Tendinopathy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000662">veterinary</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25291846</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0723-2276</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>33</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege / Deutsche Gesellschaft fr Sozialpdiatrie und Deutsche Gesellschaft fr Kinderheilkunde</Title>
<ISOAbbreviation>Kinderkrankenschwester</ISOAbbreviation>
</Journal>
<ArticleTitle>[Fundraising for anxiety- and stress-free medicine].</ArticleTitle>
<Pagination>
<MedlinePgn>359-60</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Staub</LastName>
<ForeName>Angelika</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Spendensammeln fr angst- und stressfreie Medizin.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Kinderkrankenschwester</MedlineTA>
<NlmUniqueID>8305989</NlmUniqueID>
<ISSNLinking>0723-2276</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>N</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001007">Anxiety</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000451">nursing</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004867">Equipment Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005653">Fund Raising</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D005858">Germany</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006776">Hospitals, Pediatric</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009622">Noise</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010988">Play and Playthings</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013315">Stress, Psychological</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000451">nursing</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014741">Video Recording</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25291871</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>24</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0031-2983</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>106</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Pathologica</Title>
<ISOAbbreviation>Pathologica</ISOAbbreviation>
</Journal>
<ArticleTitle>Juvenile hyaline fibromatosis: a case report.</ArticleTitle>
<Pagination>
<MedlinePgn>70-2</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Juvenile hyaline fibromatosis is a rare, hereditary disease with distinct clinical and histopathological features. Clinically, it presents with gingival hypertrophy, pappulonodular skin lesions and joint contractures. Bone involvement is usually an uncommon finding. We report a case of a 2-year-old patient, daughter of consanguineous parents, who presented since the age of 2 months with impairment of mental development, multiple joint contractures, motion limitation and nodules on the scalp. The calvarian lesions were surgically removed, and histopathological examination concluded to juvenile hyaline fibromatosis.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mestiri</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Labaied</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mama</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ayadi</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ladib</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sriha</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Krifa</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mokni</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Pathologica</MedlineTA>
<NlmUniqueID>0401123</NlmUniqueID>
<ISSNLinking>0031-2983</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biological Markers</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015415">Biological Markers</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001706">Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003286">Contracture</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005886">Gingival Hypertrophy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006818">Hyalin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D057770">Hyalinosis, Systemic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011237">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012867">Skin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24214286</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1550-0594</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>45</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Clinical EEG and neuroscience</Title>
<ISOAbbreviation>Clin EEG Neurosci</ISOAbbreviation>
</Journal>
<ArticleTitle>Transient epileptic amnesia: clinical report of a cohort of patients.</ArticleTitle>
<Pagination>
<MedlinePgn>179-83</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Transient epileptic amnesia is a seizure disorder, usually with onset in the middle-elderly and good response to low dosages of antiepileptic drugs. We describe the clinical, electroencephalography (EEG), and neuroimaging features of 11 patients with a temporal lobe epilepsy characterized by amnesic seizures as the sole or the main symptom. We outline the relevance of a detailed clinical history to recognize amnesic seizures and to avoid the more frequent misdiagnoses. Moreover, the response to monotherapy was usually good, although the epileptic disorder was symptomatic of acquired lesions in the majority of patients.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lapenta</LastName>
<ForeName>Leonardo</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brunetti</LastName>
<ForeName>Valerio</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Losurdo</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Testani</LastName>
<ForeName>Elisa</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Giannantoni</LastName>
<ForeName>Nadia Mariagrazia</ForeName>
<Initials>NM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Quaranta</LastName>
<ForeName>Davide</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Di Lazzaro</LastName>
<ForeName>Vincenzo</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Della Marca</LastName>
<ForeName>Giacomo</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Clin EEG Neurosci</MedlineTA>
<NlmUniqueID>101213033</NlmUniqueID>
<ISSNLinking>1550-0594</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020236">Amnesia, Transient Global</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000927">Anticonvulsants</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004305">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004569">Electroencephalography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004833">Epilepsy, Temporal Lobe</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005071">Evoked Potentials</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005625">Frontal Lobe</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018670">Monitoring, Ambulatory</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012815">Signal Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013702">Temporal Lobe</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24293161</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1550-0594</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>45</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Clinical EEG and neuroscience</Title>
<ISOAbbreviation>Clin EEG Neurosci</ISOAbbreviation>
</Journal>
<ArticleTitle>Real-time functional mapping with electrocorticography in pediatric epilepsy: comparison with fMRI and ESM findings.</ArticleTitle>
<Pagination>
<MedlinePgn>205-11</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>SIGFRIED (SIGnal modeling For Real-time Identification and Event Detection) software provides real-time functional mapping (RTFM) of eloquent cortex for epilepsy patients preparing to undergo resective surgery. This study presents the first application of paradigms used in functional magnetic resonance (fMRI) and electrical cortical stimulation mapping (ESM) studies for shared functional cortical mapping in the context of RTFM. Results from the 3 modalities are compared. A left-handed 13-year-old male with intractable epilepsy participated in functional mapping for localization of eloquent language cortex with fMRI, ESM, and RTFM. For RTFM, data were acquired over the frontal and temporal cortex. Several paradigms were sequentially presented: passive (listening to stories) and active (picture naming and verb generation). For verb generation and story processing, fMRI showed atypical right lateralizing language activation within temporal lobe regions of interest and bilateral frontal activation with slight right lateralization. Left hemisphere ESM demonstrated no eloquent language areas. RTFM procedures using story processing and picture naming elicited activity in the right lateral and basal temporal regions. Verb generation elicited strong right lateral temporal lobe activation, as well as left frontal lobe activation. RTFM results confirmed atypical language lateralization evident from fMRI and ESM. We demonstrated the feasibility and usefulness of a new RTFM stimulation paradigm during presurgical evaluation. Block design paradigms used in fMRI may be optimal for this purpose. Further development is needed to create age-appropriate RTFM test batteries.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Korostenskaja</LastName>
<ForeName>Milena</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wilson</LastName>
<ForeName>Adam J</ForeName>
<Initials>AJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rose</LastName>
<ForeName>Douglas F</ForeName>
<Initials>DF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brunner</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schalk</LastName>
<ForeName>Gerwin</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Leach</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mangano</LastName>
<ForeName>Francesco T</ForeName>
<Initials>FT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fujiwara</LastName>
<ForeName>Hisako</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rozhkov</LastName>
<ForeName>Leonid</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Harris</LastName>
<ForeName>Elana</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Po-Ching</ForeName>
<Initials>PC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Seo</LastName>
<ForeName>Joo-Hee</ForeName>
<Initials>JH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Ki H</ForeName>
<Initials>KH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Clin EEG Neurosci</MedlineTA>
<NlmUniqueID>101213033</NlmUniqueID>
<ISSNLinking>1550-0594</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001931">Brain Mapping</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D062207">Brain-Computer Interfaces</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002540">Cerebral Cortex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D003198">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003936">Diagnosis, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004292">Dominance, Cerebral</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004558">Electric Stimulation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004827">Epilepsy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005240">Feasibility Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005625">Frontal Lobe</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D064847">Multimodal Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012815">Signal Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012984">Software</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013067">Speech Perception</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013702">Temporal Lobe</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014705">Verbal Behavior</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014825">Vocabulary</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24048241</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1550-0594</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>45</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Clinical EEG and neuroscience</Title>
<ISOAbbreviation>Clin EEG Neurosci</ISOAbbreviation>
</Journal>
<ArticleTitle>Reproducibility of EEG-fMRI results in a patient with fixation-off sensitivity.</ArticleTitle>
<Pagination>
<MedlinePgn>212-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Blood oxygenation level-dependent (BOLD) activation associated with interictal epileptiform discharges in a patient with fixation-off sensitivity (FOS) was studied using a combined electroencephalography-functional magnetic resonance imaging (EEG-fMRI) technique. An automatic approach for combined EEG-fMRI analysis and a subject-specific hemodynamic response function was used to improve general linear model analysis of the fMRI data. The EEG showed the typical features of FOS, with continuous epileptiform discharges during elimination of central vision by eye opening and closing and fixation; modification of this pattern was clearly visible and recognizable. During all 3 recording sessions EEG-fMRI activations indicated a BOLD signal decrease related to epileptiform activity in the parietal areas. This study can further our understanding of this EEG phenomenon and can provide some insight into the reliability of the EEG-fMRI technique in localizing the irritative zone.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Formaggio</LastName>
<ForeName>Emanuela</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Storti</LastName>
<ForeName>Silvia Francesca</ForeName>
<Initials>SF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Galazzo</LastName>
<ForeName>Ilaria Boscolo</ForeName>
<Initials>IB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bongiovanni</LastName>
<ForeName>Luigi Giuseppe</ForeName>
<Initials>LG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cerini</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fiaschi</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Manganotti</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Clin EEG Neurosci</MedlineTA>
<NlmUniqueID>101213033</NlmUniqueID>
<ISSNLinking>1550-0594</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>S88TT14065</RegistryNumber>
<NameOfSubstance UI="D010100">Oxygen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000927">Anticonvulsants</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001931">Brain Mapping</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002540">Cerebral Cortex</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017029">Epilepsy, Complex Partial</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005403">Fixation, Ocular</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006439">Hemodynamics</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016014">Linear Models</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D064847">Multimodal Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009778">Occipital Lobe</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010100">Oxygen</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012683">Sensory Deprivation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24114074</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1550-0594</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>45</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Clinical EEG and neuroscience</Title>
<ISOAbbreviation>Clin EEG Neurosci</ISOAbbreviation>
</Journal>
<ArticleTitle>A patient with progressive cognitive decline and periodic abnormal waves in EEG: PLEDs of neurosyphilis or PSDs of Creutzfeldt-Jakob disease?</ArticleTitle>
<Pagination>
<MedlinePgn>218-21</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We report one Chinese patient with neurosyphilis exhibiting periodic lateralized epileptiform discharges (PLEDs) in the electroencephalogram (EEG). The patient (male, 59 years old) manifested with progressive cognitive decline and abnormal behavior. After several days, he gradually lost contact with others, and fell into a coma. EEG revealed periodic abnormal waves, predominantly located in the right anterior frontal region. The serum and cerebrospinal fluid Venereal Disease Research Laboratory test and Treponema pallidum hemagglutination assay were positive. Magnetic resonance imaging (MRI) of brain showed focal atrophy in the right frontal and temporal region. Diffusion-weighted MRI showed "lace sign" in cortex, which could be seen as an early and special feature in Creutzfeldt-Jakob disease (CJD). To differentiate "PLEDs of neurosyphilis on EEG" from "periodic synchronous discharges (PSD) of CJD on EEG," we treated this patient with diazepam 20 mg intravenously. After 10 minutes, periodic abnormal waves on EEG disappeared, with improved mental status, which confirmed the diagnosis of PLEDs of neurosyphilis. Then, after the treatment with penicillin, the patient improved and returned to work.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lv</LastName>
<ForeName>Yudan</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chu</LastName>
<ForeName>Fengna</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Meng</LastName>
<ForeName>Hongmei</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Zan</ForeName>
<Initials>Z</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cui</LastName>
<ForeName>Li</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Clin EEG Neurosci</MedlineTA>
<NlmUniqueID>101213033</NlmUniqueID>
<ISSNLinking>1550-0594</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>Q3JTX2Q7TU</RegistryNumber>
<NameOfSubstance UI="D003975">Diazepam</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001284">Atrophy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D002681">China</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003128">Coma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007562">Creutzfeldt-Jakob Syndrome</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003704">Dementia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003975">Diazepam</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D038524">Diffusion Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004292">Dominance, Cerebral</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004827">Epilepsy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005071">Evoked Potentials</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005625">Frontal Lobe</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009494">Neurosyphilis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013702">Temporal Lobe</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24690985</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>23</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0003-4894</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>123</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>The Annals of otology, rhinology, and laryngology</Title>
<ISOAbbreviation>Ann. Otol. Rhinol. Laryngol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Prediction of the attachment site of sinonasal inverted papillomas by preoperative imaging.</ArticleTitle>
<Pagination>
<MedlinePgn>468-74</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Accurate preoperative identification of the attachment site is the key to the successful surgical management of sinonasal inverted papillomas (IPs). This study investigated the value of preoperative imaging to identify the attachment sites of IPs.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed I 0 consecutive patients with pathologically proven IPs. Two radiologists predicted the attachment sites of IPs from computed tomography (CT), 3.0 Tesla magnetic resonance imaging (3.0T MRI), 1.5T MRI, and CT plus 3.0T MRI. The actual tumor attachment sites were confirmed via pathological examination of specimens and compared with the predicted sites.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Computed tomography showed the highest sensitivity (P &lt; .0001), although both MRI formats showed greater specificity (P &lt; .0001). The sensitivity of MRI plus CT was equal to that of CT and better than that of MRI (P &lt; .0001), whereas its specificity was better than that of CT (P &lt; .0001) and comparable to that of MRI. Prediction using 3.0T MRI appeared slightly superior to that using 1.5T MRI in terms of sensitivity and specificity, although the differences were not significant.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Computed tomography and MRI had different features for prediction of sinonasal IP attachment sites. Preoperative CT plus MRI provided more useful information than CT or MRI alone.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nakamaru</LastName>
<ForeName>Yuji</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fujima</LastName>
<ForeName>Noriyuki</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Takagi</LastName>
<ForeName>Dai</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tsukahara</LastName>
<ForeName>Akiko</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yoshida</LastName>
<ForeName>Daisuke</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fukuda</LastName>
<ForeName>Satoshi</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Ann Otol Rhinol Laryngol</MedlineTA>
<NlmUniqueID>0407300</NlmUniqueID>
<ISSNLinking>0003-4894</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018308">Papilloma, Inverted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010255">Paranasal Sinus Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000530">radiography</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011237">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011300">Preoperative Care</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24659238</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1573-2568</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>59</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Digestive diseases and sciences</Title>
<ISOAbbreviation>Dig. Dis. Sci.</ISOAbbreviation>
</Journal>
<ArticleTitle>An overview of magnetic resonance enterography for Crohn's disease.</ArticleTitle>
<Pagination>
<MedlinePgn>2040-9</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Magnetic resonance enterography (MRE) is a relatively new imaging modality that has shown promise for diagnosing, staging, and monitoring Crohn's disease (CD) and its complications while avoiding exposure to ionizing radiation. In addition to clinical implications, MRE has the potential to be used as an objective measure of disease activity for clinical trials. We provide the rationale for MRE, indications for its use, and an overview of the typical procedure and common findings for institutions who want to begin or refine the use of MRE for CD.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pola</LastName>
<ForeName>Suresh</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Santillan</LastName>
<ForeName>Cynthia</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Levesque</LastName>
<ForeName>Barrett G</ForeName>
<Initials>BG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Feagan</LastName>
<ForeName>Brian G</ForeName>
<Initials>BG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sandborn</LastName>
<ForeName>William J</ForeName>
<Initials>WJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Dig Dis Sci</MedlineTA>
<NlmUniqueID>7902782</NlmUniqueID>
<ISSNLinking>0163-2116</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000284">Administration, Oral</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003287">Contrast Media</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003424">Crohn Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000744">contraindications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018579">Patient Selection</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25295504</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>22</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1533-4406</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>371</Volume>
<Issue>15</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
<Day>9</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Case records of the Massachusetts General Hospital. Case 31-2014. A 50-year-old man with back pain, fatigue, weight loss, and knee swelling.</ArticleTitle>
<Pagination>
<MedlinePgn>1447-55</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMcpc1404517</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fisher</LastName>
<ForeName>Mark C</ForeName>
<Initials>MC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Stone</LastName>
<ForeName>John H</ForeName>
<Initials>JH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Palmer</LastName>
<ForeName>William E</ForeName>
<Initials>WE</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016429">Clinical Conference</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
<ISSNLinking>0028-4793</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C442644">HLA-B*27:19 antigen</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015796">HLA-B27 Antigen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001416">Back Pain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059350">Chronic Pain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005221">Fatigue</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015796">HLA-B27 Antigen</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000032">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006327">Heart Block</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007717">Knee</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008159">Lumbar Vertebrae</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013167">Spondylitis, Ankylosing</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013904">Thoracic Vertebrae</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015431">Weight Loss</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25306800</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>13</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>17</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0023-9852</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>62</Volume>
<Issue>3</Issue>
<PubDate>
<MedlineDate>2014 Jul-Sep</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Le Journal mdical libanais. The Lebanese medical journal</Title>
<ISOAbbreviation>J Med Liban</ISOAbbreviation>
</Journal>
<ArticleTitle>Osteomyelitis at two noncontiguous sites caused by Mycobacterium marinum in an immunocompetent host: case report and literature review.</ArticleTitle>
<Pagination>
<MedlinePgn>180-2</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Nontuberculous mycobacteria are rare causes of skin, soft tissue, and musculoskeletal infections. Mycobacterium marinum remains one of the most commonly encountered mycobacterial species in humans, causing superficial cutaneous as well as deep infections. We are reporting a case of M. marinum osteomyelitis involving two primary noncontiguous sites in an immunocompetent host, which was successfully treated with surgical drainage and antibiotic therapy.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kamel</LastName>
<ForeName>Ghassan</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Youssef</LastName>
<ForeName>Mona</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Haidar</LastName>
<ForeName>Rachid</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Khater</LastName>
<ForeName>Beatrice</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kanafani</LastName>
<ForeName>Zeina A</ForeName>
<Initials>ZA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Lebanon</Country>
<MedlineTA>J Med Liban</MedlineTA>
<NlmUniqueID>0375352</NlmUniqueID>
<ISSNLinking>0023-9852</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D007121">Immunocompetence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050279">Metacarpal Bones</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008683">Metatarsophalangeal Joint</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009165">Mycobacterium Infections, Nontuberculous</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019910">Mycobacterium marinum</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010019">Osteomyelitis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000382">microbiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25306142</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>13</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1591-996X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>15</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>European journal of paediatric dentistry : official journal of European Academy of Paediatric Dentistry</Title>
<ISOAbbreviation>Eur J Paediatr Dent</ISOAbbreviation>
</Journal>
<ArticleTitle>In vitro analysis of extracted dens invaginatus using various radiographic imaging techniques.</ArticleTitle>
<Pagination>
<MedlinePgn>265-70</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="AIM" NlmCategory="OBJECTIVE">Dens Invaginatus (DI) is a rare malformation of the teeth, showing a broad spectrum of morphologic variations. The aim of this study was to perform in vitro radiographic analyses of three extracted dens invaginatus (DI) teeth with complex root anatomy using plain radiographs, CBCT, MRI and micro CT techniques.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Study design: Three maxillary lateral incisors (A, B and C) from two patients were extracted due to poor prognosis and were radiographically analysed. Initially, conventional two dimensional digital radiographs were taken. Subsequently CBCT, micro CT and MRI analyses were performed.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">According to the Schulze and Brand system of classification, teeth A, B and C were classified as A2, B3 and B2 respectively. To detect the relationship between the invagination to the oral cavity and pulp chamber, conventional two dimensional radiographs were of no help. CBCT and MRI images were found to be complementary to each other but provided lesser structural detail than micro CT images.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Reporting on these three DI teeth, normal conventional radiographs did not provide detailed structural information about the malformation due to geometric distortion and lack of information. Even though Oehlers classification system is the most widely used, classification by Schulze and Brand is more applicable in rare and deviant teeth.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rajasekharan</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Paediatric Dentistry and Special Care, PaeCaMeD research, Ghent University.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martens</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Paediatric Dentistry and Special Care, PaeCaMeD research, Ghent University.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vanhove</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Medical Imaging and Signal Processing, Infinity Lab, Ghent University, UZ Ghent.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Aps</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatric Dentistry, University of Washington, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Eur J Paediatr Dent</MedlineTA>
<NlmUniqueID>101121881</NlmUniqueID>
<ISSNLinking>1591-996X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054893">Cone-Beam Computed Tomography</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003719">Dens in Dente</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003743">Dental Enamel</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000002">abnormalities</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003782">Dental Pulp</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000002">abnormalities</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003786">Dental Pulp Cavity</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000002">abnormalities</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007180">Incisor</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000002">abnormalities</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019252">Radiography, Dental, Digital</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019227">Tooth Apex</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000002">abnormalities</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019228">Tooth Crown</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000002">abnormalities</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014092">Tooth Root</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000002">abnormalities</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055114">X-Ray Microtomography</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25314780</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>15</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>28</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0040-3660</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>86</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Terapevticheski arkhiv</Title>
<ISOAbbreviation>Ter. Arkh.</ISOAbbreviation>
</Journal>
<ArticleTitle>[Thrombosis of the sinus durae matris as a complication of therapy in patients with Hodgkin lymphoma].</ArticleTitle>
<Pagination>
<MedlinePgn>68-72</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="AIM" NlmCategory="OBJECTIVE">To describe thrombosis of the sinus durae matris (TSDM) in lymphomas.</AbstractText>
<AbstractText Label="SUBJECTS AND METHODS" NlmCategory="METHODS">402 patients with Hodgkin lymphoma were treated using the BEACOPP-14 protocol in 2006 to 2013. Thrombotic events occurred in 6% of the patients, including 3 (0.8%) who developed brain magnetic resonance imaging-verified TSDM.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">TSDM developed in 3 women aged 17, 18, and 25 years during 3-6 chemotherapy cycles involving glucocorticosteroids in a dose of 80 mg/m2 on days 1-7 and an oral contraceptive used continuously for 1.5-3 months. The symptoms of thrombosis were severe headache; 2 patients had convulsive syndrome with short-term loss of consciousness. Anticoagulant therapy with intravenous heparin 20,000--24,000 U/day led to thrombus recanalization within 4-10 days. No rethromoboses were observed during a subsequent follow-up.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The BEACOPP-14 treatment in young women with Hodgkin lymphoma who continuously take oral contraceptives should be combined with anticoagulant therapy, by monitoring their coagulogram.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shitareva</LastName>
<ForeName>I V</ForeName>
<Initials>IV</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Moiseeva</LastName>
<ForeName>T N</ForeName>
<Initials>TN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Al'-Radi</LastName>
<ForeName>L S</ForeName>
<Initials>LS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Margolin</LastName>
<ForeName>O V</ForeName>
<Initials>OV</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Khlavno</LastName>
<ForeName>A B</ForeName>
<Initials>AB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Iatsyk</LastName>
<ForeName>G A</ForeName>
<Initials>GA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kravchenko</LastName>
<ForeName>S K</ForeName>
<Initials>SK</Initials>
</Author>
</AuthorList>
<Language>rus</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Russia (Federation)</Country>
<MedlineTA>Ter Arkh</MedlineTA>
<NlmUniqueID>2984818R</NlmUniqueID>
<ISSNLinking>0040-3660</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017984">Enoxaparin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000925">Anticoagulants</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000971">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002560">Cerebrovascular Circulation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D003392">Cranial Sinuses</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017984">Enoxaparin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006689">Hodgkin Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012851">Sinus Thrombosis, Intracranial</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25314840</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>15</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1042-7260</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>45</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians</Title>
<ISOAbbreviation>J. Zoo Wildl. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>The use of magnetic resonance imaging to better define hoof pathology in the reticulated giraffe (Giraffa camelopardalis reticulata).</ArticleTitle>
<Pagination>
<MedlinePgn>668-71</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>A 22-yr-old bull giraffe (Giraffa camelopardalis reticulata) with severely altered hoof conformation in both forelimbs was presented for necropsy following acute mortality. Due to multiple challenges that prevented safe immobilization, corrective hoof trimming procedures were never performed on this animal. To better define the extent of the damage of the soft tissue structures and bone within the hoof, a magnetic resonance imaging (MRI) system was used to obtain images of these structures. The MRI study found evidence of severe osteolysis, phalangeal fractures of both forelimbs, and tenosynovitis of several tendon sheaths. These findings help demonstrate the impact that hoof overgrowth can have on internal structures within the hoof. By managing hoof problems early in the course of disease and investing in appropriate facilities that make giraffe immobilization safer, morbidity and mortality associated with hoof disease and overgrowth can potentially be reduced.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wakeman</LastName>
<ForeName>Kyle A</ForeName>
<Initials>KA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sanchez</LastName>
<ForeName>Carlos R</ForeName>
<Initials>CR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lung</LastName>
<ForeName>Nancy P</ForeName>
<Initials>NP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hersman</LastName>
<ForeName>Jake</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Barrett</LastName>
<ForeName>Myra F</ForeName>
<Initials>MF</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Zoo Wildl Med</MedlineTA>
<NlmUniqueID>8915208</NlmUniqueID>
<ISSNLinking>1042-7260</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000038">Abscess</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000382">microbiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000662">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000836">Animals, Zoo</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000866">Antelopes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005534">Foot Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000662">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006724">Hoof and Claw</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000662">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013290">Streptococcal Infections</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000662">veterinary</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320775</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Generalized multiresolution hierarchical shape models via automatic landmark clusterization.</ArticleTitle>
<Pagination>
<MedlinePgn>1-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Point Distribution Models (PDM) are some of the most popular shape description techniques in medical imaging. However, to create an accurate shape model it is essential to have a representative sample of the underlying population, which is often challenging. This problem is particularly relevant as the dimensionality of the modeled structures increases, and becomes critical when dealing with complex 3D shapes. In this paper, we introduce a new generalized multiresolution hierarchical PDM (GMRH-PDM) able to efficiently address the high-dimension-low-sample-size challenge when modeling complex structures. Unlike previous approaches, our new and general framework extends hierarchical modeling to any type of structure (multi- and single-object shapes) allowing to describe efficiently the shape variability at different levels of resolution. Importantly, the configuration of the algorithm is automatized thanks to the new agglomerative landmark clustering method presented here. Our new and automatic GMRH-PDM framework performed significantly better than classical approaches, and as well as the state-of-the-art with the best manual configuration. Evaluations have been studied for two different cases, the right kidney, and a multi-object case composed of eight subcortical structures.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Cerrolaza</LastName>
<ForeName>Juan J</ForeName>
<Initials>JJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Villanueva</LastName>
<ForeName>Arantxa</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reyes</LastName>
<ForeName>Mauricio</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cabeza</LastName>
<ForeName>Rafael</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gonzlez Ballester</LastName>
<ForeName>Miguel Angel</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Linguraru</LastName>
<ForeName>Marius George</ForeName>
<Initials>MG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059925">Anatomic Landmarks</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003198">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008953">Models, Anatomic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320776</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Hierarchical bayesian modeling, estimation, and sampling for multigroup shape analysis.</ArticleTitle>
<Pagination>
<MedlinePgn>9-16</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>This paper proposes a novel method for the analysis of anatomical shapes present in biomedical image data. Motivated by the natural organization of population data into multiple groups, this paper presents a novel hierarchical generative statistical model on shapes. The proposed method represents shapes using pointsets and defines a joint distribution on the population's (i) shape variables and (ii) object-boundary data. The proposed method solves for optimal (i) point locations, (ii) correspondences, and (iii) model-parameter values as a single optimization problem. The optimization uses expectation maximization relying on a novel Markov-chain Monte-Carlo algorithm for sampling in Kendall shape space. Results on clinical brain images demonstrate advantages over the state of the art.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yu</LastName>
<ForeName>Yen-Yun</ForeName>
<Initials>YY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fletcher</LastName>
<ForeName>P Thomas</ForeName>
<Initials>PT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Awate</LastName>
<ForeName>Suyash P</ForeName>
<Initials>SP</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>5R01EB007688</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P41-RR12553</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54-EB005149</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000544">Alzheimer Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001499">Bayes Theorem</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003198">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006624">Hippocampus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008953">Models, Anatomic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015233">Models, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018401">Sample Size</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320780</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>BrainPrint: identifying subjects by their brain.</ArticleTitle>
<Pagination>
<MedlinePgn>41-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Introducing BrainPrint, a compact and discriminative representation of anatomical structures in the brain. BrainPrint captures shape information of an ensemble of cortical and subcortical structures by solving the 2D and 3D Laplace-Beltrami operator on triangular (boundary) and tetrahedral (volumetric) meshes. We derive a robust classifier for this representation that identifies the subject in a new scan, based on a database of brain scans. In an example dataset containing over 3000 MRI scans, we show that BrainPrint captures unique information about the subject's anatomy and permits to correctly classify a scan with an accuracy of over 99.8%. All processing steps for obtaining the compact representation are fully automated making this processing framework particularly attractive for handling large datasets.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wachinger</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Golland</LastName>
<ForeName>Polina</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reuter</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P41 EB015896</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P41 EB015902</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P41-EB015896</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P41-EB015902</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P41-RR014075</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54 EB005149</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54-EB005149</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000544">Alzheimer Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056667">Biometric Identification</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012984">Software</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS637906 [Available on 01/01/15]</OtherID>
<OtherID Source="NLM">PMC4216735 [Available on 01/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320781</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Diffeomorphic shape trajectories for improved longitudinal segmentation and statistics.</ArticleTitle>
<Pagination>
<MedlinePgn>49-56</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Longitudinal imaging studies involve tracking changes in individuals by repeated image acquisition over time. The goal of these studies is to quantify biological shape variability within and across individuals, and also to distinguish between normal and disease populations. However, data variability is influenced by outside sources such as image acquisition, image calibration, human expert judgment, and limited robustness of segmentation and registration algorithms. In this paper, we propose a two-stage method for the statistical analysis of longitudinal shape. In the first stage, we estimate diffeomorphic shape trajectories for each individual that minimize inconsistencies in segmented shapes across time. This is followed by a longitudinal mixed-effects statistical model in the second stage for testing differences in shape trajectories between groups. We apply our method to a longitudinal database from PREDICT-HD and demonstrate our approach reduces unwanted variability for both shape and derived measures, such as volume. This leads to greater statistical power to distinguish differences in shape trajectory between healthy subjects and subjects with a genetic biomarker for Huntington's disease (HD).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Muralidharan</LastName>
<ForeName>Prasanna</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fishbaugh</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Johnson</LastName>
<ForeName>Hans J</ForeName>
<Initials>HJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Durrleman</LastName>
<ForeName>Stanley</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Paulsen</LastName>
<ForeName>Jane S</ForeName>
<Initials>JS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gerig</LastName>
<ForeName>Guido</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fletcher</LastName>
<ForeName>P Thomas</ForeName>
<Initials>PT</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>5R01NS040068</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>5R01NS054893</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>NS050568</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>NS40068</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>S10 RR023392</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 NS082086</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54 EB005149</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000375">Aging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003627">Data Interpretation, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006816">Huntington Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008137">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320784</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Co-occurrence of local anisotropic gradient orientations (CoLIAGe): distinguishing tumor confounders and molecular subtypes on MRI.</ArticleTitle>
<Pagination>
<MedlinePgn>73-80</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We introduce a novel biologically inspired feature descriptor, Co-occurrence of Local Anisotropic Gradient Orientations (CoLlAGe), that captures higher order co-occurrence patterns of local gradient tensors at a pixel level to distinguish disease phenotypes that have similar morphologic appearances. A number of pathologies (e.g. subtypes of breast cancer) have different histologic phenotypes but similar radiographic appearances. While texture features have been previously employed for distinguishing subtly different pathologies, they attempt to capture differences in global intensity patterns. In this paper we attempt to model CoLlAGe to identify higher order co-occurrence patterns of gradient tensors at a pixel level. The assumption behind this new feature is that different pathologies, even though they may have very similar overall texture and appearance on imaging, at a local scale, will have different co-occurring patterns with respect to gradient orientations. We demonstrate the utility of CoLIAGe in distinguishing two subtly different types of pathologies on MRI in the context of brain tumors and breast cancer. In the first problem, we look at CoLlAGe for distinguishing radiation effects from recurrent brain tumors over a cohort of 40 studies, and in the second, discriminating different molecular subtypes of breast cancer over a cohort of 73 studies. For both these challenging cohorts, CoLlAGe was found to have significantly improved classification performance, as compared to the traditional texture features such as Haralick, Gabor, local binary patterns, and histogram of gradients.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Prasanna</LastName>
<ForeName>Prateek</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tiwari</LastName>
<ForeName>Pallavi</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Madabhushi</LastName>
<ForeName>Anant</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>PC120857</GrantID>
<Acronym>PC</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01CA136535-01</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01CA140772-01</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01DK098503-02</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21CA167811-01</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014408">Tumor Markers, Biological</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016880">Anisotropy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001943">Breast Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014408">Tumor Markers, Biological</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320785</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Automatic clustering and thickness measurement of anatomical variants of the human perirhinal cortex.</ArticleTitle>
<Pagination>
<MedlinePgn>81-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The entorhinal cortex (ERC) and the perirhinal cortex (PRC) are subregions of the medial temporal lobe (MTL) that play important roles in episodic memory representations, as well as serving as a conduit between other neocortical areas and the hippocampus. They are also the sites where neuronal damage first occurs in Alzheimer's disease (AD). The ability to automatically quantify the volume and thickness of the ERC and PRC is desirable because these localized measures can potentially serve as better imaging biomarkers for AD and other neurodegenerative diseases. However, large anatomical variation in the PRC makes it a challenging area for analysis. In order to address this problem, we propose an automatic segmentation, clustering, and thickness measurement approach that explicitly accounts for anatomical variation. The approach is targeted to highly anisotropic (0.4x0.4x2.0mm3 ) T2-weighted MRI scans that are preferred by many authors for detailed imaging of the MTL, but which pose challenges for segmentation and shape analysis. After automatically labeling MTL substructures using multi-atlas segmentation, our method clusters subjects into groups based on the shape of the PRC, constructs unbiased population templates for each group, and uses the smooth surface representations obtained during template construction to extract regional thickness measurements in the space of each subject. The proposed thickness measures are evaluated in the context of discrimination between patients with Mild Cognitive Impairment (MCI) and normal controls (NC).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Xie</LastName>
<ForeName>Long</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pluta</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Hongzhi</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Das</LastName>
<ForeName>Sandhitsu R</ForeName>
<Initials>SR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mancuso</LastName>
<ForeName>Lauren</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kliot</LastName>
<ForeName>Dasha</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Avants</LastName>
<ForeName>Brian B</ForeName>
<Initials>BB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ding</LastName>
<ForeName>Song-Lin</ForeName>
<Initials>SL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wolk</LastName>
<ForeName>David A</ForeName>
<Initials>DA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yushkevich</LastName>
<ForeName>Paul A</ForeName>
<Initials>PA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D060825">Mild Cognitive Impairment</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013702">Temporal Lobe</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320786</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Constructing 4D infant cortical surface atlases based on dynamic developmental trajectories of the cortex.</ArticleTitle>
<Pagination>
<MedlinePgn>89-96</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Cortical surface atlases play an increasingly important role for analysis, visualization, and comparison of results across different neuroimaging studies. As the first two years of life is the most dynamic period of postnatal structural and functional development of the highly-folded cerebral cortex, longitudinal (4D) cortical surface atlases for the infant brains during this period is highly desired yet still lacking for early brain development studies. In this paper, we construct the first longitudinal (4D) cortical surface atlases for the dynamic developing infant cortical structures at 1, 3, 6, 9, 12, 18 and 24 months of age, based on 202 serial MRI scans from 35 healthy infants. To ensure longitudinal consistency and unbiasedness of the 4D infant cortical surface atlases, we first compute the within-subject mean cortical folding geometries by groupwise registration of longitudinal surfaces of each infant. Then we establish intersubject cortical correspondences by groupwise registration of the within-subject mean cortical folding geometries of all infants. More importantly, for the first time, we further parcellate the 4D infant surface atlases into developmentally and functionally distinctive regions based solely on the dynamic developmental trajectories of the cortical thickness, by using the spectral clustering method. Specifically, to deal with the problem that each infant has different number of scans, we first compute the within-subject affinity matrix of vertices' cortical thickness trajectories of each infant, and then we use the averaged affinity matrix of all infants for parcellation. Our constructed 4D infant cortical surface atlases with developmental trajectories based parcellation will greatly facilitate the surface-based analysis of dynamic brain development in infants.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Gang</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Li</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shi</LastName>
<ForeName>Feng</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lin</LastName>
<ForeName>Weili</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shen</LastName>
<ForeName>Dinggang</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000375">Aging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002540">Cerebral Cortex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000254">growth &amp; development</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003198">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007231">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008137">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008953">Models, Anatomic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008959">Models, Neurological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009929">Organ Size</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320787</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Low-rank to the rescue - atlas-based analyses in the presence of pathologies.</ArticleTitle>
<Pagination>
<MedlinePgn>97-104</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Low-rank image decomposition has the potential to address a broad range of challenges that routinely occur in clinical practice. Its novelty and utility in the context of atlas-based analysis stems from its ability to handle images containing large pathologies and large deformations. Potential applications include atlas-based tissue segmentation and unbiased atlas building from data containing pathologies. In this paper we present atlas-based tissue segmentation of MRI from patients with large pathologies. Specifically, a healthy brain atlas is registered with the low-rank components from the input MRIs, the low-rank components are then re-computed based on those registrations, and the process is then iteratively repeated. Preliminary evaluations are conducted using the brain tumor segmentation challenge data (BRATS '12).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Xiaoxiao</ForeName>
<Initials>X</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Niethammer</LastName>
<ForeName>Marc</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kwitt</LastName>
<ForeName>Roland</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>McCormick</LastName>
<ForeName>Matthew</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Aylward</LastName>
<ForeName>Stephen</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R41EB015775</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R41NS081792</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003198">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005910">Glioma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008953">Models, Anatomic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008959">Models, Neurological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320788</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Optimized patchMatch for near real time and accurate label fusion.</ArticleTitle>
<Pagination>
<MedlinePgn>105-12</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Automatic segmentation methods are important tools for quantitative analysis of magnetic resonance images. Recently, patch-based label fusion approaches demonstrated state-of-the-art segmentation accuracy. In this paper, we introduce a new patch-based method using the PatchMatch algorithm to perform segmentation of anatomical structures. Based on an Optimized PAtchMatch Label fusion (OPAL) strategy, the proposed method provides competitive segmentation accuracy in near real time. During our validation on hippocampus segmentation of 80 healthy subjects, OPAL was compared to several state-of-the-art methods. Results show that OPAL obtained the highest median Dice coefficient (89.3%) in less than 1 sec per subject. These results highlight the excellent performance of OPAL in terms of computation time and segmentation accuracy compared to recently published methods.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ta</LastName>
<ForeName>Vinh-Thong</ForeName>
<Initials>VT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Giraud</LastName>
<ForeName>Rmi</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Collins</LastName>
<ForeName>D Louis</ForeName>
<Initials>DL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Coup</LastName>
<ForeName>Pierrick</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003199">Computer Systems</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006624">Hippocampus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012016">Reference Values</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012984">Software</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320790</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Bayesian principal geodesic analysis in diffeomorphic image registration.</ArticleTitle>
<Pagination>
<MedlinePgn>121-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Computing a concise representation of the anatomical variability found in large sets of images is an important first step in many statistical shape analyses. In this paper, we present a generative Bayesian approach for automatic dimensionality reduction of shape variability represented through diffeomorphic mappings. To achieve this, we develop a latent variable model for principal geodesic analysis (PGA) that provides a probabilistic framework for factor analysis on diffeomorphisms. Our key contribution is a Bayesian inference procedure for model parameter estimation and simultaneous detection of the effective dimensionality of the latent space. We evaluate our proposed model for atlas and principal geodesic estimation on the OASIS brain database of magnetic resonance images. We show that the automatically selected latent dimensions from our model are able to reconstruct unseen brain images with lower error than equivalent linear principal components analysis (LPCA) models in the image space, and it also outperforms tangent space PCA (TPCA) models in the diffeomorphism setting.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Miaomiao</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fletcher</LastName>
<ForeName>P Thomas</ForeName>
<Initials>PT</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>5R01EB007688</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001185">Artificial Intelligence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001499">Bayes Theorem</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320791</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>New partial volume estimation methods for MRI MP2RAGE.</ArticleTitle>
<Pagination>
<MedlinePgn>129-36</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Magnetic resonance imaging (MRI) is commonly used as a medical iagnosis tool, especially for brain applications. Some limitations affecting image quality include receive field (RF) inhomogeneity and partial volume (PV) effects which arise when a voxel contains two different tissues, introducing blurring. The novel Magnetization-Prepared 2 Rapid Acquisition Gradient Echoes (MP2RAGE) provides an image robust to RF inhomogeneity. However, PV effects are still an issue for automated brain quantification. PV estimation methods have been proposed based on computing the proportion of one tissue with respect to the other using linear interpolation of pure tissue intensity means. We demonstrated that this linear model introduces bias when used with MP2RAGE and we propose two novel solutions. The PV estimation methods were tested on 4 MP2RAGE data sets.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Duch</LastName>
<ForeName>Quentin</ForeName>
<Initials>Q</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Raniga</LastName>
<ForeName>Parnesh</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Egan</LastName>
<ForeName>Gary F</ForeName>
<Initials>GF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Acosta</LastName>
<ForeName>Oscar</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gambarota</LastName>
<ForeName>Giulio</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Salvado</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Saint-Jalmes</LastName>
<ForeName>Herv</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009929">Organ Size</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320792</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Single-subject structural networks with closed-form rotation invariant matching mprove power in developmental studies of the cortex.</ArticleTitle>
<Pagination>
<MedlinePgn>137-44</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Although much attention has recently been focused on single-subject functional networks, using methods such as resting-state functional MRI, methods for constructing single-subject structural networks are in their infancy. Single-subject cortical networks aim to describe the self-similarity across the cortical structure, possibly signifying convergent developmental pathways. Previous methods for constructing single-subject cortical networks have used patch-based correlations and distance metrics based on curvature and thickness. We present here a method for constructing similarity-based cortical structural networks that utilizes a rotation-invariant representation of structure. The resulting graph metrics are closely linked to age and indicate an increasing degree of closeness throughout development in nearly all brain regions, perhaps corresponding to a more regular structure as the brain matures. The derived graph metrics demonstrate a four-fold increase in power for detecting age as compared to cortical thickness. This proof of concept study indicates that the proposed metric may be useful in identifying biologically relevant cortical patterns.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kandel</LastName>
<ForeName>Benjamin M</ForeName>
<Initials>BM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Danny J J</ForeName>
<Initials>DJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gee</LastName>
<ForeName>James C</ForeName>
<Initials>JC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Avants</LastName>
<ForeName>Brian B</ForeName>
<Initials>BB</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002540">Cerebral Cortex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000254">growth &amp; development</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D063132">Connectome</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009415">Nerve Net</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000254">growth &amp; development</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012399">Rotation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320793</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>T2-relaxometry for myelin water fraction xtraction using wald distribution and extended phase graph.</ArticleTitle>
<Pagination>
<MedlinePgn>145-52</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Quantitative assessment of myelin density in the white matter is an emerging tool for neurodegenerative disease related studies such as multiple sclerosis and Schizophrenia. For the last two decades, T2 relaxometry based on multi-exponential fitting to a single slice multi-echo sequence has been the most common MRI technique for myelin water fraction (MWF) mapping, where the short T2 is associated with myelin water. However, modeling the spectrum of the relaxations as the sum of large number of impulse functions with unknown amplitudes makes the accuracy and robustness of the estimated MWF's questionable. In this paper, we introduce a novel model with small number of parameters to simultaneously characterize transverse relaxation rate spectrum and B1 inhomogeneity at each voxel. We use mixture of three Wald distributions with unknown mixture weights, mean and shape parameters to represent the distribution of the relative amount of water in between myelin sheets, tissue water, and cerebrospinal fluid. The parameters of the model are estimated using the variable projection method and are used to extract the MWF at each voxel. In addition, we use Extended Phase Graph (EPG) method to compensate for the stimulated echoes caused by B1 inhomogeneity. To validate our model, synthetic and real brain experiments were conducted where we have compared our novel algorithm with the non-negative least squares (NNLS) as the state-of-the-art technique in the literature. Our results indicate that we can estimate MWF map with substantially higher accuracy as compared to the NNLS method.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Akhondi-Asl</LastName>
<ForeName>Alireza</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Afacan</LastName>
<ForeName>Onur</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mulkern</LastName>
<ForeName>Robert V</ForeName>
<Initials>RV</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Warfield</LastName>
<ForeName>Simon K</ForeName>
<Initials>SK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 HD018655</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 HD018655</GrantID>
<Acronym>HD</Acronym>
<Agency>NICHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 EB013248</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 EB013248</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 LM010033</GrantID>
<Acronym>LM</Acronym>
<Agency>NLM NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 LM010033</GrantID>
<Acronym>LM</Acronym>
<Agency>NLM NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 NS079788</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 NS079788</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R03 EB008680</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R03 EB008680</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R42 MH086984</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R42 MH086984</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 1994 Jun;31(6):673-7</RefSource>
<PMID Version="1">8057820</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neuroimaging. 2007 Apr;17(2):156-63</RefSource>
<PMID Version="1">17441837</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2012 Oct 15;63(1):533-9</RefSource>
<PMID Version="1">22776448</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Magn Reson Med. 2009 Jul;62(1):106-15</RefSource>
<PMID Version="1">19353659</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2010 Nov 11;468(7321):244-52</RefSource>
<PMID Version="1">21068833</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001834">Body Water</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003198">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009682">Magnetic Resonance Spectroscopy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015233">Models, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009186">Myelin Sheath</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016008">Statistical Distributions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014018">Tissue Distribution</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS631607</OtherID>
<OtherID Source="NLM">PMC4209472</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320794</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Compact and informative representation of functional connectivity for predictive modeling.</ArticleTitle>
<Pagination>
<MedlinePgn>153-60</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Resting state functional connectivity holds great potential for diagnostic prediction of neurological and psychiatric illness. This paper introduces a compact and information-rich representation of connectivity that is geared directly towards predictive modeling. Our representation does not require a priori identification of localized regions of interest, yet provides a mechanism for interpretation of classifier weights. Experiments confirm increased accuracy associated with our representation and yield interpretations consistent with known physiology.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rustamov</LastName>
<ForeName>Raif M</ForeName>
<Initials>RM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Romano</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reiss</LastName>
<ForeName>Allan L</ForeName>
<Initials>AL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Guibas</LastName>
<ForeName>Leonidas J</ForeName>
<Initials>LJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>T32 MH019908</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003198">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D063132">Connectome</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005074">Evoked Potentials, Visual</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008959">Models, Neurological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015233">Models, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009415">Nerve Net</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014796">Visual Perception</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320797</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Multiple-network classification of childhood autism using functional connectivity dynamics.</ArticleTitle>
<Pagination>
<MedlinePgn>177-84</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Characterization of disease using stationary resting-state functional connectivity (FC) has provided important hallmarks of abnormal brain activation in many domains. Recent studies of resting-state functional magnetic resonance imaging (fMRI), however, suggest there is a considerable amount of additional knowledge to be gained by investigating the variability in FC over the course of a scan. While a few studies have begun to explore the properties of dynamic FC for characterizing disease, the analysis of dynamic FC over multiple networks at multiple time scales has yet to be fully examined. In this study, we combine dynamic connectivity features in a multi-network, multi-scale approach to evaluate the method's potential in better classifying childhood autism. Specifically, from a set of group-level intrinsic connectivity networks (ICNs), we use sliding window correlations to compute intra-network connectivity on the subject level. We derive dynamic FC features for all ICNs over a large range of window sizes and then use a multiple kernel support vector machine (MK-SVM) model to combine a subset of these features for classification. We compare the performance our multi-network, dynamic approach to the best results obtained from single-network dynamic FC features and those obtained from both single- and multi-network static FC features. Our experiments show that integrating multiple networks on different dynamic scales has a clear superiority over these existing methods.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Price</LastName>
<ForeName>True</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wee</LastName>
<ForeName>Chong-Yaw</ForeName>
<Initials>CY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gao</LastName>
<ForeName>Wei</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shen</LastName>
<ForeName>Dinggang</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001321">Autistic Disorder</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D063132">Connectome</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009415">Nerve Net</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D060388">Support Vector Machines</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320798</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Deriving a multi-subject functional-connectivity atlas to inform connectome estimation.</ArticleTitle>
<Pagination>
<MedlinePgn>185-92</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The estimation of functional connectivity structure from functional neuroimaging data is an important step toward understanding the mechanisms of various brain diseases and building relevant biomarkers. Yet, such inferences have to deal with the low signal-to-noise ratio and the paucity of the data. With at our disposal a steadily growing olume of publicly available neuroimaging data, it is however possible to improve the estimation procedures involved in connectome mapping. In this work, we propose a novel learning scheme for functional connectivity based on sparse Gaussian graphical models that aims at minimizing the bias induced by the regularization used in the estimation, by carefully separating the estimation of the model support from the coefficients. Moreover, our strategy makes it possible to include new data with a limited computational cost. We illustrate the physiological relevance of he learned prior, that can be identified as a functional connectivity atlas, based on an experiment on 46 subjects of the Human Connectome Dataset.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Phlypo</LastName>
<ForeName>Ronald</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Thirion</LastName>
<ForeName>Bertrand</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Varoquaux</LastName>
<ForeName>Gal</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>1U54MH091657</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003198">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D063132">Connectome</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008959">Models, Neurological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320799</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Discriminative sparse connectivity patterns for classification of fMRI Data.</ArticleTitle>
<Pagination>
<MedlinePgn>193-200</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Functional connectivity using resting-state fMRI has emerged as an important research tool for understanding normal brain function as well as changes occurring during brain development and in various brain disorders. Most prior work has examined changes in pairwise functional connectivity values using a multi-variate classification approach, such as Support Vector Machines (SVM). While it is powerful, SVMs produce a dense set of high-dimensional weight vectors as output, which are difficult to interpret, and require additional post-processing to relate to known functional networks. In this paper, we propose a joint framework that combines network identification and classification, resulting in a set of networks, or Sparse Connectivity Patterns (SCPs) which are functionally interpretable as well as highly discriminative of the two groups. Applied to a study of normal development classifying children vs. adults, the proposed method provided accuracy of 76%(AUC= 0.85), comparable to SVM (79%,AUC=0.87), but with dramatically fewer number of features (50 features vs. 34716 for the SVM). More importantly, this leads to a tremendous improvement in neuro-scientific interpretability, which is specially advantageous in such a study where the group differences are wide-spread throughout the brain. Highest-ranked discriminative SCPs reflect increases in long-range connectivity in adults between the frontal areas and posterior cingulate regions. In contrast, connectivity between the bilateral parahippocampal gyri was decreased in adults compared to children.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Eavani</LastName>
<ForeName>Harini</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Satterthwaite</LastName>
<ForeName>Theodore D</ForeName>
<Initials>TD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gur</LastName>
<ForeName>Raquel E</ForeName>
<Initials>RE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gur</LastName>
<ForeName>Ruben C</ForeName>
<Initials>RC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Davatzikos</LastName>
<ForeName>Christos</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000375">Aging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001185">Artificial Intelligence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D063132">Connectome</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016002">Discriminant Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009415">Nerve Net</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018401">Sample Size</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320813</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Deep learning based imaging data completion for improved brain disease diagnosis.</ArticleTitle>
<Pagination>
<MedlinePgn>305-12</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Combining multi-modality brain data for disease diagnosis commonly leads to improved performance. A challenge in using multimodality data is that the data are commonly incomplete; namely, some modality might be missing for some subjects. In this work, we proposed a deep learning based framework for estimating multi-modality imaging data. Our method takes the form of convolutional neural networks, where the input and output are two volumetric modalities. The network contains a large number of trainable parameters that capture the relationship between input and output modalities. When trained on subjects with all modalities, the network can estimate the output modality given the input modality. We evaluated our method on the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, where the input and output modalities are MRI and PET images, respectively. Results showed that our method significantly outperformed prior methods.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Rongjian</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Wenlu</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Suk</LastName>
<ForeName>Heung-Il</ForeName>
<Initials>HI</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Li</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Jiang</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shen</LastName>
<ForeName>Dinggang</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ji</LastName>
<ForeName>Shuiwang</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000544">Alzheimer Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D064847">Multimodal Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016571">Neural Networks (Computer)</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320816</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>A novel structure-aware sparse learning algorithm for brain imaging genetics.</ArticleTitle>
<Pagination>
<MedlinePgn>329-36</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Brain imaging genetics is an emergent research field where the association between genetic variations such as single nucleotide polymorphisms (SNPs) and neuroimaging quantitative traits (QTs) is evaluated. Sparse canonical correlation analysis (SCCA) is a bi-multivariate analysis method that has the potential to reveal complex multi-SNP-multi-QT associations. Most existing SCCA algorithms are designed using the soft threshold strategy, which assumes that the features in the data are independent from each other. This independence assumption usually does not hold in imaging genetic data, and thus inevitably limits the capability of yielding optimal solutions. We propose a novel structure-aware SCCA (denoted as S2CCA) algorithm to not only eliminate the independence assumption for the input data, but also incorporate group-like structure in the model. Empirical comparison with a widely used SCCA implementation, on both simulated and real imaging genetic data, demonstrated that S2CCA could yield improved prediction performance and biologically meaningful findings.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Du</LastName>
<ForeName>Lei</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jingwen</LastName>
<ForeName>Yan</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Sungeun</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Risacher</LastName>
<ForeName>Shannon L</ForeName>
<Initials>SL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Heng</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Inlow</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Moore</LastName>
<ForeName>Jason H</ForeName>
<Initials>JH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Saykin</LastName>
<ForeName>Andrew J</ForeName>
<Initials>AJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Shen</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<CollectiveName>Alzheimer's Disease Neuroimaging Initiative</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 AG010133</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 AG10133</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AG019771</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AG19771</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 LM009012</GrantID>
<Acronym>LM</Acronym>
<Agency>NLM NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 LM009012</GrantID>
<Acronym>LM</Acronym>
<Agency>NLM NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 LM010098</GrantID>
<Acronym>LM</Acronym>
<Agency>NLM NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 LM010098</GrantID>
<Acronym>LM</Acronym>
<Agency>NLM NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 LM011360</GrantID>
<Acronym>LM</Acronym>
<Agency>NLM NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 LM011360</GrantID>
<Acronym>LM</Acronym>
<Agency>NLM NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>RC2 AG036535</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>RC2 AG036535</GrantID>
<Acronym>RC</Acronym>
<Agency>CCR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 AG024904</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 AG024904</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000544">Alzheimer Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001185">Artificial Intelligence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D063132">Connectome</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020022">Genetic Predisposition to Disease</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020641">Polymorphism, Single Nucleotide</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D040641">Quantitative Trait Loci</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS610133 [Available on 01/01/15]</OtherID>
<OtherID Source="NLM">PMC4203420 [Available on 01/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320819</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>A universal and efficient method to compute maps from image-based prediction models.</ArticleTitle>
<Pagination>
<MedlinePgn>353-60</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Discriminative supervised learning algorithms, such as Support Vector Machines, are becoming increasingly popular in biomedical image computing. One of their main uses is to construct image-based prediction models, e.g., for computer aided diagnosis or "mind reading." A major challenge in these applications is the biological interpretation of the machine learning models, which can be arbitrarily complex functions of the input features (e.g., as induced by kernel-based methods). Recent work has proposed several strategies for deriving maps that highlight regions relevant for accurate prediction. Yet most of these methods o n strong assumptions about t he prediction model (e.g., linearity, sparsity) and/or data (e.g., Gaussianity), or fail to exploit the covariance structure in the data. In this work, we propose a computationally efficient and universal framework for quantifying associations captured by black box machine learning models. Furthermore, our theoretical perspective reveals that examining associations with predictions, in the absence of ground truth labels, can be very informative. We apply the proposed method to machine learning models trained to predict cognitive impairment from structural neuroimaging data. We demonstrate that our approach yields biologically meaningful maps of association.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sabuncu</LastName>
<ForeName>Mert R</ForeName>
<Initials>MR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>1K25EB013649-01</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001185">Artificial Intelligence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003198">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003704">Dementia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008959">Models, Neurological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015233">Models, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320824</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Clustering-induced multi-task learning for AD/MCI classification.</ArticleTitle>
<Pagination>
<MedlinePgn>393-400</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In this work, we formulate a clustering-induced multi-task learning method for feature selection in Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) diagnosis. Unlike the previous methods that often assumed a unimodal data distribution, we take into account the underlying multipeak distribution of classes. The rationale for our approach is that it is likely for neuroimaging data to have multiple peaks or modes in distribution due to the inter-subject variability. In this regard, we use a clustering method to discover the multipeak distributional characteristics and define subclasses based on the clustering results, in which each cluster covers a peak. We then encode the respective subclasses, i.e., clusters, with their unique codes by imposing the subclasses of the same original class close to each other and those of different original classes L2,1-penalized regression framework by taking the codes as new label vectors of our training samples, through which we select features for classification. In our experimental results on the ADNI dataset, we validated the effectiveness of the proposed method by achieving the maximal classification accuracies of 95.18% (AD/Normal Control: NC), 79.52% (MCI/NC), and 72.02% (MCI converter/MCl non-converter), outperforming the competing single-task learning method.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Suk</LastName>
<ForeName>Heung-Ii</ForeName>
<Initials>HI</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shen</LastName>
<ForeName>Dinggang</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000544">Alzheimer Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001185">Artificial Intelligence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000531">radionuclide imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D060825">Mild Cognitive Impairment</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25320825</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 3</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>A novel multi-relation regularization method for regression and classification in AD diagnosis.</ArticleTitle>
<Pagination>
<MedlinePgn>401-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In this paper, we consider the joint regression and classification in Alzheimer's disease diagnosis and propose a novel multi-relation regularization method that exploits the relational information inherent in the observations and then combines it with an L2,1-norm within a least square regression framework for feature selection. Specifically, we use three kinds of relationships: feature-feature relation, response-response relation, and sample-sample relation. By imposing these three relational characteristics along with the L2,1-norm on the weight coefficients, we formulate a new objective function. After feature selection based on the optimal weight coefficients, we train two support vector regression models to predict the clinical scores of Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) and Mini-Mental State Examination (MMSE), respectively, and a support vector classification model to identify the clinical label. We conducted clinical score prediction and disease status identification jointly on the Alzheimer's Disease Neuroimaging Initiative dataset. The experimental results showed that the proposed regularization method outperforms the state-of-the-art methods, in the metrics of correlation coefficient and root mean squared error in regression and classification accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve in classification.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zhu</LastName>
<ForeName>Xiaofeng</ForeName>
<Initials>X</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Suk</LastName>
<ForeName>Heung-Ii</ForeName>
<Initials>HI</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shen</LastName>
<ForeName>Dinggang</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>AG041721</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>AG042599</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>EB006733</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>EB008374</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>EB009634</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>MH100217</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000544">Alzheimer Disease</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001185">Artificial Intelligence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D003661">Decision Support Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D060825">Mild Cognitive Impairment</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012044">Regression Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25317871</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>28</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1533-4406</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>371</Volume>
<Issue>16</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
<Day>16</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>The effect of malpractice reform on emergency department care.</ArticleTitle>
<Pagination>
<MedlinePgn>1518-25</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMsa1313308</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Many believe that fear of malpractice lawsuits drives physicians to order otherwise unnecessary care and that legal reforms could reduce such wasteful spending. Emergency physicians practice in an information-poor, resource-rich environment that may lend itself to costly defensive practice. Three states, Texas (in 2003), Georgia (in 2005), and South Carolina (in 2005), enacted legislation that changed the malpractice standard for emergency care to gross negligence. We investigated whether these substantial reforms changed practice.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Using a 5% random sample of Medicare fee-for-service beneficiaries, we identified all emergency department visits to hospitals in the three reform states and in neighboring (control) states from 1997 through 2011. Using a quasi-experimental design, we compared patient-level outcomes, before and after legislation, in reform states and control states. We controlled for characteristics of the patients, time-invariant hospital characteristics, and temporal trends. Outcomes were policy-attributable changes in the use of computed tomography (CT) or magnetic resonance imaging (MRI), per-visit emergency department charges, and the rate of hospital admissions.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">For eight of the nine state-outcome combinations tested, no policy-attributable reduction in the intensity of care was detected. We found no reduction in the rates of CT or MRI utilization or hospital admission in any of the three reform states and no reduction in charges in Texas or South Carolina. In Georgia, reform was associated with a 3.6% reduction (95% confidence interval, 0.9 to 6.2) in per-visit emergency department charges.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Legislation that substantially changed the malpractice standard for emergency physicians in three states had little effect on the intensity of practice, as measured by imaging rates, average charges, or hospital admission rates. (Funded by the Veterans Affairs Office of Academic Affiliations and others.).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Waxman</LastName>
<ForeName>Daniel A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>From RAND Health (D.A.W., M.D.G., M.S.R.) and RAND Institute for Civil Justice (P.H.), Santa Monica, CA; the Department of Emergency Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles (D.A.W.); and Uniformed Services University of the Health Sciences, Bethesda, MD (A.L.K.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Greenberg</LastName>
<ForeName>Michael D</ForeName>
<Initials>MD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ridgely</LastName>
<ForeName>M Susan</ForeName>
<Initials>MS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kellermann</LastName>
<ForeName>Arthur L</ForeName>
<Initials>AL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Heaton</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
<ISSNLinking>0028-4793</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003675">Defensive Medicine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004635">Emergency Medicine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000331">legislation &amp; jurisprudence</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000592">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004636">Emergency Service, Hospital</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000191">economics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000331">legislation &amp; jurisprudence</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018588">Fee-for-Service Plans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018166">Health Care Reform</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000331">legislation &amp; jurisprudence</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006760">Hospitalization</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016365">Liability, Legal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000656">utilization</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008318">Malpractice</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000331">legislation &amp; jurisprudence</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006278">Medicare</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000656">utilization</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25321911</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1538-3598</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>312</Volume>
<Issue>15</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>JAMA</Title>
<ISOAbbreviation>JAMA</ISOAbbreviation>
</Journal>
<ArticleTitle>Facial droop, left-sided weakness, and cystic brain lesions.</ArticleTitle>
<Pagination>
<MedlinePgn>1581-2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2014.5553</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Beaird</LastName>
<ForeName>Omer E</ForeName>
<Initials>OE</Initials>
<AffiliationInfo>
<Affiliation>Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Northway</LastName>
<ForeName>Claire</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Malani</LastName>
<ForeName>Preeti N</ForeName>
<Initials>PN</Initials>
<AffiliationInfo>
<Affiliation>Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan2Associate Editor, JAMA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>JAMA</MedlineTA>
<NlmUniqueID>7501160</NlmUniqueID>
<ISSNLinking>0098-7484</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001927">Brain Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003560">Cysts</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005158">Facial Paralysis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005909">Glioblastoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018908">Muscle Weakness</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25327092</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>06</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0004-5772</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>62</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of the Association of Physicians of India</Title>
<ISOAbbreviation>J Assoc Physicians India</ISOAbbreviation>
</Journal>
<ArticleTitle>Heart in the brain.</ArticleTitle>
<Pagination>
<MedlinePgn>46-7</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chaudhary</LastName>
<ForeName>S C</ForeName>
<Initials>SC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sawlani</LastName>
<ForeName>K K</ForeName>
<Initials>KK</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Atam</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Parihar</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Modi</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Assoc Physicians India</MedlineTA>
<NlmUniqueID>7505585</NlmUniqueID>
<ISSNLinking>0004-5772</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001927">Brain Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003337">Corpus Callosum</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011856">Radiographic Image Enhancement</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25327107</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>06</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0004-5772</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>62</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of the Association of Physicians of India</Title>
<ISOAbbreviation>J Assoc Physicians India</ISOAbbreviation>
</Journal>
<ArticleTitle>Dyke-Davidoff-Masson syndrome.</ArticleTitle>
<Pagination>
<MedlinePgn>83-4</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ola</LastName>
<ForeName>Vipin</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mathur</LastName>
<ForeName>Gaurav</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sihag</LastName>
<ForeName>Bhupendra</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Meel</LastName>
<ForeName>J K</ForeName>
<Initials>JK</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sirohi</LastName>
<ForeName>Parmendra</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Agrawal</LastName>
<ForeName>R P</ForeName>
<Initials>RP</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Assoc Physicians India</MedlineTA>
<NlmUniqueID>7505585</NlmUniqueID>
<ISSNLinking>0004-5772</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001284">Atrophy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002552">Cerebral Ventricles</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054022">Cerebrum</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004108">Dilatation, Pathologic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004830">Epilepsy, Tonic-Clonic</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006429">Hemiplegia</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049268">Positron-Emission Tomography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013577">Syndrome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25333107</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Application-driven MRI: joint reconstruction and segmentation from undersampled MRI data.</ArticleTitle>
<Pagination>
<MedlinePgn>106-13</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Medical image segmentation has traditionally been regarded as a separate process from image acquisition and reconstruction, even though its performance directly depends on the quality and characteristics of these first stages of the imaging pipeline. Adopting an integrated acquisition-reconstruction-segmentation process can provide a more efficient and accurate solution. In this paper we propose a joint segmentation and reconstruction algorithm for undersampled magnetic resonance data. Merging a reconstructive patch-based sparse modelling and a discriminative Gaussian mixture modelling can produce images with enhanced edge information ultimately improving their segmentation.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Caballero</LastName>
<ForeName>Jose</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bai</LastName>
<ForeName>Wenjia</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Price</LastName>
<ForeName>Anthony N</ForeName>
<Initials>AN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rueckert</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hajnal</LastName>
<ForeName>Joseph V</ForeName>
<Initials>JV</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016477">Artifacts</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006352">Heart Ventricles</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018401">Sample Size</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012815">Signal Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25333112</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Improved reconstruction of 4D-MR images by motion predictions.</ArticleTitle>
<Pagination>
<MedlinePgn>146-53</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The reconstruction of 4D images from 2D navigator and data slices requires sufficient observations per motion state to avoid blurred images and motion artifacts between slices. Especially images from rare motion states, like deep inhalations during free-breathing, suffer from too few observations. To address this problem, we propose to actively generate more suitable images instead of only selecting from the available images. The method is based on learning the relationship between navigator and data-slice motion by linear regression after dimensionality reduction. This can then be used to predict new data slices for a given navigator by warping existing data slices by their predicted displacement field. The method was evaluated for 4D-MRIs of the liver under free-breathing, where sliding boundaries pose an additional challenge for image registration. Leave-one-out tests for five short sequences of ten volunteers showed that the proposed prediction method improved on average the residual mean (95%) motion between the ground truth and predicted data slice from 0.9mm (1.9mm) to 0.8mm (1.6mm) in comparison to the best selection method. The approach was particularly suited for unusual motion states, where the mean error was reduced by 40% (2.2mm vs. 1.3mm).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tanner</LastName>
<ForeName>Christine</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Samei</LastName>
<ForeName>Golnoosh</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Szkely</LastName>
<ForeName>Gbor</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000005">Abdomen</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D016477">Artifacts</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009038">Motion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055425">Respiratory-Gated Imaging Techniques</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25333117</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Robust anatomical landmark detection for MR brain image registration.</ArticleTitle>
<Pagination>
<MedlinePgn>186-93</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Correspondence matching between MR brain images is often challenging due to large inter-subject structural variability. In this paper, we propose a novel landmark detection method for robust establishment of correspondences between subjects. Specifically, we first annotate distinctive landmarks in the training images. Then, we use regression forest to simultaneously learn (1) the optimal set of features to best characterize each landmark and (2) the non-linear mappings from local patch appearances of image points to their displacements towards each landmark. The learned regression forests are used as landmark detectors to predict the locations of these landmarks in new images. Since landmark detection is performed in the entire image domain, our method can cope with large anatomical variations among subjects. We evaluated our method by applying it to MR brain image registration. Experimental results indicate that by combining our method with existing registration method, obvious improvement in registration accuracy can be achieved.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Han</LastName>
<ForeName>Dong</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gao</LastName>
<ForeName>Yaozong</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Guorong</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yap</LastName>
<ForeName>Pew-Thian</ForeName>
<Initials>PT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shen</LastName>
<ForeName>Dinggang</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AG041721</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AG042599</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 EB006733</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 EB008374</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 EB009634</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 MH100217</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>IEEE Trans Med Imaging. 2001 Jan;20(1):45-57</RefSource>
<PMID Version="1">11293691</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Image Anal. 2001 Jun;5(2):143-56</RefSource>
<PMID Version="1">11516708</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>IEEE Trans Med Imaging. 2002 Nov;21(11):1421-39</RefSource>
<PMID Version="1">12575879</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Image Anal. 2005 Oct;9(5):457-66</RefSource>
<PMID Version="1">16019252</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Image Anal. 2013 Dec;17(8):1293-303</RefSource>
<PMID Version="1">23410511</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Brain Mapp. 2014 Mar;35(3):1044-60</RefSource>
<PMID Version="1">23283836</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059925">Anatomic Landmarks</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS633980</OtherID>
<OtherID Source="NLM">PMC4206085</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25333118</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Free-form deformation using lower-order B-spline for nonrigid image registration.</ArticleTitle>
<Pagination>
<MedlinePgn>194-201</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In traditional free-form deformation (FFD) based registration, a B-spline basis function is commonly utilized to build the transformation model. As the B-spline order increases, the corresponding B-spline function becomes smoother. However, the higher-order B-spline has a larger support region, which means higher computational cost. For a given D-dimensional nth-order B-spline, an mth-order B-spline where (m &lt; or = n) has (m +1/n + 1)D times lower computational complexity. Generally, the third-order B-spline is regarded as keeping a good balance between smoothness and computation time. A lower-order function is seldom used to construct the deformation field for registration since it is less smooth. In this research, we investigated whether lower-order B-spline functions can be utilized for efficient registration, by using a novel stochastic perturbation technique in combination with a postponed smoothing technique to higher B-spline order. Experiments were performed with 3D lung and brain scans, demonstrating that the lower-order B-spline FFD in combination with the proposed perturbation and postponed smoothing techniques even results in better accuracy and smoothness than the traditional third-order B-spline registration, while substantially reducing computational costs.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sun</LastName>
<ForeName>Wei</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Niessen</LastName>
<ForeName>Wiro J</ForeName>
<Initials>WJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Klein</LastName>
<ForeName>Stefan</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003198">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015233">Models, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25333119</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Multispectral image registration based on local canonical correlation analysis.</ArticleTitle>
<Pagination>
<MedlinePgn>202-9</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Medical scans are today routinely acquired using multiple sequences or contrast settings, resulting in multispectral data. For the automatic analysis of this data, the evaluation of multispectral similarity is essential. So far, few concepts have been proposed to deal in a principled way with images containing multiple channels. Here, we present a new approach based on a well known statistical technique: canonical correlation analysis (CCA). CCA finds a mapping of two multidimensional variables into two new bases, which best represent the true underlying relations of the signals. In contrast to previously used metrics, it is therefore able to find new correlations based on linear combinations of multiple channels. We extend this concept to efficiently model local canonical correlation (LCCA) between image patches. This novel, more general similarity metric can be applied to images with an arbitrary number of channels. The most important property of LCCA is its invariance to affine transformations of variables. When used on local histograms, LCCA can also deal with multimodal similarity. We demonstrate the performance of our concept on challenging clinical multispectral datasets.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Heinrich</LastName>
<ForeName>Mattias P</ForeName>
<Initials>MP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Papiez</LastName>
<ForeName>Bartomiej W</ForeName>
<Initials>BW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schnabel</LastName>
<ForeName>Julia A</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Handels</LastName>
<ForeName>Heinz</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004285">Dogs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018482">Muscle, Skeletal</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013223">Statistics as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25333122</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Spatially-varying metric learning for diffeomorphic image registration: a variational framework.</ArticleTitle>
<Pagination>
<MedlinePgn>227-34</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>This paper introduces a variational strategy to learn spatially-varying metrics on large groups of images, in the Large Deformation Diffeomorphic Metric Mapping (LDDMM) framework. Spatially-varying metrics we learn not only favor local deformations but also correlated deformations in different image regions and in different directions. In addition, metric parameters can be efficiently estimated using a gradient descent method. We first describe the general strategy and then show how to use it on 3D medical images with reasonable computational ressources. Our method is assessed on the 3D brain images of the LPBA40 dataset. Results are compared with ANTS-SyN and LDDMM with spatially-homogeneous metrics.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vialard</LastName>
<ForeName>Franois-Xavier</ForeName>
<Initials>FX</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Risser</LastName>
<ForeName>Laurent</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001185">Artificial Intelligence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003627">Data Interpretation, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25333127</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Gaussian process interpolation for uncertainty estimation in image registration.</ArticleTitle>
<Pagination>
<MedlinePgn>267-74</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Intensity-based image registration requires resampling images on a common grid to evaluate the similarity function. The uncertainty of interpolation varies across the image, depending on the location of resampled points relative to the base grid. We propose to perform Bayesian inference with Gaussian processes, where the covariance matrix of the Gaussian process posterior distribution estimates the uncertainty in interpolation. The Gaussian process replaces a single image with a distribution over images that we integrate into a generative model for registration. Marginalization over resampled images leads to a new similarity measure that includes the uncertainty of the interpolation. We demonstrate that our approach increases the registration accuracy and propose an efficient approximation scheme that enables seamless integration with existing registration methods.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wachinger</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Golland</LastName>
<ForeName>Polina</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reuter</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wells</LastName>
<ForeName>William</ForeName>
<Initials>W</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P41 EB015898</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P41 EB015902</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P41-EB015898</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P41-EB015902</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54 EB005149</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54-EB005149</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003198">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003627">Data Interpretation, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015233">Models, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016011">Normal Distribution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS637911 [Available on 01/01/15]</OtherID>
<OtherID Source="NLM">PMC4219919 [Available on 01/01/15]</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25333131</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Hierarchical label fusion with multiscale feature representation and label-specific patch partition.</ArticleTitle>
<Pagination>
<MedlinePgn>299-306</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Recently, patch-based label fusion methods have achieved many successes in medical imaging area. After registering atlas images to the target image, the label at each target image point can be subsequently determined by checking the patchwise similarities between the underlying target image patch and all atlas image patches. Apparently, the definition of patchwise similarity is critical in label fusion. However, current methods often simply use entire image patch with fixed patch size throughout the entire label fusion procedure, which could be insufficient to distinguish complex shape/appearance patterns of anatomical structures in medical imaging scenario. In this paper, we address the above limitations at three folds. First, we assign each image patch with multiscale feature representations such that both local and semi-local image information can be encoded to increase robustness of measuring patchwise similarity in label fusion. Second, since multiple variable neighboring structures could present in one image patch, simply computing patchwise similarity based on the entire image patch is not specific to the particular structure of interest under labeling and can be easily misled by the surrounding variable structures in the same image patch. Thus, we partition each atlas patch into a set of new label-specific atlas patches according to the existing label information in the atlas mages. Then, the new label-specific atlas patches can be more specific and flexible for label fusion than using the entire image patch, since the complex image patch has now been semantically divided into several distinct patterns. Finally, in order to correct the possible mis-labeling, we hierarchically improve the label fusion result in a coarse-to-fine manner by iteratively repeating the label fusion procedure with the gradually-reduced patch size. More accurate label fusion results have been achieved by our hierarchical label fusion method with multiscale feature presentations upon label-specific atlas patches.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Guorong</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shen</LastName>
<ForeName>Dinggang</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000544">Alzheimer Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013194">Staining and Labeling</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25333134</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Bayesian model selection for pathological data.</ArticleTitle>
<Pagination>
<MedlinePgn>323-30</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The detection of abnormal intensities in brain images caused by the presence of pathologies is currently under great scrutiny. Selecting appropriate models for pathological data is of critical importance for an unbiased and biologically plausible model fit, which in itself enables a better understanding of the underlying data and biological processes. Besides, it impacts on one's ability to extract pathologically meaningful imaging biomarkers. With this aim in mind, this work proposes a fully unsupervised hierarchical model selection framework for neuroimaging data which permits the stratification of different types of abnormal image atterns without prior knowledge about the subject's pathological status.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sudre</LastName>
<ForeName>Carole H</ForeName>
<Initials>CH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cardoso</LastName>
<ForeName>Manuel Jorge</ForeName>
<Initials>MJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bouvy</LastName>
<ForeName>Willem</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Biessels</LastName>
<ForeName>Geert Jan</ForeName>
<Initials>GJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Barnes</LastName>
<ForeName>Josephine</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ourselin</LastName>
<ForeName>Sbastien</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001499">Bayes Theorem</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001927">Brain Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003198">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008959">Models, Neurological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015233">Models, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25333143</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>A cautionary analysis of STAPLE using direct inference of segmentation truth.</ArticleTitle>
<Pagination>
<MedlinePgn>398-406</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In this paper we analyze the properties of the well-known segmentation fusion algorithm STAPLE, using a novel inference technique that analytically marginalizes out all model parameters. We demonstrate both theoretically and empirically that when the number of raters is large, or when consensus regions are included in the model, STAPLE devolves into thresholding the average of the input segmentations. We further show that when the number of raters is small, the STAPLE result may not be the optimal segmentation truth estimate, and its model parameter estimates might not reflect the individual raters' actual segmentation performance. Our experiments indicate that these intrinsic weaknesses are frequently exacerbated by the presence of undesirable global optima and convergence issues. Together these results cast doubt on the soundness and usefulness of typical STAPLE outcomes.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Van Leemput</LastName>
<ForeName>Koen</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sabuncu</LastName>
<ForeName>Mert R</ForeName>
<Initials>MR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K25EB013649</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P41-RR14075</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01EB013565</GrantID>
<Acronym>EB</Acronym>
<Agency>NIBIB NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001185">Artificial Intelligence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016247">Information Storage and Retrieval</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008954">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015233">Models, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D012984">Software</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012986">Software Validation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25333169</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Automated colorectal tumour segmentation in DCE-MRI using supervoxel neighbourhood contrast characteristics.</ArticleTitle>
<Pagination>
<MedlinePgn>609-16</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a powerful protocol for assessing tumour progression from changes in tissue contrast enhancement. Manual colorectal tumour delineation is a challenging and time consuming task due to the complex enhancement patterns in the 4D sequence. There is a need for a consistent approach to colorectal tumour segmentation in DCE-MRI and we propose a novel method based on detection of the tumour from signal enhancement characteristics of homogeneous tumour subregions and their neighbourhoods. Our method successfully detected 20 of 23 cases with a mean Dice score of 0.68 +/- 0.15 compared to expert annotations, which is not significantly different from expert inter-rater variability of 0.73 +/- 0.13 and 0.77 +/- 0.10. In comparison, a standard DCE-MRI tumour segmentation technique, fuzzy c-means, obtained a Dice score of 0.28 +/- 0.17.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Irving</LastName>
<ForeName>Benjamin</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cifor</LastName>
<ForeName>Amalia</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Papiez</LastName>
<ForeName>Bartomiej W</ForeName>
<Initials>BW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Franklin</LastName>
<ForeName>Jamie</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Anderson</LastName>
<ForeName>Ewan M</ForeName>
<Initials>EM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brady</LastName>
<ForeName>Sir Michael</ForeName>
<Initials>SM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schnabel</LastName>
<ForeName>Julia A</ForeName>
<Initials>JA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D001185">Artificial Intelligence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015179">Colorectal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25333181</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Detection and registration of ribs in MRI using geometric and appearance models.</ArticleTitle>
<Pagination>
<MedlinePgn>706-13</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Magnetic resonance guided high intensity focused ultrasound (MRgHIFU) is a new type of minimally invasive therapy for treating malignant liver tissues. Since the ribs on the beam path can compromise an effective therapy, detecting them and tracking their motion on MR images is of great importance. However, due to poor magnetic signal emission of bones, ribs cannot be entirely observed in MR. In the proposed method, we take advantage of the accuracy of CT in imaging the ribs to build a geometric ribcage model and combine it with an appearance model of the neighbouring structures of ribs in MR to reconstruct realistic centerlines in MRIs. We have improved our previous method by using a more sophisticated appearance model, a more flexible ribcage model, and a more effective optimization strategy. We decreased the mean error to 2.5 mm, making the method suitable for clinical application. Finally, we propose a rib registration method which conserves the shape and length of ribs, and imposes realistic constraints on their motions, achieving 2.7mm mean accuracy.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Samei</LastName>
<ForeName>Golnoosh</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Szkely</LastName>
<ForeName>Gbor</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tanner</LastName>
<ForeName>Christine</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003198">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008954">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012272">Ribs</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000530">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25333184</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Label inference with registration and patch priors.</ArticleTitle>
<Pagination>
<MedlinePgn>731-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In this paper, we present a novel label inference method that integrates registration and patch priors, and serves as a remedy for labelling errors around structural boundaries. With the initial label map provided by nonrigid registration methods, its corresponding signed distance function can be estimated and used to evaluate the segmentation confidence. The pixels with less confident labels are selected as candidate nodes to be refined and those with relatively confident results are settled as seeds. The affinity between seeds and candidate nodes, which consists of regular image lattice connections, registration prior based on signed distance and patch prior from the warped atlas, is encoded to guide the label inference procedure. For method evaluation, experiments have been carried out on two publicly available data sets and it only takes several seconds for our method to improve the segmentation quality significantly.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bao</LastName>
<ForeName>Siqi</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chung</LastName>
<ForeName>Albert C S</ForeName>
<Initials>AC</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000033">anatomy &amp; histology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004282">Documentation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25333188</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Combining generative models for multifocal glioma segmentation and registration.</ArticleTitle>
<Pagination>
<MedlinePgn>763-70</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In this paper, we propose a new method for simultaneously segmenting brain scans of glioma patients and registering these scans to a normal atlas. Performing joint segmentation and registration for brain tumors is very challenging when tumors include multifocal masses and have complex shapes with heterogeneous textures. Our approach grows tumors for each mass from multiple seed points using a tumor growth model and modifies a normal atlas into one with tumors and edema using the combined results of grown tumors. We also generate a tumor shape prior via the random walk with restart, utilizing multiple tumor seeds as initial foreground information. We then incorporate this shape prior into an EM framework which estimates the mapping between the modified atlas and the scans, posteriors for each tissue labels, and the tumor growth model parameters. We apply our method to the BRATS 2013 leaderboard dataset to evaluate segmentation performance. Our method shows the best performance among all participants.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kwon</LastName>
<ForeName>Dongjin</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shinohara</LastName>
<ForeName>Russell T</ForeName>
<Initials>RT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Akbari</LastName>
<ForeName>Hamed</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Davatzikos</LastName>
<ForeName>Christos</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 NS042645</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 NS042645</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>IEEE Trans Med Imaging. 1999 Oct;18(10):885-96</RefSource>
<PMID Version="1">10628948</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroimage. 2006 May 15;31(1):228-39</RefSource>
<PMID Version="1">16466677</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Pathol. 2006;1:97-117</RefSource>
<PMID Version="1">18039109</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Math Biol. 2008 Jun;56(6):793-825</RefSource>
<PMID Version="1">18026731</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosurgery. 2008 Apr;62(4):753-64; discussion 264-6</RefSource>
<PMID Version="1">18496181</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acad Radiol. 2008 Aug;15(8):966-77</RefSource>
<PMID Version="1">18620117</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Oncology. 2010;79(3-4):306-12</RefSource>
<PMID Version="1">21412017</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>IEEE Trans Med Imaging. 2012 Oct;31(10):1941-54</RefSource>
<PMID Version="1">22907965</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Image Comput Comput Assist Interv. 2012;15(Pt 3):369-76</RefSource>
<PMID Version="1">23286152</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>IEEE Trans Med Imaging. 2014 Mar;33(3):651-67</RefSource>
<PMID Version="1">24595340</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Image Anal. 2014 May;18(4):647-59</RefSource>
<PMID Version="1">24717540</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003198">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005910">Glioma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008954">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS596553</OtherID>
<OtherID Source="NLM">PMC4205485</OtherID>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25333189</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>17</Volume>
<Issue>Pt 1</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention</Title>
<ISOAbbreviation>Med Image Comput Comput Assist Interv</ISOAbbreviation>
</Journal>
<ArticleTitle>Partial volume estimation in brain MRI revisited.</ArticleTitle>
<Pagination>
<MedlinePgn>771-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We propose a fast algorithm to estimate brain tissue concentrations from conventional T1-weighted images based on a Bayesian maximum a posteriori formulation that extends the "mixel" model developed in the 90's. A key observation is the necessity to incorporate additional prior constraints to the "mixel" model for the estimation of plausible concentration maps. Experiments on the ADNI standardized dataset show that global and local brain atrophy measures from the proposed algorithm yield enhanced diagnosis testing value than with several widely used soft tissue labeling methods.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Roche</LastName>
<ForeName>Alexis</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Forbes</LastName>
<ForeName>Florence</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<CollectiveName>Alzheimer's Disease Neuroimaging Initiative</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Med Image Comput Comput Assist Interv</MedlineTA>
<NlmUniqueID>101249582</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000465">Algorithms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000544">Alzheimer Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007089">Image Enhancement</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007090">Image Interpretation, Computer-Assisted</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009929">Organ Size</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010363">Pattern Recognition, Automated</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D013382">Subtraction Technique</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25335310</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0035-9033</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>100</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Journal of the Royal Naval Medical Service</Title>
<ISOAbbreviation>J R Nav Med Serv</ISOAbbreviation>
</Journal>
<ArticleTitle>The accuracy of magnetic resonance imaging (MRI) in detecting meniscal pathology.</ArticleTitle>
<Pagination>
<MedlinePgn>157-60</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="AIMS" NlmCategory="OBJECTIVE">The purpose of this study was to determine the accuracy of Magnetic Resonance Imaging (MRI) scanning in the detection of meniscal pathology in a district general hospital.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively analysed a single-surgeon series of 240 knee arthroscopic investigations for all indications. The arthroscopic reports included an outline diagram of the meniscus upon which the surgeon could record his operative findings. 112 of these patients had also had a recent MRI scan. We compared the MRI findings with the arthroscopy findings.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">66 patients had a positive MRI scan. 64 of these were found to have a meniscal tear at surgery. 37 MRI scans were reported as "no tear", of which four were found to have a meniscal tear at surgery. Nine MRI scans were descriptive, e.g. "signal change, possible tear", or "tear cannot be ruled out." These tended to correspond with equivocal arthroscopic findings of "degeneration" or "fibrillation". In our series of 112 patients with meniscal pathology, MRI scanning was 90.5% sensitive, 89.5% specific and 90.1% accurate.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">False positive MRI scans may lead to unnecessary surgery. Patients with negative MRI scans had a mean delay to surgery of 33 weeks compared to 18 weeks for patients with positive MRI scans. Patients with false negative MRI results may wait longer for their surgery. Two of the false negative MRI scan reports clearly showed meniscus tears, which were not identified by the reporting radiologist. In our series, the MRI scan itself was more accurate than the reporting. It is important to have an experienced musculoskeletal radiologist to minimise the number of missed meniscal tears. It is also important for the surgeon to review the MRI scan itself, as well as the report.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chambers</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cooney</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Caplan</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dowen</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kader</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J R Nav Med Serv</MedlineTA>
<NlmUniqueID>7503111</NlmUniqueID>
<ISSNLinking>0035-9033</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001182">Arthroscopy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007718">Knee Injuries</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008592">Menisci, Tibial</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000293">injuries</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25335130</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1538-3598</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>312</Volume>
<Issue>16</Issue>
<PubDate>
<MedlineDate>2014 Oct 22-29</MedlineDate>
</PubDate>
</JournalIssue>
<Title>JAMA</Title>
<ISOAbbreviation>JAMA</ISOAbbreviation>
</Journal>
<ArticleTitle>CDC to clinicians: Be alert for children with poliolike illness.</ArticleTitle>
<Pagination>
<MedlinePgn>1623</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2014.14248</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Stephenson</LastName>
<ForeName>Joan</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>JAMA</MedlineTA>
<NlmUniqueID>7501160</NlmUniqueID>
<ISSNLinking>0098-7484</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002487">Centers for Disease Control and Prevention (U.S.)</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D004196">Disease Outbreaks</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D030016">Enterovirus D, Human</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004769">Enterovirus Infections</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018908">Muscle Weakness</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009422">Nervous System Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000821">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013116">Spinal Cord</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D014481">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25338348</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1220-4749</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>52</Volume>
<Issue>2</Issue>
<PubDate>
<MedlineDate>2014 Apr-Jun</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Romanian journal of internal medicine = Revue roumaine de mdecine interne</Title>
<ISOAbbreviation>Rom J Intern Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Meningeal carcinomatosis in a patient with Crohn's disease.</ArticleTitle>
<Pagination>
<MedlinePgn>111-20</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Leptomeningeal carcinomatosis, also known as carcinomatous meningitis, is defined by spreading of neoplastic cells to the meninges and ventricles, and is a form of cancer dissemination. In this case, a patient with inflammatory bowel disease had developed a neoplastic process that spread to the meninges. A 49-year-old woman developed an abdominal pain, and was diagnosed the same month with Crohn's disease, complicated with intestinal perforation, for which she was hospitalized. Pathological examination revealed acute phase-terminal ileitis. She undergone many hospitalizations during which she was suspected to have celiac disease, inflammatory bowel disease, and tuberculous meningitis, as well as femoral head necrosis after she had been unsuccessfully treated with Prednisone for Crohn's disease. After she developed peripheral bilateral facial paresis, bilateral hypoacusia, hypotonia, tetraparesis and diminished osteotendinous reflexes at the legs, the patient was admitted in our department. Several lumbar punctures were performed but no specific disease could be detected. The MRI performed showed pachymeningeal and leptomeningeal inflammation. Tuberculous meningitis was taken into consideration and the patient was transferred into an Infectious Disease Department where this diagnostic was infirmed. The patient was retransferred into the Department of Neurology where after an episode of hematemesis she had a cardiac arrest and deceased. Inflammatory bowel disease may involve different segments of the intestine, and may be accompanied by a variety of conditions, such as neurologic findings, osteoarticular manifestations and also may be the starting point of a neoplastic process. The patient had an inflammatory bowel condition, which by the time it was appropriately diagnosed as being Crohn's disease, a neoplastic process spread to the meninges, causing multiple cranial nerve palsy, tetraparesis, along other neurological manifestations.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Trac</LastName>
<ForeName>Daniela</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>erban</LastName>
<ForeName>Adelina Simona</ForeName>
<Initials>AS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>tefnescu</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Roianu</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Amet</LastName>
<ForeName>Zela Cofoian</ForeName>
<Initials>ZC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Morari</LastName>
<ForeName>Oana</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zurac</LastName>
<ForeName>Sabina</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pop</LastName>
<ForeName>Cristiana</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Haidar</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gogulescu</LastName>
<ForeName>Rodica</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bumbea</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Antonic</LastName>
<ForeName>Doina</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ionescu</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cojocaru</LastName>
<ForeName>Inimioara Mihaela</ForeName>
<Initials>IM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Romania</Country>
<MedlineTA>Rom J Intern Med</MedlineTA>
<NlmUniqueID>9304507</NlmUniqueID>
<ISSNLinking>1220-4749</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003424">Crohn Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055756">Meningeal Carcinomatosis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020364">Paraneoplastic Polyneuropathy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25338444</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1003-0034</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>27</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Zhongguo gu shang = China journal of orthopaedics and traumatology</Title>
<ISOAbbreviation>Zhongguo Gu Shang</ISOAbbreviation>
</Journal>
<ArticleTitle>[MRI characteristic of proximal femur bone marrow edema syndrome].</ArticleTitle>
<Pagination>
<MedlinePgn>575-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the MRI features of proximal femur bone marrow edema syndrome for further improve the understanding of the disease.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">MRI imaging of 10 patients with proximal femur bone marrow edema syndrome was retrospectively reviewed,including 6 males and 4 females with an average age of 41.5 years old ranging from 36 to 57. The courses of diseases ranged from 1 week to 3 months. Among them, 9 cases had clinical manifestations of sudden hip pain, 7 cases had limited ability of walking and hip movement;all patients had no obvious injury history, non of the female patients was pregnant. All patients were followed up from 3 to 12 months, the following-up were topped after MRI when the symptoms disappeared for 3 months.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The MRI demonstrated diffuse bone marrow edema involving the femoral head, neck and the inter-trochanteric region, 13 hips of 10 patients with bone marrow edema included 6 cases in grade 1, 5 cases in grade 2,2 cases in grade 3; 9 hips with hip hydrarthrosis included 6 hips in grade I ,1 hip in grade II, 2 hips in grade III. After treatment for 3 to 12 months the hip symptoms of the patients disappeared and MRI images were normal.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">MRI is useful in defining the location and extent of proximal femur bone marrow edema syndrome.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Xi-Yuan</ForeName>
<Initials>XY</Initials>
</Author>
</AuthorList>
<Language>chi</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>China</Country>
<MedlineTA>Zhongguo Gu Shang</MedlineTA>
<NlmUniqueID>9815790</NlmUniqueID>
<ISSNLinking>1003-0034</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001855">Bone Marrow Diseases</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004487">Edema</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005269">Femur</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013577">Syndrome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25354108</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1533-4406</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>371</Volume>
<Issue>18</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Case records of the Massachusetts General Hospital. Case 34-2014. A 7-year-old boy with focal seizures and progressive weakness.</ArticleTitle>
<Pagination>
<MedlinePgn>1737-46</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMcpc1305993</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Thibert</LastName>
<ForeName>Ronald L</ForeName>
<Initials>RL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Duhaime</LastName>
<ForeName>Ann-Christine</ForeName>
<Initials>AC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Caruso</LastName>
<ForeName>Paul A</ForeName>
<Initials>PA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Stemmer-Rachamimov</LastName>
<ForeName>Anat</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016429">Clinical Conference</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
<ISSNLinking>0028-4793</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004401">Dysarthria</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004660">Encephalitis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005625">Frontal Lobe</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055423">Ketogenic Diet</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D054220">Malformations of Cortical Development</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008590">Meningoencephalitis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012640">Seizures</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>

<?xml version='1.0' encoding='utf8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">25359942</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>31</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>14</Day>
</DateCompleted>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1095-9203</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>346</Volume>
<Issue>6209</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
<Day>31</Day>
</PubDate>
</JournalIssue>
<Title>Science (New York, N.Y.)</Title>
<ISOAbbreviation>Science</ISOAbbreviation>
</Journal>
<ArticleTitle>Neuroscience. An easy consciousness test?</ArticleTitle>
<Pagination>
<MedlinePgn>531-2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1126/science.346.6209.531</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Underwood</LastName>
<ForeName>Emily</ForeName>
<Initials>E</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016423">Congresses</PublicationType>
<PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Science</MedlineTA>
<NlmUniqueID>0404511</NlmUniqueID>
<ISSNLinking>0036-8075</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002516">Ceramics</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C588156">KCa5(Si2O7)(Si6O15)(OH)F</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001930">Brain Injuries</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002516">Ceramics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003128">Coma</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D003243">Consciousness</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005898">Glass</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059906">Neuroimaging</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D009483">Neuropsychological Tests</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
